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National Program Assessment
Animal Health
2000-2004
National Program Assessments are conducted every five-years through the organization of one or more
workshop. Workshops allow the Agricultural Research Service (ARS) to periodically update the vision and
rationale of each National Program and assess the relevancy, effectiveness, and responsiveness of ARS
research. The National Program Staff (NPS) at ARS organizes National Program Workshops to facilitate the
review and simultaneously provide an opportunity for customers, stakeholders, and partners to assess the
progress made through the National Program and provide input for future modifications to the National
Program or the National Program’s research agenda. A workshop for Animal Health has been scheduled for
October 2004, Greensboro, North Carolina. This report provides the accomplishments for the 2000-2004
National Program Cycle. You will find detailed information on research objectives, achievements, and impact.
Results are provided according to location. Comments and assessments should be addressed to
mailto:cgg@ars.usda.gov prior to October 2004.

Leading America towards a better future
through agricultural research and information.
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EXECUTIVE SUMMARY
This report provides the accomplishments of research conducted under the Agricultural Research Services
(ARS) Animal Health National Program from 2000 to 2004. The purpose of this report is to assess the impact
of the program. An assessment is conducted at the end of each 5-year program cycle to update the vision and
rationale of the program. The goal of this assessment is to determine whether the program has had an impact
on the field of science, animal health, American agriculture, and the U.S. economy.
A summary of the Action Plan prepared at the start of the animal health national program cycle is provided.
The Action Plan identified seven research components that are the focus of the Animal Health Research
Program: Pathogen Detection and Diagnostics; Microbial Genomics; Animal Immunology; Mechanisms of
Disease; Genetic Resistance to Disease; Epidemiology of Disease; and Strategies to Control Infectious and
Non-Infectious Diseases. The Action Plan provides the research direction, goals, and the anticipated outcomes
and impact. Research plans with specific objectives wre derived from the Action Plan. A total of 60 research
projects were identified, subjected to external peer review, and implemented by 18 Research Units located
throughout the United States.
Research accomplishments with the greatest impact are summarized for each of the seven research
components. The accomplishments are presented relative to their impact on specific diseases. Many diseases
affect a single species or are specific to a particular animal industry or management system (e.g., dairy verus
beef) but many cross host barriers and affect more than one animal segment (e.g., brucellosis). Thus, the
impact of accomplishments can only be assessed through a comprehensive understanding of veterinary
medicine, animal health, and the management systems of the applicable animal industries. Because of the
tremendous number of variables associated with animal health and various management systems, this report
only attempts to assess impact within specific disease areas. The broader impact on specific commodity
groups, regulatory and action agencies, American agriculture, the U.S economy, or the field of sciencewill be
determined by our customers, stakeholders, and partners. As such, this report will be broadly distributed and
subject to an external panel review.
Many of the anticipated outcomes and impacts identified at the start of the animal health national program
cycle have been achieved. The research component with the greatest success and impact has been in the area
of diagnostic discovery and development. Several new and improved tests have been discovered by ARS
scientists. Many of these tests have been commercialized or adopted by animal health officials in the control
and eradication of diseases. Many of the diagnostic discoveries have been for zoonotic diseases that impact
public health and biological threat agents that could cause tremendous harm to our economy and the Nation.
Animal Health program impact has been achieved in all areas of the action plan;
¾ The goal of research component #1 “Pathogen detection and diagnositics” was to produce a new
generation of diagnostics tools. Diagnostic tools were produced for detection of Anaplasmosis, avian
influenza, classical swine fever, chronic wasting disease, Johne’s disease, Listeria moncytogenese,
Newcastle disease, Poult enteritis mortality syndrome, toxoplasmosis, trichellosis and tuberculosis.
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¾ The goal of research component #2 “Microbial Genomics” was to use functional genomic analysis of
pathogenic microorganisms to solve significant animal disease problems. Microbial genomics was used
to understand how avian influenza evolves and adaptes to poultry populations; used to study the
differences in low and high virulence BVD viruses in host cells; used to identify specific regions of
Johne’s disease and Leptospirosis that can be used as vaccine candidates; used to do a comparative
assessment of six different pox viruses which will lead to a better understanding of pox viruses
pathogensis.
¾ The goal of research component #3 “Animal Immunology” was to understand the early development of
the immune system allowing scientists to apply new approaches to vaccine delivery and use biotherapeutics for disase treatment. In this area ARS scientists created reagents for the assessment of
immune responses in poultry, “designer” immune reagents to assess swine immune responses and
immunomodulators that influence coccidiosis in chickens and bovine mastitis.
¾ The goal of research component #4 “Mechanisms of Disease” was to understand at the molecular level
how pathogens cause disease. The disease mechanisms that were further understood were those of
Marek’s disease (genes involved in pathogenicity, replication and cell transformation were identified),
pine needle abortion (toxins, toxin producers and toxin producing conditions were identified) and
Porcine Reproduction and Respiratory Syndrome (host cell gene expression patterns were determined).
¾ The goal of research component #5 “Genetic resistance to disease” was to develop means by which the
genomes of agricultural species can be utilized to reduce the economic impact of animal diseases. ARS
scientists developed a genetic test that can determine if a chicken is resistant to Avian Leukosis virus
infection; developed a genotyping system in cattle that can associate alleles with infection phenotype in
commercial beef populations; identified several candidate genes in chickens that may confere resistance
to Marek’s disease; determined a means by which genetics can be used to breed increased resistance in
sheep to Scrapie infection.
¾ The goal of research component #6 “Epidemiology of Disease” was to incorporate epidemiological
analysis into research programs. Molecular epidemiology was used to show that Avian Influenza has
circulated in live bird markets for years; that wild birds could be a source of Avian Pneumovirus for
turkeys; allow epidemiological tracebacks of Brucellosis; establish the shedding patterns of Malignant
Catarrhal Fever virus in sheep; that Neosporosis is a primary cause of abortion in cattle and that dogs
are an important on-farm risk factor; white-tailed deer were the primary source of Tuberculsis infection
to cattle; Vesicular Stomatitis infections in the USA often originate from Mexico.
¾ The goal of research component #7 “Strategies to Control Infectious and Non-Infectious Diseases” was
to develop and integrate basic research information into applied solution that can be used by farmers
and ranchers to control animal disease. In this area ARS scientists have determined a means by which
Foot and Mouth Disease virus infections can be stopped; developed a nutrional solution that will help
to prevent cows from getting milk fever; developed a method to rapidy and evenly vaccinate laying
hens against Mycoplasma infection; developed a candidate vaccine against Newcastle disease that can
easily be differentiated from natural infection; a swine influenza vaccine that can be used in the face of
maternal antibody.
5

The contributions made to the field of science by ARS scientists cannot be underestimated and the impact can
easily be assessed by reviewing the list of publications provided in the appendix of this report.
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BACKGROUND INFORMATION
Agricultural Research Service (ARS)
Role
Mission
National Program Cycle
National Program Assessment
Animal Health National Program (NP 103)

Agricultural Research Service
The Agricultural Research Service (ARS) is the principal in-house research agency of the
U.S. Department of Agriculture (USDA). ARS is one of four agencies in the Research,
Education, and Economics (REE) mission area. ARS is charged with extending the
Nation's scientific knowledge with research projects in agriculture, human nutrition,
food safety, natural resources, the environment, and other topics affecting the
American people on a daily basis. ARS supports more than 2,100 scientist years
organized into approximately 1,050 permanent research projects at over 100 locations
across the country and five overseas laboratories and more than 150 librarians, technical
information specialists, and other library specialists.
Role
ARS conducts innovative research to find solutions to problems of high National priority. ARS often selects
high-risk scientific endeavors to make significant breakthroughs in important problem areas but also
complements the work of State Colleges and Universities, State Agricultural Experiment Stations (SAES),
other Federal agencies, and the private sector. Mechanisms for addressing State and local issues are already in
place; therefore, activities within ARS focus on issues having a regional or national scope and where there is a
clear Federal role. ARS also provides research support to USDA action and regulatory agencies and to several
other Federal regulatory agencies, including the Food and Drug Administration and the Environmental
Protection Agency.
Mission
Our mission is to conduct research to develop and transfer solutions to agricultural problems of high national
priority and provide information access and dissemination to:
•
•
•
•
•

Ensure high-quality, safe food, and other products
Access the nutritional needs of Americans
Sustain a competitive agricultural economy
Enhance the natural resource base and the environment
Provide economic opportunities for rural citizens, communities, and society as a whole
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National Program Cycle
The management and execution of all ARS research programs is organized around the five-year National
Program Cycle, consisting of four sequential phases designed to ensure the relevance, quality, and impact of
every National Program: 1) Input; 2) Planning; 3) Implementation; and 4) Assessment.

National Program Cycle
Relevance

Input

Quality

Planning

Workshop

Impact

Implementation

Assessment

Implementation Memoranda
ARMP
RPES

Action Plan
Prospectus
Project Plan

OSQR Review

Site Reviews
National Program Annual Report
National Program Assessment
GPRA

National Program Assessment
A National Program Assessment is conducted every five-years through the organization of one or more
workshop. Workshops allow ARS to periodically update the vision and rationale of each National Program
and assess the relevancy, effectiveness, and responsiveness of ARS research. The National Program Staff
organizes National Program Workshops to facilitate the review and simultaneously provide an opportunity for
customers, stakeholders, and partners to assess the progress made through the National Program and provide
input for future modifications to the National Program or the National Program’s research agenda.
Animal Health National Program (NP 103)
The mission of the Animal Health Program is to conduct basic and applied research on
selected diseases of economic importance to the United States livestock and poultry
industries. The goals of the research mission are to produce knowledge and technology to
reduce economic losses from infectious, genetic, and metabolic diseases of livestock and
poultry. Dr. Robert A. Heckert, National Program Leader, Animal Health, and Dr. Cyril G.
Gay, National Program Leader, Animal Health and Safety lead this ARS research program.
Dr. Gay is lead on domestic disease issues and vaccine and drug discovery projects, and
Dr. Heckert is lead on projects involving foreign and emerging diseases. The Animal
Health National Program currently includes 60 research projects supported by 118
scientists located at 14 research sites throughout the country. The ARS research budget for
the Animal Health Program is approximately $54.3 million (NET).
8
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ACTION PLAN
Introduction
A workshop for the Animal Health Program was held September 21-23, 1999 in College Park, Maryland. The
workshop was attended by 127 stakeholders and 50 ARS scientists. Invited stakeholders were encouraged to
send letters presenting their animal health priorities. Input received from our stakeholders was used to
formulate an Action Plan for the Animal Health National Program, consisting of seven research components
and the anticipated results to be generated from the proposed research. This process was meant to provide a
coordinated multi-location plan for research projects conducted by ARS scientists and cooperators that address
regional and national priorities and result in fundamental advances in agricultural science. All projects were
prospectively reviewed by an external panel in 2001, in accordance with Office of Scientific and Quality
Review (OSQR) policy and procedures.
The following outlines the goals of the action plan for each of the seven research components, including the
anticipated outcomes and impact identified at the onset of the Animal Health National Program Cycle. The
complete action plan can be reviewed on-line at
http://www.ars.usda.gov/research/programs/programs.htm?np_code=103&docid=288
Research Components
Research Component 1: Pathogen Detection and Diagnostics
Goals
To produce a new generation of diagnostic tools are needed that will facilitate detection and identification of
known pathogens and diseases, new variants of infectious and non-infectious agents, and emerging organisms
and diseases. As appropriate, the procedures will be adapted for use in either field or laboratory diagnostic
situations. These new technologies will be transferred to private organizations for the purpose of
commercialization, or to state and federal diagnostic laboratories for regulatory or limited field use.
Techniques that are applicable to national animal disease programs or human health problems will be
standardized and validated through collaboration with other federal agencies to provide a scientific basis for
their use in surveillance of animals, animal feeds, animal products, and the environment. Application of these
techniques will enhance the general health of U.S. livestock, fish, poultry, and wildlife, and provide assurance
that animals and animal products intended for domestic or international trade are free of infectious and toxic
agents.
Outcomes
• Availability of more sensitive and specific techniques for diagnosis of animal disease.
• Capability for more rapid identification of new or re-emerging diseases.
• Development of predictive data bases for risk assessment studies.
• Increased domestic and international trade of animals and animal products.
• Reduced public health risk from food-borne illness.
• A safer environment.
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Impact
Efficient and profitable animal production systems in which animal well-being is maximized and in which
disease detection is rapid and causes minimal impact on production, trade, human health and the environment.
Research Component 2: Microbial Genomics
Goals
To use functional genomic analysis of pathogenic microorganisms, including bacteria, viruses, protozoa,
parasites and fungi to solve significant animal disease problems. Specifically to: 1) understand fundamental
genetic and biological processes underlying microbial pathogenesis and host resistance; 2) facilitate pathogen
gene discovery for use as disease control targets; 3) provide pathogen gene sequences for development of
improved gene and protein-based diagnostic tests; and 4) identify pathogen gene targets for development of
improved vaccines and therapeutics.
Outcomes
• Improved pathogen detection and diagnosis
• Improved tools for epidemiological disease investigations
• Understanding of new metabolic pathways.
• Improved vaccines and therapeutics
• Novel disease control strategies
Impact
Better and faster means to develop diagnostic tests and track microbial pathogens in animal hosts and the
environment, better vaccines and therapeutics and novel disease control strategies based on a new
understanding of the molecular mechanism of disease.
Research Component 3: Animal Immunology
Goals
Understanding the early development of the immune system in each of our food animals will enable scientists
to apply new approaches to vaccine delivery and to use novel bio-therapeutics for disease treatments. Adapting
existing knowledge of rodent and human immunology to domestic animals will speed up the process and cost
effectiveness of research. Fundamental research is urgently needed in mucosal immunology and the
mechanisms involved in innate and acquired immunity in order to have a solid foundation to improved
methods of targeting host/pathogen interactions. Understanding how a host responds to invasion by a pathogen
will lead to development of a whole new series of methods to prevent primary infection and abrogate the
development of disease.
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Outcomes
• New vaccines, better vaccine delivery, new therapeutic interventions and immunomodulators to control
or prevent disease.
• New tools to quantitate a broader range of host immune responses for a better understanding of immune
function and how to maximize new approaches to vaccine delivery.
• New methods of disease prevention and control.
• Novel vaccines and therapeutics, improved food safety, decreased antimicrobial and pesticide
dependence.
• Better immuno-diagnostics and improved nutrition to promote disease resistance.
Impact
New knowledge in animal immunology will enable more rapid progress toward understanding the function of
immunity in host/pathogen interactions.
Research Component 4: Mechanisms of Disease
Goals
Understand how pathogens function at a molecular level, how they invade tissue surfaces, how they evade host
immune responses and how they interact with higher organisms at a molecular level to cause disease and
associated lesions.
Determine which genes encode virulence factors for important pathogens. Identify management practices that
can exacerbate virulence mechanisms, e.g., antibiotic usage or specific dietary components. Alter host and
pathogen genes to cause and evaluate predicted changes in pathogen virulence as well as latency to prove the
relevance of the postulated interactions.
Define how nutrition and basic physiology and metabolism interface with both infectious and noninfectious
disease. Define the toxic products of plants and determine how they cause disease in livestock.
Define which pathogens, and specifically which isolate and which genes in the pathogen, are primary factors in
disease pathogenesis. In mixed infections determine how each pathogen influences disease pathogenesis.
Define strategies to ameliorate the results of complex pathogen interactions. Understand the complexities of
the real world interactions of pathogens with each other and with hosts.
Outcomes
• New understanding of complex host/pathogen interactions will lead directly to novel preventative and
therapeutic interventions.
• New diagnostic tools and potential intervention strategies that can be tested empirically.
• New strategies for inhibiting pathogen interactions with hosts.
• Generation of effective and safe new drugs, vaccines, and perhaps other products that allow industry to
package modern technology into simple solutions for formerly intractable problems.
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Impact
Understanding mechanisms of disease will enable more rapid progress toward understanding virulence and
host immunity that influence host/pathogen interactions.
New knowledge in this area will enable more rapid progress toward understanding virulence of pathogens and
complex interactions between toxins, physiologic and nutritional interfaces with the many environmental and
management factors that influence host/pathogen interactions and precipitate disease.
Research Component 5: Genetic Resistance to Disease
Goals
The overall goal of studies into genetic resistance to disease are to develop means by which the vast diversity
present in the genomes of important agricultural species can be utilized in integrated systems to reduce the
economic impact of important animal diseases. The first step in such a program will be to acquire
comprehensive data that adequately defines the genotypic and phenotypic compositions of selected test
populations and of lines and breeds used in production systems. Present limitations include inadequate markers
for desirable traits, inexact means to precisely measure desirable traits and inadequate tools to delineate
associations between genetic structure and the desired traits. As markers for desirable traits and accurate means
to measure the traits are perfected it will then become possible to identify genes or genomic regions within
genes that are associated with resistance to important diseases of agricultural and public health interest. In
addition to collection of genomic data and definition of important phenotypes, it will be necessary to develop
adequate bioinformatics systems to facilitate analyses of the vast number of observations expected when
measuring complex biologic traits such as disease resistance. As genomic regions are identified as being linked
to desirable traits, research efforts will focus on the validation in production animals raised in standard
production.
Outcomes
• Identification of genes important in disease resistance.
• Mapping of loci that encode genes important to disease resistance/susceptibility.
• Use of naturally disease and stress resistant animals in production systems.
• Lowered use of antibiotics and vaccines.
Impact
Efficient and profitable animal production systems in which animal well-being is maximized and in which
disease is controlled through genetic selection of animals most suited to production schemes.
Research Component 6: Epidemiology of Disease
Goals
Incorporate hypothesis-driven epidemiologic analysis into selected current and future ARS research programs.
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Outcome
• Develop an understanding of animal disease incidence and prevalence in livestock and poultry
populations.
• Develop understanding of disease life cycles in nature as a means to interrupt disease transmission
between livestock and wildlife animals.
• Devise better disease intervention strategies based on epidemiologic observations.
• Identify most effective disease management interventions through comparative on-farm studies.
• Reduce or eradicate key diseases in wildlife that impact livestock production.
• Reduce the incidence of disease in animal production units through use of better management practices,
genetics, immune modulation and vaccines.
Impact
More cost-effective livestock production through promotion of animal health and well-being and protection of
human health from zoonotic diseases.
Research Component 7: Strategies to Control Infectious and Non-Infectious Diseases
Goals
Develop integrated farm management systems that advance animal health and promote economic viability of
rural America.
Maximize the return on limited USDA research resources by developing a prioritized list of livestock and
poultry diseases which need the most urgent research and whose control will have the greatest impact on
reducing total disease incidence and will provide the maximum economic return.
Identify the needs and the gaps in our basic and applied knowledge concerning control of the highest priority
diseases of livestock and poultry.
Develop and integrate basic research information into applied solutions that can be used by farmers and
ranchers to control animal diseases in the field. This will include transfer of technology to commercial
manufacturers, government agencies and university partners.
Develop comprehensive control strategies that will reduce the incidence and economic losses from endemic,
emerging and re-emerging diseases. Eradication strategies will be developed to eliminate some diseases from
individual farms, states, regions or the entire country.
Develop strategies to prevent introduction of exotic or foreign animal diseases such as foot-and-mouth disease,
classical swine fever and highly pathogenic avian influenza, and develop eradication strategies for rapid
elimination of such diseases should they be introduced.
Outcomes
• Development of integrated animal health strategies for the application of new and improved disease
control and prevention methods.
• Development of vaccines for diseases that currently have no vaccine.
14

•
•
•
•
•
•

Development of more effective (greater efficacy, easier application, and reduced cost) and safer
vaccines to replace existing inadequate products.
Development of improved pharmaceutical products such as antibiotics, antiviral drugs, antifungal
compounds, anthelmintics and compounds that kill ectoparasites.
Development of compounds that reduce or prevent toxic effects of poison plants and other toxins.
Eradication of some animal diseases in US.
Healthier and more productive animal agricultural industry.
Reduced public health risk from food-borne illness.

Impact
Implementation of control strategies promotes both animal and human health and well-being. Development
and maintenance of healthy livestock and poultry populations will provide a low-cost, high quality protein
source that promotes health and nutrition to all U.S. citizens, including those of low income and from
economically-disadvantaged backgrounds.
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PROGRAM IMPACT
Introduction
Pathogen Detection and Diagnostics
Microbial Genomics
Animal Immunology
Mechanisms of Disease
Genetic Resistance to Disease
Epidemiology of Disease
Strategies to Control Infectious and Non-Infectious Diseases
Introduction
The basis for determining whether the Animal Health National Program has been successful is to look at its
impact. For the purpose this assessment, impact is defined as research that has or will significantly influence
the field of science, animal health, American agriculture, and the U.S. economy. Since this is a qualitative
assessment that is subject to bias it is critical that a large number of our customers, stakeholders, and partners
be given the opportunity to independently review and assess the impact of the program. Accordingly, a survey
will accompany this report and will be distributed electronically to reach as many customers, stakeholders, and
partners as possible.
The following summarizes the impact of the research conducted during the 2000-2004 Animal Health National
Program Cycle. The information to assess the impact of the Animal Health National Program is provided in
the appendix of this report. The appendix identifies the 18 research management units and 60 current research
information system (CRIS) projects that comprise the Animal Health National Program. The goals,
accomplishments, impact, technology transfers, and publications are provided for each of the 60 CRIS projects.
Pathogen Detection and Diagnostics
Anaplasmosis
Anaplasmosis causes disease in cattle on all six continents, being present in South Africa, Australia, Asia, the
former USSR, South America, and the United States. Anaplasmosis causes anemia, weight loss, unthriftiness,
abortion, and death in affected cattle. Cattle may not exhibit symptoms until they are stressed, such as when
calving or when moved to a feedlot. The competitive inhibition Enzyme Linked Immonosorbent Assay
(ELISA) test developed by ARS scientists in Pullman, Washington, can be used to detect silent carriers of the
bloodborne parasite. This test will allow us to test and ship cattle to Canada and other countries that do not
have Anaplasmosis.
Avian Influenza (AI)
A need exists for a rapid and sensitive diagnostic test for the direct detection of both low pathogenic and highly
pathogenic avian influenza to support control and eradication strategies during an outbreak in poultry. In
collaboration with the National Veterinary Services Laboratory (NVSL), Animal and Plant Health Inspection
Service (APHIS), a real time (RT)-PCR test was developed by ARS scientists at the Southeast Poultry
Research Laboratory in Athens, GA, which was validated for the detection of any influenza virus and the
16

subsequent sub-typing of the virus. The test was validated and adopted for clinical use by APHIS and three
State veterinary laboratories (Virginia, Pennsylvania, and North Carolina). This diagnostic test has already
been used to help control the recent H7N2 influenza outbreak in Virginia and will enhance our nation’s ability
to rapidly control avian influenza in the event of future outbreaks.
Classical Swine Fever Virus (CSFV)
Rapid identification and diagnosis of a foreign animal disease is critical for successfully controlling and
eradicating the disease following introduction. Rapid field-based assays to detect CSFV are not yet available.
A rapid real-time fluorogenic hydrolysis probe TaqMan assay was developed by ARS scientists at the Plum
Island Animal Disease Center, New York, and evaluated in pigs experimentally infected with a moderately
virulent CSF isolate, Haiti-96. The assay was highly sensitive and specific, detecting infected animals up to 5
days prior to the appearance of CSF clinical symptoms. This rapid, real-time RT-PCR assay for CSFV
provides a new diagnostic tool that will redefine disease management and control strategies for this highly
significant disease.
Chronic Wasting Disease (CWD)
Accurate diagnosis of chronic wasting disease is extremely important for control and eradication. ARS
scientists at the Animal Disease Research Unit in Pullman, WA in collaboration with Colorado State
University and the Colorado Division of Wildlife, established that the tonsils of deer are a reliable early
indicator of infection and established a valid method for detecting this marker in live deer. This test is suitable
for use in surveillance of deer in highly populated areas, where hunting is not allowed but artificial feeding
may increase disease prevalence. In addition, scientists have established that the dorsal motor nucleus of the
vagus nerve is the earliest site of PrP-CWD accumulation in mule deer. This work identifies the tissue to be
selected for diagnostic testing in hunter harvest surveys.
Johne’s Disease
Johne’s disease is a chronic, progressive enteric disease of ruminants caused by Mycobacterium
paratuberculosis. Improved diagnostic tools for detection of the disease are urgently needed for early
detection of subclinically infected animals and reduction of environmental contamination. Scientists at the
National Animal Disease Center (NADC), Ames, Iowa, optimized a simple polymerase chain reaction (PCR)
assay using DNA in blood and fecal samples for detection of M. paratuberculosis. The new DNA sequence of
M. paratuberculosis has been transferred to a commercial company for development of the assay. This assay
will allow early detection of subclinically infected livestock.
Listeria monocytogenes
Research was conducted by ARS scientists at the Animal Disease Research Unit in Pullman, WA to design an
assay that allowed a large number of L. monocytogenes strains to be serotyped rapidly and inexpensively. As
part of a collaborative project between USDA-ARS, Albany, CA and USDA-ARS-ADRU, Pullman, WA, the
conventional slide agglutination serotyping assay was converted to an ELISA format. ELISA serotyping of 89
of 101 L. monocytogenes isolates agreed with slide agglutination serotyping data, and 100 previously
uncharacterized isolates were serotyped unambiguously using the ELISA method. This ELISA assay greatly
reduces the time and expense of serotyping L. monocytogenes strains and this will facilitate serotype
determination by research and public health labs.
Poult Enteritis Mortality Syndrome (PEMS)
17

ARS scientists at the Southeast Poultry Research Laboratory (SEPRL), Athens, GA, identified a novel strain of
astrovirus isolated from the thymus of turkeys with poult enteritis and mortality syndrome (PEMS) and
sequenced the entire genome of the nonhuman strain of astrovirus. ARS researchers then verified that this
purified astrovirus caused PEMS-like disease in naive turkey poults as characterized by growth depression,
mortality, enteritis, and immunosuppression. A new diagnostic test (RT-PCR) was developed to identify
conserved and divergent regions of the astrovirus genome and this test kit was used to detect astrovirus in
commercial turkey flocks. These studies indicate an important role of the new astrovirus in PEMS-associated
pathology in turkeys. The RT-PCR test was transferred to scientists at Virginia Polytechnical Institute and
Texas Veterinary Medical Diagnostic Laboratory and is currently being used to detect astrovirus in commercial
flocks. By providing new ways to understand the pathogenesis of astrovirus infection (and PEMS infection)
the test will ultimately increase basic knowledge on the interactions between the turkey immune system and
virus infections and enable development of a vaccine against turkey PEMS. A rapid and sensitive real-time
reverse transcriptase polymerase chain reaction test (RRT-PCR) was subsequently developed to detect turkey
astrovirus type-2, one of the major viruses involved in production of PEMS in turkeys. Real-time RT-PCR is a
relatively new technology, which offers substantial advantages over the older standard RT-PCR technology,
including improved accuracy, speed and sensitivity.
Toxoplasmosis
Toxoplasmosis is the leading cause of blindness in underdeveloped countries. It is also one of the most
common causes of parasitic diseases in humans and animals. Pig products are a major source of Toxoplasma
gondii infection in the U.S. ARS scientists at Animal Parasite Diseaase Laboratory in Beltsville, Maryland,
with funding from the National Pork Producers Council, have developed a sensitive DNA test for the parasite
in pig or other animal tissues. The test is very sensitive and specific and will be an important tool for
protecting America’s food supply and for epidemiological investigations to decrease the numbers of pigs
infected with this parasite.
Trichinellosis
The parasitic worm Trichinella spiralis contributes to sporadic outbreaks of trichinellosis of humans.
Scientists at the Animal Parasite Dsease Laboratory, Beltsville, Maryland, developed a new multiplex PCR test
to detect all of the different species of Trichinella at the level of a single worm. This new technique has been
transferred to the International Trichinella Reference Center and the Danish Center of Experimental
Parasitology. Being able to identify Trichinella species will lead to better control strategies for trichinellosis.
Tuberculosis
In the last seven years, Mycobacterium bovis has been isolated from free ranging white-tailed deer in 12
counties in the northern part of the lower peninsula of Michigan. About 5 percent of wild deer, in an area
identified as the TB core area, have TB. Tuberculosis has also been found in coyotes, raccoons, a fox, bear,
feral cat, elk and bobcat and in 16 beef cattle and two dairy cattle herds in northern Michigan. This is the first
reservoir of TB in wildlife identified within the United States and presents significant obstacles to the
eradication effort. ARS scientists at the Bacterial Diseases of Livestock Research Unit at the National Animal
Disease Center (NADC), Ames, Iowa, have responded to the challenge by developing an indirect blood test
that measures nitric oxide induced in mammals in response to Mycobacterium bovis infections. The test can
detect human, avium, and bovine TB. The advantage of this test is that it can be used in most mammals and
only requires one blood sample, and thus the handling of animals once, as opposed to the official standard skin
test that requires animals to be handled twice.
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Microbial Genomics
Avian Influenza (AI)
ARS scientists at the Southeast Poultry Research Labotaory, Athens, Georgia, have sequenced numerous
strains of avian influenza from around the world. They have elucidated the nature and rates of genetic
variation of avian influenza viruses in various hosts. We know that the avian influenza viruses are undergoing
rapid and continuous mutation events as a natural consequence of adaptation to poultry populations. This rate
is slower in the natural hosts, wild waterfowl, but even in these hosts evolution continues to generate novel
strains. This information has been useful to basic influenza scientists and has contributed to our fundamental
understanding of influenza. In addition, ARS scientists have been able to decode what genetic and
biochemical changes occur to make the influenza virus turn into a highly virulent virus.
Bovine Viral Diarrhea Virus (BVDV)
There is a wide spectrum of clinical disease that occurs following BVDV (Bovine Virus Diarrhea Virus)
infections. The severity of disease depends on the immune and reproductive status of the animal, the presence
of other pathogens and the strain of BVDV that the animal was exposed to. In the past ARS scientists have
identified high and low virulence BVDV. In the last cycle, scientists at the USDA-ARS-National Animal
Disease Center (NADC), Ames, IA, in collaboration with scientists at the Hannover School of Veterinary
Medicine, characterized differences in pathology in vivo, host cell interaction in vitro, and associated genetic
differences. They will continue to build on this research as they work to identify the factors that control
virulence. They expect that this research will lead to better means of intervention to limit the effects of viral
infection. This research has yielded the first published pathogenic studies of high and low virulence BVDV
and generated tag sequence libraries for sequential analysis of gene expression (SAGE libraries) in infected
cells in vitro. This information will be used to study the interaction of high and low virulence viruses with host
cells.
Brucellosis
Brucellosis remains a critical zoonotic pathogen with impact on the reproductive health of cattle, swine, sheep,
and goats, and effects on human health. ARS scientists were critical partners this year in supporting a multicenter effort for sequencing the genome of Brucella suis, the cause of swine brucellosis. Completing the
sequencing of Brucella suis is a major accomplishment that will lead to comparative genomics studies that
could provide precise targets for developing vaccines against Brucella strains that are currently affecting
livestock and wildlife reservoir hosts in the United States.
Johne’s Disease
ARS scientists at our Bacterial Diseases of Livestock Research Unit at NADC, Ames, Iowa, in collaboration
with the University of Minnesota completed the sequencing of the entire genome of Mycobacterium avium spp.
paratuberculosis (M. paratuberculosis), the pathogen responsible for Johne’s Disease. This bacterium is
related to the tubercle bacillus and causes a chronic wasting and debilitating enteritis and eventual death in
cattle, sheep, goats, llamas, deer, and other wild or domestic ruminants. Public health officials are also
concerned about recently published medical reports suggesting a link between M. paratuberculosis and Crohn's
disease, a chronic inflammatory bowel disease in humans. ARS scientist have identified 19 unique sequences
that will be the basis for functional genomics studies that may eventually lead to the development of new
effective diagnostics and preventive and therapeutics tools for the control and eradication of this disease in the
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United States. Seven regions of the DNA of M. paratuberculosis that stimulate protective responses and one
that exacerbates infection have been identified to date. Sequencing was completed on two of the protective
regions and a microarray system of gene pooling is being tested. Genes from these regions may be useful in
development of a DNA vaccine for M. paratuberculosis infection.
Leptospirosis
Little is known about the genetic organization or content of Leptospira borgpetersenii serovar hardjo, the
major cause of bovine leptospirosis worldwide and an important zoonotic disease. The genome of this
bacterium is being sequenced at our Bacterial Diseases of Livestock Research Unit at NADC, Ames, Iowa, to
identify genes associated with virulence and potential vaccine candidates. In 2002, a genomic library was
successfully constructed and our scientists completed the shotgun phase of sequencing, resulting in the
determination of about 95% of the total sequence. These data resulted in the identification of several outer
membrane protein genes and genes associated with virulence factors and will have an impact on future vaccine
development initiatives.
Marek’s Disease
ARS scientists at the Avian Diseases and Oncology Laboratory (ADOL), East Lansing, Michigan, sequenced
175,000 bases of DNA of the GA strain of Marek’s disease virus (MDV), a serotype 1 MDV, thus providing a
crucial roadmap for understanding viral gene function as an first important step toward better diagnosis of
MDV in commercial meat-type chickens. Molecular DNA sequencing of the serotype 1 MDV was transferred
to academia and the poultry industry to help the global effort to elucidate the function of various viral genes
and the epidemiology of MDV infection. Completion of the entire DNA sequence of the GA strain of MDV
will advance the development of novel molecular vaccines for MDV. Furthermore, the DNA sequence
information of MDV will enhance understanding of the immunology of MDV infection, and that may prove
useful in controlling other types of viruses important to the U.S. poultry industry.
Pox viruses
ARS scientists at our Plum Island Animal Disease Research Center, New York, have sequenced pox virus
genes from many different species of animals. The genes of lumpy skin disease, camel pox, avian pox, sheep
pox, goat pox and others have been fully sequenced, analyzed and compared. By comparing the genes of many
different pox viruses, it has been possible to determine which genes are tightly conserved across the pox virus
family. This will enable scientists to learn more about how pox viruses invade the host and cause disease and
to develop successful intervention strategies for the future.
Animal Immunology
Immunological Reagents
The accurate assessment of the host immune response to poultry infectious agents such as bacteria, viruses, and
parasites is critical for monitoring the health of the flocks. ARS scientists at the Animal Parasite Disease
Laboratory, Beltsville, Maryland, produced several monoclonal antibodies to study host immune responses in
chickens and have transferred them to diagnostic firms for further development. Several of these monoclonal
antibodies can now be used to assess the immune status of chickens vaccinated with different infectious
agents. The results to date indicate that these monoclonal antibodies are useful in the identification of
lymphocyte subpopulations and macrophages in the tissues and the peripheral blood from chickens infected
with microbial agents or vaccinated with the viral vaccines.
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Scientists at the Animal Parasitic Diseases Laboratory developed a comprehensive panel of "designer" immune
reagents to assess swine immune responses for use in analyses of disease and vaccine studies and neonatal pig
development. These include sensitive gene expression tests for >300 swine immune genes, mAb markers for
swine cell subsets and immune cytokines, and biotherapeutics. Products from this research will enhance an
expanding base of scientific knowledge on mucosal and neonatal immunology of swine, techniques and
reagents for veterinary application, practical outcomes for control of zoonotic pathogens and characterization
of products with commercial applications.
Coccidiosis
Avian coccidiosis, an intestinal disease caused by intracellular parasites, is estimated to cost the U.S. poultry
industry over $600 million annually. Due to the increasing incidence of drug-resistant parasites, drugindependent control strategies are warranted. Scientists at the Animal Parasite Diseases Laboratory, Beltsville,
Maryland, identified and genetically engineered a recombinant chicken cytokine molecule called interferon
gamma (IFN-γ), which is secreted by T-lymphocytes, and demonstrated its protective effects against coccidian
parasites. A U.S. patent issued to the USDA covering several IFN-γ monoclonal antibodies and a sensitive
immunoassay to detect chicken IFN-γ is being licensed to a commercial company for worldwide distribution.
These antibodies and the assay will allow the assessment of poultry cell-mediated immune responses to
vaccines and diseases, facilitating the development of a new generation of immunological control strategies
against avian coccidiosis.
Immune Modulators
Novel vaccination strategies using antigen-encoding DNA plasmids have recently been shown to successfully
induce protective cellular and humoral immune responses against a variety of infectious diseases. Scientists at
our Animal Parasite Disease Laboratory in Beltsville, MD, have documented for the first time in chickens that
immune responses induced by DNA vaccination can be enhanced by co-injecting recombinant cytokines or
plasmids encoding these cytokines. Administration of recombinant IFN-γ gene decreased coccidia oocyst
production, enhanced body weight gain, and improved disease resistance following coccidia challenge
infection. The results of this study clearly document that chicken cytokines can be powerful adjuvants
providing additional impetus to further investigate their biological activities at the molecular and
immunological levels.
Mastitis
Three hundred thousand dairy cows suffer acute endotoxin shock and death annually due to mastitis caused by
Escherichia coli, which occurs primarily during the early periparturient period. Scientists at our Bovine
Functional Genomics Laboratory in Beltsville, Maryland, have identified and characterized the gene for
soluble CD14, which binds and neutralizes endotoxins responsible for mastitis. The gene was cloned and
recombinant bovine (rbo)-CD14 protein was successfully produced and evaluated. Intraperitoneal injection of
rboCD14 together with endotoxin reduced fatality in mice. Preliminary studies indicate that intramammary
injection of soluble rboCD14 is 100% effective in preventing mastitis by E. coli in lactating dairy cows. This
research will potentially lead to a product that for the first time can be used effective to treat and prevent
mastitis caused by E. coli.
Mechanisms of Disease
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Marek’s Disease Virus (MDV)
Marek's disease is a lymphocyte proliferation (a type of cancer) and immune suppressive disease of chickens
caused by a herpesvirus. Infections with this virus are nearly universal among commercial chicken flocks
worldwide. The virus is relatively stable in the environment and is easily spread through the air. Despite
widespread use of vaccines, economic losses from mortality of layers and breeders and condemnation of
broilers continue to plague producers. Losses tend to be sporadic and unpredictable. Moreover, the virus
continues to mutate to greater virulence, potentially reducing the effectiveness of many existing vaccines and
causing concerns that vaccines currently considered effective will not protect in the future. Scientists at our
Avian Disease and Oncology Laboratory (ADOL) in East Lansing, Michigan, have been conducting functional
genomics studies of selected Marek's disease viral genes to better understand the mechanism by which the
virus causes changes in infected chickens. Several virus preparations with specific deletions or changes in
selected genes were developed and the effects compared to unaltered virus. Results to date indicate that the
132 base pair nucleic acid repeats are nonessential for MDV replication in cell culture and chickens and viruses
lacking these repeat sequences are still pathogenic. Furthermore, the putative MDV oncogene called “meq’
could be deleted but was found to be essential for the transformation of lymphocytes in infected chickens. It
was also found that the pp38 gene in the vaccine virus, Rispens, functions identically to the pp38 gene in the
very virulent Md5 virus. Together, these studies are enhancing our knowledge of the mechanisms of virus
replication and virulence, which is essential for developing a new class of vaccines against this very important
disease.
Pine Needle Abortion
Grazing needles of ponderosa pine, lodgepole pine, common juniper or Monterey Cypress by pregnant cattle
results in abortion/premature parturition, retained placentas and endometritis. Substantial economic losses to
cattle producers in the western U.S. and Canada occur annually from ponderosa pine needle-induced abortion.
A significant accomplishment by ARS scientists has been the isolation and identification of isocupressic acid
(ICA) as the abortifacient toxin in pine needles. Furthermore, two ICA derivatives, succinyl and acety ICA
were also identified in pine needles and were active abortifacient toxins. ELISA’s were developed for ICA and
it’s sera metabolites using polyclonal antibodies. Using this assay, the absorption into the serum and
elimination into the urine of three ICA metabolites was measured in a cow dosed orally with common juniper.
Other accomplishments include screening twenty-three tree and shrub species from throughout the western and
southern states for abortifacient levels of ICA. Seasonal changes in ICA levels were monitored in ponderosa
pine populations in 5 locations. Field and pen studies determined that nutrient status influenced cows to graze
pine needles. Similarly, weather patterns had significant impacts on cow’s propensity to graze pine needles.
This better understanding of what toxins are involved, what species of plant is involved and when the toxin is
produced will give ranchers better ability to control the poisoning.
Porcine Reproductive and Respiratory Syndrome (PRRS)
PRRS is a highly infectious disease caused by an RNA virus. Infections in the United States account for up to
15-20% of the yearly economic losses in the swine industry. The vaccines currently on the market have been
reported to be relatively ineffective. It is important to understand the reasons for these vaccine failures and the
impact on the incidence of disease so that better control strategies can be developed. Scientists at our U.S.
Meat Animal Research Center (MARC) in Clay Center, Nebraska, have obtained 18 different PRRS virus
isolates from disease outbreaks in the Midwest and sequenced the NSP2 genes of these viruses to examine
variations that may correlate with disease expression. Recombinant antigens have been developed and
immunity to individual PRRS virus proteins evaluated in sera from naturally infected swine from around the
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country. The research team at MARC has conducted kinetic analysis studies of host-cell gene expression in
response to PRRS virus infection using cDNA microarrays. Studies to date indicate that there are a number of
responsive genes that increase in expression while others decrease in expression as a result of PRRS virus
infection. In combination with the sequence analysis of a number of PRRS virus isolates, this research project
will lead to an understanding of the host-virus interactions in the field and identification of viral genes
responsible for induction of a protective immune response.
Genetic Resistance to Disease
Avian Leukosis Virus (ALV)
Avian Leukosis is a serious threat to the poultry industry since it induces tumors, decreases egg production,
and increases mortality in infected chickens. Scientists at the USDA-ARS Avian Disease and Oncology
Laboratory, East Lansing, MI, developed a DNA-based test for the ALV receptor gene known as TVB. This
genetic test can distinguish if a chicken carries TVB alleles that confer resistant to ALV subgroups B or E,
which are some of the most prevalent ALV types in the field. This procedure allows poultry breeders to
accurately select for chickens for resistance to specific ALVs, which would enhance
Genetic Diversity Panel
Scientists at our U.S. Meat Animal Research Center (MARC) in Clay Center, Nebraska, have now
characterized over 180 single nucleotide polymorphisms (SNPs) in more than 50 bovine genes. These have
been used to estimate the genetic diversity in beef cattle with automated SNP assays developed for highthroughput MALDI-TOF MS genotyping. This is significant because DNA sequence variation provides the
fundamental material for improving livestock through selection. Our results indicated that once the halotypes
for a given gene locus are sufficiently characterized it is possible to correctly assign halotypes to the vast
majority of the genotypes in commercial populations of cattle. This allows the evaluation of these alleles as
risk factors for infection phenotypes in commercial populations of cattle.
Marek’s Disease Virus (MDV)
With Marek’s disease costing the poultry industry over $160 million a year, developing methods that augment
current vaccinal control methods is a high priority. ARS, in collaboration with the University of Delaware,
screened chickens that were disease resistant and susceptible by the new technology of DNA microarrays,
which measures expression levels of many genes. Genetic mapping of the differentially expressed genes
revealed many positional candidate genes for resistance to Marek’s disease. This approach of integrating
global expression studies with mapping shows great promise to rapidly identify disease resistance genes, which
can be quickly transferred to the poultry industry to enhance disease resistance.
Scrapie
Scrapie is a member of a group of diseases caused by prions that are called Transmissible Spongiform
Encephalopathies (TSEs), which includes bovine spongiform encephalopathy (BSE). Scrapie is efficiently
transmitted during lambing but other modes of transmission are poorly understood. Scientists at our Virus and
Prion Diseases of Livestock Research Unit at NADC, Ames, Iowa, and our Animal Research Unit in Pullman,
Washington, initiated transmission studies by describing the distribution and biochemical characteristics of the
prion precursor in placenta and fetal tissues and fluids. It was discovered that if the fetus is genetically
resistant to disease, the fetal placental cells do not support prion accumulation and it is therefore probable that
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transmission by the infected ewe does not occur. These findings will directly impact control and eradication
procedures for sheep scrapie in the U.S.

Epidemiology of Disease
Avian Influenza (AI)
Avian influenza, H7N2, has been circulating in the live bird markets (LBMs) of the Northeast since 1994. This
virus has the potential for becoming highly pathogenic. ARS scientists at the Southeast Poultry Research
Laboratory in Athens, Georgia, in collaboration with the National Veterinary Services Laboratory (NVSL),
Animal Plant Health Inspection Service (APHIS), and state officials from New York, New Jersey, and
Pennsylvania, have conducted molecular epidemiology studies of viruses coming from the LBMs and have
developed a Real Time (RT)-PCR test to rapidly detect birds infected with the influenza virus. The molecular
epidemiology studies showed that a single family of viruses has remained in the markets for the last seven
years. The RT-PCR test was compared with virus isolations for specificity and sensitivity as part of a
validation study for deploying this diagnostic test. The molecular epidemiology data have increased our
understanding of this virus and the RT-PCR test when validated will support multi-State influenza eradication
efforts in the LBM system.
Avian Pneumovirus (APV)
APV, now classified as an avian metapneumovirus, was isolated from commercial turkeys in Colorado in
1996. The disease was reported in the United Kingdom in 1985 and prior to 1996 the disease was exotic to
North America. The virus causes a mild, but rapidly spreading, upper respiratory disease and adverse effect on
weight gain and feed conversion. Last year, APV antibody was demonstrated in wild birds in the Southeast
U.S. and suggests wild birds could be a source of APV virus transmission to turkeys. Southeast Poultry
Research Laboratory scientists in Athens, GA collected swabs from the species of wild birds previously found
to have APV antibodies. APV was identified from 12 of the sampled wild birds and it was determined through
sequence analysis of the glycoprotein, matrix and fusion genes that the wild bird viruses are closely related to
viruses found in domestic poultry. The presence of virus in wild birds and the relatedness to viruses found in
domestic poultry indicate the potential for wild birds to spread APV infections in areas of the United States
where the virus is currently not found in poultry.
Brucellosis
The ability to epidemiologically trace the origin of brucellosis infections is of great importance for regulatory
personnel. At the USDA-ARS-National Animal Disease Center (NADC), Ames, IA, the B. abortus genome
sequencing project was used to identify variable regions in the genome in an effort to differentiate B. abortus
strains. An assay was developed that allows strains from single origins to be differentiated from other strains
such that epidemiologic tracebacks to identify the source of brucellosis infections may now be possible. This
assay will be valuable in determining the source of a brucellosis infection in a cattle herd (i.e. wildlife or other
cattle) and help in determining if a brucellosis outbreak is from single or multiple sources.
Chronic Wasting Disease (CWD)
CWD is another member of a group of diseases called TSEs, which includes BSE and Scrapie. CWD is
associated with serious losses to the captive elk industry and the wildlife management industries through loss
of hunting revenues. The only choice currently available to animal health officials for controlling this disease
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is extensive depopulation of captive and free ranging animals exposed to the disease. Moreover, the
interspecies transmission barriers of these diseases are not understood. CWD is reported in several areas of the
U.S. but the true extent of the epidemic is not known because of the considerable cost of diagnostic testing.
Using samples submitted by cooperating state wildlife management agencies, ARS scientists at the Animal
Research Unit in Pullman, Washington, developed an inexpensive high throughput diagnostic test for early
detection of infection in hunter-killed deer. The test has been transferred to private industry and is being
evaluated for licensing by the USDA Center for Veterinary Biologics. The impact of this work will be to
facilitate increased surveillance within and outside the endemic areas.
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Malignant Catarrhal Fever (MCF)
The epidemiology of sheep-associated Malignant catarrhal fever has long remained an area of great
uncertainty. Scientists at the Animal Disease Research Unit in Pullman, WA, Collaborating with Washington
State University and the ARS-US Sheep Experiment Station developed a refined picture of the viral shedding
patterns in both adolescent and adult sheep. The data indicate that nasal shedding is the major mode of sheepassociated MCF virus transmission among domestic sheep and that the adolescents are by far the heaviest
shedders of virus for other species. The kinetics of the shedding patterns documented in adolescent sheep
appear to be a unique biological phenomenon without precedent and definition of the virus-host mechanisms
underlying this behavior should lead to new knowledge of the potential ways viruses can interact with hosts.
Neosporosis
Neospora caninum has been identified as a major cause of abortion and neonatal mortality in cattle worldwide.
Losses in California dairies due to neosporosis-associated abortions are estimated to be $35 million annually.
Epidemiological investigations indicate that up to 45 percent of abortions in dairy cows are caused by N.
caninum. ARS scientists discovered that the dog was the definitive host and the source of new infections.
ARS investigated the prevalence of N. caninum antibodies in dogs and established that levels were
significantly higher in dogs from beef and dairy cattle farms than dogs from urban areas. However, recent
reports suggest that congenital infection from reactivation of the parasite is the main mode of transmission and
cause of abortions. Considerable work remains to understand the biology and epidemiology of N. caninum,
including the survival of oocysts in the environment and elucidating the life-cycle in dogs. ARS will continue
to conduct studies that will provide information to help dairy farmers develop biosecurity measures to control
abortions due to Neosporosis.

Tuberculosis
Bovine tuberculosis is considered a public health threat because humans can become infected with the
infectious agent, Mycobacterium bovis, through contact with infected animals or contaminated foods. ARS
scientists at the National Annimal Disease Center (NADC), Ames, Iowa, demonstrated that white-tailed deer
populations living in northeastern Michigan were the source of tuberculosis infection of livestock. These
results will facilitate development of new eradication control strategies to block the transmission of M. bovis
from wildlife to domestic livestock and thereby reduce the possibility of human disease.
Vesicular Stomatitis Virus
Vesicular stomatitis virus (VSV) from an unknown source caused great economic losses to the cattle and horse
industries in the southwestern United States in 1995, 1997, and 1998. Using genomic sequencing and analysis,
ARS scientists at Plum Island, New York, demonstrated that the outbreaks resulted from VSV most similar to
those circulating in Mexico. The new molecular test for VSV field strains has been used by a USDA-APHISsupported diagnostic laboratory for vesicular disease studies in South American countries.
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Strategies to Control Infectious and Non-Infectious Disease
Foot-and-Mouth Disease Virus (FMD)
Current models and simulations have predicted devastating economical and environmental consequences if
FMDV were introduced in the United States. Based on recent experiences with FMDV outbreaks in Europe,
vaccination is now being considered as a first-line intervention tool in the containment of a potential outbreak
in the U.S., rather than traditional depopulation strategies that would result in destruction of millions of
animals. Scientist at our FMDV Research Unit at the Plum Island Animal Disease Center, New York, have
developed adenoviral based constructs containing the structural proteins of the FMDV capsid and the viral
protease required to process these protein molecules into empty capsids. Laboratory tests of these viral
vaccines have demonstrated virus neutralizing activity and protection of animals as early as five days after a
single inoculation, lasting for at least 42 days. The same adenoviral vectors have been engineered to contain
antivirals such as Type I porcine interferon (Ad5-pIFNalpha) and have been shown to confer protection from
viral challenge as early as 24 hours and for as long as four days after a single inoculation. The combination of
empty capsid vaccines and antivirals have been tested in swine and shown to induce complete protection from
infection in 24 hours and for as long as 42 days upon direct challenge with FMDV. This combined therapy
provides for the first time a true outbreak response strategy to arrest the spread of FMDV and limit animal
exposure to this highly contagious disease. Further work will be needed to research and develop these
innovative control tools for other animal species, including cattle.
Milk Fever
Scientists at the Periparturient Diseases of Livestock Research Unit, National Animal Disease Center (NADC),
Ames, Iowa, fed various sources of chloride and sulfate containing chemicals to dry non-pregnant dairy cows
and demonstrated that chloride consistently counteracted the effects of dietary potassium by causing a decrease
in blood acidity which contributes to hypocalcemia (milk fever). This new information has resulted in the
development of hydrochloric acid treatment of feeds by at least two feed companies (West Central Corp.,
Ralston, Iowa, and Nutritech, Abbottsford, British Columbia) and allowed farmers, veterinarians, and
nutritionists to more accurately choose the most effective feeds and chloride sources for balancing transition
dairy cow rations. These results will also be applicable to the inability of dairy cows to respond to the high
demand for calcium at parturition and ultimate development of peri-parturient hypocalcemia. This research
has provided a more detailed understanding of the pathogenesis of milk fever. It has emphasized the
importance of dietary methods for reversing alkalosis in order to reestablish the target tissue sensitivity to
parathyroid hormone and to prevent clinical and sub-clinical hypocalcemia in dairy cows. An enhanced
understanding of the effects of dietary factors on the overall health of young and adult dairy cattle will benefit
U.S. producers and consumers.
Scientists at the Periparturient Diseases of Livestock Research Unit have also investigated the utility of
Solanum glaucophyllum in the prevention of subclinical hypocalcemia in periparturient dairy cows. Solanum
glaucophyllum is a plant that contains the active form of vitamin D. ARS scientists discovered that when used
in combination with diets high in anions (chloride), we can significantly reduce the incidence of subclinical
hypocalcemia in dairy cows. Availability of this plant will offer further opportunities to dairy farmers in
avoiding complications due to hypocalcemia such as displaced abomasum, retained placenta, and mastitis.
Mycoplasma gallisepticum (MG)
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Approximately 90% of commercial layer flocks are infected with Mycoplasma gallisepticum (MG); and to
combat its effects, three live MG vaccines are available for use; however, MG vaccine administration has
become a major problem from the perspective of uniformity and consistency. Research into the development
of a self-propelled vaccinator capable of vaccinating 75,000 chickens in 7½ minutes was conducted at the MidSouth Area Poultry Research Unit at Mississippi State, MS and involved collaborators from the commercial
table egg company Cal-Maine Foods, Inc., Jackson, MS. The research has resulted in a machine which is
capable of uniformly and consistently delivering MG vaccine to 75,000 chickens in less than 8 minutes as
compared to 50 minutes while reducing labor by 60%. The impact of this research is that producers using the
available commercial vaccines in conjunction with this vaccinator can administer MG vaccines quicker and
more consistently and uniformly to pullets.
Newcastle Disease
Newcastle disease is a foreign animal disease that has the potential to devastate the poultry industry. The
capability to easily differentiate vaccinated from infected birds would enhance current Newcastle Disease
control programs. At the Southeast Poultry Research Laboratory in Athens, GA, a vaccine was developed that
is a shell of the whole virus and retains the important surface structures that induce immunity. The virus used
in this vaccine cannot infect or be transmitted from bird to bird because the virus genome and internal proteins
have been removed. This “virosome” Newcastle disease vaccine was administered intra-nasally and shown to
protect chickens against a lethal Newcastle disease virus challenge. Because vaccinated birds can be
differentiated from infected birds, this vaccine may provide an effective tool to control future outbreaks of
Newcastle disease virus in the United States.
Swine Influenza Virus (SIV)
SIV is a serious respiratory disease in pigs. Inactivated and/or modified-live vaccines for respiratory pathogens
do not stimulate protective immunity if given to piglets too early before maternally-derived antibodies have
decayed. To overcome this problem, scientists at USDA-ARS-National Animal Disease Center (NADC),
Ames, IA, used a recombinant human adenovirus (rAd5) vaccine in combination with an inactivated
commercial vaccine to stimulate protective immunity in piglets that had natural field exposure levels of
maternally-derived antibodies. Piglets suckling gilts that were naturally infected with H3N2 influenza virus
were primed with the rAd5-swine influenza virus (SIV) vaccine or sham-inoculated with a non-expressing
rAd5 vector at 7 days of age. The sham-inoculated group and half of the rAd5-SIV vaccinated pigs were
boosted with a commercial bivalent vaccine when 4 weeks old. The boosted pigs that had been primed in the
presence of maternal interfering antibody had strong anamnestic immunity. But, like the problems
encountered in the field, the sham-inoculated pigs did not respond to the commercial vaccine because of
interfering maternal antibodies. Two weeks after the commercial booster vaccination the pigs were challenged
with a different, virulent H3N2 influenza virus. The efficacy of the vaccination protocol was demonstrated by
abrogation of clinical signs, by clearance of challenge virus from lung lavage fluids, by markedly reduced virus
shedding in nasal secretions, and by the absence of moderate or severe SIV-induced lung lesions. These rAd5SIV vaccines will be used for priming of the immune system to overcome the effects of maternally-derived
antibody which interferes with conventional SIV vaccines.
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PROJECTS
Foot and Mouth Disease Research
• Development of Novel Strategies to Control Foot-and-Mouth Disease
• Determination of the Molecular Basis for Re-Emergence, Pathogenesis,
And Host Range of FMDV
• Pathogenesis and Genomics of Vesicular Stomatitis Viruses and Foot and
Mouth Disease
African Swine Fever Research
• High Consequence Pathogen Detection
• Functional Pathogen Genomics: Virulence and Host Range Genes of
Swine Fever Virus
• Identification and Characterization of African Swine Fever Virus Protective Antigens
• Detection and Diagnosis of Hog Cholera (CSF)
• Advanced Animal Vaccines and Diagnostic Applications
• Advanced Veterinary Vaccines and Diagnostics
• Program for Prevention of Animal Infections and Advanced Technologies
for Vaccines and Diagnostics
• Development of Rapid Real Time PCR-Based Assays for Selected OIE
Class A Diseases
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Foot and Mouth Disease Research
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Development of Novel Strategies to Control Foot-and-Mouth
Disease
1940-32000-034-00D
Grubman, M., Golde, W., Baxt, B., and Gregg, D.
Plum Island Animal Disease Center, Office of the Center Director, Foot and Mouth
Disease research
Grubman, M., Phone: (631) 323-3329, Fax: (631) 323-3006
mgrubman@piadc.ars.usda.gov

PROJECT OBJECTIVES:
Foot-and-mouth disease (FMD) is a highly contagious viral disease of livestock. FMD virus (FMDV), the
causative agent, spreads quickly between animals, and herds, resulting in devastating epizootics and significant
economic hardship. Normally controlled by slaughter and vaccination with chemically inactivated virus,
concerns with the effectiveness of this vaccine and the fact that Federal law prohibits its production in the US
creates a significant need for genetically engineered vaccines as potential alternatives. We are evaluating the
basis for protective immunity and developing new vaccines that are safer and more effective than
traditional products. To investigate non-traditional control strategies, we are obtaining detailed knowledge of
virus-host cell interactions and the immune response to viral infection. Our approach towards these objectives
includes examining the means by which the virus inhibits the initial host defense response and developing
subunit vaccine candidates that do not contain infectious material but induce protective immunity. These latter
products could be produced in the US since they do not contain infectious FMDV. In addition, we are
developing new knowledge of the immune response to FMDV and FMD vaccines to improve this vaccine.
OVERALL PROJECT ACCOMPLISHMENTS:
Demonstrated that the FMDV L nonstructural protein is a major virulence factor in viral pathogenesis allowing
for a better understanding of virus-host interaction.
Developed novel subunit vaccine candidates including naked DNA, and replication-defective human
adenovirus as vectors for delivery of FMDV capsid antigens. These vaccine candidates have a number of
advantages over traditional chemically inactivated FMD vaccines including the possibility of producing them
in the US.
Demonstrated that one inoculation of a replication-defective human adenovirus containing the capsid coding
region of FMDV serotype A24 can completely protect swine from direct inoculation challenge as early as 7
days and as long as 42 days. In preliminary studies in cattle, two doses of the same vaccine can induce
complete protection from direct inoculation as well as contact challenge.
Developed a model of acute infection in swine for analysis of the initiation of the innate and adaptive immune
response to viral infection.
Demonstrated immune cell dysfunction during acute phase infection correlates with interruption of specific
cytokine production.
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Developed a method to isolate skin derived dendritic cells for analysis of the role of these cells in innate
immunity and initiation of adaptive immunity. Showed that these cells constitutively express IFNα in situ.
Demonstrated that one inoculation of a recombinant adenovirus vector containing the gene for porcine
interferon alpha (Ad5-pIFNalpha) can protect swine from FMDV challenge one day post inoculation.
Demonstrated that the combination of IFN alpha administration and vaccination with our Ad5-vectored FMDV
capsid antigen construct can induce both immediate as well as long term protection.
IMPACT:
The development of a adenovirus vectored combination vaccine and antiviral against FMDV that provides
immediate protection in 1 day through its antiviral activity and long-term protection through its FMD empty
capsid vaccine has had a major impact on the world view of FMD outbreak control. This has resulted in
recommendations favoring vaccination over mass slaughtering of millions of animals. The Ad5 vaccine is the
first genetically engineered vaccine against FMDV shown to induce full protection in swine with one dose as
early as 7 days post vaccination. Preliminary studies in cattle indicated that two doses of this vaccine can
induce complete protection and serological data after the first inoculation suggest that protection can be
induced after only one dose. These vectors can be produced in the US and be part of the US response in the
event of an FMD outbreak in this country.

TECHNOLOGY TRANSFER:
Our research studies have been published in peer-reviewed scientific journals. Genetically engineered vaccine
candidates have been produced, and have been proven effective in livestock (swine and bovine) but they have
not undergone final development.
Patents:
We have filed a Patent concerning some of our new concepts to control FMD.
Foot and Mouth Disease Virus Vaccine, Grubman, Marvin J., Chinsangaram, Jarasvech, Koster, Marla,
Moraes, Mauro, P. Patent, Docket Number:0128.01, Serial Number: 60/286, 345, Date Filed: 4/26/2002.
Cooperative Research Development Agreements (CRADA):
We have entered into a CRADA with Merial Limited to produce antivirals using poxvirus vectors as a means
of inducing immediate protection against FMD as well as an SCA with Merial to produce poxvirus vectored
FMDV empty capsid vaccines. We have entered an SCA with the University of Connecticut at Storrs to study
the immune response and pathogenesis of FMDV and VSV in swine. We have entered into a second SCA with
the University of Connecticut at Storrs for testing rapid acting FMDV vaccine formulations in cattle. We have
a MTA with Qiagen to test their exclusive immune stimulator compounds in combination with commercial
FMD vaccines.
PUBLICATIONS:
Brown, C.C., Chinsangaram, J., and Grubman, M.J. Type I interferon production in cattle
infected with 2 strains of foot-and-mouth disease virus, as determined by in situ
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hybridization. Canadian J. Vet. Res. 64:130-133, 2000.
Grubman, M.J. and Chinsangaram, J. Foot-and-mouth disease virus: The role of the leader proteinase in viral
pathogenesis. Recent Res. Devel. Virol, 2:123-134, 2000.
Mayr, G.S., O’Donnell, V., Chinsangaram, J., Mason, P.W., and Grubman, M.J. Immune
responses and protection against foot-and-mouth disease virus (FMDV) challenge in
swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162, 2001.
Chinsangaram, J., Koster, M., and Grubman, M.J. Inhibition of L-deleted foot-and-mouth
disease virus replication by alpha/beta interferon involves double-stranded RNA
-dependent protein kinase. J. Virol. 12:5498-5503, 2001.
Mason, P.W. and Grubman, M.J. Controlling FMD with vaccines? Australian Vet.
J. 79:342-343, 2001.
Moraes, M.P., Mayr, G.A., and Grubman, M.J. pAd5-Blue: an easy to use, efficient,
direct ligation system for engineering recombinant adenovirus constructs. BioTechniques.
31:1050-1056. 2001.
Moraes, M.P., Mayr, G.A., Mason, P.W., and Grubman, M.J. Early protection against
homologous challenge after a single dose of replication-defective human adenovirus type
5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
Vaccine. 20:1631-1639, 2002.
Grubman, M.J. and Mason, P.W. Prospects, including time frames, for improved foot
-and-mouth disease vaccines. In Foot and mouth disease: facing the new dilemmas. Rev.
sci. tech. Off. Int. Epiz. 21:589-600. 2002.
Bautista, E., D. Gregg, and W.T. Golde. Characterization and functional analysis of skin-derived dendritic cells
from swine without a requirement for in vitro propagation. Veterinary Immunology and Immunopathology. 87:
137-145, 2002.
Mason, P.W., Grubman, M.J., and Baxt, B. Molecular basis of pathogenesis of FMDV. In
Foot-and-mouth disease (D. Rowlands ed.). Virus Res. 91:9-32, 2003.
Chinsangaram, J., Moraes, M.P., Koster, M. and Grubman, M.J. A novel viral disease
control strategy: adenovirus expressing interferon alpha rapidly protects swine from foot
-and-mouth disease. J. Virol. 77:1621-1625, 2003.
Grubman, M.J., Moraes, M.P., Chinsangaram, J., Mayr, G.A., and Mason, P.W. New
approaches to control foot-and-mouth disease, p. 337-343. Foot and mouth disease:
Control strategies. (B. Dodet and M. Vicari eds). Elsevier. 2003.
Mason, P.W., Chinsangaram, J., Moraes, M.P., Mayr, G.A., and Grubman, M.J.
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Engineering better vaccines for foot-and-mouth disease. Vaccines for OIE List A and Emerging Animal
Diseases. Dev. Biol. Basel, Karger (Brown, F, Roth, J eds). 114:79-88, 2003.
Wu, Q., Moraes, M.P., Grubman, M.J. Recombinant adenovirus co-expressing capsid proteins of two serotypes
of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies
against FMDV in swine. Virus Research. 2003. v. 93. p. 211-219.
Bautista, E., Ferman, G.S., Golde, W.T. Induction of lymphopenia and inhibition of T cell function during
acute infection of swine with foot and mouth disease virus (FMDV). Veterinary Immunology and
Immunopathology. 2003. v. 92. p. 61-73.
Wu, Q., Brum, M.C.S., Caron, L., Koster, M., and Grubman, M.J. Adenovirus-mediated type I interferon
expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. J. Int. Cyt.
Res., 23:371-380, 2003.
Grubman, M.J. New approaches to control foot-and-mouth disease. Proceedings of the International
Symposium on Foot-and-Mouth Disease, Strasbourg, France, pp. 83-87, 2003.
Moraes, M.P., Chinsangaram, J., Brum, M.C.S., and Grubman, M.J. Immediate protection of swine from footand-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease
virus subunit vaccine. Vaccine. 22:268-279, 2003.
Grubman, M.J. New approaches to rapidly control foot-and-mouth disease outbreaks. Expert Rev. Anti-infect.
Ther. 1:89-96, 2003.
Rodriguez, L. L., J. Barrera, E. Kramer, J. Lubroth, A. Walfield, F. Brown and W. T. Golde. A synthetic
peptide containing the consensus sequence of the G-H loop region of FMDV type O VP1 combined with a
promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral
challenge. Vaccine 21: 3751-3756, 2003.
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Foot and Mouth Disease Research
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Determination of the Molecular Basis for Re-Emergence, Pathogenesis and Host Range
of FMDV
1940-32000-035-00D
Baxt, B., Rieder, E., Grubman, M., Golde, W., Gregg, D.
Plum Island Animal Disease Center, Office of the Center Director, Foot and Mouth
Disease Research
Baxt, B., Phone: (631) 323-3354, Fax: (631) 323-3006, bbaxt@piadc.ars.usda.gov

PROJECT OBJECTIVES:
Foot-and-mouth disease (FMD) is a highly contagious viral disease of livestock. The causative agent, foot-andmouth disease virus (FMDV), has been extensively studied due to its economic impact. Recently, FMD has reemerged in Europe, South America and Asia with devastating consequences. This re-emergence has
emphasized how little is known about the detailed virus-host interactions in different susceptible livestock
species that control the pathogenesis and virulence of the virus. This information is necessary to develop new
strategies to assist in preventing FMD epizootics. The Plum Island Animal Disease Center (PIADC)
performs research developing such strategies to assist in preventing the introduction of FMD and to
control it if it is introduced. As part of this program, this project will determine the virus-host interactions at
the cellular and molecular levels. These interactions, critical in the replication cycle and spread of FMDV,
start with the interaction between the virus and receptor molecules on susceptible cells and follow intracellular
pathways of viral replication and mechanisms of viral exit. We will use this information to find targets for
novel anti-viral therapeutics and means to prevent infection of susceptible animals. In addition, knowledge of
the genetic basis of viral transmission and spread will be obtained to help us better cope with the disease, if it is
introduced into the United States.
OVERALL PROJECT ACCOMPLISHMENTS:
• Molecular cloning and characterization of all cell surface molecules from the bovine that serve as
receptors for FMDV.
• Identification of at least one viral (3A protein), and host (ITAF45) factor that play roles in determining
virulence and species specificity.
• Development of models to measure FMDV virulence and spread as it relates to the genetic makeup of
the virus.
• Analysis of the efficiency of utilization of the different receptor molecules by the different viral
serotypes.
• Generation of soluble FMDV receptors which can neutralize viral infectivity.
IMPACT:
The identification of the receptors for FMDV has enhanced our ability to study the pathogenesis of the disease.
In addition, the cloning of these receptors has allowed us to study new ways of using these molecules in rapid
diagnosis. Data showing that soluble receptors can neutralize viral infectivity suggest that receptor
intervention using antivirals may be a feasible way to interfere with viral replication in susceptible animals.
The identification of viral and host cell proteins important for FMDV virulence and host specificity has
identified important new targets for anti-viral therapeutics.
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TECHNOLOGY TRANSFER:
Transfer of a genetically improved cell line to APHIS that allows more effective isolation of foot-and-mouth
disease virus (FMDV). A hamster cell line (BHK-21) frequently used for the diagnosis of FMDV, was
engineered to increase its susceptibility to FMDV by expressing the integrin alphaVbeta3 and alphaVbeta6
receptors, previously discovered at Plum Island as one of the main cellular receptors for FMDV.
PUBLICATIONS:
Neff, S., Mason, P. W., and Baxt, B. High efficiency utilization of the bovine integrin αVβ3 as a receptor for
foot-and-mouth disease virus is dependent on the bovine β3 subunit. J. Virol. 74:7298-7306. 2000.
Neff, S., and Baxt, B. The ability of the integrin αVβ3 to function as a receptor for foot-and-mouth disease
virus is not dependent on the presence of complete subunit cytoplasmic domains. J. Virol. 75:527-532. 2001.
O'Donnell, V. K., Pacheco, J. M., Henry, T. M., and Mason, P. W. Subcellular distribution of the foot-andmouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms
of 3A. Virology 287:151-162. 2001.
Baxt, B., Neff, S., Rieder, E., and Mason, P. W. Foot-and-mouth disease virus-receptor interactions: Role in
pathogenesis and tissue culture adaptation. In Semler, B. L., and Wimmer, E. (eds.). Molecular Biology of
Picornaviruses. ASM Press, Washington, DC. pp. 115-123. 2002.
Van Rensburg, H. G., and Mason, P. W. Construction and evaluation of a recombinant foot-and-mouth disease
virus: implications for inactivated vaccine production. Ann. NY Acad. Sci. 969:83-87. 2002.
Mason, P. W., Bezborodova, S.V., and Henry, T. M. Identification and characterization of a cis-acting
replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol.
76: 9686-9694. 2002.
Duque, H., and Baxt, B. Foot-and-mouth disease virus receptors: Comparison of bovine alphaV integrin
utilization by type A and O viruses. J. Virol. 77:2500-2511. 2003.
Mason, P. W., Grubman, M. J., and Baxt, B. Molecular basis of pathogenesis of FMDV. Virus Res. 91:9-32.
2003.
Zhao, Q., Pacheco, J. M., and Mason, P. W. Evaluation of genetically engineered derivatives of a Chinese
strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in
animals. J. Virol. 77:3269-3280. 2003
Mason, P. W., Pacheco, J. M., Zhao, Q. Z., and Knowles, N. J. Comparison of the complete genomes of
Asian, African, and European isolates of a recent foot-and-mouth disease virus type O pandemic strain
(PanAsia). J. Gen. Virol. 84:1583-1593. 2003.
Mason, P. W., Chinsangaram, J., Moraes, M. P., Mayr, G. A., and Grubman, M. J. Engineering better vaccines
for foot-and-mouth disease. Dev. Biol. 114:79-88. 2003.
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Pacheco, J. M., Henry, T. M., O'Donnell, V. K., Gregory, J. B., and Mason P. W. Role of nonstructural
proteins 3A and 3B in host range and pathogenicity of foot-and-mouth disease virus. J. Virol. 77: 1301713027. 2003.
van Rensburg, H. G., Henry, T. M., and Mason, P. W. Studies of genetically defined chimeras of a European
type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth
disease virus. J. Gen. Virol. 85: 61-68. 2004.
Grubman, M. J., and Baxt, B. Foot-and-mouth disease. Clin. Microb. Rev. 17:465-493. 2004.
Baxt, B., and Rieder, E. Molecular Aspects of foot-and-mouth disease virus virulence and host range: Role of
host cell receptors and viral factors. In Sobrino, F., and Domingo, E. (eds.). Foot-and-Mouth Disease: Current
Perspectives. Horizon Scientific Press, in press, 2004.
Duque, H., LaRocco, M., Golde, W. T., and Baxt, B. Interactions of foot-and-mouth disease virus with soluble
bovine αVβ3 and αVβ6 integrins. J. Virol., in press, 2004.
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Foot and Mouth Disease Research
Project Title:
CRIS Number::
Scientists:
Location:
Contact:

Pathogenesis and Genomics of Vesicular Stomatitis Viruses and Foot and Mouth
Disease
1940-32000-040-00D
Rodriguez, L., Golde, W., Gregg, D.
Plum Island Animal Disease Center, Office of the Center Director
Foot and Mouth Disease Research
Rodriguez, L.,Phone: (631)323-3364, Fax: (631)323-3295,
lrodriguez@piadc.ars.usda.gov

PROJECT OBJECTIVES:
Vesicular stomatitis (VS) is a viral disease that causes serious economic losses to the cattle and horse industries
due to decreased animal production and quarantines. The disease is clinically indistinguishable from foot-andmouth disease, one of the most devastating exotic diseases in livestock. VS is the most commonly reported
vesicular disease in livestock in the Americas and is included as a List-A disease by OIE. Outbreaks of VS
occur sporadically in the south-western United States. VS virus (VSV) strains causing these outbreaks are
closely related to those circulating in enzootic areas of Mexico but their means of transmission and
introduction to the United States remain unclear. Other exotic VS viruses circulate in South America.
Knowledge about these viruses is limited and rapid sensitive and specific diagnostic tests for VSV are lacking.
Host and viral factors influencing clinical presentation and mediating protective immune responses to VSV are
poorly understood. This information is required in order to design appropriate prevention and outbreak control
methods. This project has two separate components both aimed at minimizing the occurrence of VS in the US:
Objective 1 utilizes viral genomics for diagnosis and molecular epidemiology, to rapidly detect and track
the origin of VSV strains causing outbreaks. Objective 2 addresses pathogenesis aspects specifically the
role of viral and host factors in determining the outcome of viral infections. This could result in the
development of therapeutic agents capable of preventing clinical disease during outbreaks.
OVERALL PROJECT ACCOMPLISHMENTS:
ORIGIN OF VESICULAR STOMATITIS OUTBREAKS IN SOUTH WEST.
Using genomic analyses, determined that viruses causing the 1995, 1997 and 1998 VS outbreaks were newly
emerging viruses, they were different from viruses causing previous US outbreaks but similar to viruses
circulating in enzootic areas of southern Mexico. This information is valuable in focusing our attention on the
factors influencing the introduction of VSV into the US.
FIRST FULL-LENGTH GENOMIC SEQUENCES OF VSV FIELD STRAINS. Full length genomic
sequences were determined for each of the major serotypes and subtypes of VSV. These sequences provided
crucial information for understanding the genomic basis of viral pathogenesis and allowed the identification of
genetic signatures for diagnostic assay development, such the VSV rapid real-time RT-PCR.
ROLE OF THE GLYCOPROTEIN IN PATHOGENESIS OF VESICULAR STOMATITIS IN LIVESTOCK.
Host and viral factors influencing clinical presentation and mediating protective immune responses to VSV are
poorly understood. This information is required in order to design appropriate prevention and outbreak control
methods. In collaboration with the University of Alabama-Birmingham, we showed that the VSNJV
glycoprotein is a determinant of pathogenesis in swine. Furthermore, genetically engineered VSVs containing
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glycoproteins from both serotypes induced immune responses to both VSNJV and VSIV but could only protect
against VSIV challenge. This information is valuable for designing effective vaccines.
IMPACT:
Phylogenetic analyses of VSV strains combined with epidemiological information provided valuable tools for
understanding the molecular epidemiology of VSV in the United States. Full-length genomic information
provide de the basis for the design of rapid detection methods for VSV based on real-time RT-PCR. This rapid
diagnostic test currently under validation in APHIS, is part of a National strategy for developing real-time
RT_PCR test for rapid detection of foreign animal disease agents. Identifying the glycoprotein gene as a
virulence determinant for VSV has had a major impact in understanding the protective immune responses to
VSV.
TECHNOLOGY TRANSFER:
Material Transfer Agreement
ONE-TUBE RAPID DIAGNOSTIC TEST FOR VESICULAR STOMATITIS. This test based on real-time
PCR was designed to detect a wide range of vesicular stomatis virus strains from various geographical regions
of the Americas. The test has been transferred to APHIS-FADDL for ongoing validation and will be
transferred to other regional laboratories of the National Animal Health Laboratory Network during 2004.
PUBLICATIONS:
Rodriguez, L L, Bunch T A, Fraire M, and Llewellyn Z. 2000. Re-emergence of vesicular stomatitis in the
western United States is associated with distinct viral genetic lineages. Virology 271: 171-181.
Flanagan, E. B., J. M. Zamparo, L. A. Ball, L. L. Rodriguez, and G. W. Wertz. 2001. Rearrangement of the
genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine
development. Journal of Virology 75: 6107-6114.
Rodriguez L L. 2002. Emergence and Re-Emergence of Vesicular Stomatitis in The United States. Virus
Research 85: 211-219
Rodriguez, L.L., S.J. Pauszek, T. A. Bunch and K.R. Schumann. 2002. Full-Length Genome Analysis of
Natural Isolates of Vesicular Stomatitis Virus (Indiana 1 Serotype) from North, Central and South America.
Journal of General Virology 83: 2475-2483.
Llewellyn, Z., M.D. Salman, S. J. Pauszek, and L.L. Rodriguez. 2002. Growth and Molecular Evolution of
Natural Isolates of Vesicular Stomatitis Virus Serotype New Jersey in Insect Cells. Virus Research 89: 65-73.
Meissner F., Maruyama T., Frentsch M., Hessell A. J. Rodriguez L.L., Geisbert T.W., Jahrling P.B., Burton
D.R., and Parren W.H.I. 2002. Detection of Antibodies against the Four Subtypes of Ebola Virus in Sera from
Any Species Using a Novel Antibody-Phage Indicator Assay. Virology 300: 236-243
Martinez I., Rodriguez L.L., Jimenez C., Pauszek S.J. and Wertz G.W. 2003. Vesicular Stomatitis Virus
Glycoprotein is a Determinant of Pathogenesis in Swine, a Natural Host. Journal of Virology 77: 8039-47.
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Rodriguez L.L., Barrera J.C., Kramer E., Lubroth J., Brown F., and Golde W.T. 2003. A Synthetic Peptide
Containing The Consensus Sequence Of The G-H Loop Region Of FMDV Type O VP1 Combined With A
Promiscuous T-Helper Epitope Induces Peptide-Specific Antibodies But Fails To Protect Cattle Against Viral
Challenge. Vaccine 21: 3751-3756.
Magnuson RJ, Triantis J, Rodriguez LL, Perkins A, Meredith CO, Beaty B, McCluskey B, Salman M. 2003.
A single-tube multiplex reverse transcription-polymerase chain reaction for detection and differentiation of
vesicular stomatitis Indiana 1 and New Jersey viruses in insects. Journal of Veterinary Diagnostic
Investigations. v15 p. 561-567
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African Swine Fever Research

Project Title:
CRIS Number::
Scientists:
Location:
Contact:

High Consequence Pathogen Detection
1940-32000-041-02S
Rock, D., Huxsoll, D., McKenna, T., Adams, L.
Plum Island Animal Disease Center
Office of the Center Director
Rodriguez, L.,Phone: (631)323-3364, Fax: (631)323-3295,
lrodriguez@piadc.ars.usda.gov

PROJECT OBJECTIVES:
Although exotic livestock diseases, Foot-and-Mouth Disease Virus (FMDV), Classical Swine Fever (CSF),
African swine fever (ASF), rinderpest (RP), contagious bovine pleuropneumonia (CBPP) and lumpy skin
disease (LSD)may enter the United States mainland by various means, the potential for terrorists, seeking
vulnerable or soft targets in the US, to deliberately introduce foreign animal diseases has added a new
dimension to livestock diseases as a threat to the national economy. Foreign animal diseases (FAD) are a
likely choice for terrorists in that many of the disease agents are easy to acquire, dissemination is not difficult,
the diseases are readily transmissible, the livestock population is highly susceptible, and the economic impact
of a major outbreak would be catastrophic.
To counter the new threat concerns the U.S. Department of Agriculture is developing a system of rapid realtime PCR assays for selected OIE class A animal pathogens to enable rapid detection and identification of
diseased animals and effective management of disease outbreaks resulting from accidental or intentional
introduction into the United States. This report serves to document the accomplishments of this project for
fiscal year 03.
OVERALL PROJECT ACCOMPLISHMENTS:
The major accomplishments over the life of this project include the design, development, optimization, and
bench validation of a "dried-down" real-time RT-PCR assay for FMDV and CSFV. The FMDV and CSFV
assays are ready for field validation.
Work is underway to complete bench validation on real-time PCR assays for other OIE List A diseases such as
RP, ASF, CBPP and LSD. The introduction of a foreign animal disease into the United States would have a
great economic impact upon the agricultural system. Movement of animals and animal products would be
interrupted until a clear epidemiological picture could be established. Therefore, it is essential that a rapid and
accurate method of diagnosis is available. These assays will provide the agricultural industry and the US
government with rapid, deployable assays that are sensitive and capable of detecting the presence of a foreign
animal disease in the United States. Real-time PCR will play a critical role in determining the epidemiological
pattern and management of a foreign animal disease outbreak within the United States.
IMPACT:
TECHNOLOGY TRANSFER:
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The CSFV real-time RT-PCR assay was transferred from ARS to APHIS in April 2003. The FMDV real-time
assay is scheduled to be transferred to APHIS within the first two weeks of September of 2003
Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of footand-mouth disease virus.
PUBLICATIONS:
Risatti, G.R., Callahan, J.D., Nelson, W.M., Borca, M.V. Rapid detection of classical swine fever virus by a
portable real-time reverse transcriptase PCR assay. Journal of Clinical Microbiology. 2003 v. 41(1). p. 500505.
Callahan JD, Brown F, Osorio FA, Sur JH, Kramer E, Long GW, Lubroth J, Ellis SJ, Shoulars KS, Gaffney
KL, Rock DL, Nelson WM. J Am Vet Med Assoc. 2002 June 1;220(11):1636-42.
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African Swine Fever Research

Project Title:
CRIS Number::
Scientists:
Location:
Contact:

Functional Pathogen Genomics: Virulence and Host Range Genes of swine Fever Virus
1940-32000-036-00D
Rock, D., Neilan, J., Zsak, L., Afonso, C., Lu, Z.
Plum Island Animal Disease Center, Office of the Center Director, African Swine Fever
Research
Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044,
drock@cshore.com

PROJECT OBJECTIVES:
African swine fever (ASF) is a highly lethal hemorrhagic disease of domestic swine with mortality rates
approaching 100%. The causative agent, African swine fever virus (ASFV), is a unique and genetically
complex DNA virus. It is the sole member of a newly named virus family and the only known DNA arbovirus.
Cycling of virus between soft ticks and the genus Ornithodoros and wild pig populations (wart hogs and bush
pigs) in sub-Saharan Africa provides a natural reservoir of virus that poses a constant threat to domestic pig
populations worldwide. There is no vaccine for ASF. Either a vaccine or other novel control methods is needed
to reduce the threat posed by this highly significant viral disease.
Work here is focused on: 1) Identifying and characterizing viral genes responsible for virulence, viral latency
and host range in both the swine and tick host; 2) Identifying host cell genes associated with host susceptibility
and/or resistance;3) Developing vaccines and/or other novel approaches for disease control that exploit
virulence and host range mechanisms; and 4) Developing genomic based methods to rapidly identify and
phenotypically characterize viruses. Identification of viral virulence-associated genes will permit the rational
design and genetic engineering of live attenuated viruses for use as vaccines. Additionally, an understanding of
these genes and their functions may permit development of novel approaches for disease control that exploit
aspects of viral host range.
OVERALL PROJECT ACCOMPLISHMENTS:
Characterization of the ASFV genome - The genome of a pathogenic African ASFV isolate, Malawi Lil-20/1,
was sequenced and analyzed. Data provided primary structure of all encoded genes and overall genome
organization. Sequence homologies with other known genes have had great predictive value for proposing and
examining ASFV gene function and have led to the identification of significant swine virulence and host range
genes. Additionally, these data have also facilitated the identification of putative immunogenic proteins - viral
membrane and envelope proteins.
Identification of viral genes function in virulence and host range is difficult and very time consuming,
especially when the genes are novel - lacking homology with other known genes. Putative ASFV virulence and
host range genes were identified using a novel comparative genome approach. Analysis of complete genome
sequences of seven pathogenic field isolates of ASFV identified several highly conserved genes in regions of
the viral genome known to contain other pathobiologically significant genes. Impact - Comparative genomic
approaches - facilitated by highly throughput DNA sequencing - may greatly simplify identification of novel
genes with critical functions in the host. The strategy developed here for ASFV will have broad applicability
for characterization of other threat agent pathogens.
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Genetic engineering of the ASFV genome - Techniques were developed to genetically engineer pathogenic
isolates of ASFV. These techniques which allow the addition or deletion of specific genes have permitted both
genetic and reverse genetic research approaches for determining viral gene function. Recombinant ASFV genedeletion mutants have been used to identify and characterize swine virulence and host range genes. This
technology has proven critical for engineering live-attenuated ASFV vaccine viruses.
Identification and characterization of ASFV swine virulence and host range genes - Using genetic based
strategies and ASFV gene-deletion mutants, a number of pathobiologically significant viral genes, many of
which are novel, have been identified and characterized.
Virulence-associated genes, NL-S and UK were identified in pathogenic European ASFV isolates. Deletion of
either of these genes from the viral genome resulted in complete attenuation of the virus in swine. A third
distinct virulence determinant which includes multiple members of the multigene family 530 genes AVAD,
was identi-fied in the left variable region of the genome. These genes which are required for viral virulence are
novel, lacking similarity to any other known genes.
ASFV genes involved with the regulation of apoptosis in virus infected cells (bcl-2 and iap homologs) and
genes with functions involving immune evasion in the swine host (CD2 and IkB homologs) were identified and
characterized. CD2 and IkB genes had not been previously described in any virus. This is the first example of a
pathogen using of a CD2-like molecule in immune evasion.
ASFV genes which affect macrophage host range were also identified and
characterized. The thymidine kinase gene (TK) and a second gene 9-GL are required for efficient replication of
virus in infected cells; deletion of either gene resulted in a 99% to 99.9% reduction in viral growth and
virulence attenuation.
9-GL is a novel gene whose function in virus replication is unknown. A novel macrophage growth-associated
determinant which includes multiple members of the multigene family 360 genes was identified in the left
variable region of the ASFV genome. These genes are novel lacking homology to other known genes.
ASFV and CSF infect and replicate in cells of the monocyte-macrophage lineage. Revealing molecular
mechanisms involved in macrophage responses to infection is important to devise novel disease control
strategies. A macrophage-specific swine cDNA microarray of 8029 clones was constructed and used to analyze
the transcriptional profiles of swine macrophages infected with ASFV and gene deleted mutant viruses.
Infection with virus caused a transcriptional response characterized by changes in the levels of expression of
multiple macrophage genes. Up-regulated genes included novel and previously known genes, some of these
involved in leukocyte differentiation, protein trafficking, endosome acidification and modulation of the
antiviral response by nuclear factor kappa beta. Comparison of wild type and gene-deleted viruses revealed
that ASFV genes from families 360 and 530 suppress early innate host responses induced by interferon
alpha/beta. Mutant viruses containing deletion of 360 and 530 genes displayed enhanced expression of
interferon induced early response genes and chemokines involved in the inflammatory response. Impact: These
finding contribute to our understanding of swine resistance/susceptibility to viral infection and mechanisms of
pathogenesis and may lead to early recognition of viral infection, predication of clinical outcome and
identification of macrophage response genes associated with disease resistance.
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A novel viral virulence determinant which includes multiple members of the MGF 530 genes has been
identified in the left variable region of the ASFV genome using in vivo marker rescue. These genes will be an
important target for engineering liveattenuated ASF vaccine viruses.
An understanding of pathogen-host interactions is critical for development of traditional and/or novel disease
control strategies. The yeast two-hybrid system, used for the study of protein-protein interactions, was adapted
specifically for investigating ASFV - swine macrophage interactions. ASFV infected swine macrophage cDNA
libraries were constructed in a yeast activation domain GAL4 vector. Library Quality was assessed by
nucleotide sequence and bio-informatic analysis. Two ASFV genes (5HL and 6FR) screened in this system,
identified positive host cell interactor proteins. 5HL, an ASFV gene previously found to have a role in the
modulation of apoptosis, baited host genes predicted to have roles in the regulation of programmed cell death
pathways and cell cycle modulation. 6FR, a novel gene which has been implicated to have a critical role in
ASFV infection, baited genes involved in host cell transcriptional regulation.
Overall, the identification of significant virulence and host range genes provides a rational basis for
development of genetically engineered attenuated or nonreplicating (in the swine host) ASFV viruses for use as
vaccines. Further, an understanding of how these novel genes function in the swine host will contribute to our
overall understanding of viral virulence/host range, viral persistence and pathogen-vector-host interactions;
information that may have broad impact on swine infectious disease in general.
Characterized latent infection with ASFV - Determined ASFV establishes a true latent infection in peripheral
blood monocytes/macrophages, bone marrow and tonsil all recovered pigs, one in which viral replication does
not occur. Knowledge of the existence of ASFV carrier animals is of critical importance for developing disease
control programs in disease endemic regions.
Characterized ASFV-tick host interactions - Our identification of a large number of highly conserved ASFV
genes with no apparent role in the swine host suggested these genes may be associated with aspects of
infection in the tick host. Colonies of Ornithodoros ticks for use in investigating virus-tick interactions were
established at PIADC from wild ticks collected in South Africa. Detailed pathogenesis studies of ASFV
infection in the tick host revealed important aspects of this virus-host interaction. Recombinant ASF viruses
containing deletions of putative tick host range genes were constructed and examined in the ticks. The viral TK
gene has recently been shown to be necessary for viral replication in midgut epithelial cells. And, a second tick
host range determinant has been mapped to the left variable region of the ASFV genome. Identification of ASF
viral genes functioning in host range in Ornithodoros porcinus ticks. Viral genes necessary for infecting ticks
were identified. Multigene family 360 genes are required for efficient virus replication and generalization of
infection in O.porcinus ticks. Successful identification of tick host range genes will permit the design of live
attenuated ASFV vaccine viruses that are incapable of infecting or being transmitted by ticks. The functional
characterization of these genes, will also likely contribute to our understanding of pathogen-arthropod host
interactions in general.
Functional genomics of cytoplasmic DNA viruses - A viral genomics approach was used to identify putative
ASFV arthropod host range genes. Two cytoplasmic DNA viruses representing distinct virus families,
Chlorella virus PBCV-1 (330 Kbp) and the Melanoplus Sanguinipes Entomopoxvirus (236 Kbp) and a
Baculovirus pathogenic for Culex nigripalpus were completely sequenced and analysed. The Chlorella virus
genome represents the largest viral genome sequenced to date. These data provided information on the primary
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structure of all encoded genes, their organization, potential regulatory sequences and their evolutionary
relationship to one another. In both viruses a number of novel and unexpected genes were identified. Sequence
homologies with these viruses have led to the identification of ASFV genes with putative functions in virusarthropod host interactions. This work has led to ASFV being placed into its own virus family, the
Asfarviridae, and it has provided the genetic underpinning for all future research aimed at understanding the
complex biology and evolution of large cytoplasmic DNA viruses.
Development of ASFV diagnostics and reagents - A PCR-based diagnostic assay for ASFV DNA, with a
sensitivity equal to that of animal inoculation, was developed for use with blood and tissue samples. The assay
is being used for research and diagnostic applications in the US, Spain, UK, South Africa, and China. Cloned
genes, protein expression vectors, and both polyclonal and monoclonal antibody reagents have been developed
and provided to research and diagnostic laboratories in the US, UK, Spain, South Africa, the Netherlands, and
China.
The genomes of Fowlpox virus, Marek's disease virus, Turkey herpesvirus and Swine pox were completely
sequenced and analyzed. An understanding of the genetic basis of viral virulence and host range will permit the
engineering of novel vaccine viruses and expression vectors with enhanced efficacy and greater versatility.
The capripox viruses are responsible for highly significant foreign animal diseases (FAD) found in Africa and
Central Asia and significantly they can be confused with a disease of sheep present in the United States caused
by a parapoxvirus (orf virus). To improve diagnostic assays to distinguish between these viruses and to
improve on existing vaccines for these diseases the genomes of lumpy skin disease-virus (151 kpb, 156 genes),
sheeppox virus (146 kpb, 150 genes) and goatpox virus (151 kpb and 150 genes) were completely sequenced
and analyzed. Virus specific gene targets were identified as were genes important for viral virulence and host
range. Impact: Genomic sequences of these FAD viruses will allow for development of highly sensitive and
specific diagnostic tests. Additionally, an understanding of the genetic basis of viral virulence and host range
will permit the engineering of novel vaccine viruses and expression vectors with enhanced efficacy and greater
versatility and will contribute novel concepts of pathogen-host interactions. This is fundamental information
that will have broad impact on future strategies for controlling animal infectious diseases in general.
IMPACT:
The understanding of the genetic basis of ASFV virulence and host range generated here permit development
of the first safe and efficacious ASF vaccine.
Information generated here on novel mechanisms of viral disease provide fundamental new insights on
pathogen-host interactions and will have broad impact on future strategies for controlling animal infectious
disease in general.
TECHNOLOGY TRANSFER:
Viruses, genomic sequences, cloned viral genes, protein expression vectors, and both polyclonal and
monoclonal antibody reagents have been provided to research and diagnostic laboratories in the US, UK,
Spain, the Netherlands, Denmark and China.
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Identification and Characterization of African Swine Fever Virus Protective Antigens
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Research
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PROJECT OBJECTIVES:
African swine fever (ASF) is a highly lethal hemorrhagic disease of domestic swine with mortality rates
approaching 100%. The causative agent, African swine fever virus (ASFV), is a unique and genetically
complex DNA virus. It is the sole member of a newly named virus family and the only known DNA arbovirus.
Cycling of virus between soft ticks of the genus Ornithodoros and wild pig populations (wart hogs and bush
pigs) in sub-Saharan Africa provides a natural reservoir of virus that poses a constant threat to domestic pig
populations worldwide. There is no vaccine for ASF.
Either a vaccine or other novel control methods is needed to reduce the threat posed by this highly significant
viral disease. The long term goal of the ASF research group at the Plum Island Animal Disease Center
(PIADC) is development of an effective control strategy for this viral disease. This research project focuses on
vaccination as a potential control strategy. Research involves defining the protective immune response to
ASFV. Specifically to: 1) Evaluate genetically engineered ASFV with deletions of virulence/host range genes
as vaccines for ASF; 2) Identify and characterize ASF viral proteins that induce a protective immune response
in swine; 3) Define antigenic variability ASFV strains; 4) Define critical protective host immune responses;
and 5) Develop new methods for effective vaccine delivery in swine. This research will allow evaluation of
vaccination as a potential control measure for ASFV and will provide both the theoretical and practical basis
for subsequent vaccine development.
OVERALL PROJECT ACCOMPLISHMENTS:
Our recent work in ASFV protective immunity has: 1) Clearly demonstrated the importance of the humoral
immune response in protective immunity to ASFV infection; 2) Demonstrated the existence of neutralizing
antibodies in the serum of recovered ASFV infected animals; 3) identified for the first time a specific viral
protein (p72) involved in mediating virus neutralization and mapped the protein epitope responsible; 4)
Demonstrated that ASFV neutralizing antibodies are not sufficient for antibody-mediated protection and that
other antibody-mediated immune mechanisms are responsible for the protective effect; 5) Anti-ASFV
antibodies mediating a novel anti-viral mechanism, monocyte infection-inhibition (M-II), were identified and
shown to function in a strain-specific manner, suggesting a role for them in protective immunity; 6) Identified
additional viral genes with possible significance to a protective immune response including those encoding,
putative virion and infected cell membrane proteins, highly variable viral proteins and putative secreted viral
virulence factors; 7) Demonstrated the feasibility of using genetically engineered live attenuated ASF viruses
as vaccines. A live attenuated ASFV was constructed by deleting the 9GL gene (a gene required for efficient
growth in swine macrophages). Pig infected (immunized) with this genetically engineered mutant virus were
completely protected from lethal challenge with homologous and several heterologous virus strains indicating
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that highly virulent African ASFV field isolates can be attenuated by gene deletion and that these viruses
induce a protective immune response in swine; 8) Several virulent African strains of ASFV were attenuated by
deleting virulence associated genes and then used in cross protection studies in pigs. Cross protection was
observed for all South African viruses examined indicating that protection from heterologous viruses within a
geographic region can be achieved. These data indicate that ASFV strain variation may not be as great as
previously thought thus, vaccination with a single virus strain may be a viable option for controlling ASFV
within a geographic region; and 9) Immune sera to different ASFV isolates were raised and tested in an in vitro
monocyte infection-inhibition (M-II) assay where homologous and region-specific heterologous protective
effects were observed. Significant correlation between the specificity of M-II assay and cross protection from
heterologous viruses was observed. Findings will permit identification of viral proteins mediating M-II.
IMPACT:
Characterization of protective anti-viral host responses and viral antigens responsible for inducing them permit
the development of a subunit vectored ASF vaccines that could be used in the U.S. in the event of a disease
outbreak.
Insight into novel anti-viral host immune responses identified here will have broad impact on future strategies
for controlling animal infectious disease in general.
TECHNOLOGY TRANSFER:
Viruses, genomic sequences, cloned viral genes, protein expression vectors, and both polyclonal and
monoclonal antibody reagents have been provided to research and diagnostic laboratories in the US, UK,
Spain, South Africa, the Netherlands, Denmark and China.
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Micro. (Submitted for Publication).
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Detection and Diagnosis of Hog Cholera (CSF)
1940-32000-038-00D
Vacant, Vacant
Plum Island Animal Disease Center, Office of the Center Director, African Swine Fever
Research

PROJECT OBJECTIVES:
Classical Swine Fever (CSF) is a highly infectious disease of swine. Morbidity and mortality rates in infected
herds can be high. Infected sows can also transmit the virus to their offspring, creating asymptomatic carriers
of the virus that shed virus in their feces, thereby contaminating the environment and posing risk to susceptible
populations. As a foreign animal disease (FAD), an outbreak of CSF would significantly affect the U.S. pork
industry and export markets. Improved CSF diagnostic tests and a marker live-attenuated CSF vaccine are
needed to further reduce the risk posed by this FAD.
The goal of this research is directed at: 1) Developing molecular epidemiological capabilities for CSF; 2)
Developing rapid field diagnostic tests for CSF; 3) Developing laboratory diagnostic tests that will differentiate
field from marker vaccine strains of CSF; 4) Defining the pathogenesis of moderately virulent CSF viruses in
pigs; 5) Identifying CSF virulence and host range determinants; and 6)
Developing a marker live attenuated CSF vaccine.
OVERALL PROJECT ACCOMPLISHMENTS:
Rapid identification and diagnosis of a FAD is critical for successfully controlling and eradicating the disease
following introduction. Rapid field-based assays to detect CSFV are not yet available. A rapid real-time
fluorogenic hydrolysis probe TaqMan assay was developed and evaluated in pigs experimentally infected with
a moderately virulent CSF isolate, Haiti-96. The assay was highly sensitive and specific, detecting infected
animals up to 5 days prior to the appearance of CSF clinical symptoms. Impact: This rapid, real-time RT-PCR
assay for CSFV provides a new diagnostic tool that will redefine disease management and control strategies for
this highly significant FAD. This is a new project initiated in FY 2001.
Engineering new markered live-attenuated CSF vaccines requires knowledge of viral virulence and host range
determinants. Currently, little is known about CSFV in this regard. Insertional mutagenesis was used to define
CSFV virulence and host range determinants. A CSFV genomic region associated with viral virulence was
identified. Mutant viruses with changes in this region were: 1) completely attenuated in pigs; and 2) capable of
inducing a protective immune response in pigs. Impact: The mapping of genetic determinants associated with
viral virulence and host range represents the first step toward rational design of improved markered liveattenuated CSF vaccines.
IMPACT:
Rapid real-time PCR test for CSF provides new diagnostic tool that has redefined emergency disease
management and control strategies for this high consequence disease.
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Work here on identification and characterization of CSFV virulence and host range determinants permits
rational design of improved markered live-attenuated CSF vaccines.
TECHNOLOGY TRANSFER:
Rapid detection method transferred to APHIS.
PUBLICATIONS:
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Risatti, G.R., Holinka, L.G., Lu, Z., Kutish, G.F., Callahan, J.D., Nelson, W.M., Brea Tio, E. and Borca, M.V.
2004. Diagnostic Evaluation of a Portable Real-Time Reverse Transcriptase PCR Assay for the Detection of
Classical Swine Fever. J. Clin. Micro. (In Press).
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PROJECT OBJECTIVES:
New disease control strategies are needed to reduce the threat posed by high consequence foreign animal
diseases (FAD). Functional pathogen genomics offers an unprecedented opportunity for addressing this critical
issue. High throughput pathogen genome sequencing together with detailed genome analysis will be used to
provide improved tools for pathogen detection, disease diagnosis and epidemiological disease investigations,
improved vaccines and therapeutics, and in all likelihood, completely novel disease control strategies with
increased efficacy and utility. Specifically the goal of this research is to: 1) Develop methods for rapid strain
identification and epidemiological investigations for key FAD agents; 2) Develop rapid field diagnostic tests
for key FAD agents; 3) Develop improved vaccines for key FAD; and 4) Develop new methods on strategies
for efficient and effective
disease control.
OVERALL PROJECT ACCOMPLISHMENTS:
Rapid field-based assays to detect foot and mouth disease virus (FMDV) are not yet available. A rapid RTPCR assay was developed and evaluated in experimentally infected animals. The assay was both highly
sensitive and specific and, it detected the virus before the animals showed signs of disease. Impact: A rapid (1 1 ½ hr) field-based diagnostic assay for FMDV provides a new and powerful tool that in all likelihood will
revolutionize disease management and control strategies for this highly significant viral disease.
Canarypox virus (CPV) is a increasingly important mammalian vaccine vector; however, little information
regarding the canarypox genome is currently available. The 360 kpb CPV genome was sequenced and
compared to fowlpox virus, a related avipoxvirus of domestic birds. Analysis revealed 325 genes, including
those conserved with fowlpox virus, other novel genes in expanded gene families, and virulence and host range
genes unique to CPV. Impact: Knowledge of the entire coding capacity of CPV has identified specific genes
which may affect unique aspects of CPV virulence and host range, allowing more directed studies to determine
gene function in the host. Engineering of improved and more efficacious CPV vaccine vectors will result.
Poxviral infections in wild animal species are increasingly documented, indicating the presence of other, yet to
be characterized poxviruses circulating in wild animal species. These can be confused with FAD viruses. Two
deerpox viruses isolated in the western U.S. from free ranging mule deer were sequenced. Both virus genomes
of 165 kbp shared 95% nucleotide identity. They differed from other known poxviruses both in central
conserved regions and in terminal genomic regions where they contained a unique complement of virulence
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and host range genes. Impact: Genomic information will permit design of improved diagnostic assays to
distinguish between this virus and other exotic poxviruses associated with FAD of domestic animals.
IMPACT:
Rapid real-time PCR tests for high consequence foreign animal diseases developed here provides new
diagnostic tools that have redefined emergency disease management and control strategies for these high
significant diseases.
Pathogen comparative genomics has provided new tools for epidemiological and forensic investigations of
foreign animal diseases and fundamental information that permit development of safer and more efficacious
vaccines and vaccine vectors.
TECHNOLOGY TRANSFER:
Rapid FAD diagnostic tests for FMD, CSF and ASF have been developed. Evaluated and transferred to APHIS
for use.
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PROJECT OBJECTIVES:
The US food animal economy has long been threatened by infectious diseases that could devastate the cattle,
swine and poultry industries. Viral and bacterial infections affecting the airways and other mucosal tissues
present the major risk to these economically important animal species. Pathogenic microbes are now, and will
continue to be, the most significant cause of animal disease and economic loss. The easy pathogens have been
dealt with, the difficult, intractable ones remain. New pathogens are continuously emerging and, in some cases,
past disease control strategies (vaccines, antibiotics, other drugs and chemicals) are either losing effectiveness
and/or public support for their use. Development and administration of new, more effective vaccines to
counteract these pathogens will increase food safety, quality and production that will strengthen our markets at
home and abroad.
OVERALL PROJECT ACCOMPLISHMENTS:
We have identified and characterized numerous virulence determinants in Mycoplasma gallisepticum and
gained a greater understanding of the regulation of gene expression as well as posttranslational processing
mechanisms of proteins in this pathogen. We have initiated studies aimed at determining the host response to
this pathogen and assess how this contributes to the overall pathogenesis.
IMPACT:
Development of more effective vaccines for significant animal diseases will reduce losses associated with
disease permitting increased food safety, quality and production and strengthen economic markets at home and
abroad.
TECHNOLOGY TRANSFER:
"Use of a Live Attenuated Mycoplasma gallisepticum Strain as a Vaccine and Vector for the Protection of
Chickens and Turkeys From Respiratory Disease" (Full patent filed 4/19/02).
PUBLICATIONS:
Papazisi,L., Silbart, L.K., Frasca Jr., S., Rood, D., Liao, X., Gladd, M. Javed, M.A. and Geary, S.J. A Modified
Live Mycoplasma gallisepticum Vaccine to Protect Chickens From Respiratory Disease, Vaccine, 2002, 20(3132):3709-3719.
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Papazisi, L., Frasca, S. Jr., Gladd, M., Liao, X., Yogev, D., Geary, S.J. GapA and CrmA co-expression is
essential for Mycoplasma gallisepticum cytadherence and virulence, Infect. Immunity, 2002, 70:6839-6845.
The complete genome sequence of Mycoplasma gallisepticum Strain R , GenBank Accession #: AE015450,
October 17th, 2002.
Orenstein, S.M., Levisohn, S., Geary, S.J., Yogev, D. Cytadherence-Deficient Mutants of Mycoplasma
gallisepticum Generated by Transposon Mutagenesis, Infect. Immunity, 2003, 71(7):3812-3820.
Papazisi, L., Gorton, T., Kutish, G., Markham, P., Browning, G., Nguyen, D., Swartzell, S., Madan, A.,
Mahairas, G. and Geary, S.J. "The complete genome sequence of the avian pathogen Mycoplasma
gallisepticum strain Rlow". Microbiology,2003, 149(9):2307-2316
Zinckgraf, J.W. and Silbart, L.K. Modulating gene expression using DNA vaccines with different 3'-UTRs
influences antibody titer, seroconversion rate and cytokine profile. Vaccine, 2003, 21(15):1640-1649.
Fisher, D., Rodd, D., Barrette, R.W., Zuwallack, A., Kramer, E., Brown, F. and Silbart, L.K. Intranasal
immunization of guinea pigs with an immunodominant FMDV peptide conjugate induces mucosal and
humoral antibodies and protection against challenge. J. Virology, 2003, 77(13):7486-7491.
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African Swine Fever Research

Project Title:
CRIS Number::
Scientists:
Location:

Contact:

Program for Prevention of Animal Infections and Advanced Technologies
for Vaccines and Diagnostics
1940-32000-039-05S
Rock, D., Estes, M.
Plum Island Animal Disease Center
Office of the Center Director
African Swine Fever Research
Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044,
drock@cshore.com

PROJECT OBJECTIVES:
The infectious agents under study cause significant production losses to domestic food animals and include
agents of foreign animal diseases that threaten a key segment of the agricultural economy. We are developing
strategies for improved diagnostics and vaccine approaches to meet this challenge.
OVERALL PROJECT ACCOMPLISHMENTS:
We have begun to establish a comparative framework for genomic investigation of the Mycoplasma mycoides
cluster of bovine and caprine pathogens that will be mined continually for potential diagnostic and therapeutic
targets. This database will underpin new efforts to complete genomic sequences for the remaining species in
this cluster, other bovine mycoplasma pathogens, and isolated strains of those species correlated with
worldwide disease outbreaks. It is anticipated that the now completed genome sequence of M. capricolum
subspecies capricolum Kid strain will drive the development of a genetic system for analysis of virulence traits
for this group of organisms, leading to an accelerated understanding of their pathobiology and strategies to
diagnose and treat these infectious diseases.
IMPACT:
Rapid diagnostic tests for high consequence foreign animal diseases will provide new diagnostic tools and will
redefine emergency disease management and control strategies for these high significant diseases.
TECHNOLOGY TRANSFER:
The project has been underway for three years (since 3-1-00). Mycoplasmal genomic sequences will be
deposited in public databases as they are annotated. Some delays in reaching these objectives occurred during
the current period, reflecting the need to refine annotation methodology and to acquire the most recent
comparative data. Prototype diagnostic applications are anticipated in the next two years. Vaccine material for
tuberculosis is anticipated within the next two years. Adjuvant materials developed in this study show promise
in tests in chimeric mice and can be applied to several vaccines under study within the consortium. Constraints
may apply to the use of commercial materials obtained within the defined conditions of Material Transfer
Agreements. New PRRSV infectious clones should be available within the next year and subsequent
investigation is projected to provide potential vaccine reagents to commercial swine producers and scientists in
the following several years. RNAi technology as an anti-parasitic sterilization therapy will be tested
thoroughly in the coming year. Its application across the spectrum of animal parasitic diseases will be
regulated by the pace by which parasite genomic sequence data become available.
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PUBLICATIONS:
Austin, A., Haas, K.M., Jordan, K., Naugler, S. and Estes, D.M. Identification of a novel regulatory factor:
Immunoglobulin A inducing protein. J. Immunol., 2003, 171:1336-1342.
Bajer, A., Jordan, K.R., Werling, D., Howard, C.J. and Estes, D.M. Ruminant dendritic cells derived from
peripheral blood mononuclear cell precursors promote IgG1-restricted B cell responses in vitro. J. Leuk. Biol.,
2003, 73:100-106.
Kleiboeker, S.B., Lee, S.M., Jones, C., and Estes, M.D. Lack of detectable BHV1, BVDV1 and BVDV2
shedding following immunization of calves with a modified-live vaccine. J. Am. Vet. Med. Assoc., 2003,
222:1399-403.
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African Swine Fever Research

Project Title:
CRIS Number::
Scientists:
Location:
Contact:

Development of Rapid Real Time PCR-Based Assays for Selected OIE
Class A Diseases
1940-32000-041-00X
Rock, D., Huxsoll, D., Rodriguez, L., McKenna, T.
Plum Island Animal Disease Center
Office of the Center Director
Rock, D., Phone: (631) 323-3330, Fax: (631) 323-3044,
drock@cshore.com

PROJECT OBJECTIVES:
Although exotic livestock diseases, Foot-and-Mouth Disease Virus (FMDV), Classical Swine Fever (CSF) and
Vesicular Stomatitis Virus (VSV) may enter the United States mainland by various means, the potential for
terrorists, seeking vulnerable or soft targets in the US, to deliberately introduce foreign animal diseases has
added a new dimension to livestock diseases as a threat to the national economy. Foreign animal diseases are a
potential choice for terrorists in that many of the disease agents are easy to acquire, dissemination is not
difficult, the diseases are readily transmissible, the livestock population is highly susceptible, and the economic
impact of a major outbreak would be catastrophic.
To counter the new threat concerns the U.S. Department of Agriculture is developing a system of rapid realtime PCR assays for selected OIE class A animal pathogens to enable rapid detection and identification of
diseased animals and effective management of disease outbreaks resulting from accidental or intentional
introduction into the United States. This report serves to document the accomplishments of this project for
fiscal year 2003.
OVERALL PROJECT ACCOMPLISHMENTS:
The major accomplishments over the life of this project include the design, development, optimization, and
bench validation of a "dried-down" real-time RT-PCR assay for FMDV and CSFV. In addition, a real-time
assay for VSV has been designed and optimized on wet-reagents and is now ready for production as a "drieddown" assay. All of the aforementioned assays have been or will be "dried-down" in a format specific for use
in the SmartCycler (Cepheid, Sunnyvale, CA). The FMDV and CSFV assays are ready for field validation.
APHIS is finalizing agreements with foreign countries such as Argentina, Bolivia, Afghanistan, and Mexico to
obtain samples from FMDV and CSFV outbreak areas in order to proceed with field validation of the real-time
RT-PCR assays. Likewise, VSV field validation in negative animal cohorts will be initiated in the fall of 2003
through collaborative projects with Colorado State University and University of California-Davis (see annual
reports for projects 1940-32000-040 03S and 1940-32000-041 03S) and through ongoing collaborations with
ARS's Arthropod Borne Disease Research Laboratory (ABDRL). Field validation in positive cohorts for the
VSV assay will be initiated in the fall of 2003 through collaborative agreements already in place with Mexico's
Exotic Animal Disease Commission (5410-32000-012-01S and Costa Rica's School of Veterinary Medicine
(5410-32000-012-02S). These collaborative agreements were established by ABDRL in FY03.
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A training and proficiency test system has been put in place in order to have the real-time assays, once field
validated, transferred to the NAHLN laboratories. BEI inactivated FMDV and CSFV isolates are currently
being produced and tested both in vitro and in vivo. These inactivated viruses will be used in proficiency
panels and as positive controls in the NAHLN laboratories. Once trained and tested, the NAHLN laboratory
personnel will be capable of screening and helping diagnose the introduction of a foreign animal diseases into
the United States. In the event of the outbreak, personnel trained to perform the real-time assays in the
NAHLN laboratories would be available to assist the Foreign Animal Disease Diagnostic Laboratory at Plum
Island in the diagnosis and management of additional cases.
Work is underway to complete bench validation on real-time PCR assays for other OIE List A diseases such as
Rinderpest and African Swine Fever.
The introduction of a foreign animal disease into the United States would have a great economic impact upon
the agricultural system. Movement of animals and animal products would be interrupted until a clear
epidemiological picture could be established. Therefore, it is essential that a rapid and accurate method of
diagnosis is available. These assays will provide the agricultural industry and the US government with rapid,
deployable and sensitive tools to detect the presence of a foreign animal disease in the United States. Realtime PCR will play a critical role in determining the epidemiological pattern and management of a foreign
animal disease outbreak within the United States.
IMPACT:
Rapid real-time PCR tests for high consequence foreign animal diseases developed here provides new
diagnostic tools that have redefined emergency disease management and control strategies for these high
significant diseases.
TECHNOLOGY TRANSFER:
The CSFV real-time RT-PCR assay was transferred from ARS to APHIS in April 2003. The FMDV real-time
assay is scheduled to be transferred to APHIS within the first two weeks of September of 2003. APHIS will be
training and proficiency testing NAHLN laboratory personnel on real-time RT-PCR using the Cepheid
SmartCycler platform in the fall of FY'04. These two real-time assays will be deployed to the NAHLN
laboratory network for negative field sample collection and diagnostic specificity testing in December (CSFV)
and January/February (FMDV), respectively. Complete deployment of each assay to the end-user (NAHLN) is
expected by March 2004 (CSFV) and July 1, 2004 (FMDV).
PUBLICATIONS:
Risatti, G.R., Callahan, J.D., Nelson, W.M., Borca, M.V. Rapid detection of classical swine fever virus by a
portable real-time reverse transcriptase PCR assay. Journal of Clinical Microbiology. 2003. vol. 41(1). p. 500505.
Callahan JD, Brown F, Osorio FA, Sur JH, Kramer E, Long GW, Lubroth J, Ellis SJ, Shoulars KS, Gaffney
KL, Rock DL, Nelson WM. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay
for rapid detection of foot-and-mouth disease virus. J Am Vet Med Assoc. 2002 Jun 1;220(11):1636-42.
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Eastern Regional Research Center
Wyndmoor, PA

EASTERN REGIONAL RESEARCH CENTER, Wyndmoor, PA
Cherry, John P, Center Director
(215) 233-6595
600 EAST MERMAID LANE
Wyndmoor PA 19038
Dairy Processing and Products Research
Tomasula, Peggy M., Research Leader
(215) 233-6703
EASTERN REGIONAL RESEARCH CTR
600 EAST MERMAID LANE
Wyndmoor PA 19038
PROJECTS
Dairy Processing and Products Research
• Biosecurity of Milk from the Farm to the Dairy Processing Plant
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Dairy Processing and Products Research
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Biosecurity of Milk from the Farm to the Dairy Processing Plant
1935-41000-062-00D
Tomasula, P., Rodriguez, L.
Eastern Regional Research Center, Dairy Processing and Products Research
Tomasula, P., Phone: (215) 233-6703, x. 6703, Fax: (215) 233-6795
ptomasula@arserrc.gov

PROJECT OBJECTIVES:
Foot and-mouth disease (FMD), caused by the foot-and-mouth disease virus (FMDV), is not a public health
threat but is highly contagious to cloven-footed animals. The virus may be shed into milk up to 33 hrs before
there are any apparent signs of the disease in dairy cows. Some of the literature on pasteurization of milk
infected with FMDV reports that the virus survives in milk and milk products pasteurized according to current
standards. Animals fed these products may then become infected with the virus.
The purpose of this project is to review past experiments and conduct additional relevant experiments to
determine the thermal resistance of FMDV in milk and milk products and to ensure that current pasteurization
standards for high temperature short time pasteurization, the method used in most processing plants, provides a
safety margin for elimination of FMDV in milk and milk products. In addition, technologies that have been
developed since the earlier research conducted in the ‘70s and that are currently available for dairy
applications, will be applied to solve potential biosecurity problems at the farm, during transport of milk, and
at the processing plant. This knowledge is needed for the development of science-based strategies for
elimination of the virus in the event of an outbreak. The research and approaches are relevant to all pathogens
that may cause animal safety or food safety concerns.
OVERALL PROJECT ACCOMPLISHMENTS:
This project was initiated in FY 2002, in collaboration with the Plum Island Animal Disease Center (PIADC)
to support FMD research priorities. Both research locations are members of the FMD Dairy Research Working
Group, an industry-driven group comprised of representatives from the dairy marketing cooperatives, milk
processing groups, cheese processors, dairy farmers, representatives from the FDA – CFSAN and CVM and
other government groups, and representatives from industry. The purpose of the FMD Dairy Research WG is
to develop science-based guidelines that may be used by APHIS and local, state, and federal officials in the
event of an outbreak to effect a coordinated response.
Methods Review: Examined the methodology that was used in experiments conducted in the ‘70s and 80’s to
determine the thermal resistance of foot-and-mouth disease in milk. This data was and still is used in the
guidelines issued by APHIS and OIE for treatment of milk infected with FMDV. Concluded that much of the
data was obtained using laboratory methods not in use today that do not simulate high temperature short time
pasteurization. The data may over or under predict the thermal treatment delivered to milk in commercial
pasteurization. Also, the data cannot be used to determine exact temperature-time relationships required to
inactivate the FMD virus in milk as a function of log reduction of virus in milk. However, the data are useful
to determine the ultimate effectiveness of a particular temperature in eliminating the virus in milk and past
research has demonstrated that the difficulty in eliminating the virus in milk is most likely due to encapsulation
of the virus by fat globule membrane or interaction with protein.
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Review of guidelines: Current APHIS and OIE guidelines recommend that double pasteurization be used to
eliminate virus in milk prior to feeding to animals. Determined from a literature review that these guidelines
are not based on peer reviewed data but are an apparent extrapolation of data.
Pasteurization of infected milk: Experiments were conducted at PIADC, NY, to test the efficacy of HTST
pasteurization for elimination of FMDV in milk using pilot plant scale equipment. This is preferable to use of a
commercial unit because several thousand gallons of milk naturally infected with FMDV would be necessary
for processing. In addition, milk containing at least 2log virus is required to measure pasteurization
effectiveness, a level high enough for kinetic studies. Results from this study are also being interpreted in
terms of on-farm destruction of milk.
At ERRC, developed methodology for determination of residence time distribution and fastest moving particle
determination so that temperature-time relationships may be determined for pathogens in milk using smaller
scale equipment and applied to commercial pasteurizers.
Milk tanker biosecurity : In preliminary work at ERRC, demonstrated the parameters for operation of the
tanker at the farm and the processing plant, if existing tankers are retrofitted with equipment to secure the
contents of the tanker.
IMPACT: Work performed to date has led to the strategies now being implemented by the dairy industry for
improved biosecurity, in general, and for handling milk infected with FMDV at the farm, in transit, and at the
processing plant. The strategies developed in this work are sufficiently general that their implementation will
improve the security and safety of milk and dairy products against most pathogens.
TECHNOLOGY TRANSFER:
The results of the experiments are regularly discussed with dairy stakeholder groups and APHIS, USDA, and
the FDA. The dairy stakeholder groups have shared the knowledge obtained in this study with their users.
PUBLICATIONS:
Tomasula, P.M. and R.P. Konstance. 2004. The survival of foot-and-mouth disease virus in raw and
pasteurized milk and milk products. J. Dairy Sci. 87: 1115-1121.
Tomasula, P.M. and M.F. Kozempel. 2004. Flow characteristics of a pilot scale high temperature short time
pasteurizer. Submitted to J. Dairy Science.
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National Animal Disease Center (NADC)
Ames, IA

NATIONAL ANIMAL DISEASE CENTER (NADC)
Murray, Keith
Center Director
(515) 663-7201
NATIONAL ANIMAL DISEASE CENTER
P.O. BOX 70, 2300 DAYTON ROAD
Ames IA 50010
Periparturient Diseases of Cattle
Horst, Ronald L
Research Leader
(515) 663-7312
PERIPARTURIENT DISEASES OF CATTLE RESEARCH UNIT
2300 DAYTON AVENUE
Ames IA 50010
Bacterial Diseases of Livestock
Whipple, Diana L
Research Leader
663-7325
BACTERIAL DISEASES/LIVESTOCK
P.O. BOX 70, DAYTON RD.
50010

(515)
NADC,
Ames IA
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Virus and Prion Diseases of Livestock
Kehrli, Marcus
Research Leader
(515) 663-7254
VIRUS AND PRION DISEASES/LIVESTOCK
P.O. BOX 70, DAYTON RD.
50010

NADC,
Ames IA

Respiratory Diseases of Livestock
Howard
Acting Reseach Leader
(515) 663-7255
RESPIRATORY DISEASES OF LIVESTOCK
USDA/ARS/NADC, P.0. BOX 70, 2300 DAYTON AVENUE
Ames IA 50010

Lehmkuhl,

PROJECTS
Periparturient Diseases of Cattle
• Molecular, Nutrient and Endocrine Basis for Metabolic Disease in the
Transition Dairy Cow
• Identification of Factors Causing Immune Suppression at Parturition
Bacterial Diseases of Livestock
• Genomic and Immunological Analysis of Spirochetes that Infect Livestock
• Brucellosis: Vaccines, Immune Responses, Diagnostic Reagents
• Understanding Host-Pathogen Interactions for the Diagnosis and Control of Paratuberculosis (Johne's)
• Diagnosis and Control of Tuberculosis in Livestock and Wildlife
Virus and Prion Diseases of Livestock
• Emerging Viral Diseases of Swine
• Virus-Induced Respiratory and Reproductive Diseases of Swine
• Detection and Control of Bovine Viral Diarrhea Viruses
• Bovine Spongiform Encephalopathy and Other Transmissible
Spongiform Encephalopathies
Respiratory Diseases of Livestock
• Respiratory Diseases of Poultry
• Control of Porcine Respiratory Diseases of Complex Etiology
• Haemophilus Parasuis Proteomics for Vaccine Design
• Controlling Losses from Respiratory Disease in Cattle, Sheep, and Goats
• Construction of Live Mucosal and Injectable Bacterial Vaccines Against
Avian and Bovine Respiratory Diseases
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Periparturient Diseases of Cattle
Project Title:
CRIS Number::
Scientists:
Location:
Contact:

Molecular, Nutrient and Endocrine Basis for Metabolic Disease in the
Transition Dairy Cow
3625-32000-058-00D
Reinhardt, T., Horst, R.
Ames, IA, National Animal Disease Center, Periparturient Diseases of Cattle
Reinhardt, T., Phone: (515) 663-7540, Fax: (515) 663-7669, treinhar@nadc.ars.usda.gov

PROJECT OBJECTIVES:
Clinical hypocalcemia (Milk Fever) and subclinical hypocalcemia have an 8% and 75% incidence,
respectively, in the periparturient dairy cow. Epidemiological studies have shown that metabolic diseases do
not occur in isolation from each other, and hypocalcemia increases the incidence of other metabolic and
infectious disorders in cows. It is clear that hypocalcemias are the initiators of a metabolic and infectious
disease complex in the periparturient dairy cow. Hypocalcemia results in a 9-fold increase in ketosis, 6 times
more dystosia, and a 4-fold increase in left displaced abomasum and retained placenta. In addition, the
majority of infectious diseases (mastitis, salmonellosis, bovine viral diarrhea (BVD) and Johnes disease) that
occur are associated with or increased by hypocalcemia. We are attempting to resolve this problem with an
applied and basic research program focusing on understanding the diseases and improving methods we have
developed to prevent hypocalcemia.
OVERALL PROJECT ACCOMPLISHMENTS:
Prior to our research, pre-calving diets high in calcium were thought to be the cause of milk fever. We proved
this is not true in a seminal experiment with milk fever (hypocalcemia)-prone Jersey cows fed a high or low
calcium diet, with either 1, 2, or 3% dietary potassium. Dietary calcium was found to have no effect on the
development of milk fever or hypocalcemia. However the experiment did demonstrate that milk fever is
primarily caused by high dietary potassium. Additional experiments suggest that high dietary potassium
interferes with the ability of a key calcium regulating hormone – parathyroid hormone- to regulating the cow's
blood calcium concentration .
We have also found the level of expression of a calcium-pumping gene in the mammary gland is a predictor of
the metabolic disease complex associated with the stresses of parturition in dairy cows. We have developed
reagents that can be used to study mammary gland calcium transport (during milk fever) and have potential as
indicators of milk and milk protein production. We have contributed to the basic endocrinology/cell biology of
the periparturient period in cows and model systems. We have identified factors predisposing cows to
metabolic disease, such as age and diet, and we have established how these factors contribute to the
development of the disease at the cellular level. For example, key hormone receptors involved in the control of
blood calcium concentration were found to decline with age, the stresses of parturition, and the breed of cow.
Diets to enhance the function of key hormone receptors have been developed and these are currently being
applied for prevention of milk fever.
IMPACT:
These data have resulted in our development of new practical dietary supplements, which are now being used
to lower the incidence of milk fever. As an outcome of our research, 50-60% of dairies now control potassium
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content of diets fed to dry cows and 20-30% of dairies are now adding chloride supplements to adjust dietary
cation-anion difference in their dry cow feeding programs.
TECHNOLOGY TRANSFER:
Our discovery that potassium is the cause of milk fever is now being included in every new veterinary medical
textbook. The research was published in many of the major lay dairy publications in the U.S. Nearly all dairy
nutritionists carefully determine dietary potassium when formulating rations for dairy cattle. Some are
beginning to change agronomic practices designed to reduce potassium and increase chloride content of
forages grown for dairy dry cows. Summaries of our recent experiments on the use of dietary hydrochloric
acid as a means of counteracting high dietary potassium have also appeared in nearly every major lay dairy
publication. The industry has been very quick to adopt the technology that has arisen from this project. Within
months of our presentation of the work on hydrochloric acid at a scientific meeting, a company began
marketing a feed supplement with hydrochloric acid to aid in prevention of milk fever. There are two
companies (West Central Cooperative, Ralston, IA, and Nutritech Solutions, Ltd, Clearbrook, BC, Canada)
now marketing products with HCl using formulas that are essentially our recipe. Technology transferred has
also been scientific knowledge for use by other scientists and us. The knowledge should be reasonably durable
but is subject to modification and change as the project's research moves forward. The probes and reagents
developed should provide sound scientific tools required for further understanding of mammary function and
milk production as well as tools for evaluation of practical metabolic disease prevention methods that will
make it to the farmer.
T. Reinhardt
Invited to speak At the Stu Patten Wilderness Conference on Mammary Biology, on “Calcium Homeostasis in
the Mammary Gland”, 2003
Invited to present a seminar at the Dept of Molecular Biology and Biochemistry ISU winter semester seminar
series, on “Calcium transport in the Mammary Gland”, 2004
Invited to speak at the 18th Brunner Symposium at Michigan State Univ, “Calcium Pumps and Calcium
Transport in the Mammary Gland”, 2004
R. Horst
Invited to lecture on “Role of Vitamin D in Calcium Homeostasis and its use in Milk Fever Prevention” at the
Abildgaard Symposium on Hypocalcemia, Acidosis and Calcium Homeostasis, Copenhagen, Denmark, August
16-17, 2001.
Invited to lecture on “Troubleshooting Transition Rations for the Dairy Cow” at the 62nd Minnesota Nutrition
Conference, Bloomington, MN, September 11-12, 2001.
Invited to lecture annual Wisconsin Agriculture Systems Association meeting on “Managing the Close UP
Transition Cow” Wisconsin Dells, WI Jan 24-25 , 2002
Invited to lecture at the 17th annual Southwest Nutrition and Management Conference, on “Troubleshooting
Transition Rations for the Dairy Cow” Feb 21-23, 2002, Pheonix, AZ
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Invited to lecture to the University of Colorado Veterinary College on “Managing Hypocalcemia in the
Periparturient Dairy Cow” March 19, 2002. Ft. Collins, CO
Invited to lecture at the annual Iowa Feed and Nutrition Seminar. Iowa State University, "Management of the
transition dairy cow" April 23, 2002.
Invited to lecture at the Brown University DeLuca Symposium on Vitamin D on “Rat Cytochrome P450C24
(Cyp24) does not Metabolize 1,25-Dihydrovitamin D2 to Calcitroic Acid” Taos, NM, June 15-19, 2002.
Invited by Faculty of Veterinary Medicine, Warsaw Agricultural University to give a lecture at the Conference
on “Prevention of Periparturient Diseases in Dairy Cows” September 4-5 2003, Warsaw, Poland.
Invited to co-author a review on “Vitamin D Metabolism” for Vitamin D 2nd edition edited by D. Feldman,
F.H, Glorieux, J.W. Pike, 2004.
PUBLICATIONS:
Cheng YH, Goff JP, Sell JL, Dallorso ME, Gil S, Pawlak SE, Horst RL. Utilizing Solanum glaucophyllum
alone or with phytase to improve phosphorus utilization in broilers. Poult Sci. 2004 Mar;83(3):406-13.
Foote MR, Horst RL, Huff-Lonergan EJ, Trenkle AH, Parrish FC Jr, Beitz DC. The use of vitamin D3 and its
metabolites to improve beef tenderness. J Anim Sci. 2004 Jan;82(1):242-9.
Waldron MR, Nonnecke BJ, Nishida T, Horst RL, Overton TR. Effect of lipopolysaccharide infusion on
serum macromineral and vitamin D concentrations in dairy cows. J. Dairy Sci. 2003 Nov;86(11):3440-6.
Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL. Mycobacterium bovis infection of vitamin Ddeficient NOS2-/- mice. Microb Pathog. 2004 Jan;36(1):11-7.
Goff JP, Horst RL. Milk fever control in the United States. Acta Vet Scand Suppl. 2003;97:145-7. Review.
Goff JP, Horst RL. Role of acid-base physiology on the pathogenesis of parturient hypocalcaemia (milk
fever)--the DCAD theory in principal and practice. Acta Vet Scand Suppl. 2003;97:51-6. Review.
Horst RL, Goff JP, Reinhardt TA. Role of vitamin D in calcium homeostasis and its use in prevention of
bovine periparturient paresis. Acta Vet Scand Suppl. 2003;97:35-50. Review.
Waters WR, Nonnecke BJ, Foote MR, Maue AC, Rahner TE, Palmer MV, Whipple DL, Horst RL, Estes DM.
Mycobacterium bovis bacille Calmette-Guerin vaccination of cattle: activation of bovine CD4+ and gamma
delta TCR+ cells and modulation by 1,25-dihydroxyvitamin D3. Tuberculosis (Edinb). 2003;83(5):287-97.
Reinhardt TA, Horst RL, Waters WR. Characterization of Cos-7 cells overexpressing the rat secretory
pathway Ca2+-ATPase. Am J Physiol Cell Physiol. 2004 Jan;286(1):C164-9. Epub 2003 Sep 10.
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Nonnecke BJ, Waters WR, Foote MR, Horst RL, Fowler MA, Miller BL. In vitro effects of 1,25dihydroxyvitamin D3 on interferon-gamma and tumor necrosis factor-alpha secretion by blood leukocytes
from young and adult cattle vaccinated with Mycobacterium bovis BCG.
Int J Vitam Nutr Res. 2003 Jul;73(4):235-44.
Fujiwara I, Aravindan R, Horst RL, Drezner MK. Abnormal regulation of renal 25-hydroxyvitamin D1alpha-hydroxylase activity in X-linked hypophosphatemia: a translational or post-translational defect. J Bone
Miner Res. 2003 Mar;18(3):434-42.
Horst RL, Omdahl JA, Reddy S. Rat cytochrome P450C24 (CYP24) does not metabolize 1,25dihydroxyvitamin D2 to calcitroic acid. J Cell Biochem. 2003 Feb 1;88(2):282-5.
Goff JP, Kimura K, Horst RL.Effect of mastectomy on milk fever, energy, and vitamins A, E, and betacarotene status at parturition. J Dairy Sci. 2002 Jun;85(6):1427-36.
Kimura K, Goff JP, Kehrli ME Jr, Reinhardt TA. Decreased neutrophil function as a cause of retained
placenta in dairy cattle. J Dairy Sci. 2002 Mar;85(3):544-50.
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Periparturient Diseases of Cattle
Project Title:
CRIS Number::
Scientists:
Location:
Contact:

Identification of Factors Causing Immune Suppression at Parturition
3625-32000-068-00D
Horst, R., Goff, J., Schmerr, M., Lippolis, J., Harp, J.
Ames, IA, National Animal Disease Center, Periparturient Diseases of Cattle
Horst, R., Phone: (515) 663-7312, Fax: (515) 663-7669, rhorst@nadc.ars.usda.gov

PROJECT OBJECTIVES:
The major portion of health problems in dairy cattle occur at or around the time of calving; i.e., the
periparturient period. These problems include mastitis, milk fever, retained placenta, and metabolic disorders
such as ketosis and fatty liver. A common thread to many of these disorders may be diminished immune
function. Our work will address mechanisms of immunity as they relate to two of the most economically
important diseases of dairy cattle, mastitis and retained placenta. We will examine the effects of nutritional
supplementation, milk production, or hormone treatments on periparturient immunosuppression in cows. We
will test the actual activity of the immune system of the animals by intramammary challenge of the animals
with common mastitis causing organisms such as the coliform and Streptococcus species. These studies will
also provide information allowing us to investigate the relationship between immunological parameters we can
measure in the lab and actual resistance to disease. These infection models also allow us to examine the
molecular and cellular basis of the host-pathogen interaction in the bovine mammary gland to each bacterial
infection. We are using proteomic analysis, as well as more traditional cytokine and leukocyte function assays
to identify host proteins that are up or down-regulated during infection. We are working to determine whether
bacterial protein expression differs inside the mammary gland from that observed when the bacteria are grown
in culture media by comparing in vivo to in vitro grown bacterial protein expression. Ultimately antigens
expressed in vivo, but not in vitro, could help define antigens necessary for incorporation into vaccines. We
are also using the mammary gland infection model to compare the expression of lymphocyte cell surface
receptors that regulate the migration and activation of immune cells in the mammary gland.
We have recently established an association between immune suppression and the retention of fetal membranes
after calving (retained placenta). We continue to examine the immunologic parameters important in the
etiology of retained placenta by identifying factors affecting neutrophil chemotaxis towards placental
homogenate and attempting to modulate these interactions. A sensitive fluorescence immunoassay for IL8
using laser induced fluorescence on a capillary electrophoresis platform is under development. This assay will
be able to measure IL8 at physiological levels. In addition, we are using genomic and proteomic analysis to
compare protein profiles in placental tissues from cows with and without retained placenta to identify "diseasespecific proteins" that may be critical to the success or failure of placental expulsion.
Completion of these objectives will result in an increased understanding of the mechanisms controlling two of
the most economically important diseases in dairy cattle, mastitis and retained placenta. These findings will
provide insight into rational measures for controlling these diseases.
OVERALL PROJECT ACCOMPLISHMENTS:
We demonstrated that the presence of the mammary gland affects the degree of immune suppression
experienced by the cow during the periparturient period, most likely because milk production causes the cow to
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experience prolonged periods of negative calcium and energy balance. These studies suggest that improved
nutrition to address these two metabolic problems involving energy and calcium balance could have a positive
impact on immune function and resistance to disease. Studies were then conducted to determine whether
manipulation of the energy balance of cows at calving would have an impact on immune function. Cows
outfitted with rumen cannulas were fed a balanced diet formulated to meet their energy needs. Control cows
were allowed to undergo the usual decline in feed intake observed in most cows around the time of calving.
However, treated cows were force-fed their diet through the rumen cannula so that energy intakes were not
permitted to decline. This tactic succeeded in improving the energy balance of the cows but failed to prevent a
decline in immune function in the cows. This research does not mean that energy balance is not important to
the immune system but does suggest that improving energy balance alone will not restore full function to the
immune system. The periparturient cow model we have developed permits assessment of the effects of a
variety of nutritional factors on immune function around the time of calving.
The discovery of a role for the immune system in the etiology of retained placenta has redirected research
focused on prevention of retained placenta into a whole new direction. Scientists now understand why the
search for a link between the hormones associated with the act of parturition and retained placenta was so
frustrating. Immune dysfunction is more likely at the heart of the retained placenta problem. We have
discovered that cows developing retained placenta have lower levels of a cytokine, interleukin-8, in their blood
than do cows that expel the placenta normally. Since interleukin-8 is considered the primary factor involved in
neutrophil recruitment, a reason for the lack of production of this cytokine is our current focus.
IMPACT:
Demonstrating that all cows are immune suppressed for 1-2 weeks before and after calving has been
instrumental in changing certain farm practices. For instance vaccination of cows on the day of calving was
common because it was a convenient time to handle the cow. We are slowly convincing the industry that the
cow will not respond to vaccinations administered at this time. We have clearly demonstrated that metabolic
disease can worsen the degree of immune suppression experienced by the cow around the time of calving.
Unfortunately we have not determined a way to fix damaged cows and our current focus is on understanding
how to prevent the metabolic diseases from impacting the immune system through improved nutrition and
management.
TECHNOLOGY TRANSFER:
Producers and veterinarians are excited about the implications of this research as it explains why vaccination
protocols for periparturient cows often fail to provide protetion. Our work has clearly defined the major causes
of the immune system shutdown. Producers are very familiar with the veterinary costs incurred during the first
weeks of lactation in dairy cows from masitits and other infectious disease, and have been anxious to learn
more about the factors that contribute to immune suppression in the newly calved cow. Scientists within this
unit have been invited to many National and International meetings in the last two-three years to provide
information on immune function in the periparturient cow and its implications to veterinarians, producers and
allied industry personnel.
J. Goff
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Invited to present a lecture on “Periparturient Immune Suppression and Nutrition” at the University of
California-Davis Veterinary Continuing Education Program at the Tulare Farm Progress Show, Tulare, CA,
February 10, 2001.
Invited to speak on “Milk Fever and Its Association with Metabolic Disease in Dairy Cows” at the Empire
State Corn Days, Miner Institute, Chazy, NY, February 27, 2001.
Invited to speak on “Physiologic Factors to Consider in the Transition Dairy Cow” at the Western Dairy
Management Conference, Las Vegas, NV, April 5, 2001.
Invited to speak at the Guelph University Continuing Education Conference for Dairy Practitioners on “New
Research on Transition Cows”, Guelph, Ontario, Canada May 30, 2001.
Invited to speak at the Feed Additives Update Conference for Dairy Nutritionists on “Adjusting DCAD and
Minerals to Improve Transition Cow Health,” East Lansing, MI, June 5, 2001.
Invited to speak on “The Role of Acid-base Physiology in Control of Hypocalcemia” and “Strategies for
Prevention of Milk Fever” at the Abildegaard Veterinary Conference, Royal Veterinary College,
Fredericksburg, Denmark, August 16, 2001.
Invited to present a seminar on “Mineral and DCAD Adjustments to Prevent Metabolic Disease” for the
ZinPro-Balchem-Kemin joint Ohio Nutrition Conference, Akron, OH, August 28, 2001.
Invited to present a full-day pre-convention seminar on “Dry Cow Nutrition” at the Americasn Association of
Bovine Practitioners Conference, VanCouver, British Columbia, Canada, September 12, 2001. (Unable to
participate due to the tragedy of 09/11/01).
Invited to speak at the Nutritionist Conference for Dairy Consultants on “Dry Cow Physiology and Nutrition,”
Albuquerque, NM, September 26, 2001.
Invited to speak at the Idaho Feed Industry Consortium of Dairy Nutritionists on “Dry Cow Nutrition,” Boise,
ID, September 28, 2001.
Invited to present a Dairy Science departmental seminar on “Physiology of the Transitin Cow” at Penn State
University, State College, PA, November 16, 2001.
Invited to speak at the Colorado Nutrition Conference on “Mineral Management of the Dry Cow, Including
Oral Drenching,” Greeley, CO, January 29, 2002.
Invited to give a lecture in the Plenary Session of the National Mastitis Council meeting on “Mechanisms by
Which Metabolic Diseases Predispose Cows to Infectious Disease,” Orlando, FL, February 5, 2002.
Presented an invited paper on “Management and feeding of the transition cow “ at the Central Wisconsin
Nutrition Meeting, July 23, 2003 in Eau Claire, WI. (75 dairy nutritionists)
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Taught section of a course on dairy herd management and troubleshooting to senior veterinary students at the
Iowa State University Veterinary College from August 11-15 2003. ( 30 veterinary students)
Taught 2 day seminar on nutrition and management of the transition cow at the American Association of
Bovine Practitioners Meeting in Columbus Ohio on September 16 and 17, 2003.
Presented a series of dairy extension talks on “Metabolic disease control and mastitis resistance” to dairy
producers and veterinarians in Valdosta, Ga September 17, 2003,; Chiefland, FL on September 18, 2003; and
Okeechobee, FL on September 19, 2003.
Presented a paper on “Effect of the presence of the mammary gland on periparturient immune function” at the
USDA-ARS Immunology Conference in Bethesda MD on December 2, 2003.
Presented talks on “Macromineral nutrition” and “Factors affecting trace mineral requirements of cattle” at the
Shur-gain Nutrition Conference in Stratford, Ontario, Canada on December 4, 2003.
Served on Committee on Animal Nutrition for the National Research Council of the National Academies of
Science.
Serving on the subcommittee of the Board on Agriculture of the National Academy of Science to revise the
book “Mineral Tolerances of Domestic Animals”.
Section Editor of the Digestive Physiology and Metabolism portion of the revised edtition of the book “Duke’s
Physiology of Domestic Animals” which is a primary textbook for veterinary students.
M. Schmerr
Presented paper “Isolation of the Cytokine IL8 from Bovine Pla sma” HPCE2003 in San Diego, CA January
2003. Mary Jo Schmerr and Kayoko Kimura
Presented paper “Analysis of a Fluorescence Immunoassay for the Cytokine IL-8 by Capillary Electrophoresis”
at HPCE2004 in Salzburg, Austria February 2004
Mary Jo Schmerr and Kayoko Kimura
J. Harp
Chaired Immunology Section at 2002 (St. Louis) and 2003 (Chicago) Annual Meetings of Conference of
Research Workers in Animal Diseases.
PUBLICATIONS:
Cheng YH, Goff JP, Sell JL, Dallorso ME, Gil S, Pawlak SE, Horst RL.
alone or with phytase to improve phosphorus utilization in broilers.
Poult Sci. 2004 Mar;83(3):406-13.
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Utilizing Solanum glaucophyllum

Harp, J.A., Stabel, J.R., Pesch, B.A. and Goff, J.P. Expression of adhesion molecules on milk and blood
leukocytes from periparturient dairy cattle with Johne’s disease. Vet. Immunol. Immunopathol. 98:69-76.
2004.
Stabel JR, Goff JP, Kimura K. Effects of supplemental energy on metabolic and immune measurements in
periparturient dairy cows with Johne's disease.
J Dairy Sci. 2003 Nov;86(11):3527-35.
Goff JP, Horst RL. Milk fever control in the United States. Acta Vet Scand Suppl. 2003;97:145-7. Review.
Harp JA. Cryptosporidium and host resistance: historical perspective and some novel approaches. Anim Health
Res Rev. 2003 Jun;4(1):53-62. Review.
Chen W, Harp JA, Harmsen AG. Cryptosporidium parvum infection in gene-targeted B cell-deficient mice. J
Parasitol. 2003 Apr;89(2):391-3.
Goff JP, Horst RL. Role of acid-base physiology on the pathogenesis of parturient hypocalcaemia (milk fever)-the DCAD theory in principal and practice.
Acta Vet Scand Suppl. 2003;97:51-6. Review.
Horst RL, Goff JP, Reinhardt TA. Role of vitamin D in calcium homeostasis and its use in prevention of
bovine periparturient paresis. Acta Vet Scand Suppl. 2003;97:35-50. Review.
Melendez P, Donovan GA, Risco CA, Littell R, Goff JP. Effect of calcium-energy supplements on calvingrelated disorders, fertility and milk yield during the transition period in cows fed anionic diets.
Theriogenology. 2003 Sep 15;60(5):843-54.
Nonnecke BJ, Kimura K, Goff JP, Kehrli ME Jr. Effects of the mammary gland on functional capacities of
blood mononuclear leukocyte populations from periparturient cows.
J Dairy Sci. 2003 Jul;86(7):2359-68.
Trott DJ, Moeller MR, Zuerner RL, Goff JP, Waters WR, Alt DP, Walker RL, Wannemuehler MJ.
Characterization of Treponema phagedenis-like spirochetes isolated from papillomatous digital dermatitis
lesions in dairy cattle. J Clin Microbiol. 2003 Jun;41(6):2522-9.
Harp, J.A. Parasitic infections of the gastrointestinal tract. Curr. Opin. Gastroenterol. 19:31-36. 2003.
Kimura K, Goff JP, Kehrli ME Jr, Harp JA, Nonnecke BJ. Effects of mastectomy on composition of peripheral
blood mononuclear cell populations in periparturient dairy cows.
J Dairy Sci. 2002 Jun;85(6):1437-44.
Goff JP, Kimura K, Horst RL. Effect of mastectomy on milk fever, energy, and vitamins A, E, and betacarotene status at parturition. J Dairy Sci. 2002 Jun;85(6):1427-36.
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Kimura K, Goff JP, Kehrli ME Jr, Reinhardt TA. Decreased neutrophil function as a cause of retained placenta
in dairy cattle. J Dairy Sci. 2002 Mar;85(3):544-50.
El-Samad H, Goff JP, Khammash M. Calcium homeostasis and parturient hypocalcemia: an integral feedback
perspective. J Theor Biol. 2002 Jan 7;214(1):17-29.
Lippolis JD, White FM, Marto JA, Luckey CJ, Bullock TN, Shabanowitz J, Hunt DF, Engelhard VH. Analysis
of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol. 2002
Nov 1;169(9):5089-97.
Tang M, Harp JA, Wesley RD. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza
virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch Virol. 2002
Nov;147(11):2125-41.
Sonea IM, Palmer MV, Akili D, Harp JA. Treatment with neurokinin-1 receptor antagonist reduces severity of
inflammatory bowel disease induced by Cryptosporidium parvum.
Clin Diagn Lab Immunol. 2002 Mar;9(2):333-40.
Waters WR, Nonnecke BJ, Rahner TE, Palmer MV, Whipple DL, Horst RL.
Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25dihydroxyvitamin D(3). Clin Diagn Lab Immunol. 2001 Nov;8(6):1204-12.
Sunita Rao D, Balkundi D, Uskokovic MR, Tserng K, Clark JW, Horst RL, Satyanarayana Reddy G. Double
bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies
in chronic myeloid leukemia (RWLeu-4) cells and rat kidney.
J Steroid Biochem Mol Biol. 2001 Aug;78(2):167-76.
Luckey CJ, Marto JA, Partridge M, Hall E, White FM, Lippolis JD, Shabanowitz J, Hunt DF, Engelhard VH.
Differences in the expression of human class I MHC alleles and their associated peptides in the presence of
proteasome inhibitors. J Immunol. 2001 Aug 1;167(3):1212-21.
Schell TD, Lippolis JD, Tevethia SS. Cytotoxic T lymphocytes from HLA-A2.1 transgenic mice define a
potential human epitope from simian virus 40 large T antigen.
Cancer Res. 2001 Feb 1;61(3):873-9.
Chen, W., Chadwick, V.S., Tie, A., and Harp, J.A. Cryptosporidium parvum in intestinal mucosal biopsies
from patients with inflammatory bowel disease. Am. J. Gastroenterol. 96:3463-3464. 2001.
Purdy, C.W., Straus, D.C., Harp, J.A., Mock, R., and Popham, T.W. Microbial pathogen survival in a high
plains feedyard playa. Texas J. Sci. 53:247-266. 2001
Kehrli ME Jr, Harp JA. Immunity in the mammary gland. Vet Clin North Am Food Anim Pract. 2001
Nov;17(3):495-516, vi. Review.

77

Heidari M, Harp JA, Kehrli ME Jr. Expression, purification, and in vitro biological activities of recombinant
bovine granulocyte-colony stimulating factor. Vet Immunol Immunopathol. 2001 Aug 30;81(1-2):45-57.
Moore D, Waters WR, Wannemuehler MJ, Harp JA. Treatment with agmatine inhibits Cryptosporidium
parvum infection in infant mice. J Parasitol. 2001 Feb;87(1):211-3.
Nepom GT, Lippolis JD, White FM, Masewicz S, Marto JA, Herman A, Luckey CJ, Falk B, Shabanowitz J,
Hunt DF, Engelhard VH, Nepom BS. Identification and modulation of a naturally processed T cell epitope
from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad
Sci U S A. 2001 Feb 13;98(4):1763-8.
Lippolis JD, Denis-Mize KS, Brinckerhoff LH, Slingluff CL Jr, Galloway DR, Engelhard VH.
Pseudomonas exotoxin-mediated delivery of exogenous antigens to MHC class I and class II processing
pathways. Cell Immunol. 2000 Aug 1;203(2):75-83.
Pelan-Mattocks LS, Kehrli ME Jr, Casey TA, Goff JP. Fecal shedding of coliform bacteria during the
periparturient period in dairy cows. Am J Vet Res. 2000 Dec;61(12):1636-8.
Hagemoser WA, Goff JP, Sanderson TP, Haynes JS. Osteopenic disease in growing pigs: diagnostic methods
using serum and urine calcium and phosphorus values, parathoromone assay, and bone analysis. J Vet Diagn
Invest. 2000 Nov;12(6):525-34.
Goff JP. Pathophysiology of calcium and phosphorus disorders. Vet Clin North Am Food Anim Pract. 2000
Jul;16(2):319-37, vii. Review.
Moore SJ, VandeHaar MJ, Sharma BK, Pilbeam TE, Beede DK, Bucholtz HF, Liesman JS, Horst RL, Goff JP.
Effects of altering dietary cation-anion difference on calcium and energy metabolism in peripartum cows. J
Dairy Sci. 2000 Sep;83(9):2095-104.
Akili D, Harp JA. A factor derived from adult rat and cow small intestine reduces Cryptosporidium parvum
infection in infant rats. J Parasitol. 2000 Oct;86(5):979-82.
Waters WR, Palmer MV, Wannemuehler MJ, Sacco RE, Harp JA. B cells are required for the induction of
intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium
parvum. J Parasitol. 2000 Oct;86(5):1073-7.
Waters WR, Frydman B, Marton LJ, Valasinas A, Reddy VK, Harp JA, Wannemuehler MJ, Yarlett N.
[(1)N,(12)N]Bis(Ethyl)-cis-6,7-dehydrospermine: a new drug for treatment and prevention of Cryptosporidium
parvum infection of mice deficient in T-cell receptor alpha.
Antimicrob Agents Chemother. 2000 Oct;44(10):2891-4.
Jackman R, Schmerr MJ. Analysis of the performance of antibody capture methods using fluorescent peptides
with capillary zone electrophoresis with laser-induced fluorescence.
Electrophoresis. 2003 Mar;24(5):892-6.

78

Hamir AN, Miller JM, Schmerr MJ, Stack MJ, Chaplin MJ, Cutlip RC. Diagnosis of preclinical and subclinical
scrapie in a naturally infected sheep flock utilizing currently available postmortem diagnostic techniques. J Vet
Diagn Invest. 2001 Mar;13(2):152-4.
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Bacterial Diseases of Livestock
Genomic and Immunological Analysis of Spirochetes that Infect
Livestock
CRIS Number:
3625-32000-060-00D
Scientists:
Zuerner, R., Alt, D., Whipple, D. Stanton, T. Vacant
Location:
Ames, IA, National Animal Disease Center, Bacterial Diseases of Livestock
Contact:
Zuerner, R., Phone: (515) 663-7392, Fax: (515) 663-7458
rzuerner@nadc.ars.usda.gov
Project Title:

PROJECT OBJECTIVES:
Spirochetes are bacteria that cause a variety of diseases in animals and humans. Our project studies spirochete
diseases of livestock caused by Leptospira, Brachyspira, and Treponema. Leptospirosis, caused by Leptospira,
is a common cause of reproductive failure (abortion, stillbirth, and production of weak offspring) in livestock.
Diagnosis or isolation of these bacteria in culture is difficult, but essential for controlling the spread of disease.
Leptospirosis can be resolved through the use of antibiotics, and vaccines provide some protection. However,
the effectiveness of vaccination varies among animal species. Furthermore, Leptospira strains are diverse, and
vaccination produces specific immunity with little cross protection against different strains. The Spirochete
Diseases Research Project, Genomic and Immunological Analysis of Spirochetes That Infect Livestock, at the
USDA-ARS National Animal Disease Center (NADC), Ames, IA, is developing novel and sensitive methods
for diagnosis of spirochetes in livestock, conducting genetic and pathogenesis studies to determine how these
bacteria cause disease, and identifying new targets for vaccine development. Brachyspira are intestinal
spirochetes that cause swine dysentery and porcine intestinal spirochetosis. These diseases can cause
significant losses in swine production. Porcine intestinal spirochetosis is difficult to diagnose. Therefore, we
are developing tools for serological diagnosis of infection. Brachyspira are also the only spirochetes with a
known mechanism of genetic exchange. The process by which these bacteria exchange DNA is unusual, and
we are characterizing the process to determine its usefulness for genetic manipulation of spirochetes. Members
of the genus Treponema are associated with papillomatous digital dermatitis (PDD), the primary cause of
lameness in dairy cattle. We are characterizing the bacteria associated with this disease to develop diagnostic
probes and study how these bacteria contribute to the disease.
OVERALL PROJECT ACCOMPLISHMENTS:
Leptospiral vaccines for cattle have been available for years, but field data suggested that effectiveness for
protection against certain types of bovine leptospirosis was not adequate. A new vaccine that was
commercially available in Australia, New Zealand, Ireland and the United Kingdom was evaluated to
determine if it would protect cattle challenged with a United States strain of Leptospira. The vaccine
prevented colonization and shedding of the organism and protected animals against infection. This was in
contrast to poor protection that resulted when cattle were vaccinated with other commercially available
leptospiral vaccines.
Immune responses stimulated by the effective vaccine were characterized to determine why this vaccine was
effective when others were not. Results of this research demonstrated that a potent cell mediated response was
important for protection. This information is important for understanding how to design other effective
vaccines against leptospirosis and other diseases.
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The composition of the Leptospira outer membrane was characterized with the discovery of several major
surface exposed proteins. These proteins are the subjects of studies being done in conjunction with academic
collaborators aimed at developing subunit vaccines for leptospirosis. The major outer membrane protein,
LipL32, was characterized and is well conserved among pathogenic leptospira species. This protein is highly
antigenic and is potentially useful for both diagnosis and vaccine development.
Cattle infected with Leptospira were treated with streptomycin until its withdrawal from the U.S. market.
Alternative antibiotic treatments were tested for efficacious treatment of bovine leptospirosis. This work
provides essential benchmark data that can be used in negotiating export-import restrictions designed to limit
the spread of leptospirosis.
The genome of Leptospira borgpetersenii serovar hardjo, the primary cause of bovine leptospirosis, is being
sequenced. Analysis of genome sequence data led to identification of a surface exposed protein conserved
among pathogenic spirochetes. Conserved and variable regions of other outer membrane proteins were
identified and characterized. Combined, these data will form the basis for subunit vaccine development for
leptospirosis.
Bacteria were isolated from PDD lesions and characterized. These Treponema phagedenis-like bacteria are
similar to bacteria detected in PDD lesions from cattle around the world, and their isolation in pure culture is a
key step in identifying the cause of this disease and developing strategies to control the development of PDD.
Cattle with PDD developed antibody to these bacteria and also developed a cellular immune response to
bacterial antigens. Using a technique called Serial Analysis of Gene Expression (SAGE), the global response
of bovine macrophages to a Treponema phagedenis-like bacterium isolated from a PDD lesion was
characterized. This study is the first description of global host response to any spirochete, and therefore is
breaking new ground in the field. The results of these studies are providing key information on how these
spirochete bacteria affect the host, and thereby establish infection.
Methods were developed to isolate the outer membrane of Brachyspira, leading to identification of outer
membrane proteins. Outer membrane proteins are ideal targets for vaccine development, and may be useful for
sensitive diagnostic assays. These studies established an essential framework for analysis of porcine intestinal
spirochetosis.
IMPACT:
Understanding host immune responses stimulated by effective vaccines will lead to development of improved
vaccines for leptospirosis as well as other diseases. Identification and characterization of specific proteins and
genes of Leptospira could lead to development of efficacious subunit vaccines. Improved vaccines to prevent
disease will result in decreased economic losses to the livestock industry.
Characterizing the organisms that cause PPD is important for developing tools to treat and prevent the disease,
which is a leading cause of lameness in dairy cattle and results in significant economic loss.
Determining the whole genomic sequence of Leptospira borgpetersenii serovar hardjo will lead to
identification of genes and proteins that are associated with virulence of the organism and clues to how the
organism causes disease. This information can be used to develop improved diagnostic tests, vaccines, and
other intervention strategies.
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TECHNOLOGY TRANSFER:
Methods and reagents were provided to diagnostic laboratories to aid in diagnosis of leptospirosis in livestock,
and to assist in isolation of these bacteria in pure culture. Leptospira challenge strains for testing the efficacy of
vaccines were provided to biologics firms, academic laboratories, and to the Center for Veterinary Biologics.
ARS scientists have assisted in evaluation of leptospiral vaccines in collaboration with biologics firms.
PUBLICATIONS:
Haake DA, Suchard MA, Kelley MM, Dundoo M, Alt DP, Zuerner RL. Molecular Evolution and Mosaicism
of Leptospiral Outer Membrane Proteins Involves Horizontal DNA Transfer. J Bacteriol. 2004; 186(9):28182828.
Trott DJ, Alt DP, Zuerner RL, Bulach DM, Wannemuehler MJ, Stasko J, Townsend
KM, Stanton TB. Identification and cloning of the gene encoding BmpC: an outer-membrane lipoprotein
associated with Brachyspira pilosicoli membrane vesicles. Microbiology. 2004;150(Pt 4):1041-1053.
Stanton TB, Thompson MG, Humphrey SB, Zuerner RL. Detection of bacteriophage VSH-1 svp38 gene in
Brachyspira spirochetes. FEMS Microbiol Lett. 2003;224(2):225-9.
Trott DJ, Moeller MR, Zuerner RL, Goff JP, Waters WR, Alt DP, Walker RL, Wannemuehler MJ.
Characterization of Treponema phagedenis-like spirochetes isolated from papillomatous digital dermatitis
lesions in dairy cattle. J Clin Microbiol. 2003; 41(6):2522-9.
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new IS, IS1502. FEMS Microbiol Lett. 2002; 215(2):175-82.
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involvement of WC1(+) gammadelta and CD4 T cells. Infect Immun. 2002; 70(11):6147-57.
Trott DJ, Alt DP, Zuerner RL, Wannemuehler MJ, Stanton TB. The search for Brachyspira outer membrane
proteins that interact with the host. Anim Health Res Rev. 2001; 2(1):19-30.
Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine
induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun.
2001; 69(12):7550-8.
Alt DP, Zuerner RL, Bolin CA. Evaluation of antibiotics for treatment of cattle infected with Leptospira
borgpetersenii serovar hardjo. J Am Vet Med Assoc. 2001;219(5):636-9.
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Antimicrob Agents Chemother. 2001; 45(3):870-7.
Hsu T, Hutto DL, Minion FC, Zuerner RL, Wannemuehler MJ. Cloning of a beta-hemolysin gene of
Brachyspira (Serpulina) hyodysenteriae and its expression in Escherichia coli. Infect Immun. 2001; 69(2):70611.
Bolin CA, Alt DP. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding
in cattle exposed to Leptospira borgpetersenii serovar hardjo. Am J Vet Res. 2001; 62(7):995-1000.
Wagenaar J, Zuerner RL, Alt D, Bolin CA. Comparison of polymerase chain reaction assays with
bacteriologic culture, immunofluorescence, and nucleic acid hybridization for detection of Leptospira
borgpetersenii serovar hardjo in urine of cattle. Am J Vet Res. 2000 Mar;61(3):316-20.
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Brucellosis: Vaccines, Immune Responses, Diagnostic Reagents
3625-32000-061-00D
Olsen, S., Bricker, B., Stoffregen, W., Halling, S., Whipple D.
Ames, IA, National Animal Disease Center, Bacterial Diseases of Livestock
Olsen, S., Phone: (515) 663-7230, Fax: (515) 663-7458, solsen@nadc.ars.usda.gov

PROJECT OBJECTIVES:
Brucellosis is a disease of cattle that causes abortion and associated economic losses and has been nearly
eradicated from cattle in the U.S. after 60 years of regulatory efforts. However, a high percentage of feral
swine, and elk and bison in Yellowstone National Park and surrounding areas have brucellosis and have the
potential to transmit the disease to cattle. During the winter months, elk may share feed grounds with cattle,
and bison may migrate from Yellowstone National Park to areas where they may have direct contact with
cattle. We have identified Brucella abortus strain RB51 as an efficacious vaccine for bison and cattle that does
not interfere with identification of Brucella-infected cattle. However, recent data suggest that the strain RB51
vaccine does not protect elk against brucellosis. Through studies at the USDA-ARS-National Animal Disease
Center (NADC), Ames, IA, and collaborative work with scientists from other agencies, we are working to
develop new vaccines that are safe and efficacious and vaccine delivery systems that would protect wildlife
and domestic livestock against brucellosis. This will facilitate the completion of the Brucellosis Eradication
program and assist in reducing or eradicating the disease from wildlife. ARS is also conducting research to
determine the duration of immunity when cattle are vaccinated as calves with B. abortus strain RB51. This is
important to determine how long cattle are protected against brucellosis. Several feral swine populations in the
US are infected with B. suis and pose a potential threat to the livestock industry. ARS scientists are conducting
research to develop efficacious vaccines to protect feral swine against B. suis infection and prevent
transmission of the organisms to domestic livestock. In addition, the whole genome of a field strain of B.
abortus is being sequenced to identify potential vaccine candidates and tools for molecular epidemiology.
OVERALL PROJECT ACCOMPLISHMENTS:
As a result of work first initiated in 1991, the B. abortus strain RB51 vaccine received full licensure from the
USDA-Animal and Plant Health Inspection Service (APHIS) in 2003 as the first new brucellosis vaccine for
cattle in over 50 years. Strain RB51 has replaced the strain 19 vaccine throughout the U.S. and is being used,
or considered for use, in numerous other countries. The strain RB51 vaccine induces similar protection in cattle
against brucellosis as the previously used strain 19 vaccine, and also has a significant advantage over strain 19
in that cattle vaccinated with strain RB51 do not have antibody responses that cause positive reactions on
brucellosis surveillance tests. This has eliminated countless vaccine-induced, false-positive serologic responses
that previously would have required investigation by regulatory personnel. Our studies have demonstrated that
strain RB51 is safe in cattle or bison as a calfhood vaccine, is safe in adult bison bulls, and can be safely
administered at a reduced dosage to pregnant cattle. Our data also demonstrate that calfhood vaccination of
bison with strain RB51 protects against Brucella-induced abortion or fetal infection. With the completion of
appropriate safety and efficacy studies in target and nontarget species, it is anticipated that strain RB51 will be
utilized in bison in the Greater Yellowstone Area. Our studies have also suggested that antigens that stimulate
protective cell-mediated immunity may be conserved across Brucella species. These data suggest that genes or
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gene products which mediate protection against B. abortus will have efficacy in protection against other strains
of brucellosis which are more prevalent in other countries.
A new method to determine and compare the DNA fingerprint of Brucella isolates was developed using
information generated from the project to sequence the whole genome of B. abortus. This method has been
used to help identify potential sources of infection and aid in epidemiological investigations of outbreaks of
brucellosis in cattle.
IMPACT:
Results of ARS research were used to support granting full licensure for use of B. abortus strain RB51 as the
first new brucellosis vaccine for cattle in 50 years. The vaccine is now used throughout the US and other parts
of the world. The safety and efficacy of B. abortus strain RB51 is now being evaluated in bison for possible
use in Yellowstone National Park.
The DNA fingerprinting method developed by ARS scientists is being used to aid state and federal regulatory
officials in their investigations of outbreaks of brucellosis. This is the first method that can be used to reliably
determine the fingerprint of Brucella strains beyond species and biovar level and represents an important
advance in the field of science.
Research conducted by ARS scientists has led to the discovery of B. abortus infection in a population of feral
swine that is also infected with B. suis. This is an important discovery and suggests that feral swine my pose a
threat for transmission of both organisms to domestic livestock. Additional research is being conducted to
determine the extent of the problem and to develop vaccines to protect feral swine against infection with
Brucella.
TECHNOLOGY TRANSFER:
The Brucella abortus strain RB51 vaccine has been transferred to a company that is producing a commercial
strain RB51 product which is approved by the Animal and Plant Health Inspection Service (APHIS). The
RB51 vaccine is being universally utilized by producers throughout the U.S. and in a number of other
countries. Through attendance and presentations at international meetings, national meetings, symposia, the
Greater Yellowstone Interagency Brucellosis Committee, and local presentations, the results from our research
have been presented to scientists, regulatory personnel and producers for field application. Knowledge on
development of brucellosis vaccines and characterization of immunologic responses has also been transferred
to Russian scientists through a cooperative program in the Department of Defense. Scientists are continuing to
assist APHIS in completion of an environmental assessment of RB51. Knowledge gained by ARS scientists in
regards to the use of the strain RB51 vaccine in cattle, bison, and elk has been transferred to state and federal
regulatory personnel and is being incorporated into brucellosis management programs.
PUBLICATIONS:
Olsen SC, Holland SD. Safety of revaccination of pregnant bison with Brucella abortus strain RB51. J Wildl
Dis. 2003; 39(4):824-9.
Bricker BJ, Ewalt DR, Halling SM. Brucella 'HOOF-Prints': strain typing by multi-locus analysis of variable
number tandem repeats (VNTRs). BMC Microbiol. 2003; 3(1):15.
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Bricker BJ, Ewalt DR, Olsen SC, Jensen AE. Evaluation of the Brucella abortus species-specific polymerase
chain reaction assay, an improved version of the Brucella AMOS polymerase chain reaction assay for cattle. J
Vet Diagn Invest. 2003; 15(4):374-8.
Ewalt DR, Bricker BJ. Identification and differentiation of Brucella abortus field and vaccinestrains by BaSSPCR. Methods Mol Biol. 2003; 216:97-108.
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Bricker BJ. PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002; 90(1-4):435-46.
Halling SM. Paradigm shifts in vaccine development: lessons learned about antigenicity,
pathogenicity and virulence of Brucellae. Vet Microbiol. 2002; 90(1-4):545-52.
Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, Dodson
RJ, Umayam L, Brinkac LM, Beanan MJ, Daugherty SC, Deboy RT, Durkin AS, Kolonay JF, Madupu R,
Nelson WC, Ayodeji B, Kraul M, Shetty J, Malek J, Van Aken SE, Riedmuller S, Tettelin H, Gill SR, White
O, Salzberg SL, Hoover DL, Lindler LE, Halling SM, Boyle SM, Fraser CM. The Brucella suis genome
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A. 2002;99(20):13148-53.
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bacterial pellets. Biotechniques. 2002; 33(3):480, 482.
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Vet Diagn Invest. 2001; 13(5):379-82.
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rodents and birds with Brucella abortus strain RB51 vaccine. J Wildl Dis. 2001; 37(3):532-7.
Redkar R, Rose S, Bricker B, DelVecchio V. Real-time detection of Brucella abortus, Brucella melitensis and
Brucella suis. Mol Cell Probes. 2001;15(1):43-52.
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Understanding Host-Pathogen Interactions for the Diagnosis and Control of
Paratuberculosis (Johne's Disease)
3625-32000-062-00D
Stabel, J., Bannantine, J., Robbe Austerman, S., Paustian, M., Peterson-Burch, B.,
Whipple, D.
Ames, IA, National Animal Disease Center, Bacterial Diseases of Livestock
Stabel, J., Phone: (515) 663-7304, Fax: (515) 663-7458, jstabel@nadc.ars.usda.gov

PROJECT OBJECTIVES:
Paratuberculosis (Johne's disease) is a chronic, progressive enteric disease of ruminants caused by infection
with Mycobacterium paratuberculosis. Economic losses are estimated to be $200/infected cow/year and are the
result of animal culling, reduced milk production, poor reproductive performance, and reduced carcass value.
Research in improved diagnostic tests for detection of this disease will provide tools for reducing
contamination of the environment with M. paratuberculosis and the spread of infection in a herd. Research on
the pathogenesis and immunology of M. paratuberculosis infections of cattle is conducted to allow design of
more rational diagnostic and control procedures. Sequencing the genome of M. paratuberculosis will lead to
identification of specific antigens for M. paratuberculosis and will result in better diagnostic tests to allow
early detection of subclinically infected animals and reduce the incidence of disease in herds.
OVERALL PROJECT ACCOMPLISHMENTS:
Significant progress has been made in the development and/or optimization of new diagnostic tools for the
detection of Johne's disease. Fecal culture methodology has been improved and diagnostic laboratories
throughout the U.S. are using this technique. Optimization of the gamma-interferon test for detection of
subclinically infected animals has been achieved through incorporation of our antigen preparations in the test,
allowing for detection of infected animals less than 6 months of age. The ability to accurately identify animals
in the early stages of disease is a critical control point. Development of the fecal polymerase chain reaction
(PCR) test may yield more timely and sensitive detection of infected animals that are shedding the bacteria in
their feces.
Little information is available on host immune responses to M. paratuberculosis infection in cattle and other
species of ruminants. Host immune responses in the subclinical and clinical stages of disease have been
evaluated using cattle, bison, and a mouse model. Our work has shown that secretion of proteins (cytokines,
IFN-g, IL-10, TGF-b) by immune cells and activation of immune cells is affected by the different stages of
infection. This information is helpful in developing diagnostic tools for Johne's disease as well as treatment
strategies.
M. paratuberculosis has been implicated as a causative factor in Crohn's disease, an inflammatory bowel
disease, in humans. A proposed method of infection is via contaminated dairy products from cows with Johne's
disease. Experiments were conducted to evaluate current pasteurization standards set by the dairy industry on
the destruction of M. paratuberculosis in raw milk using state-of-the-art technology. Our work has
demonstrated that continuous flow pasteurization of milk effectively destroys M. paratuberculosis. This work
is critical in ensuring a safe, clean product for U.S. consumers.
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Improvement of diagnostic tools and development of vaccines is dependent upon the identification of specific
antigens for M. paratuberculosis. A genomic library for M. paratuberculosis was screened and several clones
specific to M. paratuberculosis were recovered. One clone, HspX, has been characterized in our laboratory and
has been patented. Thirty additional genes have been cloned and expressed and are being evaluated for use in
diagnostic tests. Further characterization of additional clones and expression of proteins from them will aid in
the development of more sensitive diagnostic tests.
IMPACT:
Results of ARS research showed that M. paratuberculosis is effectively killed at high concentrations in milk
during pasteurization. In the study, several heat treatment regimes were evaluated using three different strains
of M. paratuberculosis. Evaluation of current pasteurization methods used by the U.S dairy industry
significantly impacted the recommendation that pasteurized milk is safe for human consumption.
Identification of new unique genes for M. paratuberculosis will have significant impact on development of
diagnostic tools for detection of Johne’s disease in ruminants. Currently, cross-reactivity with other
mycobacterial species in serologic tests can result in false positive test results for Johne’s disease, which causes
economic loss for livestock producers. In addition, sensitivity of detection is a significant problem in most
diagnostic tests for Johne’s disease. Developing and optimizing improved diagnostic tests for identification of
infected animals is important for controlling the spread of this disease. Furthermore, these antigens can be
evaluated as vaccine candidates in the calves to either prevent infection or decrease clinical signs.
Continued work on host immune responses in different stages of disease (subclinical and clinical) will provide
information on how the disease progresses and what causes the progression from the latent state to clinical
stages of disease. This information can be used to develop new management strategies to prevent escalation of
disease within a herd or treatment options that may be cost-effective for the producer.
TECHNOLOGY TRANSFER:
Polyclonal antibodies to preparations of M. paratuberculosis developed in our laboratory have been transferred
to several companies (Cooperative Research and Development Agreements or MTAs) in collaborative efforts
to develop new diagnostic tools for Johne's disease. Commercial availability of the new diagnostic tools is
dependent upon the companies involved and successful use of these tools.
Invitations to speak about effects of pasteurization on destruction of M. paratuberculosis have resulted in the
transfer of this information to the dairy industry and producers.
ARS scientists have transferred technology by giving numerous presentations on various aspects of Johne’s
disease research to scientific organizations and livestock industry groups. Groups have been particularly
interested in research on pasteurization of milk, development of improved diagnostic tests, and application of
the project to sequence the genome of M. paratuberculosis.
PUBLICATIONS:
Khalifeh MS, Stabel JR. Effects of Gamma Interferon, Interleukin-10, and Transforming Growth Factor beta
on the Survival of Mycobacterium avium subsp. paratuberculosis in Monocyte-Derived Macrophages from
Naturally Infected Cattle. Infect Immun. 2004; 72(4):1974-82.
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diagnosis. J Clin Microbiol. 2003; 41(5):2015-26.
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90

Stabel JR, Wells SJ, Wagner BA. Relationships between fecal culture, ELISA, and bulk tank milk test results
for Johne's disease in US dairy herds. J Dairy Sci. 2002; 85(3):525-31.
Bannantine JP, Stabel JR. Killing of Mycobacterium avium subspecies paratuberculosis within macrophages.
BMC Microbiol. 2002; 2(1):2.
Lee H, Stabel JR, Kehrli ME Jr. Cytokine gene expression in ileal tissues of cattle infected with
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Dargatz DA, Byrum BA, Barber LK, Sweeney RW, Whitlock RH, Shulaw WP, Jacobson RH, Stabel JR.
Evaluation of a commercial ELISA for diagnosis of paratuberculosis in cattle. J Am Vet Med Assoc. 2001;
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Diagnosis and Control of Tuberculosis in Livestock and Wildlife
3625-32000-063-00D
Palmer, M., Waters, W., Whipple, D.
Ames, IA, National Animal Disease Center, Bacterial Diseases of Livestock
Palmer, M. Phone: (515) 663-7474, Fax: (515) 663-7458, mpalmer@nadc.ars.usda.gov

PROJECT OBJECTIVES:
Bovine tuberculosis, which is caused by Mycobacterium bovis, is an infectious disease that affects many
species of animals as well as human beings. Animals infected with M. bovis can shed organisms as they exhale
or cough and in various secretions including saliva, milk, and urine. Elimination of animals infected with M.
bovis is important to prevent the spread of disease among animals and to human beings. The U.S. initiated a
program to eradicate tuberculosis from cattle in 1917 when the prevalence of disease was approximately 5%.
In general, the eradication program has been successful and today, less than 0.002% of cattle are infected with
M. bovis. However, a low prevalence of disease has persisted over the last 10-15 years and it has not been
possible to eradicate bovine tuberculosis from the U.S. using available technology. Improved diagnostic tests
and control measures are needed to detect and eliminate the few remaining cattle herds that have bovine
tuberculosis. In addition, tuberculosis has been detected in captive deer and elk and in wild white-tailed deer,
coyotes, raccoons, bear, bobcat, opossum, and fox. There is epidemiological and experimental evidence to
suggest that tuberculosis has been transmitted from deer to cattle. The presence of tuberculosis in wildlife
poses a serious threat to the national eradication program. Other countries with tuberculosis in wildlife species
have been unable to eradicate the disease from the domestic livestock population. The Bovine Tuberculosis
Research Project at the USDA-ARS-National Animal Disease Center (NADC), Ames, IA, is conducting
research to develop a better understanding of the interactions between various host species and M. bovis,
including immune response, antemortem diagnosis, prevention through vaccination, disease progression and
interspecies transmission.
OVERALL PROJECT ACCOMPLISHMENTS:
A new test, the polymerase chain reaction (PCR) for detection and identification of M. bovis in tissue samples
collected for microscopic examination was developed. When animals are slaughtered, meat inspectors collect
tissue samples from animals that are suspected of having tuberculosis. Tissue samples are examined for
microscopic evidence of tuberculosis and for the presence of organisms. Stains used to detect M. bovis in a
tissue sample also stain other organisms making it impossible to identify the organism in the sample. The new
test detects a specific piece of DNA that is present only in organisms that cause tuberculosis. The new test
permits more accurate and rapid identification of animals with tuberculosis than was previously possible. The
test is used extensively at the request of state and federal regulatory officials to confirm suspected cases of
tuberculosis in animals. This technology has been transferred to USDA, APHIS.
A method differentiate strains of M. bovis was developed. Differences among various strains of M. bovis can
be identified by using specific genetic markers. Using these markers, it is possible to determine if different
animals are infected with a common strain or different strains of M. bovis. This information is used by
epidemiologists to determine possible sources of infection in outbreaks of tuberculosis in animals. This
technology has been transferred to USDA, APHIS.
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An interferon gamma blood based assay for the diagnosis of tuberculosis in cattle is currently available. NADC
scientists, in cooperation with USDA, APHIS and various state agencies evaluated the accuracy of this assay
compared to traditional skin testing. Such research allowed the approval of the interferon gamma assay for use
in cattle.
An experimental model of tuberculosis in white-tailed deer was developed using intratonsilar inoculation. The
resulting disease is very similar to that observed in naturally infected deer. This model has been used
extensively by NADC scientists to study the transmission of tuberculosis among deer and between deer and
cattle and has demonstrated that deer can transmit M. bovis to other deer or cattle through indirect contact such
as the sharing of feed. This model has also been used to develop and evaluate improved tests for diagnosis of
tuberculosis in deer and to determine the effectiveness of vaccines to prevent infection.
Current surveys to determine the prevalence of tuberculosis in wild white-tailed deer are based on examination
of tissues in the head to detect lesions. In a study that involved detailed examination of the entire deer carcass,
we determined that about 35-50% of the infected deer did not have lesions in the head. This underestimation of
disease prevalence should be considered when estimating prevalence through surveillance efforts that focus on
examination of the head only.
A safe, reliable, and reproducible method of aerosol delivery of Mycobacterium bovis to cattle, or other large
ruminants was developed and validated by scientists at NADC. Aerosol exposure is believed to be a primary
means of M. bovis transmission between cattle. NADC scientists conducted the first and only studies on
aerosol exposure of M. bovis in cattle. These studies have shown that this method of exposure results in lesions
similar to those seen in naturally infected cattle. Such a delivery method is being used at NADC to investigate
disease pathogenesis, transmission, immune responses, and vaccine efficacy and could be used to deliver other
pathogens of cattle where aerosol delivery is critical. Aerosol exposure of deer to M. bovis did not result in
disease similar to that seen in naturally infected deer, further supporting the hypothesis that transmission of M.
bovis between deer involves routes such as sharing of feed.
The outbreak of tuberculosis in white-tailed deer in Michigan, identified in 1995, represents the first wildlife
reservoir of M. bovis in North America and a serious threat to the federal bovine tuberculosis eradication effort.
ARS scientists at NADC demonstrated that M. bovis can be transmitted between deer in close contact, through
the sharing of feed and to deer fawns through oral infection with milk containing M. bovis. These results
document that contaminated milk, in addition to saliva, nasal secretions, urine and feces may be involved in
transmission of M. bovis between deer. Such information is vital for state and federal officials to make
educated decisions concerning disease control strategies.
Currently, tuberculin skin testing is the most common method of antemortem testing of deer for tuberculosis;
however, tuberculin skin testing of deer lacks specificity and requires the capture and handling of animals at
least twice for testing. ARS scientists at NADC have investigated various blood-based assays for the diagnosis
of tuberculosis in deer species common in North America. ARS scientists have shown that a commercially
available assay for interferon gamma may be useful in white-tailed deer, reindeer, and possibly elk. After
further work, this assay could potentially supplement or replace skin testing in captive Cervidae, decreasing
animal handling and testing time. Such tests would decrease overall cost to producers, animal stress and time to
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diagnosis. Serological assays have also been investigated and may be useful for screening animals in field
situations.
IMPACT:
The technology for PCR testing of formalin fixed tissues has been transferred to major stakeholders, USDA,
APHIS, NVSL. This testing has allowed more rapid confirmation of tuberculosis, allowing epidemiologic
investigation to start much earlier than was previously possible. Quarantine times for producers are reduced
and continued spread of disease through animal movements is minimized.
Methods for differentiation of M. bovis strains has been transferred to USDA, APHIS, NVSL and are used to
aid in identification of the source of herd infections and trace movements of infected animals.
The experimental model of infection in white-tailed deer has been used extensively by ARS scientists to study
disease pathogenesis, evaluation of diagnostic tests, vaccine efficacy and interspecies transmission. This model
is currently being used by investigators in other countries (Canada) to examine tuberculosis in red deer and elk.
Utilizing this model, NADC scientists have demonstrated the ability of deer to transmit M. bovis to other deer
and cattle through indirect contact such as the sharing of feed. This information has been extensively used by
Michigan wildlife and agricultural officials to lobby for the banning of supplemental feeding of wildlife to
control the tuberculosis outbreak in northern Michigan. Subsequent epidemiological investigations have
supported these findings and shown an association between supplemental feeding and disease prevalence.
Aerosol methods of infection with M. bovis have been used by ARS scientists to evaluate vaccine efficacy in
cattle. These are the first studies to examine aerosol infection in cattle, the method considered to be the most
likely means of transmission between cattle. Aerosol infection studies in deer conducted by ARS have
demonstrated that white-tailed deer infected by aerosol inoculation do not develop disease similar to that seen
in naturally infected deer. This information further supports the hypothesis that supplemental feeding and
shared feed are primary means of disease transmission and supports state and federal efforts to discontinue the
practice of supplemental feeding of wildlife.
Research on improved diagnosis of tuberculosis in Cervidae has resulted in a change in the interpretation of
tuberculin skin testing results in reindeer by state and federal veterinarians. Based on ARS research a new
scattergram was adopted by USDA, APHIS for interpretation of skin tests results in reindeer that results in
decreased numbers of false positive results, decreased needles destruction of animals, and decreased cost to
USDA. Research on blood based diagnostic assays has resulted in the recommendation by the USAHA in 2003
that the gamma interferon assay for deer be evaluated side by side with skin testing to determine if this blood
based assay may be a suitable replacement for skin testing. Serological assays developed or evaluated by
NADC scientists have been used to assist Michigan wildlife officials in screening of large numbers of trapped
wild deer as an approach to selectively remove tuberculous deer.
Research by NADC scientists comparing traditional tuberculin skin testing and the gamma interferon test for
cattle resulted in the adoption of the gamma interferon test as an officially approved test by USDA for the
diagnosis of tuberculosis in cattle. Furthermore, the gamma interferon test can be used in place of the
comparative cervical skin test. This test is now being widely used in states such as Michigan and Texas.
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Research on an assay to detect nitric oxide as a means of antemortem diagnosis of tuberculosis was patented by
ARS. Patent # 6,673,566. PC 0152.01. Another patent on the use of a recombinant protein for tuberculosis
diagnosis is in the process of being filed.
Diseases at the interface of wildlife and domestic animals have become increasingly important. The study of
infectious diseases in wildlife is costly and challenging and very few institutions are involved in such research
involving agents requiring bio-containment. NADC has been visited by scientists from Plum Island, Winnipeg
and other laboratories to observe how NADC scientists conduct such research. The impact of the overall
wildlife research at NADC has been that NADC scientists are consulted regularly on research in wildlife in
bio-containment involving BL-3 agents and foreign animal diseases.
TECHNOLOGY TRANSFER:
PCR of formalin fixed tissues transferred to USDA, APHIS, NVSL.
Technology to differentiate strains of M. bovis transferred to USDA, APHIS, NVSL.
The gamma interferon assay as well as serological assays have been used on numerous occasions to assist state
and federal animal health officials to more rapidly and accurately diagnose M. bovis infection in deer and
cattle.
NADC scientists have presented research findings on improved diagnostic tests for Cervidae to producer
groups such as the North American Deer Farmers Association and the Reindeer Owner’s and Breeders
Association at their annual meetings.
NADC scientists have presented research findings on improved diagnosis of tuberculosis through use of the
interferon gamma assay in cattle and deer to the United States Animal Health Association on various
occasions.
NADC scientists have presented research findings on the transmission of M. bovis between deer and from deer
to cattle at various meetings of Michigan wildlife and agricultural officials, the United States Animal Health
Association and USDA, APHIS. These officials have used such findings to implement a ban on supplemental
feeding of wildlife to control the tuberculosis outbreak in Michigan.
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Emerging Viral Diseases of Swine
3625-32000-071-00D
Lager, K., Cheung, A., Kehrli, M., Vacant
Ames, IA, National Animal Disease Center, Virus and Prion Diseases of Livestock
Lager, K., Phone: (515) 663-7371, Fax: (515) 663-7458, klager@nadc.ars.usda.gov

PROJECT OBJECTIVES:
Recently, swine influenza virus (SIV) has changed or mutated into different strains or subtypes that have
caused significant losses for the swine industry. There are at least several SIV subtypes circulating in U.S.
swine and currently available vaccines may not protect against all of the subtypes. In addition to the SIV
concerns there has emerged a new swine virus, porcine circovirus type 2 (PCV2), that is associated with a
newly recognized disease syndrome that causes significant losses for the industry, especially in young pigs.
The overall goal of this project is to better understand how SIV and PCV2 cause disease in swine and then
apply this knowledge to develop strategies that can protect swine from these viruses and control the disease
that they cause.
OVERALL PROJECT ACCOMPLISHMENTS:
An inactivated swine influenza virus (SIV) vaccine was developed and this technology was transferred to a
biologics company that is now marketing the vaccine to reduce the economic impact of swine flu. Rapid
diagnostic tests have been developed for the detection of SIV, PCV2, and porcine reproductive and respiratory
syndrome virus (PRRSV) and validation of these assays is underway. Recent studies have demonstrated
Adenovirus-vectored SIV vaccines in young pigs may be used to circumvent the inhibitory effect of passively
acquired SIV maternal antibody, and a potential attenuated SIV virus vaccine has been developed. Porcine
circovirus studies have characterized the molecular biology of the virus resulting in a better understanding of
how this virus replicates and future experiments will apply this knowledge towards understanding how the
virus infects swine and causes disease.
IMPACT:
Use of the inactivated vaccine by pork producers has aided in the prevention and control of swine influenza.
The rapid diagnostic tests can increase the efficincy of diagnostics and may decrease the cost of diagnostic
work. Pathogenesis studies have indicated that even within the same SIV subtype (H3 subtype) there are
antigenically distinct groups of virus and a single H3 vaccine strain may not cross-protect against all H3 SIV
subtypes. This finding may explain potential vaccine failures and it indicates a potential need for continually
evaluating SIV vaccine strains. Understanding the replication of porcine circovirus will provide a means to
evaluate how this virus can cause disease and insight into possible ways the virus could be changed to produce
a vaccine for prevention of disease.
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TECHNOLOGY TRANSFER:
Transfer of SIV vaccine to a biologics company that licensed the vaccine and is currently selling it. Transfer
PRRSV and SIV real-time reverse transcription-polymerase chain reaction (RT-PCR) assays to North Carolina
State, Iowa State, and Oregon State Veterinary Diagnostic Laboratories for use in routine diagnostics.
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PROJECT OBJECTIVES:
Porcine reproductive and respiratory syndrome (PRRS) is a virus-induced disease of swine that is characterized
clinically by reproductive failure of gilts and sows and a respiratory tract illness that is especially severe in
young pigs. It was discovered first in the U.S. in 1987 and soon spread worldwide. The sudden emergence of
PRRS virus in the swine population has led to speculation that it may have arisen by mutation of a similar virus
of another species. However, as of today the origin of PRRS virus is still in question. Our current research is
focused on developing methods for diagnosing, preventing, controlling, and eventually eradicating this costly
disease.
OVERALL PROJECT ACCOMPLISHMENTS:
Accomplishments over the life of the project include: 1) developing better methods of diagnosing PRRS; 2)
developing, evaluating and licensing a laboratory procedure for identifying strains of PRRS virus; 3)
developing, evaluating and licensing a new vaccine for the prevention of atypical PRRS; 4) defining when and
how PRRS virus causes disease; and 5) providing service and consultation to industry representatives, swine
practitioners, other researchers, and swine producers in their efforts to prevent and control PRRS.
IMPACT:
The vaccine is being used by pork producers to prevent and control PRRS. The diagnostic assay has been used
extensively by diagnosticians and field veterinarians for differentiating PRRSV isolates. The animal studies
have provided insight into the pathogenesis of the virus and this knowledge is being used to develope and
improve PRRS control and prevention strategies.
TECHNOLOGY TRANSFER:
A unique PRRSV isolate was developed into an attenuated vaccine and transferred to a biologics company for
liscensing and marketing. Likewise a unique diagnostic assay was developed that can be used to differentiate
PRRSV isolates by a simple code, this technology is used daily by veterinarians and pork producers. Formal
collaborations between ARS and industry has provided information about the safety and efficacy of PRRSV
vaccines and this information has been applied by veterinarians in the development of PRRS control and
prevention strategies. Information concerning the use of replication defective human adenovirus-5 vaccines to
overcome maternal antibody interference was provided to the National Pork Board and the International Pig
Veterinary Society for use by their members. A Cooperative Research and Development Agreement with an
international veterinary biologics company is being initiated to investigate these vectors or others to overcome
this vaccine interference problem.
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PROJECT OBJECTIVES:
Bovine viral diarrhea viruses (BVDV) acting alone or in conjunction with other pathogens are a source of
major economic loss to the U.S. farm economy. Pathogenesis varies from strain to strain and appears to be the
result of a very complex interaction between virus and host. Variation in virulence is not correlated with
replication rates or cytopathology in vitro. Pathogenesis appears to be due in part to the host's response to viral
replication rather than viral replication itself. The goals of this project are to improve the industry's ability to
limit and control infections. Our approach is to correlate variations among BVDV with differences in immune
response and pathogenesis.
OVERALL PROJECT ACCOMPLISHMENTS:
This is a project based on a Project Plan certified by the OSQR February 2, 2002. Current research activity
follows from the previous project. Major accomplishments for the proceeding project include the recognition
of a new type of BVDV (genotype BVDV2). BVDV2 strains differ from previously described BVDV strains
(genotype BVDV1) in the way they are recognized by the immune system, in the makeup of their genetic
information and in the diseases they cause. It was shown that differences between BVDV2 and BVDV1 strains
result in diagnostic and vaccine failure. Further, it was shown that viruses, which cause the most severe form of
acute BVDV infection, belong to the BVDV2 genotype. The first complete characterization of the genetic
makeup of BVDV2 strains was performed. In response to suggestions that BVDV2 strains represented a
variation of the bovine border disease virus (BDV) the first complete characterization of a BDV genome was
done. Comparison of the genetic makeup of BVDV1, BVDV2 and BDV viruses demonstrated that BVDV2
strains were more closely related to BVDV1 strains than BDV strains. Tests based on these comparisons were
developed that differentiated BVDV2 strains from BVDV1 and BDV strains. These tests are now standard
protocol at numerous state diagnostic laboratories and the USDA-Animal and Plant Health Inspection Services
(APHIS), National Veterinary Services Laboratory (NVSL) Diagnostic Virology Laboratory (DVL), Ames, IA.
Two new BVDV vaccines, that are the result of collaboration between NADC and commercial biologics
companies, were recently released. These vaccines offer a wider spectrum of protection compared to previous
vaccines.
IMPACT:
Research done in this project has resulted in a new generation of diagnostics and vaccine that do a better job of
detecting and controlling BVDV infections.
TECHNOLOGY TRANSFER:
Both scientist were on the organizing committee for the meeting “Detecting and Controlling BVDV Infections
held in Ames, IA April 4-5, 2002. The purpose of this meeting was to foster discussion and interaction
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between researchers, diagnosticians, practitioners and biologics company employees regarding strategies
aimed at reducing BVDV losses.
Both scientists acted as editors and contributed articles for a special volume of the journal Biologicals that was
devoted to issues involved with detecting, limiting and preventing BVDV infections. The target audience for
this volume was diagnosticians and field veterinarians.
In conjunction with Agrilabs produced a compact disk that included information on the significance of BVDV
genotypes and biotypes to BVDV management programs. This CD was generated for distribution to producers
and field veterinarians.
Attended meeting and contributed to proceeding of meeting (Paris, March 30, 2001) hosted by Office
International des Epizooties (OIE) called to discuss international standards for purity of reagents used in
biologics production. Asked to speak on BVDV contamination of fetal calf serum.
Conducted classes for veterinarians and producers on the basic biology of BVDV, impact of BVDV and
development of BVDV vaccines for producers and veterinarians (classes qualified as 2 to 3 hours of continuing
education credits for attending veterinarians): Breckenridge, Colorado – July 10, 2002; Reno, Nevada February 28, 2003; Yerington, Nevada - March 1, 2003; Breckenridge, Colorado - July 9, 2003; Hot Springs,
Arkansas – Nov. 21, 2003; Scottsdale, Arizona – January 27, 2004; Oscoela, Iowa – April 7, 2004.
Contacted authors and reviewed manuscripts for a 4 part series on BVDV published in Hoard’s Dairyman in
2002- 2003. Authored one article entitled BVDV: The Basics and co-authored another entitled “To Get Ahead
of BVD: find out what strains you have, keep careful records, and take measures to prevent spread of all
diseases”.
Served as presenters at two “miniconferences” on BVDV held in conjunction with the National Cattlemen’s
Beef Association meeting (Cattlemen’s College, Phoenix, Arizona - 1/28/04) and the Western Veterinary
Conference (BVDV Control, Las Vegas, Nevada – 2/15/04).
Researchers in this project have provided numerous groups with one or more of the following: protocols,
virus, antibodies, virus characterization, SAGE techniques and tag IDs, PCR primer sequences, genomic
sequences and/or sequence analysis. These groups include: Biocor Animal Health; Centers for Disease
Control and Prevention; Center for Veterinary Biologics and Product Development; Colorado Serum
Company; Colorado State University; Cornell College of Veterinary Medicine; Fort Dodge Animal Health;
Intervet, Inc.; Iowa State University; National Veterinary Services Laboratory; OIC Virology Laboratory,
NSW, Australia; Oklahoma State University; University of California at Davis; University of Nebraska;
University of North Dakota; Washington State University; and other research projects at NADC.
In addition, researchers in this group have participated in 3 Cooperative Research and Development Agreement
(CRADA) with industry; 2 USDA-CSREES-NRI-CGP grant; attended and presented data at 4 international
meetings, 11 national meetings and 5 regional meetings; acted as outside reviewers for the Office International
des Epizooties (OIE) Manual on BVDV; and acted as scientific reviewers for the following journals:
Biologicals; Archives of Virology Comparative Immunology; Microbiology and Infectious Diseases; Journal
107

of Clinical Microbiology; Journal of Virology; Veterinary Microbiology; and Virus Research, Virology and
served on the editorial board of Virus Research and Veterinary Research Communications.
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PROJECT OBJECTIVES:
This project was expanded in January 2002 from the original TSE project that investigated scrapie. Today the
project focuses on investigations of various Transmissible Spongiform Encephalopathies (TSE), which are
fatal degenerative diseases of the central nervous system that can affect several animal species, including
humans. The causal agent is believed to be a natural tissue protein, the prion protein, that has assumed an
unnatural form. Because the altered protein is resistant to enzyme degradation, it accumulates in nervous tissue
and the resulting dysfunction ultimately leads to death. The specific TSEs being investigated in this project are
scrapie in sheep, chronic wasting disease (CWD) in deer and elk, and transmissible mink encephalopathy
(TME) in mink. The major concern about these diseases is that another TSE, bovine spongiform
encephalopathy (BSE), has been shown to cross the species barrier to cause a unique TSE in human beings.
Although there has not been a similar demonstration that scrapie, CWD or TME could present any risk to
human health, the BSE experience has raised many questions about the potential hazard these TSEs present for
transmission to other animal species, especially domesticated livestock and wildlife. The major objectives are
to assess transmissibility of the TSEs that affect livestock and wildlife species, to develop methods for
differentiation of TSE strains, and to determine the pathobiology of these diseases in the natural host and after
cross-species transmission. Results of animal inoculation studies are then compared to results obtained with a
variety of laboratory procedures to determine if they can be used as predictive models for future risk
assessments. These studies also provide information about the clinical and pathological disease characteristics
that can be expected if a TSE crosses the species barrier, thus enabling animal health specialists to recognize
such situations should they occur. Additional transmission studies in the natural host will focus on determining
the modes of transmission and disease development in scrapie and CWD so that appropriate intervention
strategies can be devised that will control the spread of these diseases. Studies, in collaboration with APHIS,
are underway to determine the role of genetics in the susceptibility of elk to CWD. The scrapie, CWD and
TME agents will be used in experiments to further assess the risk that these TSEs might pose to cattle, sheep,
and swine. These experiments will also provide information and tissues that can be used to evaluate the
effectiveness of current diagnostic protocols for animal TSEs. Cooperative research with the United Kingdom
includes strain typing of CWD isolated from cases in the U.S.A. utilizing the mouse bioassay, use of
recombinant prion proteins to develop or improve existing in vitro conversion strain-typing assays, use of
immunohistochemistry to improve the standard pathology-oriented mouse strain-typing bioassay, and
development of in vitro assays to predict infective titer of tissues derived from TSE-affected animals. Sheep
scrapie studies are underway to determine influences of strain source and host genetics in disease progression.
Current experiments are in progress to determine transmissibility of CWD from mule deer into cattle and
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sheep. White-tailed deer have been inoculated with CWD from elk, mule deer and white-tailed deer to
determine if there are strain differences in the agent that depend on host origin.
OVERALL PROJECT ACCOMPLISHMENTS:
Scientists on this project have demonstrated the transmissibility of scrapie to cattle by intracerebral inoculation
and that the pathology of scrapie-affected cattle differed from BSE; importantly, cattle were shown to be
resistant to challenge with scrapie by the oral route. Another significant accomplishment was the development
and ongoing verification of the immunohistochemistry (IHC) test used by APHIS in the BSE surveillance
program. A recent contribution of this project was the development of a method to conduct genotyping of the
sheep prion gene using formalin-fixed and paraffin-embedded tissues as the DNA source material. Most
recently, several of our research capabilities were utilized when project scientists contributed critical research
in support of the 2003 BSE diagnosis. Western blot analyses and prion allele sequencing from the index case
verified the accuracy of the APHIS IHC test and the species origin of the tissues as bovine. Current studies of
CWD transmissibility to cattle indicate a relative resistance to infection and a pathology profile which differs
from BSE. Another significant accomplishment was the demonstration that abnormal prions are not detectable
by IHC in striated muscle tissues from animals experimentally inoculated with agents of TSEs. The current
project has also demonstrated the utility of raccoons as a model for strain-typing TSEs; raccoons are very
susceptible to TME, moderately so to scrapie, and resistant to CWD. In FY 2003 a mouse facility, dedicated
for TSE strain typing of U.S. TSE isolates was built. This is a critical advance in our research capabilities to
conduct the gold standard mouse bioassay for the differentiation of TSE strains (“strain-typing”). The mouse
bioassay uses 4 inbred mouse strains with different prion protein genotypes. The new facility is essential for
rearing these mice and is now operational. Mice from different PrP genotypes are being raised for future
inoculation with defined U.S. scrapie and CWD isolates. Concurrently, in vitro strain typing efforts which rely
on biochemical analysis of the pathological form of the prion protein (PrPd) were started because the animal
bioassay is relatively slow and expensive. This methodology involves determination of molecular mass and
glycoform profile by Western Blot analysis. Preliminary results indicate CWD isolates from mule deer and
white-tailed deer differ in molecular size when compared to CWD isolates from elk. Recently, completed
work has determined that scrapie can be transmitted to elk and the resulting disease is indistinguishable from
CWD in that species.
IMPACT:
Ongoing research verification of the IHC test used by APHIS has ensured the sensitivity and specificity of the
test for BSE. Research support of the 2003 BSE case provided APHIS diagnostic pathologists with research
verification of the IHC results and assurance the brain tissue was accurately identified as bovine in origin. A
critical question for consumers is whether abnormal prion protein is present in meat, our research has shown
that abnormal prion protein is not detectable by IHC in skeletal muscle tissues of animals experimentally
inoculated with scrapie, CWD or TME. The demonstration that cattle and sheep are relatively resistant to
experimental inoculation with CWD suggests that transmission of CWD to cattle or sheep in nature is not
likely to occur easily. In addition, raccoons were shown to be a potential model for in vivo differentiation of
the 3 animal prion diseases found in the United States (scrapie, CWD, and TME).
TECHNOLOGY TRANSFER:
The current and past cross-species-transmission TSE studies have generated a unique set of tissue reagents that
have been shared with others for research and diagnostic purposes. This transfer of technology, along with the
immunohistochemistry test developed by Dr. Miller at NADC (used around the world), has provided
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diagnostic tools to many laboratories. Application of in vitro research techniques provided critical information
to APHIS during the December 2003 diagnosis of BSE in a bovine from Washington State.
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PROJECT OBJECTIVES:
Fowl cholera (caused by Pasteurella multocida) and bordetellosis (caused by Bordetella avium) are bacterial
diseases responsible for major economic losses to the poultry industry, especially the turkey industry.
Bordetellosis usually affects young turkeys, 1 day to 6 weeks of age, while fowl cholera usually affects turkeys
at 8 weeks of age and older. Often turkeys may experience both diseases, i.e., bordetellosis followed by fowl
cholera. Live-attenuated vaccines against fowl cholera often fail to protect turkeys after the birds have
experienced bordetellosis, and killed vaccines against fowl cholera do not protect poultry against different
types of P. multocida. The bacterial components and host conditions responsible for these actions have not
been identified. The components of P. multocida that produce immunity to the same and different types of the
bacteria are being purified and evaluated for use as protective vaccines against fowl cholera and for use in
developing tests of immunity in vaccinated flocks. The components of B. avium responsible for immune
suppression are being identified and their mechanisms of action on the turkey and its immune system are being
characterized.
OVERALL PROJECT ACCOMPLISHMENTS:
Hyaluronic acid, a component of host tissues and the capsule of P. multocida, was found to be responsible for
attachment of the bacteria to turkey air sac macrophages, but not to blood monocytes. Growth of monocytes in
tissue culture resulted in upregulation of a glycoprotein receptor. Because bacterial invasion of the host
initially involves attachment to a host receptor, this glycoprotein may be involved in invasion by P. multocida.
Methods or materials, which inhibit bacterial attachment to this receptor, may provide a means to protect
against fowl cholera.
Turkeys infected with B. avium respond poorly to vaccination with live-attenuated vaccines against fowl
cholera. Research has shown that B. avium infection did not result in a poor immune response to vaccination
when bacterins are used to control fowl cholera. These findings imply that strategies can be developed
whereby immunization of breeder hens to B. avium and vaccination of their offspring with P. multocida
bacterins will control fowl cholera in turkeys when vaccination with live-attenuated vaccines of P. multocida is
not feasible.
The antigen in P. multocida that produces protection against different serotypes of the bacteria was identified
and purified. This antigen is most likely responsible for the protection against different serotypes of P.
multocida conferred by live-attenuated vaccines. With identification and further characterization of the
protective determinant, it may be possible to develop reagents and tests to predict flock immunity produced by
live-attenuated vaccines.
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A method for DNA fingerprinting R. anatipestifer was developed. This molecular method can be used to
determine the epidemiology of R. anatipestifer in turkeys and ducks.
A method for DNA fingerprinting B. avium was developed. This molecular method can differentiate B. avium
from the non-pathogenic B. hinzii, which often occurs in turkeys and can be used to determine the
epidemiology of B. avium.
Monoclonal antibodies to the type specific antigen of serotypes 1, 2, and 3 P. multocida were developed and
will be used to develop new and simpler tests for serologic typing of P. multocida.
Little is known about the transmission or prevalence of B. avium in wild birds or whether wild birds may act as
a reservoir for domesticated poultry. We surveyed 237 birds, representing 61 wild bird species, for evidence of
past or present B. avium infection. Approximately 42% of the birds sampled, representing 41 species, were
identified as having been infected with B. avium. DNA analysis of B. avium isolates from wild birds showed
that at least some were indistinguishable from clinical isolates from domesticated turkeys. These results
suggest that transmission of B. avium from free-living avian populations may be possible and should be of
concern to producers.
Two genetic lines of turkeys were infected with B. avium to determine whether there might be genetic variation
in resistance to bordetellosis. No differences were found in the time of onset, incidence, or severity of clinical
signs of bordetellosis between the two lines of poults infected with B. avium. However, there was a significant
depression (12%) in body weight of one line of poults selected for rapid growth rate. This study is the first to
show genetic variation in response of poults to experimental infection with B. avium and suggests that disease
resistance to bordetellosis may be further improved by genetic selection.
With researchers at the UCLA School of Medicine, two new avian epithelial antimicrobial peptides,
Gallinacin3 and gallopavin1, were identified in tissues from chickens and turkeys, respectively. Expression of
Gallinacin3 was especially prominent in the tongue, bursa of Fabricius, and trachea of chickens. Tracheal
expression of Gallinacin3 was significantly increased following infection with Hemophilus paragallinarum,
whereas its expression in tongue, oesophagus, and bursa of Fabricius was unaffected. These peptides may be
important in the host innate immune defense mechanism to respiratory tract infection.
With researchers at Ohio State University, Beltsville Small White turkeys were found to represent a unique
source of variation in major histocompatibility complex (MHC) class II genes and could be useful for
immunological experiments that require syngeneic (MHC-matched) cells. The MHC is a chromosomal region
containing a family of genes that encode a group of proteins involved in regulating a number of cellular
processes of importance to the immune response.
The research that was accomplished will assist in efforts to use the Pasteurella lipoprotein B protein for
cloning, expressing and utilization in challenge studies for development of a new vaccine for fowl cholera.
This progress report addresses Objective 1 of the research plan to determine the mechanisms of pathogenesis
of P. multocida.
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IMPACT:
The work described to date reflects activities that were instrumental to developing new objectives outlined in
the recent OSQR Project Plan (submitted for review 9/5/03). The new objectives focus on bacterial respiratory
diseases of poultry and are as follows: (1) Define virulence mechanisms of Ornithobacterium rhinotracheale
(ORT) infection in poultry in order to optimize control strategies and diagnostic methodologies. (2) Determine
the mechanisms of pathogenesis of Bordetella avium associated with tracheal colonization and
immunosuppression in turkeys. (3) Identify and characterize virulence factors and or immunogens of
Pasteurella multocida related to colonization and the development of immunity in poultry. The impact of the
work has created the foundation to (1) develop DNA-based diagnostic tests for accurate bacterial identification
and strain differentiation among isolates; (2) utilize mutant strains of bacteria to examine the pathogenesis
related to toxin production and examine the genes involved in colonization; (3) express outer membrane
proteins of the bacteria which could provide heterologous immunity to multiple serotypes and become
effective vaccine candidates. This information will be useful in defining new methods for inhibiting infection
in poultry.
TECHNOLOGY TRANSFER:
Conducted serotyping analysis of P. multocida strains for diagnostic laboratories and industry.
Conducted DNA fingerprinting on R. anatipestifer for The Michigan State University Diagnostic laboratory to
determine vaccine efficacy.
Provided cultures of P. multocida and H. gallinarum to biologic companies, university laboratories and the
NVI (Bucharest, Romania) for research, diagnostics and vaccine development.
Provided information pertaining to nucleic acid-based detection methods for Bordetella and Pasteurella to an
international online news and information provider specific to animal health industries.
PUBLICATIONS:
Tabatabai, L.B., Zehr, E.S. Identification of five outer membrane-associated proteins among cross-protective
factor proteins of Pasteurella multocida. Infection and Immunity. 2004. 72:1195-1198.
Register, K.B., Sacco, R.E., Nordholm, G.E. Comparison of ribotyping and restriction enzyme analysis for
inter- and intraspecies discrimination of Bordetella avium and Bordetella hinzii. Journal of Clinical
Microbiology. 2003. v. 41(4). p. 1512-1519.
Andersen, A.A., Vanrompay, D. Avian chlamydiosis (Psittacosis, Ornithosis). Saif, Y.M., Barnes, H.J., Fadly,
A.M., Glisson, J.R., McDougald, L. R., Swayne, D.E., editors. Iowa State Press, Ames, IA. Diseases of
Poultry, 11th Edition. 2003. Chapter 25, p. 863-879.
Kunkle, R.A. Fungal infections. Saif, Y.M., Barnes, H.J., Glisson, J.R., Fadly, A.M., McDougald, L.R.,
Swayne, D.E., editors. Iowa State Press, Ames, IA. Diseases of Poultry, 11th Edition. 2003. p. 883-896.
Raffel, T.R., Register, K.B., Marks, S.A., Temple, L. 2002. Prevalence of Bordetella avium infection in
selected wild and domesticated birds in the Eastern USA. Journal of Wildlife Diseases. 2002. 38:40-46.
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PROJECT OBJECTIVES:
Respiratory disease in swine is complex due to interactions between different kinds of bacteria or between
viruses and bacteria, including Bordetella bronchiseptica, Pasteurella multocida, and Haemophilus parasuis.
They often act as secondary lung pathogens following viral infections. Vaccines containing killed B.
bronchiseptica and P. multocida do provide at least some benefit in reducing the economic impact of these
diseases. However, surveys reveal that the majority of U.S. producers find the efficacy of these vaccines to be
low. A major impediment to the development of improved vaccines is a gap in our understanding of the
identity and function of those products of B. bronchiseptica, P. multocida, and H. parasuis that permit the
bacteria to colonize swine and that cause disease. Understanding bacterial and host mechanisms involved in
the pathogenesis of porcine respiratory disease will permit more effective preventive measures and control
strategies to be developed. Models for respiratory diseases in swine caused by B. bronchiseptica and P.
multocida alone, together, and in combination with H. parasuis and viruses such as Porcine Reproductive and
Respiratory Syndrome Virus (PRRSV) are being developed. Products of B. bronchiseptica, P. multocida, or
H. parasuis suspected to have a role in development of disease or inducing immune protection are being
evaluated in laboratory culture systems or in animal models to determine their actual functions. Additionally,
both B. bronchiseptica and P. multocida are difficult to detect using standard laboratory procedures and, as a
result, their impact in disease is probably underestimated. New, more sensitive nucleic acid-based tests are
being developed for their identification and for use in distinguishing different strains.
OVERALL PROJECT ACCOMPLISHMENTS:
DNA vaccines designed to induce cell-mediated and/or antibody responses to the P. multocida toxin (PMT)
have been constructed. The vaccines consist of 2 slightly different eukaryotic expression vectors into which
we have cloned either a truncated PMT gene that retains all known immunogenic epitopes or the full-length
PMT gene, but with a single point mutation that results in genetic detoxification. Immunization of mice with
the recombinant plasmids demonstrated no toxic effects from any of the constructs. However, only one of the
constructs containing the entire PMT gene appears to be immunogenic in mice.
We identified two colonization factors for H. parasuis, a P-5 protein and a P-2 protein based on homologies to
H. influenzae proteins. Using monoclonal antibodies we determined that the avirulent reference strains contain
the P-2 protein as a 55 kDa protein with the exception of serovar 7 and that all virulent strains contain the P-2
protein as a 48 kDa protein with the exception of serovar 4. The P-5 protein was purified, characterized and
the gene for the P-5 protein has been cloned. Field strains will be tested for the presence of P-2 and the P-5
proteins.
Whether or not aerosol spread of respiratory pathogens occurs is of importance for determining methods for
breaking the transmission cycle. We determined that aerosol transmission of both PRRSV and B.
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bronchiseptica occurs, at least over short distances. Thus animals do not necessarily have to be in direct
contact to transmit these diseases among the herd.
Although vaccines for B. bronchiseptica have been widely utilized for many years, improvements are needed
since a majority of swine veterinary specialists report dissatisfaction with their protective efficacy. The protein
pertactin that is produced by B. bronchiseptica has been implicated as an adhesin and protective immunogen in
swine. The DNA and predicted amino acid sequences of the pertactin repeat regions from 81 recent field
isolates and 5 vaccine strains from the United States were determined, and 4 unique pertactin types were
identified. Interestingly, only 2 vaccines possess the most commonly identified pertactin type found in the
swine isolates. If immune protection to B. bronchiseptica correlates with the presence of pertactin, then
vaccine efficacy could be improved by including pertactin types matching those commonly circulating in the
field.
The protein filamentous hemagglutinin (FHA) may also be an important protective antigen for Bordetella
species. Analysis of the FHA genes from different B. bronchiseptica isolates revealed differences in the DNA
sequence and protein structure. Heterogeneity in this gene was not previously known to exist. It may be
possible to improve the efficacy of swine vaccines by ensuring they contain forms of FHA identical to those
found in swine isolates.
P. multocida toxin (PMT), known to cause loss of bone density, also causes alterations in the cells involved in
bone remodelling. B lymphocytes in the bone marrow may interact with these bone cells during their
development. We have developed an in vitro porcine bone marrow culture system in order to examine whether
changes in bone cells induced by treatment with PMT influence the development of B cells in bone marrow.
Modulation of B cell development could influence the host response to secondary infections.
Haemophilus parasuis is a re-emerging pathogen of high-health status swine. We have performed a cluster
analysis of the one-dimensional gel protein profiles of all serovars. Fifteen serovars have been identified of
which six are highly virulent (cause death), four are less virulent (cause no death), and five are completely
avirulent. The results revealed that there are two main groups consisting of the highly virulent and less virulent
strains and six sub groups consisting of similar protein profiles.
Secondary pathogens such as P. multocida and H. parasuis have difficulty establishing infection on their own.
We have shown that prior infection with B. bronchiseptica enhances colonization of both P. multocida and H.
parasuis in the swine upper respiratory tract. Thus, reduction of B. bronchiseptica infection should decrease
the incidence of secondary respiratory infections.
Infection with Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is thought to predispose to
pneumonia with bacterial pathogens. We have shown that PRRSV predisposes to bronchopneumonia with B.
bronchiseptica but not P. multocida. Unlike B. bronchiseptica, P. multocida does not colonize the respiratory
tract well on its own. Enhancing the colonization of P. multocida through prior infection with B.
bronchiseptica resulted in increased incidence of bronchopneumonia with P. multocida when the pigs were
coinfected with PRRSV. Producers should minimize this combination of organisms in their herds since more
severe disease, and possibly further infection with opportunistic bacteria, may occur in co-infected herds.
A B. bronchiseptica mutant unable to produce the dermonecrotic toxin, believed to be its primary virulence
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factor, was produced and subsequently evaluated in swine. The results demonstrated that the toxin is important
for much of the disease manifestations, but that other virulence factors appear responsible for establishing
infection as the mutant was still able to colonize well. Subsequently, experiments were conducted to determine
whether colonization despite the attenuation of disease would be able to predispose to secondary infections. It
was found that infection with the dermonecrotic toxin mutant of B. bronchiseptica was still able to enhance
colonization with P. multocida resulting in lesions of atrophic rhinitis.
Swine isolates of B. bronchiseptica were found to be resistant to killing by sera. Although the genetic locus
conferring serum resistance for other Bordetella species (brkAB) was demonstrated to be present in B.
bronchiseptica, construction and analysis of a mutant strain revealed that some other mechanism must underlie
serum resistance in this species. Therefore, the products of the brkAB genes are not likely to be beneficial as
components of a vaccine.
Ribotyping was developed as a molecular method to discriminate among strains of B. bronchiseptica and was
found to be useful as a tool for investigating outbreaks. Restriction enzyme analysis was developed as a
molecular method to distinguish among Bordetella bronchiseptica isolates.
A sensitive and specific diagnostic test was developed to simultaneously identify B. bronchiseptica and
toxigenic P. multocida in cultures from swine with respiratory disease. The test should eliminate many false
negative results obtained with conventional methods currently in use in clinical laboratories.
A B. bronchiseptica mutant deficient in a major pathway for iron acquisition was constructed and evaluated in
swine. The mutation significantly decreased the bacteria’s virulence, though not sufficiently to be useful as an
attenuated vaccine. However, the results demonstrated that disruption of iron acquisition may provide a means
to control infection.
B. bronchiseptica was found to be capable of invading and surviving within swine alveolar macrophages,
which are a primary host defence mechanism in the lung. Furthermore, B. bronchiseptica was demonstrated to
be cytotoxic for these cells. These observations may explain, in part, the ability of this organism to establish
infection in an otherwise healthy animal and to predispose infected swine to secondary respiratory pathogens.
We demonstrated in vivo and in vitro that greater numbers of bacteria adhere to cells when B. bronchiseptica is
grown at room temperature compared to body temperature, indicating a potential environmental phase in
transmission. B. bronchiseptica was found to attach to swine ciliated nasal epithelial cells through a novel
mechanism that has not been previously described. The attachment factor(s) involved is not produced under
conditions typically used for the growth of bacteria included in bacterin vaccines. Vaccine efficacy may be
improved by changes in growth conditions that would permit production of this attachment factor.
We have established a protein expression map of each of the 15 serovars of H. parasuis under an ironsufficient growth condition. This map in addition to others which will be prepared under other nutrient
limitation or environmental stress will allow us to identify unique proteins of the virulent reference strains
compared to the avirulent reference strains.
We identified two unique and two common proteins by comparing the composites of two virulent reference
strains and two avirulent reference strains grown under iron-sufficient growth conditions. The four proteins
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were characterized by mass spectrometry. One of the unique proteins is a homolog of the H. influenzae
“protective antigen.” The gene encoding this protein will be cloned, expressed, and purified for preliminary
vaccine trials in Caesarean-derived, colostrum-deprived (CDCD) nursery pigs.
We identified a virulence factor and colonization factor of H. parasuis by homology to H. influenzae using H.
influenza primers and PCR. This colonization factor was cloned and expressed in E. coli. The recombinant
adhesion protein P5 will be purified by affinity chromatography and tested in CDCD pigs for its ability to
prevent colonization of the upper and lower respiratory tract.

IMPACT:
The work addresses these objectives in our OSQR Project Plan: to determine the ability of these organisms
and their products to act in concert with other respiratory pathogens to exacerbate disease; to identify, through
genomic and proteomic analysis, changes in gene expression of the host and infectious agents during the
infectious process; and to evaluate intervention strategies to control porcine respiratory disease, including
vaccination. The accumulating amount of evidence indicates that B. bronchiseptica is important in
predisposing to a broad spectrum of respiratory diseases in swine and control of this pathogen will be
important for overall respiratory health of swine. Identification of proteins unique to virulent strains of H.
parasuis will impact vaccine development and diagnostics.

TECHNOLOGY TRANSFER:
Provide consultation to veterinary biologics companies, swine production management companies and
producers.
Have material transfer agreements with several veterinary biologics companies.
Have CRADA 58-3K95-2-921 with BRDC (Effects of PRRSV infection on gene expression in swine).
Have provided ISU diagnostic lab with Pasteurella multocida toxin testing via colony lift assay and PCR
methods and transferred the PCR technology for them to use.
Used ribotyping to investigate the epidemiology of outbreaks of Bordetella bronchiseptica for several swine
production management companies.
PUBLICATIONS:
Brockmeier, S.L. Prior infection with Bordetella bronchiseptica increases colonization with Haemophilus
parasuis in swine. Veterinary Microbiology. 2004. 99:75-78.
Brockmeier, S.L., Lager, K.M. Tissue distribution of porcine reproductive and respiratory syndrome virus
(PRRSV) in finisher age boars and gilts at various times post infection. Proceedings of the18th International
Pig Veterinary Society Congress, Hamburg, Germany. 2004.
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with severe suppurative bronchopneumonia. Journal of Veterinary Diagnostic Investigation. 2003. 15:70-74.
Brockmeier, S.L., Register, S.L. A Bordetella bronchiseptica DNT mutant predisposes pigs to infection with
toxigenic Pasteurella multocida. ASM, Washington D.C. 2003.
Brockmeier, S.L. Atrophic rhinitis and beyond. Pig Progress. Special Swine Respiratory Diseases Issue.
2003.
Register, K.B. DNA-based tools for identification of Pasteurella multocida and Bordetella bronchiseptica.
Feedinfo News Service. feedinfo.com. posted on 12-12-03 under Scientific Reviews. 2003.
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Immunity. 2002. 70:481-490.
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syndrome virus and Bordetella bronchiseptica. Veterinary Microbiology. 2002. 89:267.
Brockmeier, S.L., Lager, K.M., Palmer, M.V. Interactions among porcine reproductive and respiratory
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Proceedings of the 17th International Pig Veterinary Society Congress, Ames, IA. 2002.
Janutenaite, J., Lager, K., Stabel, T., Pesch, B., Brockmeier, S. Evaluation of immune response induced by
attenuated and wild-type PRRS virus. Proceedings of the17th International Pig Veterinary Society Congress,
Ames, IA. 2002.
Lager, K.M., Brockmeier, S.L. A review of area spread and summary of recent studies. Allen D. Leman
Swine Conference, Minneapolis, MN. 2002.
Brockmeier, S.L., Halbur, P.G., Thacker, E.L. Porcine respiratory disease complex. In Polymicrobial
Diseases, K.A. Brogden and J. Guthmiller Editors. ASM Press. 2002.
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subsequent infection with Pasteurella multocida in pigs. American Journal of Veterinary Research. 2001. 62:521525.
Register, K.B., Ducey, T., Brockmeier, S.L., Dyer, D.W. Reduced virulence of a Bordetella bronchiseptica
siderophore mutant in neonatal swine. Infection and Immunity. 2001. 69:2137-2143.
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Proceedings of the Iowa Veterinary Medical Association, Ames, Iowa. 2001.
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Diseases. St. Louis, Missouri. 2001.
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V. Pig Progress. 2001. 20-21.
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and Immunity. 2001. 69:1917-1921.
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Antimicrobial Agents and Chemotherapy. 2001. 45:2198-2203.
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intracellular survival and cytotoxicity for swine alveolar macrophages. Veterinary Microbiology. 2000. 73:1-12.
Brockmeier, S.L., Palmer, M.V., Bolin, S.R. Effects of intranasal inoculation of porcine reproductive and
respiratory syndrome virus, Bordetella bronchiseptica, alone or in combination, in pigs. American Journal of
Veterinary Research. 2000. 61:892-899.
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PROJECT OBJECTIVES:
Respiratory tract diseases are the leading cause of loss from disease in the cattle, sheep, and goat industries.
Annual loss in the United States is estimated to exceed one billion dollars for cattle alone. Viral agents are
well recognized as primary pathogens and even uncomplicated infections can cause substantial economic loss.
Infectious Bovine Rhinotracheitis Virus (IBRV), Respiratory Syncytial Virus (RSV), Parainfluenza Type 3
Virus (PI3V), and Bovine Viral Diarrhea Virus (BVDV) are generally considered the most economically
important viruses against which exist numerous commercially-available multivalent vaccines. Yet the
magnitude and complexity of the problem still exists. A portion of this problem is attributable to Respiratory
Coronavirus and Adenoviruses, which have not been extensively evaluated. Respiratory viruses also
predispose animals to costly bacterial pneumonia caused by Mannheimia haemolytica, Pasteurella multocida,
Haemophilus somnus, and Mycoplasma bovis which commonly affect beef cattle. P. multocida and M.
haemolytica commonly affect dairy cattle. These bacteria remain the major cause of loss from mortality,
reduced feed efficiency, treatment costs, and reduced product quality. Commercial vaccines are available for
bacterial respiratory disease, but their efficacy in the field is questionable. An underlying problem is the
current beef cattle marketing system, which does not allow timely vaccination before the peak period of
disease occurring soon after shipping. Antibiotic usage at this time is prevalent, costly, but beneficial.
Vaccination in sheep and goats is complicated by the broad number of M. haemolytica serovars against which
protection is necessary. The role of Adenovirus in causing or contributing to respiratory disease is being
evaluated using serologic and virus isolation methods. The molecular mechanisms of respiratory tract
colonization and disease progression are being elucidated by construction and testing of non-polar bacterial
mutants. New modified-live vaccine candidates for rapid natural induction of disease resistance are being
constructed and evaluated. Finally, innate mechanisms of respiratory tract resistance to bacterial infection are
being characterized as a new potential point for disease intervention.
OVERALL PROJECT ACCOMPLISHMENTS:
To better understand disease progression and to produce better vaccines, techniques were developed to
genetically manipulate M. haemolytica, P. multocida, and H. somnus. Many of these techniques now are
patented, and four organisms so produced are currently licensed for use in veterinary vaccines. A combination
M. haemolytica/P. multocida single-dose oral vaccine was formulated to address the need for rapid immunity
and reduction of injection-site reactions. Evaluation in laboratory and field experiments show that the vaccine
reduces nasal colonization by M. haemolytica, pneumonic lung lesions, and mortality from respiratory disease.
Vaccination with the new vaccine significantly improves the performance of calves in the feedlot, a benefit not
reported for any currently available respiratory disease vaccine. A live vaccine strain was constructed for
protection of wild Bighorn sheep, which may prove effective following application on hay in the winter. These
studies involve the Pathogen Detection and Diagnostics, Mechanisms of Disease, Epidemiology of Disease,
and Strategies to Control Infectious and Non-Infectious Disease Components of the Animal Health Program.
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High-quality reagents to characterize adenoviruses from ruminants have been lacking in the United States.
Plaque-purified clones and antibodies for prototype cattle, sheep, and goat adenoviruses were produced and
tested for purity. The adenoviruses and antiserum are being used as reference reagents to serotype newlyisolated adenoviruses from ruminants and to determine the prevalence of this group of viruses in the ruminant
population. Two new species of adenovirus were isolated and characterized from goats, and one was isolated
from deer. Two species of bovine adenovirus were isolated and characterized for the first time from U.S.
cattle. Bovine adenovirus 10 has been shown to produce clinical disease and lesions in calves. Knowledge
gained will allow for the determination of importance of specific serotypes of adenovirus in the respiratory
disease complex so that methods of control and diagnosis can be developed. These studies involve the
Pathogen Detection and Diagnostics, Mechanisms of Disease, Epidemiology of Disease, and Strategies to
Control Infectious and Non-Infectious Disease Components of the Animal Health Program.
Not all animals exposed to M. haemolytica develop pneumonia, and these differences may be related to innate
pulmonary defense mechanisms. Three antimicrobial anionic peptides were isolated from pulmonary
surfactant of cattle and sheep. These peptides were small (721.6 – 823.7 Da), hydrophilic, and contained
repeats of aspartic acid residues. Minimal inhibitory concentrations of anionic peptides and similar analogs
were comparable to those of other vertebrate antimicrobial peptides. Other antimicrobial peptides have also
been found in ruminants that are also efficacious. These include proline-rich antimicrobial peptides from
sheep and goat leukocytes and beta defensins. Further study of these innate immune mechanisms may allow
the elucidation of new potential points for disease intervention. These studies involve the Animal
Immunology, Genetic Resistance to Disease, and Strategies to Control Infectious and Non-Infectious Disease
Components of the Animal Health Program.
IMPACT:
Novel delivery of new bacterial respiratory disease vaccines has reduced nasal colonization, reduced retreatment morbidity costs, reduced mortality losses, and repeatedly improved the performance of cattle placed
into feedlots, addressing OSQR Objectives 1 and 2. Commercial veterinary biologics manufacturers are
interested in marketing vaccines based on this technology. Improvements in diagnostic capabilities for
Adenovirus have allowed us to identify type 7 as a prevalent problem among cattle. These improvements
directly address OSQR Objective 3 as we seek to determine the importance of Adenovirus in bovine
respiratory disease.
TECHNOLOGY TRANSFER:
Presented research progress and updates regarding modified-live mucosal vaccination of cattle against bacterial
bovine respiratory disease at National Cattlemen’s Beef Association Annual Conventions and United States
Animal Health Association meetings.
Invited to numerous veterinary biologics firms to present research progress on construction and use of
modified-live vaccine organisms.
Transferred plasmid constructs, recombinant organisms, and technical assistance to veterinary biologics firms
and university projects, including one studying human gingivitis and two working with bighorn sheep.
Consulted and assisted commercial veterinary biologics firms regarding design, construction, and evaluation of
vaccine candidates.
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Provided extensive field support for multiple university projects examining the impact of respiratory
coronavirus, bovine viral diarrhea, and specific vaccination, on calves under typical field conditions.
Provided Mannheimia diagnostic assistance, reagents, and bacterial strains to scientists in domestic and foreign
laboratories.
Participated in and presented “Workshop on Animal Health Research of Common Interest to Mexico and
USA” in Mexico City, where several international cooperative research projects on bovine respiratory disease
were planned, April 2003.
Participated and presented in NCBA Animal Production Research Committee meeting at NADC October 2003.
Provided adenovirus diagnostic assistance (isolation of the virus, serotyping, serologic testing and antiserum to
the prototype ovine and bovine adenoviruses) to scientists in domestic and foreign diagnostic laboratories.
Provided technical assistance on deer adenovirus hemorrhagic disease to several state Departments of Fish and
Game.
Provided technical assistance on parainfluenza virus type 3 and bovine respiratory syncytial virus to scientists
at a state university to study immune reaction to virus infection in the lung of small ruminants.
Served as reviewers for manuscripts submitted to refereed national and international scientific publications.
Corresponded with scientists (Veterinary Medical Research Institute, Hungarian Academy of Sciences) in
Budapest, Hungary, on the Adenovirus Study Group of the International Committee on Taxonomy of Viruses
on adenovirus taxonomy and classification. Results from our laboratory have helped to establish a new genus
Atadenovirus in the Adenoviridae family.
Attended the joint meetings of the American Association of Veterinary Laboratory Diagnosticians and United
States Animal Health Association and participated as a member of the Diagnostic Virology Committee
(AAVLD) and the Committee on Infectious Diseases of Cattle, Bison and Lama (Vice Chair of Committee)
and Committee on Sheep and Goats (USAHA).
Participate and organize the Meeting of the United States-Japan Cooperative Program in Natural Resources
Panel of Animal and Avian Health Meeting held in Ames, IA and Tsukuba Japan alternate years to discuss
research common to the National Animal Disease Center and the National Institute for Animal Health.
Participated in organizing and conducting the meeting on “Diseases at the Interface Between Domestic
Livestock and Wildlife Species” held in Ames, IA, July 17-18, 2003.
Participated as a member of the Sheep Health Committee of the National Institute for Animal Agriculture.
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Construction of Live Mucosal and Injectable Bacterial Vaccines Against
Avian and Bovine Respiratory Diseases
3625-32000-067-03T
Tatum, F., Briggs, R.
Ames, Iowa
National Animal Disease Center
Respiratory Diseases of Livestock
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PROJECT OBJECTIVES:
Pasteurella spp. are part of the normal nasal flora in cattle and are also present in lower numbers in the trachea.
As a consequence of shipping and feedlot stresses, Mannheimia haemolytica (Pasteurella haemolytica) 1
increase on upper respiratory tract mucosa and upon establishment in lungs result in pneumonia. M.
haemolytica produces several virulence factors, foremost of which is leukotoxin, a member of the related
family of toxins designated as RTX (repeated toxins). Other bacteria associated with bovine respiratory
disease include Pasteurella multocida, Haemophilus somnus, and Mycoplasma spp.
We have developed the tools (temperature-sensitive plasmids) and acquired the requisite genetic understanding
(characterized restriction-modification systems) to genetically engineer members of the Pasteurellaceae, a
diverse group of bacteria causing a wide range of diseases in animals and man. The replication-conditional
plasmids, pBB192 and pBBD80, have allowed us to construct 'clean' deletion mutant vaccine candidates of M.
haemolytica, P. multocida, and Haemophilus somnus. Such mutants are devoid of exogenous DNA and
considered by NIH guidelines to be non-recombinant organisms.
OVERALL PROJECT ACCOMPLISHMENTS:
A new mucosal vaccine was developed and tested, in cooperation with New Mexico State University, which
protected cattle from pneumonic Pasteurellosis within 3 days of administration. The vaccine was effective
either by top-dressing on feed or by intranasal administration at the point of first assembly. The vaccine offers
hope to many cattle producers who need a fast and effective vaccine and to the cattle industry which needs to
avoid adverse reactions to injected vaccines.
IMPACT:
TECHNOLOGY TRANSFERS:
PUBLICATIONS:
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PROJECTS
Avian Disease and Oncology Laboratory (ADOL)
• Genomics and Immunogenetics of Economically
Traits of Poultry
• Strategies for Reduction of Tumors and Viral Shedding in Marek's Disease
• Epidemiology, Diagnosis and Control of Retrovirus Infection in Poultry
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Avian Disease and Oncology Laboratory
Project Title:
CRIS Number:
Scientists:
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Contact:

Genomics and Immunogenetics of Economically Important
Traits of Poultry
3635-31320-007-00D
Cheng, H., Zhang, H., Hunt, H.
East Lansing, MI, Avian Disease and Oncology Research
Cheng, H., Phone: (517) 337-6758, Fax: (517) 337-6776, hcheng@msu.edu

PROJECT OBJECTIVES:
Poultry is the third largest agricultural commodity and at 41%, the main meat consumed in the U.S. The
utilization of advanced breeding methods and large-scale industrialization of animal production have enabled
tremendous progress in economic efficiency. The development of large-scale hatcheries and poultry farms has
prompted increased efforts in disease control. Combinations of disease agent eradication, chemoprophylaxis,
vaccination, and sanitation have helped to control but not eliminate losses due to disease. Virus-induced tumor
diseases of particular concern and importance to the poultry industry are being studied at this location. Marek's
disease (MD) is a lymphoproliferative disease (T cell cancer) caused by a member of the herpesvirus family. B
cell cancers are found in avian leukosis virus (ALV)-infected chickens. These diseases cost poultry producers
millions of dollars each year due to condemnation of the birds and reduced egg production. Control of MD has
been achieved through the use of vaccines that prevent tumor development but do not block MDV infection.
Control of ALV is conducted by eliminating virus-positive individuals to eradicate future infections. With
regard to MD, the constant presence of the pathogen, periodic outbreaks in vaccinated flocks, the emergence of
new and highly virulent strains, and the lack of new vaccines all point to the need for continued research on
alternative methods for disease control. One attractive solution is breeding for resistance and/or improved
vaccinal response. Although genetic resistance to MD is complex and controlled by many genes, genetic
selection for high levels of resistance can be obtained. Our goal is to understand the molecular, biochemical
and immunological basis of genetic resistance and vaccinal response to MD. Our multidisciplinary approach is
to develop tools and reagents that can identify all the genes, proteins and pathways involved. Once obtained,
this information will be useful to select chickens with superior disease resistance and response to vaccines,
thereby, increasing animal health, making producers more competitive, and reducing the costs to consumers. In
the case of ALV, besides eliminating virus-positive individuals to stop virus spread in infected flocks, two
other measures should be considered to prevent future outbreaks: 1) use marker-assisted selection to increase
the frequency of resistant birds, and. 2) periodic surveillance to monitor for new disease causing variants. Our
aims are to define genes and alleles that confer viral resistance, understand the mechanisms for generating new
ALV disease-causing variants, and develop chicken strains or selection schemes that would minimize the
potential for producing new highly-virulent ALV strains.
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OVERALL PROJECT ACCOMPLISHMENTS:
Since the inception of this project, the resources to identify agricultural important genes and the results from
the application of these tools have grown rapidly. Using a White Leghorn by Jungle Fowl cross, over 1,200
genetic markers or genes have been placed that cover the entire chicken genome. This genetic map is the most
comprehensive and widely used in the world. The map has been integrated with the other two chicken genetic
maps to make a consensus map containing close to 2,000 markers as well as physical maps. The integrated
genetic and physical maps formed the framework of the whole genome sequence that was released on March
2004. In addition, the genetic map was used to identify many regions containing genes that confer resistance to
MD in both experimental and commercial animals. Unique lines have been developed at our location, which
will greatly aid in the identification and biological characterization of the actual genes. New methods that look
at gene expression variation and viral-chicken protein-protein interactions have been implemented that will
complement our existing efforts. Using a screen to identify virus-chicken protein interactions, it was
determined that chicken growth hormone and stem cell antigen 2 interacts with viral proteins to modulate the
immune response, and both confer disease resistance. These are the first MD resistance genes identified. With
respect to immunology, the molecular characterization of MHC genes in eight B congenic strain was
completed. A new method was developed to make reagents that identify MHC markers on cells. These
reagents helped to demonstrate that MHC gene expression is reduced in MD virus-infected cells. An antiserum
known as R2 was developed that detects endogenous virus (EV) expression, which is valuable since EV
expression has been correlated with decreased egg and meat production, susceptibility to viral-induced tumors,
and possibly the generation of ALV variants. Furthermore, a genetic assay was developed that identifies
chickens resistant to ALV, which enables assessing genetic risk of susceptibility to subgroup B, D, and E ALV
in chicken flocks without involving actual viral challenge. More importantly, it drastically simplifies and
accelerates selection for genetically resistant (or susceptible) lines of chickens to the ALV subgroups. Finally,
a new method has been developed to culture early embryonic cells, which following genetic manipulations, are
still able to properly populate the sex organs of chimeric chickens.
IMPACT:
Our genetic map provided the framework for the chicken genome sequence. With our genetic map,
investigators have been able to identify genomic regions containing genes of agricultural importance. Our
efforts have also demonstrated how combining functional genomic screens can identify the causative genes,
which allows for more accurate breeding using molecular markers and the elucidation of biological pathways.
Our unique reagents and chicken lines also empower scientists, especially with respect to immunological
characterization.
TECHNOLOGY TRANSFER:
The majority of genetic markers were developed by our location and are being used throughout the world.
Markers for specific Marek’s disease resistance genes are being evaluated in commercial layers.
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PROJECT OBJECTIVES:
Marek's disease (MD) is a lymphoproliferative and immunodepressive disease of chickens caused by a
herpesvirus. Infection with the causative virus is nearly universal among commercial chicken flocks
worldwide. The virus is relatively stable in the environment, is spread through the air and is unlikely to be
eradicated from commercial flocks. Despite widespread use of vaccines, economic losses from mortality of
layers and breeders and condemnation of broilers continue to plague producers. Losses tend to be sporadic and
unpredictable. Moreover, the virus continues to mutate to greater virulence, reducing the effectiveness of many
existing vaccines and causing concerns that vaccines currently considered effective will not protect in the
future. Also, the host range of the virus has apparently expanded to include adult chickens and turkeys. The
major problem is the need for practical and cost-efficient technology that will better control losses, both now
and in the future. This research project addresses the problem through a comprehensive program dealing with
basic mechanisms of the disease process, characterization of the virus, and development of better vaccines.
Much of this work is also designed to complement and improve the genetic resistance of chickens to this
disease.
OVERALL PROJECT ACCOMPLISHMENTS:
We confirmed that recent MDV isolates are more virulent than earlier isolates and that there are some changes
in the MDV genome that may be indicative of different pathotypes. We also compared some highly attenuated,
moderately attenuated and some low virulent strains for their ability to protect against an MDV challenge. We
found that partly attenuated, slightly virulent strains provided the best protection. These findings will help us to
better design new vaccines. We also demonstrated that the putative oncogene of MDV (meq), could be deleted
and that meq is essential for transformation of lymphocytes in infected chickens. Using mutational analysis, we
demonstrated that the pp38 gene of the vaccine virus, Rispens, functions identically to the pp38 gene in the
very virulent Md5 virus. This knowledge helps us to understand the mechanisms by which the virus replicates,
causes disease, and may be useful in developing a new class of recombinant DNA vaccines.
IMPACT:
Research conducted on various aspects of Mareks’ disease will undoubtedly lead to development of better
methods for its control. Successful control of Marek’s will insure the viability of the United States poultry
industry and insure a supply of inexpensive meat and egg products of high quality for consumers in the U.S.
and in other countries.
TECHNOLOGY TRANSFER:
We developed a set of PCR primers that will specifically detect MDV in infected birds. These primers and the
technology to use the primers have been sent to numerous state diagnostic labs, private poultry companies, and
scientists at academic institutes. We have shared specific MD viral sequences with other scientists to enhance
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the global effort to elucidate the function of various viral genes. We have also supplied characterized MD viral
field strains to poultry companies for use in challenge experiments to test the susceptibility of different chicken
strains and the efficacy of different vaccines. An MDV with a pp38 deletion was sent to a scientist to study the
role of pp38 on cytotoxic lymphocytes. We sent the MDV cosmid clones to other laboratories to transfer the
technology of MDV mutants to the scientific community.
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PROJECT OBJECTIVES:
Avian leukosis virus (ALV) and reticuloendotheliosis virus (REV) are the most common naturally occurring
retroviruses associated with neoplastic (cancer-like) diseases in poultry. In addition to causing tumors and
other production problems, both ALV and REV are potential contaminants of live-virus vaccines of poultry.
Control of retroviruses in poultry is complicated by lack of specific diagnostics and vaccines as well as a high
frequency of antigenic and molecular variation among strains of virus. In recent years, the broiler breeder
industry has identified an ALV-induced disease termed myeloid leukosis as its highest disease priority. This
disease has the potential to negatively influence the economic viability of the entire broiler industry. On the
other hand, the principal economic concerns of REV infection are as contaminants of biologic products
produced in chicken embryo cells or tissues or as a barrier to export of breeding stock to certain countries.
However, sporadic outbreaks of neoplastic disease have been observed in turkeys and infected breeders can, in
some cases, transmit the virus to progeny. Understanding the basic mechanisms involved in virus-host
interaction, transmission of virus as well as the development of improved diagnostic technology for viruses and
tumors are integral components of any successful program for control of retrovirus infection in poultry. The
research emphasizes studies on influence of virus-, host-, and environment- related factors on retrovirusinduced diseases in poultry. Using current information on molecular and antigenic characteristics of the virus,
more sensitive and specific procedures for detection of virus and antibody will be developed. Currently
available technology will also be explored to develop vaccines for use as an adjunct to eradication programs,
the principal means for controlling retrovirus infection in poultry. The research will provide the necessary tools
for better diagnosis and control of this economically important virus infection of retrovirus infection in poultry.
OVERALL PROJECT ACCOMPLISHMENTS:
This project was initiated in fiscal year 2002. During the last five years (the life of the previous project),
infection with subgroup J ALV (ALV-J) and tumors previously thought to be not present in flocks in the U.S.
were diagnosed in broiler breeder flocks in various regions of the U.S. Two new tools were developed that
aided in the diagnosis of ALV-J: 1) a PCR test (a DNA-based test); and 2) a genetically engineered cell line
that is resistant to infection with ALV-J (C/J). Various industry and other diagnostic laboratories have
successfully used these new tools in the diagnosis of ALV-J infection in field samples. Also, the envelope gene
of the U.S. prototype of ALV-J termed ADOL-Hc1 was identified, sequenced and used as an excellent source
of antigen (protein) that is now being used in commercial diagnostic kits for detection of antibody to ALV-J.
Scientists at ADOL were first to isolate natural recombinant ALVs with an envelope of subgroup B and LTR
of subgroup J (ALV-B/J) from commercial layers flocks suffering from myeloid leukosis. This confirmed that:
a) natural recombination between two subgroups of ALV can occur, and b) a recombinant ALV-J was
associated with an outbreak of myeloid leukosis in commercial layer flocks; commercial layers are thought to
be relatively resistant to ALV-J-induced myeloid leukosis. Preliminary data suggest an influence of age at
exposure of embryos and dose of virus on the development of ALV tolerant infection (consistent viremia and
lack of antibody).
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IMPACT:
Research on avian retroviruses at ADOL, particularly avian leukosis viruses has contributed significantly to the
success of programs, currently used by most if not all of primary poultry breeder companies, to reduce or
eradicated this important virus infection from their breeding stocks. As vaccines to control avian retroviruses
are not available, eradication of virus infection at the primary breeder level is the method of choice for
controlling this economically important disease. Successful control of retrovirus infection will reduce
economic losses associated with retrovirus-induced tumor mortality and lower productivity. Therefore,
successful control of retrovirus infection in poultry will also insure the viability of the United States poultry
industry and will also insure a supply of inexpensive meat and egg products of high quality for consumers in
the U.S. and in other countries
TECHNOLOGY TRANSFER:
Important new tools were developed that aided industry and diagnostic laboratories in the diagnosis of ALV: 1)
a polymerase chain reaction (PCR) test (a DNA-based test); 2) a genetically engineered cell line that is
resistant to infection with ALV-J (C/J), and 3) a set of monoclonal antibodies. Also, the envelope gene of the
U.S. prototype of ALV-J termed ADOL-Hc1 was identified, sequenced and used as an excellent source of
antigen (protein) that is now being used in commercial diagnostic kits for detection of antibody to ALV-J.
Most recently, Scientists at ADOL transferred to their counterparts at USDA-APHIS-CVB and industry the
protocol used at ADOL for detection of ALV in vaccines and other samples.
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Development of New Technologies for Detection of Prions in Animal Feed and
Environmental Samples
5325-32000-003-00D
M. Carter, R. Wong (30%), Vacant, Vacant
Western Regional Research Center (Albany, CA)
Carter, M., phone 510.559.6053, mcarter@pw.usda.gov

PROJECT OBJECTIVES:
The primary focus of this CRIS is investigation and development of novel technologies for detection,
quantitation, and strain characterization of both normal and abnormally-folded prion proteins. The methods
investigated are suitable for use with environmental samples as well as animal feed and feed additives. Because
the food industry will not tolerate false positive or false negative test results, the new detection methods must
be highly sensitive and specific. In addition, they must be rapid, cost effect, and easily interpreted. Major goals
include 1) significant improvements in sensitivity for prion assays, including methods for strain-specific
detection. In addition to immunochemistry and traditional analytical chemistry, hybrid methods combining the
best features of both approaches are being investigated. Strain-specific detection is likely to require further
orthogonal assay technologies. Additional goals include 2) effective sampling methods for capturing,
concentrating, and detecting prions, other animal proteins, and surrogates from samples of air, water, soil, feed,
and feed additives; and 3) development of inactivation/destruction of prions for decontamination. The methods
investigated must be appropriate for sampling and decontamination of food processing surfaces and animal
holding pens. Thus they must be: free from chemical or physical extremes; safe, with no generally toxic
residue; and relatively inexpensive, for use on large areas. The objectives of this CRIS overlap somewhat with
those of CRIS 5325-42000-027-00D, Development of New Technologies for Rapid Identification of
Pathogen/Pathogen Products.
OVERALL PROJECT ACCOMPLISHMENTS:
• A method for detecting meat and bone in animal feed has been developed based on a GC/MS system that
detects the presence of cholesterol. A linear response from 0.5 ng (~ 2 picomole) to 60 ng (~ 150
picomole) is observed. This method can be used to detect MBM contamination at levels between 0.1
and 5 %. The assay is being converted into a rapid, field portable immunoassay that can be applied to
feed or meal samples.
• Significant advances have been made in the development of a mass spectrometric method for
quantitation of prions at low levels. Model peptides similar to those expected from PrPSc digests have
been analyzed by linear ion trap technology using nanoLC and electrospray technology. Limits of
detection in the low attomolar level have been obtained. If this can be achieved with PrPSc peptides, an
assay that is several orders of magnitude more sensitive than extant antibody-based methods should be
possible. Digests of hamster prions have been completed and analyzed by qualitative mass
spectrometry to identify peptide targets for quantitative work in the future. A patent disclosure has been
written which has been approved for patent filing within the next 6 months.
• New monoclonal antibodies that bind PrP have been developed by immunization of PrP ablated mice and
a modified cell fusion protocol. These antibodies have broad specificity and extend the detection range
for PrPSc in a Conformation Dependent Immunoassay.
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• In an effort to produce better PrP antibodies, PrP ablated BALB/c mice and PrP ablated BALB/c mouse
derived myeloma cells are being produced. PrP ablated animals with greater than 90% BALB/c
background already have been produced and myeloma induction is underway.
IMPACT:
More sensitive tests for prions are essential in order to develop a live-animal test. Such tests would greatly
simplify cattle management for BSE and management of cervid populations for CWD. These assays will
extend our ability to track prions in environmental samples, and they will be useful tools for evaluating prion
inactivation methods, and for pathogenesis studies.
TECHNOLOGY TRANSFER:
The mass spectrometric method for detecting prions and prion strains has been approved for a patent
application. Once issued, this approach can be licensed, making the method readily available to producers and
regulators.
PUBLICATIONS:
None
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Anaplasmosis: A Genomic Approach to Vaccine Development
5348-32000-016-00D
Scoles, G., Suarez, C., Goff, W., Knowles, D.
Pullman, WA, Animal Diseases Research Unit
Scoles, G. 509-335-6337 (VOICE) scoles@vetmed.wsu.edu

PROJECT OBJECTIVES:
Anaplasmosis is one of the most prevalent arthropod-borne hemoparasitic diseases that continue to constrain
the production, movement and utilization of cattle worldwide. Extensive losses continue within the major cattle
producing regions of the world. The economic losses occur through disease and export-import restrictions.
Immunization against the causative rickettsial pathogen, Anaplasma marginale, with a safe and effective
vaccine is not yet feasible on a practical basis. There are three main research objectives. These objectives are
the development of accurate method(s) of diagnosis, the development of a safe and efficacious vaccine and
acquisition of a detailed understanding of vector transmission with a goal of improved control methods. We
have completed the first objective. Our approach to vaccine development (objective 2) has three components.
The first component is dissection of the bovine immune response, which develops in response to infection and
is protective in the chronic (persistent) phase. The second component is dissection of the interface between
Anaplasma marginale and the tick vectors, which transmit this organism. This component has the unique
advantage of identifying components of the organism, which are exposed only during development in the
vector and therefore may be targets for vaccine development. Our final component, completed within this past
year is genomic sequencing and annotation of the A. marginale genome.
OVERALL PROJECT ACCOMPLISHMENTS:
The development and commercialization of our diagnostic test for Anaplasma marginale infection is
completed. This test is now commercially available and has been adopted by Canada as their official test. This
test will have major impact internationally on the control of anaplasmosis. This test will allow, for the first
time, accurate epidemiological studies to be conducted. During recent months we've complete a collaborative
project with CEAH, APHIS in conducting a serologic survey, using our cELISA, for detection of A. marginale
infection in cattle within the United States. Also, producers will be able to test and segregate infected cattle in
areas in which ticks are present, or adopt new management tools in handling infected cattle, such as assuring
the same needle isn't used to process both infected and uninfected cattle. Accurate diagnosis will now allow
for the possibility of opening export markets to countries which were previously thought to be free of
anaplasmosis, but upon testing with accurate methodology are found to have infected cattle, sheep or goats.
This recently occurred in Canada when through collaboration with our Unit it was discovered that bison within
Canada are infected with A. marginale.
IMPACT:
The competitive ELISA for identification of cattle persistently infected with Anaplasma marginale has been
transferred to industry and its final approval for distribution as a kit was approved in 2002. We provide to
APHIS on continual basis information to aid in vector control at the southern U.S. border. We have also aided
Canada in providing diagnostic expertise in a recent discovery of Anaplasma marginale infection in bison
within Canada. This diagnostic kit was used in 2003 for congressional budget meetings. Most importantly our
diagnostic test has been used by APHIS to begin establishing the epidemiology of A. marginale within the
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United States. These data are being used in adjusting current A. marginale import restrictions placed on U. S.
cattle by Canada.
TECHNOLOGY TRANSFER:
A competitive ELISA was licensed and transferred to industry. This test is commercially available (U.S.
Veterinary License No. 332) and has been adopted by Canada as their official import test.
PUBLICATIONS:
Davidson, W.R., Goff, W.L. Anaplasmosis. In: Infectious Diseases of Wild Mammals, 3rd edition (E.
Williams and I Barker, eds.) Iowa State University Press. 2001. p. 455-466.
Futse, J.E., Massaro, U.W., Knowles, D.P., Palmer, G.H. Transmission of Anaplasma marginale by Boophilus
microplus: Retention of vector competence in the absence of vector-pathogen interaction. Journal of Clincal
Microbiology. 2002. v. 41. p. 3829-3834.
Scoles, G.A. Phylogenetic analysis of the Francisella-like endosymbionts of Dermacentor Ticks. Journal of
Medical Entomology. 2004. v. 41 (in press).
Gorham, J., and Knowles, D. 2000. Biotechnology in the diagnosis of infectious diseases and vaccine
development. OIE Manual of Standards for diagnostic tests and standards: biotechnology, 1.7.
Bradway, D. S., Torioni de Echaide, S., Knowles, D. P., Hennager, S. G., and McElwain, T. F. 2000.
Sensitivity and specificity of the complement fixation test for detection of Anaplasma marginale persistently
infected cattle. Journal of Veterinary Diagnostic Investigation. 13:77-79.
Valdez, R. A., McGuire, T. C., Brown, W. C., Davis, W. C., and Knowles, D. P. 2001. Long-term in vivo
depletion of functional CD4+ T lymphocytes from calves requires both thymectomy and anti-CD4 monoclonal
antibody treatment. Immunology, 102:426-433.
Ferreira, A. M. T., Suzart, S., Vidotto, O., Knowles, D. P., and Vidotto, M. C. 2001. Use of repetitive DNA
elements to define genetic relationships among Anaplasma marginale isolates FEMS Microbiology Letters,
197:139-143.
Brayton, K. A., Knowles, D. P., McGuire, T. C., and Palmer, G. H. 2001. Efficient use of a small genome to
generate antigenic diversity in tick-borne ehrlichial pathogens. Proceedings National Academy of Science,
USA, 98:4130-4135.
Valdez, R. A., McGuire, T. C., Brown, W. C., Davis, W. C., Jordan, J. M., and Knowles, D. P. 2002. Selective
in vivo depletion of CD4+ T lymphocytes with anti-CD4 monoclonal antibody during acute infection of calves
with Anaplasma marginale. Clinical and Diagnostic Laboratory Immunology. 9:417-424.
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On farm Ecology of Listeria Monocytogenes
5348-32000-022-00D
Borucki, M., Knowles, D.P.
Pullman, WA, Animal Diseases Research Unit
Borucki, M., Phone: (509) 335-7407, Fax: (509) 335-8328,
mborucki@vetmed.wsu.edu

PROJECT OBJECTIVES:
Listeria monocytogenes is a bacterium capable of causing serious disease in humans and animals. L.
monocytogenes infection of cattle and sheep can lead to disease of the central nervous system and death.
Human listeriosis is a potentially fatal food borne disease often associated with the consumption of
contaminated dairy products. Because L. monocytogenes is widely distributed in the environment, a major
problem associated with the food safety issue is the source(s) of L. monocytogenes in food borne illness. The
role of domestic animals in dairy product contamination is not clearly understood. The focus of our research
program is to elucidate the sources and significance of dairy farm contamination as related to human and
animal disease. A majority of human outbreaks are caused by just 3 of the 13 L. monocytogenes serotypes,
therefore we will be focusing on identifying the prevalence of these serotypes on the dairy farm and developing
methods to precisely and reliably identify genetic subtypes that are especially virulent. Specifically, our project
has three major objectives: (1) characterize on-farm subtypes of livestock origin and compare these subtypes to
those of food-borne disease origin; (2) develop a rapid and informative assay to identify L. monocytogenes
serotypes, subtypes, and identify the genes that differ between epidemic and nonepidemic strains; (3) identify
or develop an in vivo or in vitro model capable of quantifying the virulence potential of L. monocytogenes
strains.
OVERALL PROJECT ACCOMPLISHMENTS:
Objective 1: Determine the prevalence and subtypes of L. monocytogenes present on Pacific Northwest
dairy farms. Approximately 775 raw milk samples from 474 Pacific Northwest herds were tested at multiple
timepoints and isolates obtained from the milk samples were serotyped, genetically characterized, and
evaluated for unique biological properties. A vast majority of L. monocytogenes isolates obtained from the
milk and farm samples were found to be clinically significant serotypes that persist in the dairy environment
for an extended period of time. Research was also done to investigate whether human listeriosis cases are
associated with the same subtypes of L. monocytogenes found in raw milk and area dairy farms by comparing
farm-associated subtypes to human isolates. Several human isolates were genetically similar or identical to
farm and milk strains and it was also determined that a strain responsible for a large 1985 epidemic has a
current, local on-farm reservoir and continues to cause sporadic human disease. This work was an important
step in defining the on-farm ecology of L. monocytogenes and accessing the contribution of farm
contamination as a source in human listeriosis.
Objective 2: Construct and test a DNA microarray to allow rapid, accurate and discriminatory
subtyping of L. monocytogenes isolates for the purpose of on farm molecular epidemiology and gene
discovery. Research was done to test the utility of a mixed genome DNA microarray analysis for genetic
subtyping of L. monocytogenes strains and to identify the genetic differences between subtypes. Fifty L.
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monocytogenes isolates were subtyped using a 585-probe mixed genome microarray and genes that
differentiate the major genetic divisions were identified. Microarray analysis results preserved previously
described phylogenetic relationships between major serogroups, discriminated among isolates within a
serotype, and identified specific genes that vary between isolates including several putative virulence factors.
Identification of serotype-specific regions allowed the development of PCR primers for rapid, accurate, and
inexpensive identification of L. monocytogenes serotypes.
To further investigate genetic regions that characterize subtypes, a subsequent 2000-probe mixed genome
DNA microarray was constructed and used to identify 675 polymorphic (informative) probes for sequence
analysis and construction of a condensed microarray. Fifty-five L. monocytogenes strains were genetically
characterized using the condensed array including strains that had been subtyped previously by Dr. Franco
Pagotta (Health Canada) and Dr. Sandra Smole (MA State Laboratory Institute) using pulsed-field gel
electrophoresis (PFGE), ribotyping, and multilocus sequence typing (MLST). Microarray subtyping had
resolution equal to that of PFGE (using AscI and ApaI digests), higher resolution than ribotyping and MLST
(using 8 housekeeping genes), and correctly grouped eleven out of twelve isolates that had an epidemiological
link. Additionally, a majority of epidemic strains were grouped together within phylogenetic Division I.
Discriminant function analysis allowed identification of 22 probes from the mixed-genome array that
distinguish serotypes and subtypes including several potential markers that were distinct for the epidemic
cluster. Many of the subtype-specific genes encode proteins that likely confer survival advantage in the
environment and/or host.
Objective 3: Develop in vitro and in vivo virulence models for L. monocytogenes infection that allow the
phenotypic characterization of putative virulence genes identified by microarray analysis. In order to
determine if a particular subtyping method is effectively able to differentiate virulent isolates from less virulent
“environmental” isolates one must first be able to access the virulence potential of a particular L.
monocytogenes strain. Isolates known to be associated with human or animal clinical cases are known to be
virulent. However, isolates found in the environment may also be virulent given the right host and dose.
Therefore, it is important to develop an assay that is able to predict the virulence potential of
environmental/nonclinical strains. Six human epidemic strains and six environmental strains were assayed for
invasiveness using a modified intragastric inoculation A/J mouse model (Czuprynski et al., 2003). Variation in
strain invasiveness was observed and epidemic strains were significantly more invasive than environmental
strains (P=0.01). A/J strain mice purchased from one vendor were significantly more susceptible than A/J
mice purchased from a different vendor.
IMPACT:
The prevalence of L. monocytogenes contamination in Pacific Northwest area bulk milk tanks was previously
unknown. The results from Objective 1 are an important initial step in defining the on-farm ecology of L.
monocytogenes, the regional distribution of L. monocytogenes subtypes, and accessing the contribution of farm
contamination as a source in human listeriosis. Results from Objective 2 demonstrate the applicability of
microarray analysis to L. monocytogenes subtyping and gene discovery. These results show that a relatively
simple microarray had resolution comparable to, or exceeding, existing methods and correctly identified strains
associated with food poisoning outbreaks. Importantly, this method also identified the genetic regions that
differ between strains and thus identified numerous genetic markers that are currently being used in
epidemiological and pathogenesis studies. This microarray data also allowed development of alternative
genetic methods to serotype isolates quickly and inexpensively. An intragastric inoculation mouse model was
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developed (Objective 3) that demonstrated that epidemic strains as a group are more infective than
environmental strains. The ability to accurately assess the disease-causing potential of an isolate is essential for
defining the genes that control strain virulence. Development of this model is a critical step towards
understanding why some strains cause epidemics whereas others do not.
TECHNOLOGY TRANSFER:
PUBLICATIONS:
Borucki, M.K., Krug, M.J., Muraoka, W.T., Call, D.R. Discrimination among Listeria monocytogenes isolates
using a mixed genome DNA microarrays. Veterinary Microbiology. 2003. v. 92. p. 351-362.
Call, D.R., Borucki, M.K., Besser, T E. Mixed-genome microarrays reveal multiple serotype and lineagespecific differences among strains of Listeria monocytogenes. Journal of Clinical Microbiology. 2003. v. 41.
p. 632-639.
Call, D.R., Borucki, M.K., Loge, F.J. Detection of bacterial pathogens in environmental samples using DNA
microarrays. Journal of Microbiological Methods. 2003. v. 53. p. 235-243.
Palumbo, J.D., Borucki, M.K., Mandrell, R.E., Gorski, L.A. Serotyping of Listeria monocytogenes by ELISA
and identification of mixed-serotype cultures by colony blot. Journal of Clinical Microbiology. 2003. v. 41. p.
564-571.
Muraoka, W.T., Gay, C., Knowles, D., Borucki, M.K. Prevalence of Listeria monocytogenes in bulk milk of
the Pacific Northwest. Journal of Food Protection. 2003. v. 66. p. 1413-1419.
Borucki, M.K., Peppin, J.D., White, D., Loge, F., Call, D.R. Variation in biofilm formation among strains of
Listeria monocytogenes. Applied Environmental Microbiology. 2003. v. 69. p. 7336-7342.
Borucki, M.K., Call, D.R. Listeria monocytogenes serotype identification by PCR. Journal of Clinical
Microbiology. 2003. v. 41. p. 5537-5540.
Wesley I, Borucki M, Call D.R, Larson D, Schroeder-Tucker L. Detection and diagnosis of Listeria
monocytogenes and listeriosis in animals. In: Torrence ME, Isaacson RE, eds. Microbial Food Safety in
Animal Agriculture. Ames: Iowa State Press. 2003 p. 233-242.
Kim, S.H., Bakko, M., Knowles, D., Borucki, M.K. Oral inoculation of A/J mice detects invasiveness
differences between Listeria monocytogenes epidemic and environmental strains. Infection and Immunity. (In
press).
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Biology of Ruminant Gammaherpesviruses Associated with Malignant Catarrhal Fever
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Li, H., Taus, N.S., Knowles Jr, D.P.
Pullman, WA, Animal Diseases Research Unit
Li, H., Phone: (509) 335-6002, Fax: (509) 335-8328, hli@vetmed.wsu.edu

PROJECT OBJECTIVES:
Malignant catarrhal fever (MCF) is a significant source of economic loss in several major ruminant species,
including cattle, bison, and deer. In most of the world outside of Africa, sheep are the major source of the
virus that causes the syndrome, referred to in this instance as sheep-associated MCF. Diagnosis of MCF,
particularly sheep-associated MCF, historically has been problematic. The major goals for this project are to
develop new methods for effective diagnosis and control of MCF. The program has resulted in several reliable
diagnostic assays such as competitive inhibition ELISA and quantitative fluid-phase PCR. Using these newly
developed assays, we have been able to construct a reasonable picture of the life cycle of the virus in its natural
host and to develop control programs to prevent transmission.
OVERALL PROJECT ACCOMPLISHMENTS:
Over the past few years this project has brought about fundamental and dramatic advances in the understanding
of MCF and in the preferred methodologies used for diagnoses and control. The development of the
competitive inhibition ELISA has been the single most important accomplishment, as it allowed reliable
serological diagnosis of infection, thereby enabling effective investigations into the epidemiology of the virus.
We have also applied the PCR test for sheep-associated MCF virus DNA to these same questions. The
combination of the two technologies, aggressively applied to the problems, has enabled us to develop a
reasonably comprehensive picture of the life cycle of this group of viruses in nature. Recently we intensively
examined viral shedding patterns from 6 to 9 month-old adolescent and adult sheep, showing that nasal
shedding is the major mode for viral transmission, and adolescents are the highest risk group for viral
shedding. Once we understood the transmission patterns among sheep, we were able to clear up much of the
mystery traditionally associated with MCF epidemiology, to design a management-based control program to
prevent transmission, and to produce MCF virus-free sheep. We have also developed a competitive PCR and
adapted a real-time PCR for the quantitation of sheep-associated virus DNA. These assays should prove
instrumental in defining the temporal distribution of virus in the host, and the time-specific shedding patterns
of both carriers and affected hosts. A PCR assay for sheep-associated MCF was adapted for use on DNA
extracted from formalin-fixed paraffin-embedded tissues, which enables retrospective examination of
specimens for the virus. An in situ PCR was also developed for detection of sheep-associated virus in MCFaffected animals, which is in the early stages of application to pathogenesis studies. Recently a new member
of the MCF virus group capable of causing classic MCF in white-tailed deer was identified. In addition, we
also discovered that goats are endemically infected with their own strain of MCF virus that is closely related to,
but distinct from, the classic sheep strain of virus and showed it to be capable of causing disease in deer that
presents significantly differently from the classic MCF. These findings illustrate the complexity of the life
cycles of members of the MCF virus group in nature and provide additional information to guide diagnosis and
development of control measures.
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IMPACT:
Development of an accurate and practical monoclonal antibody-based MCF serological test and establishment
of various PCR assays specific for MCF viruses have significantly improved MCF diagnostics, and have
provided essential tools for MCF research. Our additional accomplishments in epidemiological studies
represent a very significant milestone in the history of MCF investigation. Despite many studies by many
investigators over the past 60 to 70 years, the etiology and epidemiology of sheep-associated MCF have
remained a controversial enigma. Our studies provide a basis for understanding the intriguing biological
events that occur with this virus, and enable rational explanations for the previously enigmatic and confusing
observations concerning transmission. Production of virus-free sheep that pose no threat to their MCFsusceptible neighbours could be a great benefit to limited-size cattle-sheep operations and bison owners, as
well as petting zoos and game farms. The studies highlight how to effectively avoid severe MCF losses in
clinically susceptible species, particularly in bison.
TECHNOLOGY TRANSFER:
The competitive ELISA for detection of MCF viral antibody against an epitope that is conserved among MCF
group viruses in ruminant species has been transferred to industry (VMRD, Inc, Pullman) and the kit has been
distributed internationally since 2002. Four additional monoclonal antibodies against MCF virus have also
been transferred to VMRD, Inc.
A diagnostic service, consisting of cELISA and various PCRs, for MCF has been established through the
Washington Animal Disease Diagnostic Laboratory. We are now considered the reference laboratory of choice
for MCF PCR and serology.
PUBLICATIONS:
Li, H., Snowder, G., O’Toole, D., Crawford, T.B. Transmission of ovine herpesvirus 2 among adult sheep.
Veterinary Microbiology. 2000. v. 71. p. 27-35.
Li, H., Dyer, N., Keller, J., Crawford, T.B. Newly recognized herpesvirus causing malignant catarrhal fever in
white-tailed deer (Odocoileus virginianus). Journal of Clinical Microbiology. 2000. v. 38. p. 1313-1318.
Li, H., Keller, J., Knowles, D.P., Crawford T.B. Recognition of another member of the malignant catarrhal
fever (MCF) virus group: an endemic gammaherpesvirus in domestic goats. Journal of General Virology.
2001. v. 82. p. 227-232.
Li, H., Hua, Y., Snowder, G., Crawford T.B. Levels of malignant catarrhal fever viral DNA in nasal secretions
and blood of sheep: implication for transmission. Veterinary Microbiology. 2001. v. 79. p. 301-310.
Muller-Doblies, U.U., Egli, J., Li, H., Braun, U., Ackermann, M. Malignant catarrhal fever in Switzerland, part
1: epidemiology. Swiss Archives of Veterinary Medicine. 2001. v. 143. p. 173-183.
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PROJECT OBJECTIVES:
The economic losses to the sheep industry due to ovine scrapie can be reduced by a coordinated program of
live animal testing, replacement with sheep of lower susceptibility, and reducing transmission within the flock.
Scrapie is a transmissible spongiform encephalopathy associated with deposition of an abnormal isoform of a
mammalian glycoprotein, the prion protein, in tissues throughout the sheep. The highest level of accumulation
is in the brain, although detectable levels are found in lymphoid tissues and placenta/fetal tissues. Detection of
prions in peripheral lymphoid tissue can be used to identify and cull infected animals early in infection.
Further, the susceptibility of sheep to clinical scrapie and to accumulation of prions is under genetic control.
Quantitative determination of the level of protection associated with commonly occurring genotypes could
enable producers and regulatory programs to integrate protective genetics with elimination of infected stock to
reduce the amount of disease in U.S. flocks. Control of all domestic prion diseases is important in reducing
trade barriers for U.S. sheep and germplasm and for assuring the present and future global markets for cattle.
Ovine progressive pneumonia virus causes persistent viral infection and development of multi-organ
inflammatory disease in some animals. The infection rates in US sheep flocks range from 9 to 49%. A variable
and unpredictable percentage of infected animals will progress to clinical disease with high viral titers and
increased risk of transmission to flockmates. This project has produced a serologic test for the disease. The
current project includes development of a vaccine to reduce infected animals and identification of genes
associated with decreased transmission in infected sheep.
OVERALL PROJECT ACCOMPLISHMENTS:
A practical live animal test for scrapie and preclinical postmortem tests for scrapie were developed and
transferred to the regulatory agencies for use in the US. Monoclonal antibodies useful in assays on routinely
formalin fixed tissue from infected sheep, deer, elk, cattle, humans, mink, domestic cats and a wide variety of
captive wildlife potentially exposed to prion diseases were developed. Mechanisms for preventing
transmission of scrapie through genetic selection of sires were demonstrated. Along with sire testing, genetic
testing in bred ewes will ensure less transmission of scrapie from ewe to lamb. A project investigating scrapie
prevalence in goats and the importance of goats in the transmission of scrapie to sheep was initiated. We have
initiated another research project relating to transmission of OPPV at the Experimental Sheep Station in
Dubois, ID. We continue to test a small sheep flock (Future Farmers of America Herd) (<30) for OPPV in
Sumner, WA, associated with Sumner High School.
IMPACT:
The development of the third eyelid test for scrapie diagnosis and prevention of scrapie transmission by
screening for PrP diploid genotype has directly benefited the sheep industry. In addition, investigations of
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different transmission sources namely salivary glands, peripheral blood mononuclear cells, and placental
tissues has resulted in an increased understanding regarding the mechanisms of scrapie transmission. Both
determination of the sensitivity limit of PrP(Sc) detection in immunohistochemistry and determination of the
specific lymphoid cell types that accumulate truncated and full length PrP(Sc) have established the specificity
and sensitivity requirements for PrP(Sc) detection and will aid future studies on detection of PrP(Sc) in blood.
Development of a prime-boost vaccine strategy for caprine arthritis encephalitis virus (CAEV) resulted in
protection in CAEV challenged goats. Since ovine progressive pneumonia virus (OPPV) and CAEV are
considered quasispecies, this finding will guide the future testing of this vaccine on sheep. In addition, the
high sensitivity and specificity of the CAEV cELISA in both goats and sheep along with the ability to
quantitate the amount of anti-CAEV/OPPV antibody will aid accurate diagnosis and eradication of small
ruminant lentiviruses from flocks and herds throughout the United States. The cELISA was used in the
National Animal Health Monitoring System (NAHMS) for seroprevalence of OPPV in U.S. sheep flocks
which was performed by the Centers of Epidemiology and Animal Health, APHIS, Fort Collins, CO in 2001.
Together, these contributions have reduced economic losses to the sheep industry. The eventual eradication of
scrapie and OPPV will reopen U.S. sheep exports which will increase economic gains to the sheep industry.
TECHNOLOGY TRANSFER:
Licenses:
Two monoclonal antibodies to the prion protein and their use in combination as detection reagents for prions
have been patented. Both antibodies are commercially available. Only non-exclusive licenses have been
offered, to insure the widest possible use of these reagents in diagnostics, industry, and research. The
antibodies are in use internationally and collaborative programs to train personnel in Canada, Mexico, and
China are in progress. The preclinical test for scrapie has been transferred to the National Veterinary Services
Laboratory. APHIS has established a national testing network, through which veterinary and state diagnostic
laboratories will apply the technology under contract with APHIS. CAEV cELISA is currently licensed for
goats and will be licensed for sheep and commercially available in the U.S. in 6-12 months.
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Caplazi, P., O’Rourke, K.I, Baszler, T.V. Resistance to scrapie in PrP ARR/ARQ heterozygous sheep is not
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Hamir, A.N, Miller, J.M, O'Rourke, K.I, Bartz, J.C, Stack, M.J, Chaplin, M.J. Transmission of transmissible
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ovine progressive pneumonia virus (OPPV) field isolates from Dubois Idaho sheep comprise part of OPPV
clade II based on surface envelope glycoprotein (SU) sequences. Virus Research. 2004. v. 102(2) p. 215-20.
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PROJECT OBJECTIVES:
There is a threat of reintroducing bovine babesiosis, a tick borne, hemoparasitic protozoal disease, into the U.S.
from Mexico for the following reasons: 1) the USDA-APHIS surveillance program involves ticks only, 2) at
least a million cattle are moved north across the Mexican border each year, a percentage of which are Babesia
carriers, 3) acaracide resistant ticks occur in northern Mexico, 4) there is an increase in the number of wild
ungulates along the border, and these and some cattle are not treated for ticks, and 5) there is no babesiacidal
drug or vaccine approved for use in the U.S. Two products from research that would help alleviate the threat
would be safe and effective vaccines for use in the U.S (and elsewhere) and diagnostic assays capable of
handling large numbers of samples for use in surveillance. Babesia vaccine development requires the
characterization of the protective immune mechanisms, the identification of protective antigens from the
parasites, and the development of effective delivery systems. Given this, we have three areas of focus: 1) A
series of immunologic assays have been developed and are now routinely used in our laboratory to characterize
the immune response following exposure to Babesia and to assess the efficacy of immunization trials. These
assays include, gene expression of several immunoregulatory cytokines, cytokine production and secretion
assay by flow cytometry, lymphocyte, dendritic cell, and monocyte/macrophage activation, leukocyte
phenotype analysis, cellular proliferation, and antibody isotype analysis. 2) In collaboration with scientists of
the Department of Veterinary Microbiology and Pathology of WSU, we are characterizing new Babesia
antigens as potential vaccine candidates, and investigating immunological properties of CpG containing DNA
motifs present in the babesial genome. These CpG motifs have strong immunostimulatory activity. 3) We are
establishing a babesial transfection system to functionally characterize genes expressing antigens of interest
and to develop transmission-defective attenuated parasites. Reagents have also been identified for the design of
an improved diagnostic assay for Babesia bovis and B. bigemina, and formatting and validating them are
included in the objectives.
OVERALL PROJECT ACCOMPLISHMENTS:
Several assays used to evaluate the bovine immune response were developed and applied in studies providing a
more complete understanding of the mechanisms operative during Babesia infection. One important
mechanism involves the babesiacidal activity of nitric oxide and its induction by signals sent from
immunologically activated cells. Among these signals are interferon-gamma and interleukin-12, both
characteristic of a "Type-1 response". Other studies confirmed the importance of a Type-1 response in
resolution of a primary Babesia infection, and suggested that the response is tightly regulated. Other molecules
associated with a "Type-2 response", IL-4 and especially IL-10 have been shown to down-regulate the
appropriate Type-1 response. Additional studies revealed the importance of Type-1 immunity against this
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infection as a part of the strong innate immunity of young calves, and that the mechanisms are less effective in
older cattle, where the disease is more severe. Natural killer (NK) cells capable of producing interferon gamma
and that proliferate in the spleens of calves mounting a successful immune response have been identified.
Reagents to purify both splenic dendritic cells and NK cells have recently been used to develop assays for
examining the cooperative nature of these cells in response to babesial parasites in vitro as well as ex vivo
during infection.
Work on the elucidation of the role of CpG motifs as an immunomodulator and the identification of new
vaccine candidate antigens has and will further contribute to the design of future vaccines. A transition from
the previous project design to a new project with more emphasis on the tick/pathogen interface was started in
2003. While studies concerning the immunology associated with babesial infection/immunization continue, the
new project emphasizes the identification of babesial molecules involved in the transmission stages of the
disease and the development of a novel babesial transfection system for genetic manipulation of the parasites.
Recently, we developed a transient transfection system for expression of exogenous genes in Babesia bovis
under the transcriptional control of the B. bovis rap-1 promoter. A B. bovis-specific protein that had been
identified and characterized previously, was chosen for use as an epitope-defined diagnostic antigen, was
formatted as a competitive ELISA assay and has resulted in good diagnostic specificity. Validation studies
continue in efforts to establish the predictive value for the assay, and to determine conditions appropriate for
commercialization. The work has resulted in the identification of parasite components with attributes
important for the design of improved diagnostics (competitive ELISAs for each parasite (Babesia equi and
Babesia caballi). Validation of these assays for adoption as replacements for the current official, but inferior
assays has been accomplished. Improved diagnostics will improve and support the credibility of import
regulatory policies. Basic immunology studies have revealed the importance of the disease agent-specific arm
of the immune system involving T-cells in the resolution of infection whereas animals lacking T-cells suffered
severe disease despite possessing the intact non-specific arm of the immune system.
IMPACT:
The tick-borne diseases laboratory within the ADRU has been invited to apply for OIE reference laboratory
status acknowledging the development and standardization of diagnostic assays for equine and bovine
babesiosis for use throughout the world. Our diagnostic tests for Babesia equi and Babesia caballi have been
adapted by APHIS, are replacing the inaccurate CFT for importation testing and have been adopted by OIE as
the prescribed tests for these diseases.
Basic immunology studies have characterized the protective innate immune response in cattle to Babesia bovis
infection identifying critical aspects that need to be induced by new vaccines. The project has resulted in a
battery of immunological assays with which to evaluate vaccine trials.
TECHNOLOGY TRANSFER:
Material transfer agreements: The cELISA for diagnosing B. bovis in cattle has been transferred to
collaborators in Morocco, Australia, and Italy for validation. The improved diagnostic assays for equine
babesiosis have been transferred to APHIS and to collaborators in Morocco in support of a FAS-supported
epidemiology study. The equine babesiosis assays are being adopted for use by collaborators in Argentina,
Brazil, Canada, England, Israel, Japan, and Morocco and as part of an OIE inter-laboratory validation.
Five improved tick-borne disease diagnostic assays have been transferred to the Institut Agronomique et
Veterinaire (Hassan II) in Rabat, Morocco in support of ongoing epidemiology studies to determine the
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feasibility of renewed trade activities with the US cattle industry. Moroccan graduate students were trained
during the course of activities.
(Jehle, P., Goff, W.L. Scientific exchange for Moroccan technicians engaged in research on tick-borne disease
control in North Africa. AgLink U.S.-Morocco Trade Promotion Program-1998-2003. 2003. End of Project
Report. p. 49.)
Our diagnostic tests for equine babesiosis have been transferred to industry and will be commercially available
within 2004. The company and APHIS are collaborating to assure standardization of test parameters and
utilization.
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Phosphatidylcholine formation is the predominant lipid biosynthetic event in the hemoparasite Babesia bovis.
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97-109.
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Ueti, M. W., Palmer, G. H., Kappmeyer, L. S., Scoles, G. A., and Knowles, D. P. 2003. Expression of equi
merozoite antigen 2 during development of Babesia equi in the midgut and salivary gland of the vector tick
Boophilus microplus. Journal of Clinical Microbiology. 41:5803-5809.
Knowles, D. P. 2003. Equine Babesiosis (Piroplasmosis) – A barrier in the international movement of horses.
Equine Disease Quarterly 12:3-4. (Invited Review).
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Animal Disease Research Unit
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

BSE and Other TSEs Ruminant Herbivors: Diagnosis, Transmission and Genetics
5348-32000-021-00D
O’Rourke, K.I., Knowles, D.P., Alverson, J.
Pullman, WA, Animal Diseases Research Unit
O'Rourke, K. Phone: (509) 335-6020, Fax: (509) 335-8328,
korourke@vetmed.wsu.edu

PROJECT OBJECTIVES:
Free ranging and farm raised deer and elk in the U.S. develop a fatal prion disorder, chronic wasting disease
(CWD). CWD is a relatively uncharacterized TSE with novel patterns of transmission and agent distribution,
as well as the considerable challenge of a persistent disease in free ranging wildlife. The objectives of the
project are to develop inexpensive, high capacity live animal and postmortem diagnostic tests, prion detection
methods for monitoring environmental contamination, and pathogenesis/transmission experiments that provide
direction to intervention techniques and reagents. Control of all domestic prion diseases is important in
reducing trade barriers for U.S. sheep and germplasm and for assuring the present and future global markets for
cattle.
OVERALL PROJECT ACCOMPLISHMENTS:
Postmortem diagnostic test methodology for BSE using automated, monoclonal antibody
immunohistochemistry was developed and transferred to USDA, APHIS, National Veterinary Services
Laboratory. A non-automated immunohistochemistry test for BSE was developed in conjunction with private
industry and is marketed outside the United States, with all sales registered with USDA, APHIS, Center for
Veterinary Biologics.
Postmortem diagnostic test methodology for CWD using automated
immunohistochemistry was developed through a collaborative project with the Colorado State Veterinary
Diagnostic Laboratory and transferred to USDA APHIS. The test is conducted by the National Veterinary
Services Laboratory and a network of 20 contract laboratories and is used as a gold standard test to confirm the
results on rapid (ELISA) tests. The test was modified for use in live deer using tonsil biopsies collected under
general anesthesia. Monoclonal antibodies useful in assays on routinely formalin fixed tissue from infected
sheep, deer, elk, cattle, humans, mink, domestic cats and a wide variety of captive wildlife potentially exposed
to prion diseases were developed. Prion gene variation in mule deer, white-tailed deer, and elk was examined.
A processed prion pseudogene, the first reported in placental mammals, was discovered to occur in a large
proportion of mule deer and a small proportion of white-tailed deer. Genetic variants associated with relative
susceptibility to CWD were reported in white-tailed deer and elk; no evidence of relative genetic resistance to
CWD was found in mule deer.
IMPACT:
The development of an automated monoclonal antibody-based immunohistochemistry diagnostic assay has
allowed the US to provide gold standard testing for BSE and CWD at NVSL and a network of 20 contract
laboratories. The manual version of the test is the legal diagnostic test for BSE in Canada and in 17 countries
in Central and South America. This standardized approach to diagnosis in the US and with our Western
Hemisphere trading partners has allowed the cooperating nations to apply a single diagnostic standard for these
diseases and increase the confidence of the regulatory agencies and US consumers in the validity of the
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surveillance programs. The finding of a processed pseudogene in some species of deer has allowed the
regulatory and research communities to correct previous work on genetic susceptibility and sets the stage for
large scale field studies on transmission of the disease among related and unrelated members of free ranging
breeding groups.
TECHNOLOGY TRANSFER:
Licenses:
VMRD, Inc., licensed the monoclonal antibody developed for this project and completed the research and
development work on an inexpensive "dot blot ELISA" assay for early diagnosis of chronic wasting disease in
mule deer and white tailed deer. VMRD, in conjunction with ADRU, developed an inexpensive
immunohistochemistry diagnostic test for BSE. The test was validated by the Canadian Food Inspection
Agency and the Veterinary Laboratories Agency in the United Kingdom. The BSE test is marketed
internationally and is a diagnostic gold standard test in Canada. Monoclonal antibody F99/97.6.1 has been
licensed by a number of companies attempting to develop antemortem tests and is available commercially for
research purposes.
PUBLICATIONS:
O’Rourke, K.I, Spraker, T.R, Hamburg, L.K, Besser, T.E, Brayton, K.A, Knowles, D.P. Polymorphisms in the
prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting
disease in white-tailed deer. Journal of General Virology. 2004. v. 85. p. 1339-1346.
Spraker, T.R, Balachandran, A., Zhuang, D., O’Rourke, K.I. Variable patterns of PrP-CWD distribution in
obex and cranial lymphoid tissues of Rocky Mountain elk with nonclinical chronic wasting disease.
Veterinary Record . 2004 (in press).
Brayton, K.A, O’Rourke, K.I, Lyda, A.K, Miller, M.W, Knowles, D.P. A processed pseudogene contributes to
apparent mule deer prion gene heterogeneity. Gene. 2004. v. 326. p. 167-173.
O'Rourke, K.I., Zhuang, D., Lyda, A., Gomez, G., Williams, E.S., Tuo, W., Miller, M.W. Abundant PrP-CWD
in tonsil from mule deer with preclinical chronic wasting disease. Journal of Veterinary Diagnostic
Investigation 2003. v. 15. p. 320-323.
Spraker, T.R., Zink, R.R., Cummings, B.A., Sigurdson, C.J., Miller, M.W., O'Rourke, K.I. Distribution of
protease-resistant prion protein and spongiform encephalopathy in free-ranging mule deer (Odocoileus
hemionus) with chronic wasting disease. Veterinary Pathology. 2002. v. 39. p. 546-556.
Wild, M.A., Spraker, T.R., Sigurdson, C.J., O'Rourke, K.I., Miller, M.W. Preclinical diagnosis of chronic
wasting disease in captive mule deer (Odocoileus hemionus) and white-tailed deer (Odocoileus virginianus)
using tonsillar biopsy. Journal of General Virology. 2002. v. 83. p. 2629-2634.
Spraker, T.R, O’Rourke, K.I, Balachandran, A., Zink, R.R, Cummings, B.A, Miller, M.W., Powers, B.E.
Validation of monoclonal antibody F99/97.6.1 for immunohistochemical staining of brain and tonsil in mule
deer (Odocoileus hemionus) with chronic wasting disease. Journal of Veterinary Diagnostic Investigation.
2002. v. 14. p. 3-7.
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Spraker, T.R, Zink, R.R, Cummings, B.A, Wild, M.A, Miller, M.W, O’Rourke, K.I. Comparison of
histological lesions and immunohistochemical staining of proteinase resistant prion protein in a naturallyoccurring spongiform encephalopathy of free-ranging mule deer (Odocoileus hemionus) with those of chronic
wasting disease of captive mule deer. Veterinary Pathology. 2002. v. 39. p. 110-119.
Raymond, G.J, Bossers, A., Raymond, L.D, O’Rourke, K.I, McHolland, L.E, Bryant, P.K, Miller, M.W,
Williams, E.S, Smits, M., Caughey, B. Evidence of a molecular barrier limiting susceptibility of humans,
cattle and sheep to chronic wasting disease. EMBO Journal. 2000. v. 19. p. 4425-4430.
Hamir, A.N, Cutlip, R.C, Miller, J.M, Williams, E.S, Stack, M.J, Miller, M.W, O’Rourke, K.I, Chaplin, M.J.
Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle.
Journal of Veterinary Diagnostic Investigation. 2001. v. 13. p. 91-96.
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Southeast Poultry Research Laboratory
Athens, GA

Swayne, David E
Lab Director & Research Leader
(706) 546-3433
SOUTHEAST POULTRY RESEARCH LAB
934 COLLEGE STATION ROAD
Athens GA 30604
PROJECTS
Southeast Poultry Research Laboratory (SPRL)
• Poult Enteritis Mortality Syndrome
• Identification of Virulence Determinants, Pathogenetic Mechanisms and Control Methods of Avian
Paramyxoviruses
• Application of Molecular Biological Techniques to the Diagnosis and Control of Avian Influenza
• Mucosal immunization to protect poultry against avian influenza.
• Development and Validation of Rapid Diagnostic Tests for Avian Influenza and Newcastle Disease
• Development of environmental and genomic strategies to control Marek’s disease
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Southeast Poultry Research Laboratory
CRIS Title:
CRIS:
Scientists:
Location:
Contacts:

Poult Enteritis Mortality Syndrome
6612-32000-036-00D
Spackman, E.; Pantin-Jackwood, M.
Southeast Poultry Research Laboratory, Athens, GA
706-546-3617 (P); 706-546-3161 (F); espackman@seprl.usda.gov

PROJECT OBJECTIVES:
Poult enteritis mortality syndrome (PEMS) is a highly infectious disease of young turkeys. PEMS was first
reported in North Carolina in 1991. Since then, PEMS has been reported throughout the Southeastern United
States and Texas. There are also reports of a PEMS-like disease in California, Arkansas, Missouri, and Israel.
PEMS has been called one of the most devastating emergent diseases to strike the poultry industry due to
production losses from the disease complex and in some regions of the U.S. an estimated 60-90% of all
commercial turkey flocks will experience some poult enteritis like disease seasonally during grow-out. The
causative agent(s) of PEMS remains unknown. The research under this CRIS seeks to identify the PEMS
agent(s) using novel molecular techniques, develop diagnostic reagents for rapid identification, and understand
the pathogenesis of the disease.
OVERALL PROJECT ACCOMPLISHMENTS:
Accomplishments over the life of this project have included: 1) the isolation, identification and characterization
of a unique strain of astrovirus in turkeys with PEMS; 2) reproduction of a PEMS-like clinical disease in
turkeys with this astrovirus; 3) reproduction of immune deficiencies in turkeys with the astrovirus which
reduces the ability of turkeys to fight off other pathogens; 4) an evaluation of commercial disinfectants which
demonstrated that most fail to inactivate the astrovirus, with the exception of formaldehyde and Virkon S that
were effective for killing the virus; 5) the development of a specific and sensitive standard RT-PCR test to
detect turkey astrovirus and transfer of the technology to veterinary diagnostic laboratories; 6) development of
state-of-the-art molecular tests (multiplex real-time-RT-PCR) for the simultaneous detection of several PEMS
associated viruses, including; turkey astrovirus, turkey coronavirus, classical avian reoviruses and turkey
reoviruses, all from samples collected from PEMS affected turkeys; 7) an evaluation of turkey astrovirus,
turkey coronavirus and turkey reovirus shed and virus presence in selected organs at different times postexposure in order to determine optimal sampling methods for the detection of each virus with molecular tests;
and 8) a preliminary characterization of turkey reoviruses which are associated with poult enteritis complex.
IMPACT:
This work has directly addressed the objective of developing rapid, sensitive and accurate detection methods
for the viruses commonly associated with PEMS (turkey coronavirus, turkey astrovirus and avian reovirus).
Also optimal sampling methods have been determined to increase the utility of these methods in the field. The
availability of accurate molecular diagnostic tests using state-of-the-art technology, such as real-time RT-PCR
will also help to address the objective of isolating, identifying and characterizing viral agents associated with
PEMS due to the difficulty in culturing these agents. Additionally, using the improved technology we have
been able to identify reoviruses that are genetically different from classical avian reoviruses in samples
collected from commercial turkey flocks with poult enteritis and which otherwise may not have been detected.
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Therefore more pathogens can be detected and more information about them can be obtained at their initial
detection.
TECHNOLOGY TRANSFER:
Schultz-Cherry, S., L.A. Kelley, M.D. Koci and B.S. Seal. Avian Astrovirus US patent# 6,696,562
A reverse-transcription-polymerase chain reaction (RT-PCR) was developed, based on the sequence produced
at SEPRL, to identify the turkey astrovirus, and the test was transferred to the University of Guelph diagnostic
laboratory. The RT-PCR test was further enhanced into a multiplex format so that could identify both turkey
astroviruses and turkey coronaviruses from the same sample. This test was transferred for use by the Poultry
Diagnostic Research Center at the University of Georgia.
PUBLICATIONS:
Koci, M.D., Seal, B.S., Schultz-Cherry, S. Development of an RT-PCR diagnostic test for an avian astrovirus.
2000. Journal of Virological Methods. v.90 pp. 79-83
Schultz-Cherry, S., Kapczynski, D.R. Simmons, V.M. Koci, M.D., Brown, C., Barnes, H.J. Identifying
Agent(s) associated with poult enteritis mortality syndrome; importance of the thymus. 2000. Avian Diseases.
v.44. pp. 256-65.
Schultz-Cherry, S., Kind, D.J., Koci, M.D. Inactivation of an astrovirus associated with poult enteritis
mortality syndrome. 2001. Avian Diseases. v.45. pp. 76-82.
Kapczynski, D.R., Sellers, H.S., Simmons, V., Schultz-Cherry, S. Sequence analysis of the S3 gene from a
turkey reovirus. Virus Genes. 2002. v.25. p.95-100.
Koci M.D., Kelley, L.A., Larsen, D. and S. Schult-Cherry. Astrovirus induced synthesis of nitric oxide
contributes to virus control during infection, Journal of Virology, 78:1564-74, 2004
Sellers, H.S., M.D. Koci, E. Linneman, L.A.Kelley and S. Schultz-Cherry. Development of a multiplex reverse
transcription-polymerase chain reaction diagnostic test specific for turkey astrovirus and coronavirus. Avian
Diseases; in Press
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Southeast Poultry Research Laboratory
CRIS Title:
CRIS:
Scientists:
Location:
Contacts:

Identification of Virulence Determinants, Pathogenetic Mechanisms and Control
Methods of Avian Paramyxoviruses
6612-32000-038-00D
King DJ, Kapczynski DR, Yu Q, Swayne DE, Mitchell BW, Vacancy
Southeast Poultry Research Laboratory, Athens, GA
706-546-3407 (Phone), 706-546-3161 (FAX),
jking@seprl.usda.gov

PROJECT OBJECTIVES:
Avian paramyxoviruses are the cause of two diseases important to the U. S. poultry industry. Newcastle
disease (ND) is a viral disease of poultry and a worldwide problem first recognized in the U. S. in the 1930s.
Newcastle disease virus (NDV), also known as avian paramyxovirus type 1 (APMV-1), infects all known wild
and domestic bird species. Different NDV strains vary in virulence and produce differing clinical forms of the
disease that range from high mortality to mild or inapparent respiratory infections. Although the highly virulent
form of the disease was diagnosed in the U.S. in 2002-2003 for the first time since 1998, the mild form of ND
is the predominant one occurring in the U.S. and is the cause of reduced productivity from respiratory disease
and reduced rate of gain. Avian pneumovirus (APV) infections of turkeys in the U.S., in contrast to ND, are of
recent concern. APV, now classified as an avian metapneumovirus, was isolated from commercial turkeys in
Colorado in 1996. The disease was reported in the United Kingdom in 1985 and prior to 1996 the disease was
exotic to North America. The virus causes a mild, but rapidly spreading, upper respiratory disease and adverse
effect on weight gain and feed conversion. Secondary bacterial infections increase the severity of the disease.
The initial diagnosis of the disease in the U.S. was delayed because the U.S. isolate was of a different subtype
than had been isolated elsewhere and serological assays to detect the new subtype had to be developed.
Research to resolve the problems caused by these two diseases includes characterization of new isolates,
identifying the factors responsible for their causing disease, and developing control strategies, including
vaccination and diagnostics.
OVERALL PROJECT ACCOMPLISHMENTS:
Present methods for the detection of the causative agent of Newcastle disease (ND), Newcastle disease virus
(NDV), are based on isolation of the virus in embryonated chicken eggs, a sensitive and reliable method but
expensive and time consuming. ND susceptible and vaccinated chickens and turkeys were infected with the
California 2002 END virus at Southeast Poultry Research Laboratory (SEPRL) to provide samples for
comparative testing by virus isolation and a rapid diagnostic method developed by SEPRL scientists from the
avian influenza and Newcastle disease rapid diagnostic development project. A comparison of results of virus
isolation and the rapid test demonstrated the efficacy of the newly developed rapid test procedure. This
efficacy with experimental samples was the justification for proceeding with validation testing of the new rapid
procedure on field samples including those from the END outbreak of 2002-2003 and transfer of the test to the
National Veterinary Services Laboratories for use in the California NDV outbreak.
Last year, avian pneumovirus (APV) antibody was demonstrated in wild birds in the Southeast U.S. and
suggests wild birds could be a source of APV virus transmission to turkeys. Southeast Poultry Research
Laboratory scientists collected swabs from the species of wild birds previously found to have APV antibodies.
APV was identified from 12 of the sampled wild birds and it was determined through sequence analysis of the
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glycoprotein, matrix and fusion genes that the wild bird viruses are closely related to viruses found in domestic
poultry. The presence of virus in wild birds and the relatedness to viruses found in domestic poultry indicate
the potential for wild birds to spread APV infections in areas of the United States where the virus is currently
not found in poultry.
Identifying the source of the exotic Newcastle disease (END) virus that caused the END outbreak in the
Southwestern U.S. and Texas during 2002-2003 is critical to the development of control programs to prevent
future outbreaks. Southeast Poultry Research Laboratory scientists analyzed and compared the nucleotide
sequence of the virus genome of isolates from the 2002-2003 outbreaks with the sequence of recent isolates of
END virus from U.S. quarantine stations and from outbreaks in several countries in the world. The END virus
isolates from the 2002-2003 U.S. outbreaks were found to be most similar to viruses isolated from northern
Mexico during 1996 and 2000. Therefore, the most likely source of END virus that caused the California and
Texas 2002-2003 END outbreaks was virus transmission from Mexico via infected birds or virus contaminated
fomites.
Genetic changes in avian pneumovirus (APV) between its initial identification as the cause of turkey
rhinotracheitis (TRT) in Colorado during 1997 and the isolates from current outbreaks in Minnesota were
unknown. Southeast Poultry Research Laboratory scientists analyzed the nucleotide sequence of the virus
attachment protein gene (G) of isolates from 1997 and compared it to the G sequence of recent APV isolates.
APV virus G gene changes were found to have occurred between 1997 and the present. These changes suggest
selection or mutation among U.S. isolates has occurred since the first outbreak of TRT in the U.S.
The embryonated chicken egg had not been examined as a model system to evaluate virulence properties of
Newcastle disease virus (NDV) isolates and laboratory induced NDV mutations. At the Southeast Poultry
Research Laboratory, the embryos from eggs inoculated with NDV reference and mutated reference strains
were collected, formalin fixed, sectioned, and stained with a gene probe and NDV antibodies to detect virus
distribution in the tissues and membranes of the embryonated egg. Low-virulence strains were detected
exclusively in the cells of the chorioallantoic membrane, whereas more virulent NDV isolates and mutated
strains that had been demonstrated to have acquired virulence for chickens were widely disseminated in
chicken embryo tissues. The results demonstrate the potential value of this as a model system for evaluating
NDV virus virulence as an alternative to chicken inoculation.
Efficacious avian pneumovirus (APV) vaccines are needed by the turkey industry. At the Southeast Poultry
Research Laboratory, a live attenuated APV vaccine (cp30) was developed by successive adaptation of the
virus to decreasing temperatures and its efficacy in turkeys was evaluated. The results indicate the dose
necessary for complete protection from clinical signs following APV challenge also resulted in clinical signs
following vaccination. A cold adaptation of the vaccine strain to reduce post vaccinal reaction was ineffective
at reducing those reactions at a dosage required to produce protection.
Protection of commercial poultry from exotic Newcastle disease (END) is a constant threat to U.S. poultry
producers. Southeast Poultry Research Laboratory scientists conducted vaccine efficacy experiments with
END California 2002 virus in chickens. The results indicated protection from END with either a single dose of
live or inactivated vaccine. Current commercial ND vaccines are effective in protecting against disease
resulting from END virus infections.
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The capability to easily differentiate vaccinated from infected birds would enhance current Newcastle disease
(ND) control programs. A project scientist developed a vaccine that is a shell of the whole virus which retains
the important surface structures that induce immunity but can=t infect or be transmitted from bird to bird
because the virus genome and internal proteins have been removed. The vaccine is known as a Newcastle
disease virus (NDV) virosome vaccine, was administered intranasally, and protected chickens against a lethal
NDV challenge. Because vaccinated birds can be differentiated from infected birds, this vaccine may provide
an alternative to current live NDV vaccines.
Extensive genomic data of Newcastle disease virus (NDV) is largely incomplete. To extend that data, the
nucleocapsid (N) protein genes from twenty-four NDV isolates representing various pathotypes with different
geographical and chronological origins were cloned and sequenced. Comparison of N protein amino acid
sequences among members of the Paramyxoviridae resulted in NDV and avian paramyxovirus type 6
separating as a cluster distinct from the Rubulavirus genus. This data provided further support for the recently
updated classification of avian paramyxoviruses in their own genus Avulavirus among the Paramyxovirinae.
Rapid diagnostic procedures are needed for Newcastle disease virus (NDV). Viral genomic information around
a known virulence marker of NDV was used to develop a heteroduplex mobility assay (HMA) to differentiate
strains that have different genome sequences in the region of that marker. Project scientists were able to
distinguish vaccine-like viruses from other isolates potentially virulent for chickens. Use of the HMA in labs
that do not have nucleotide sequencing facilities can provide a rapid identification of potentially virulent NDV
that continue to threaten commercial poultry.
Waterfowl have been a suspect source of avian pneumovirus (APV) that infected turkeys in Minnesota.
University of Minnesota scientists placed APV-negative mallard ducks as sentinels on a turkey farm
experiencing a severe APV outbreak and were able to recover APV from swab samples and detect anti-APV
antibodies in serum of the sentinel ducks even though they did not develop clinical APV disease. Sequence
analysis at Southeast Poultry Research Laboratory of four APV isolates recovered from the APV outbreak in
turkeys shared 95% to 99% nucleotide sequence identity and 97% to 99% predicted amino acid sequence
identity with the duck isolate. These results indicate that the APV isolates from turkeys and ducks shared a
common source, and the viruses from different avian species can cross-infect.
The diversity of among avian pneumovirus (APV) isolates from commercial turkeys in the north-central region
of the U.S., particularly Minnesota had not been determined. A comparison of nucleotide and predicted amino
acid sequences from 15 U.S. AMPV isolates were completed. The results demonstrated that these viruses were
all closely related and distinct from European APV isolates. This further confirms that the U.S. viruses are
closely related genetically and form a separate sub-type relative to European viruses.
An effective APV vaccine is still needed to control the disease in turkeys. Turkeys were vaccinated with a
DNA vaccine comprised of the APV fusion protein gene, a gene whose product is believed critical in
generating an effective immune response. Vaccinated turkeys shed less challenge virus and produced higher
neutralizing antibody titers than attained with other experimental vaccines. The results suggest that improved
APV vaccines are feasible and provide the basis for expanding this vaccination approach.
Laboratory experiments with APV fail to reproduce the severity of disease seen in the field. Southeast Poultry
Research Laboratory (SEPRL) scientists conducted coinfection experiments with APV and low virulent
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Newcastle disease virus (NDV) or Escherichia coli at SEPRL. Coinfection of APV and NDV results in
increased severity of disease. This suggests that control of field NDV or more judicious use of NDV vaccines
are necessary to control APV.
Existing avian pneumovirus (APV) diagnostic tests do not work in bird species other than chickens and
turkeys. A competitive ELISA test developed in FY2001 at Southeast Poultry Research Laboratory was
validated using field sera samples in conjunction with Minnesota Bureau of Animal Health. Using the
validated test, APV positive sera samples were identified in American coots and Canada geese but not in 13
other wild bird species. This suggests that some wild birds can be infected with APV and may be a reservoir
for the virus.
IMPACT:
The work addresses the objectives in our OSQR Project Plan: 1) to characterize emergent Newcastle disease
virus and avian metapneumovirus isolates to extend the capabilities for molecular epidemiology of the most
important avian paramyxovirus infections; 2) to further characterize determinants important to avian
paramyxovirus pathogenesis; and 3) to develop improved control strategies, including vaccination, diagnostics
and identification of virus reservoirs based on information from avian paramyxovirus characterization and
pathogenesis studies. The outbreak of exotic Newcastle disease (END) that was diagnosed in the U.S. during
October 2002 served to focus and provide immediate impact for this year’s research. Project scientists
provided support in the eradication of END by analysis and experimentation that are components of the first
and third project objectives.
TECHNOLOGY TRANSFER:
Patents:
ANucleotide Sequence for the Avian Metapneumovirus (Colorado) Attachment Glycoprotein Gene@ Inventors:
Bruce S. Seal and Rene Alvarez. Docket No.: 0036.02. Serial No.: 10/285,626. Date Filed: 11/01/2002.
An invention report, No. 0186.02 entitled “A Virosome Vaccine for NDV”, was submitted to the Office of
Technology Transfer for potential patent development of the NDV virosome vaccine developed in our
laboratory.
Cooperative Research and Development Agreements (CRADA):
CRADA #58-3K95-2-914 entitled AImproved Diagnostics for Avian Pneumovirus by Use of Peptide Antigens
and Anti-peptide Antiserum to the Viral Nucleocapsid Protein and Phosphoprotein@ between ARS and IDEXX
Laboratories, Inc. Principal Investigator: Bruce Seal
PUBLICATIONS:
Seal, B. S., D. J. King, and R. J. Meinersmann. Molecular evolution of the Newcastle disease virus matrix
protein gene and phylogenetic relationships among the paramyxoviridae. 2000. Virus Research. V. 66. P.1-11.
Seal, B. S., D. J. King, and H. S. Sellers. The avian response to Newcastle disease virus. 2000. Developmental
and Comparative Immunology. V. 24. P. 257-268.
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Seal, B.S., Sellers, H.S. and Meinersmann, R.J. Fusion protein predicted amino acid sequence of the first U.S.
avian pneumovirus isolate and lack of heterogeneity among other U.S. isolates. 2000. Virus Research. V66.
p.139-147
Locke, D.P., Sellers, H.S., Crawford, J.M., Schultz-Cherry, S., King, D.J., Meinersmann, R.J., Seal, B.S.
Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells. Virus
Research. 2000. v. 69. p. 55-68.
Gulati, B.R., Cameron, K.T., Seal, B.S., Goyal, S.M., Halvorson, D.A., Njenga, M.K. Development of highly
sensitive and specific enzyme-linked immunosorbent assay based on recombinant matrix protein for detection
of avian pneumovirus antibodies. Journal of Clinical Microbiology. 2000. v.38. p. 4010-4014.
King, D.J. Selection of Thermostable Newcastle Disease Virus from Reference and Vaccine Strains. Avian
Diseases. 2001. v. 45. p. 512-516.
Berinstein, A., Sellers, H.S., King, D.J., Seal, B.S. Use of a heteroduplex mobility assay to detect differences in
the fusion protein cleavage site coding sequence among Newcastle disease virus isolates. 2001. Journal of
Clinical Microbiology. v. 39. p. 3171-3178.
Kommers, G.D., King, D.J., Seal, B.S., Brown, C.C. Virulence of pigeon-origin Newcastle disease virus
isolates for domestic chickens. 2001. Avian Diseases. v. 45. p. 906-921.
Sellers, H.S., Villegas, P., El-Attrache, J., Kapczynski, D.R., Brown, C.C. Detection of infectious bursal
disease virus in experimentally infected chickens using in situ hybridization. Avian Diseases. 2001. v. 45. p.
26-33.
Kommers, G.D., King, D.J., Seal, B.S., Carmichael, K.P., Brown, C.C. Pathogenesis of six pigeon-origin
isolates of Newcastle disease virus for domestic chickens. Veterinary Pathology. 2002. v. 39. p. 353-362.
Seal, B.S., Crawford, J.M., Locke, D.P., Sellers, H.S., King, D.J. Nucleotide sequence analysis of the
Newcastle disease virus nucleocapsid gene and phylogenetic relationships among the Paramyxoviridae. Virus
Research. 2002. v. 83. p. 119-129.
Shin, H.J., Nagaraja, K.V., McComb, B., Halvorson, D.A., Jirjis, F.F., Shaw, D.P., Seal, B.S, Njenga MK.
Isolation of avian pneumovirus from mallard ducks that is genetically similar to viruses isolated from
neighboring commercial turkeys. Virus Research. 2002. v. 83. p. 207-212.
Shin, H.-J., Cameron, K.T., Jacobs, J.A., Turpin, E.A., Halvorson, D.A., Goyal, S.M., Nagaraja, K.V., Kumar,
M.C., Lauer, D.C., Seal, B.S., Njenga, M.K. Molecular epidemiology of subgroup C avian pneumoviruses
isolated from the United States and comparison with subgroup A and B viruses. Journal of Clinical
Microbiology. 2002. v. 40. p. 1687-1693.
Turpin, E.A., Perkins, L.E.L., Swayne, D.E. Experimental infection of turkeys with avian pneumovirus and
either Newcastle disease virus or Escherichia coli. Avian Diseases. 2002. v.46. p.412-422.
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Lwamba, H.C., Halvorson, D.A., Nagaraja, K.V., Turpin, E.A., Swayne, D., Seal, B.S., Njenga, M.K.
Antigenic cross-reactivity among avian pneumoviruses of subgroups A, B, and C at the matrix but not
nucleocapsid proteins. 2002. Avian Diseases. v. 46. p. 725-729.
Turpin, E.A., Perkins, L.E.L., Swayne, D.E. Experimental Infection of Turkeys with Avian Pneumovirus and
Either Newcastle Disease Virus or Escherichia coli. Avian Diseases. 2002. v. 46. p. 412-422.
Alvarez, R., Lwamba, H.M., Kapczynski, D.R., Njenga, M.K., Seal, B.S. Nucleotide and predicted amino acid
sequence-based analysis of the avian metapneumovirus type C cell attachment glycoprotein (G) gene:
Phylogenetic analysis and molecular epidemiology of U.S. pneumoviruses. 2003. Journal of Clinical
Microbiology. v. 41. p. 1730-1735.
Jacobs, J.A., Njenga, M.K. Alvarez, R., Mawditt, K., Britton, P., Cavanagh, D., Seal, B.S. Subtype B avian
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PROJECT OBJECTIVES:
Avian influenza presents a major disease threat to the US poultry industry. The unpredictable
nature of the disease and the viral agent that causes it is the same today as it was in 1983 when
the disease struck the Northeastern United States with severe economic consequences. Because
of research on avian influenza viruses in recent years we now know that some viruses can rapidly
change from causing only mild disease to one that causes a deadly disease in chickens. It is likely
that the longer a virus infects commercial poultry, the more likely it is to cause the severe form
of the disease. The research under this CRIS unit seeks to understand the changes that are
required for this shift in ability to cause disease. The research also seeks to control the presence
of AI viruses in poultry by development of new and more effective vaccines and to develop tests
to more rapidly diagnosis infection in chickens.
The CRIS project proposal has four major objectives. They include:
1) Define the role of individual avian influenza virus (AIV) genes and the host responses in
the pathogenesis and the host range of AIV.
2) Conduct research in molecular epidemiology of AIV outbreaks in poultry and wild birds
to identify sources and reservoirs of AIV.
3) Develop and evaluate immunologic and chemotherapeutic control methods for AIV.
4) Develop rapid diagnostic tests for AIV.
The projects objectives are designed to flexible to respond to disease outbreaks, including
outbreaks that affect poultry caused by other disease agents.
OVERALL PROJECT ACCOMPLISHMENTS:
In collaboration with APHIS (National Veterinary Services Laboratory, Ames, IA), a real time
RT-PCR (RRT-PCR) test was developed that can rapidly and with high sensitivity detect both
low pathogenic and highly pathogenic avian influenza. This test was validated for the direct
detection of any influenza viruses from infected birds in an outbreak situation, and was used to
help eradicate an H7 avian influenza outbreak in Virginia in 2002. The test was adopted as an
official test by APHIS and is being used for surveillance throughout the United States, including
by the National Animal Health Laboratory Network, the federally supported state diagnostic
laboratory system. The test has continued to play a valuable role in initially diagnosing and
helping to control avian influenza outbreaks in several different states, including Delaware,
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Maryland and Texas. This was the first widespread use of a real-time RT-PCR for the control of
a animal disease outbreak in the United States.
For the control of low pathogenic avian influenza outbreaks, vaccination is being more
commonly considered, because it can potentially help control an outbreak at a lower cost than
depopulation programs. At the Southeast Poultry Research Laboratory (SEPRL), the use of
currently available and new vaccination strategies are being investigated for the control of avian
influenza. Currently only two types of vaccines are available for use for avian influenza, killed
adjuvanted vaccines and fowlpox-vectored vaccines. Our research has shown that to get optimal
protection from these vaccines, it is important to match the vaccine to the challenge strain. A
better match of vaccines allows less virus to be shed from vaccinated but infected birds.
Additional research has shown that when vaccination is used on a widespread basis antigenic
drift, similar to what is seen with human influenza viruses, can be a problem for decreased
effectiveness for the vaccine. Our laboratory was the first to show that antigenic drift can be a
problem for vaccination use for avian influenza viruses. Additional research has been focused
on using viral-vectored or recombinant vaccines for avian influenza including fowlpox vectored
vaccines, replication incompetent alphavirus vectors, and Newcastle disease virus vectored
vaccines. All three of these vaccines types have shown to provide protection from influenza
challenge, and can provide the advantage of use as a DIVA (differentiate infected from
vaccinated animals) vaccine. These vaccines are still being evaluated to determine if they have
significant advantages over commercially available vaccines and can be produced in a cost
effective manner. Additional vaccine technologies, including the reverse genetics approach to
create avian influenza viruses that can also be used with the DIVA approach have also been
shown to be effective.
The characterization of influenza isolates in the U.S. and around the world is important to assess
potential biological threats to the U.S. poultry industry. In collaboration with researchers at the
National Veterinary Services Laboratory, state veterinary diagnostic laboratories, the Hong Kong
Agriculture, Fisheries, and Conservation Department, the National Veterinary Research and
Quarantine Service in South Korea, the Chile Ministry of Agriculture, and other countries, we
have characterized influenza viruses from the U.S. and around the world by sequence analysis
and animal inoculation studies. The molecular epidemiology and animal studies derived from
this work is important for estimating the risk for each influenza outbreak and has resulted in the
characterization of a novel way for a low pathogenic avian influenza to become highly
pathogenic (Chile H7N3 outbreak). More recently, our characterization of H5N1 viruses from
Southeast Asia has been valuable in demonstrating differences between viruses from other
countries, and helping to identify risk factors for this country. Vaccination studies were also
conducted that showed that current vaccines could still protect from birds from clinical disease
for these viruses.
In the past several years, several countries including Mexico and Japan, have tried to block
imports of U.S. poultry product based on the concern for virus being transmitted in poultry meat
or egg products. Research done at SEPRL has shown for low pathogenic avian influenza, virus
infection of meat did not occur and the risk of spread through meat products was low.
Additionally, work done at SEPRL showed that commonly used pasteurization or processing
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temperatures would inactivate virus in egg products, which makes these products safe even if
they were exposed to avian influenza viruses. This information was shared directly with trade
officials as part of APHIS trade missions, and provided some relief from unfounded trade
restrictions.
Our laboratory has been partnering with several other laboratories in the U.S. and abroad to do
wild bird surveillance for avian influenza. The goal of this work is to molecularly and
antigenically characterize viruses from throughout the world to better understand the variability
of influenza viruses in the natural host population. This information will prove valuable for
preparing for disease outbreaks in the United States.
The Southeast Poultry Research Laboratory has an interest in emerging diseases that might
impact poultry, and with their Biosafety-Level 3 facilities, are in a unique position to study some
of these emerging diseases. Our laboratory was the first or one of the first laboratories to do
poultry related research for both the Severe Acute Respiratory Syndrome (SARS) virus and West
Nile virus in the U.S. The SARS virus emerged in Southeast Asia and infected over 8400
humans with over 800 deaths. Early epidemiologic evidence suggested a zoonotic potential for
the virus with animals in the live animal markets in China. The source of the virus causing
SARS is still unknown but animals may be the source or may be contributing to the spread of the
virus. The Southeast Poultry Research Laboratory conducted a study to determine if chickens,
turkeys, ducks, geese and Japanese quail were susceptible to the SARS virus and could spread
the virus to humans. The study failed to demonstrate that the SARS virus could grow in these
birds. These data indicate that the common five domestic poultry species were not the reservoir
and will not spread the SARS virus to humans. Similar research with West Nile Virus was
conducted that showed the common poultry species could be infected with these viruses, but
clinical disease seldom occurred and that with low levels of viremia, these species were unlikely
to spread the virus.
IMPACT:
Progress was made in all four major objectives of the CRIS project, and this work continues to
have direct and indirect impact for the poultry industry. The development of a real-time RTPCR for avian influenza provided an immediate benefit in helping to control the outbreak of
avian influenza in Virginia. This new test not only provided results much faster than
conventional virus isolation, it was cheaper and more tests could be performed each day. This
test has become the official standard for surveillance by APHIS and is being used by over 20
diagnostic labs in the U.S. and abroad. The ongoing commitment to do molecular epidemiology
for outbreaks in the U.S. and abroad has helped to provide the poultry industry information about
what viruses pose risks to the U.S. poultry industry. Through the isolation and sequence analysis
with both commercial and wild bird influenza viruses, a large sequence repository has been
developed that will help prepare for future outbreaks, and hopefully allow us to predict which
viruses are the most dangerous. Our work on using reverse genetics to make new vaccines
provides great potential for vaccines use in the future and allows the more widespread use of
DIVA (differentiate infected from vaccinated animals) vaccines. Several other vaccine
technologies are being investigated to try and improve on the existing vaccines, either by making
the vaccines more cost effective or by making them easier to administer. Several trade
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embargoes from Mexico and Japan initiated research at SEPRL to look at the risk of virus spread
in meat and to do pasteurization studies to demonstrate that current practices mitigated any risk
of disease spread. These studies provided the scientific basis that was used to help lift these
embargoes. Efforts to examine the pathogenesis of different avian influenza viruses have
focused on the H5N1 viruses from Southeast Asia. These viruses are highly pathogenic for
poultry, and some of them also pose a zoonotic threat. Numerous pathology studies have helped
to identify host ranges and allow better risk assessment of these rapidly changing viruses.
TECHNOLOGY TRANSFER:
The real-time RT-PCR test for avian influenza has been transferred widely to both state and
federal diagnostic laboratories. Additional test technology, including proficiency panels and
neuraminidase N2 testing, have been transferred to APHIS, NVSL for their use.
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PROJECT OBJECTIVES:
Avian influenza (AI) viruses have been circulating periodically
in domestic poultry over the past 100 years. Wild waterfowl
and shorebirds are the reservoir for all identified AI virus
subtypes and although chickens and turkeys are not natural
host species, these viruses can routinely crossover from the
wild-bird reservoir to poultry. Although the incidence of highly
pathogenic AI viruses are relatively rare, less pathogenic
strains of these viruses more often circulate through poultry
flocks and are responsible for significant morbidity, mortality
and production losses. The devastation of low pathogenic (LP) H7N2 avian influenza (AI) in
chickens and turkeys has been apparent in the eastern U.S. in 2001 and 2002 resulting in
depopulation of 4.7 million commercial turkeys and chickens and is estimated to have cost the
poultry industry approximately $130 million. In addition, outbreaks have occurred in live poultry
markets of New England. In 2004, a limited outbreak of highly pathogenic (HP) H5N2 AI
occurred in Texas.
Traditional parenteral vaccination has provided some success at providing protection against
disease but is less effective in protecting against infection. This is thought to be due in part to the
observation that systemic vaccination is a poor inducer of mucosal immunity and therefore
organisms can invade the host before the systemic immunity can impede the infection. Because
AI viruses invade mucosal surfaces, emphasis should be placed on vaccines that induce strong
mucosal immunity. Thus, the main objective of this CRIS will be to develop mucosal vaccines in
an attempt to induce greater immune protection. The development of new vaccine approaches for
controlling such emerging/reemerging pathogens can be of great importance to the profitability
of the poultry industry.
OVERALL PROJECT ACCOMPLISHMENTS:
Accomplishments over the life of the project included publication of techniques for the
identification of avian immunoglobulins. These techniques have included the development of a
monoclonal antibody (mAb) to IgA and has improved the sensitivity of measuring IgA antibody
titers in immune samples. The mAb has also reduced the background levels observed with
commercially available reagents. Other accomplishments for this CRIS included: (1) improved
biological reagents needed to measure IgG antibody responses in chickens and turkeys, (2)
development of an ELISPOT assay to measure antibody secreting cells in various tissues, (3)
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identification of mucosal adjuvants for use in inactivated poultry vaccines, and (4) develop and
evaluation of inactivated AI and a recombinant Newcastle disease virus vaccine with AI
hemagglutinin gene insert. Research at Southeast Poultry Research Laboratory has also
demonstrated that the route of vaccine influenced the optimal mucosal response in white leghorn
chickens. The identification of optimal mucosal vaccine routes(s) is crucial for improving
mucosal immune response(s) to avian influenza viruses that infect poultry. Protocols were
established for vaccines and vaccination to protect turkeys from LPAI viruses.
IMPACT:
The new assays provide a mechanism to assess the effectiveness of vaccines to protect poultry
against AI and other respiratory and intestinal pathogens at the site of pathogen growth and
injury. The vaccine technology improvements have produced vaccines for salmonella and AI that
gives improved protection against their respective diseases than produced by existing
commercial products. One of these will decrease the cost of vaccination for AI because it can be
given by spray and not injection. This information will be used to develop efficacious vaccines
for stimulating protective immunity against AI and possibly other respiratory pathogens that
affect poultry. Furthermore, the identification of immune effectors mediating protection indicates
ways to maximize protective immune responses in poultry.
TECHNOLOGY TRANSFER:
No technology transfers.
PUBLICATIONS:
Chaubal, L. H., Holt, P. S. Characterization of motility and identification of flagella proteins in
the avian pathogen Salmonella pullorum. American Journal of Veterinary Research. 2000. v. 60.
p. 1322-1327.
Katz, J.M., Lu, X., Frace, M. Morken, T., Zaki, S. R., Tumpey, T.M. Pathogenesis of and
Immunity to Avian Influenza A H5 viruses. Biomedicine Pharmacotherapy. 2000. v.54. P.178187.
Tumpey, T.M., Lu, X., Morken, T., Zaki, S. R., Katz, J.M. Depletion of lymphocytes and
diminished cytokine production in mice infected with a highly virulent influenza A virus isolated
from humans. Journal of Virology. 2000. v.73. P.6105-6116.
Tumpey, T.M., Renshaw, M., Clements, J., Katz, J.M. Mucosal delivery of inactivated influenza
vaccine induces B cell dependent heterosubtypic protection against a lethal influenza A H5N1
virus. Journal of Virology. 2001. v.75. p. 5141-5150.
Lu, X., Tumpey, T. M., Renshaw, M., Hu-Primmer, J., Katz, J. Immunity to influenza A H9N2
viruses induced by infection and vaccination. Journal of Virology 2001. v.75. P.4896-4901.
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Epstein, S.L., Tumpey, T. M., Misplon, J.A., Lo, C-Y, Cooper, L.A., Subbarao, K., Renshaw,
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V.8. p.796-801.
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Tumpey, T. M., Fenton, R., Molesworth-Kenyon, S, Oakes, J.E., Lausch, R.N. Role for MIP-2,
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Southeast Poultry Research Laboratory
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Development and Validation of Rapid Diagnostic Tests for Avian
Influenza and Newcastle Disease
6612-32000-041-00X
Swayne D., Suarez DL, King DJ, Spackman E, Kapczynski, D
Athens, Georgia
Southeast Poultry Research Laboratory
Swayne, D., Phone: (706) 546-3433, Fax: (706) 546-3161,
dswayne@seprl.usda.gov

PROJECT OBJECTIVES:
Highly pathogenic avian influenza (AI) and Newcastle
disease (ND) are severe systemic, highly transmissible
diseases of poultry that cause high mortality rates and
severe economic losses. Traditionally, diagnosis has
been slow, requiring virus isolation and identification.
This delayed diagnosis has hampered efforts for early
detection and elimination, resulting in devastating
natural outbreaks. Complicating diagnosis is the
existence of low virulent forms of AI and avian
paramyxovirus type 1 (synonymous with Newcastle
disease virus) viruses that can mutate to become highly pathogenic avian influenza and
Newcastle disease viruses, respectively. These low virulent forms must be differentiated from
common respiratory diseases. The sources of AI and ND viruses include domestic poultry and
wild birds, but genetic analysis of diverse virus isolates across time, geographic location and bird
species have not been accomplished. Genetic analysis of AI and ND viruses has been nonsystematic, leaving critical gaps on genetics in our knowledge base.
To develop a rapid diagnostic test for these two diseases, real time reverse transcriptase
polymerase chain reaction (RRT-PCR - a biotechnology test to detect genes), technology will be
developed to detect the viruses in birds and differentiate these viral infections from "look-a-like"
respiratory diseases. Initially, probes will be designed based on the current AI and ND virus
sequences, and tested in an RRT-PCR test. Second, surveillance in wild and domestic birds will
yield new genetically diverse AI and ND virus isolates to test the sensitivity and specificity of
the RRT-PCR probes. Various genes from genetically diverse isolates will be sequenced and
analyzed to improve probe design and the specificity and sensitivity of RRT-PCR test.
Furthermore, the sequences of diverse viral isolates will help build molecular epidemiological
maps for future determination of the source of outbreak viruses. Third, RRT-PCR tests will be
validated in experimental studies. Fourth, the RRT-PCR tests will be validated in the field in the
U.S. and foreign nations.
OVERALL PROJECT ACCOMPLISHMENTS:
Rapid RT-PCR (RRT-PCR) test were developed and validated in laboratory and the field to
diagnosis type A influenza virus (avian influenza virus) and differentiate H5 and H7
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hemagglutinin subtypes in diagnostic samples. RRT-PCR tests were developed and validated in
the laboratory and field to diagnose Newcastle disease.
IMPACT:
The AI RRT-PCR tests were used in the 2002 Virginia H7N2 AI outbreak and 2002 Live Poultry
Markets to make AI diagnoses in less than 24 hrs. The NDV RRT-PCR test was used in
California during 2003. These tests have become the National Standard tests for diagnosis of AI
and ND viruses at the National Veterinary Services Laboratories and have been distributed to
National Animal Health Laboratory System for use at the State Veterinary Diagnostic Levels to
get rapid diagnosis of AI and ND.
TECHNOLOGY TRANSFER:
The Southeast Poultry Research Laboratory (SEPRL) has been on the leading edge of use of real
time PCR testing as a diagnostic test for viral pathogens of poultry with its work on avian
influenza virus and Newcastle disease virus. Through collaborations with APHIS, the rapid
diagnostic test for avian influenza and Newcastle Disease was validated and adopted by APHIS
as a principle test for the detection of these agents from field samples. These tests has already
been adopted by many state veterinary diagnostic laboratories with interest from others, and they
are official tests for the National Animal Health Laboratory Network. SEPRL has been
instrumental in the technology transfer to these laboratories by providing reference reagents,
training, coded test panels and other resources materials for the implementation of the
technology in each laboratory.
PUBLICATIONS:
Spackman, E., Senne, D.A., Myers, T.J., Bulaga, L.L., Garber, L.P., Perdue, L.P., Lohman, K.,
Daum, L.T., Suarez, D.L. Development of a real-time RT-PCR assay for type A influenza and
the avian H5 and H7 hemagglutinin subtypes. 2002. Journal of Clinical Microbiology. 40:32563260.
Spackman,E., D.A. Senne, L.L. Bulaga, T.J. Myers, M.L. Perdue, L.P. Garber, K. Lohman, L.T.
Daum, and D.L. Suarez. Development of real-time RT-PCR for the detection of avian influenza
virus. 2003. Avian Diseases. 47: 1079-1082.
Suarez, D.L., E. Spackman, D. Senne, L. Bulaga, A. C. Welsch, K. Froberg. The Effect of
Various Disinfectants on Detection of Avian Influenza Virus by Real Time RT-PCR. 2003.
Avian Diseases. 47:1091-1095.
Spackman, E., D.A. Denne, L.L. Bulaga, S. Trock, and D.L. Suarez. Development of a
multiplex real-time RT-PCR as a diagnostic tool for avian influenza. 2003. Avian Diseases. 47:
1087-1090.
Wise MG, Suarez DL, Seal BS, Pedersen JC, Senne DA, King DJ, Kapczynski DR, Spackman E.
Development of a real-time reverse-transcription PCR for detection of Newcastle disease virus
RNA in clinical samples. 2004. Journal of Clinical Microbiology. 42:329-38.
198

Spackman, E., and D.L. Suarez. Use of a novel virus inactivation method for a multi-center avian
influenza real-time RT-PCR proficiency study. Journal of Veterinary Diagnostic Investigation.
(In press)
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Southeast Poultry Research Laboratory
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CRIS Number:
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Location:
Contacts:

Development of environmental and genomic strategies to control Marek’s
disease
6612-32000-043-00D
Mitchell B., Swayne D., Vacant
Southeast Poultry Research Laboratory, Athens, GA
706-546-3433 (phone), 706-546-3161 (FAX), dswayne@seprl.usda.gov

PROJECT OBJECTIVES:
Marek’s disease is a cancer of the lymphocytes in chickens caused by a herpesvirus. Vaccines
have been used since the 1960’s to prevent and/or control development of the cancer. Such
vaccines have been successful but new strains of the virus have arisen through virulence shifts
that have overcome vaccine protection. The objectives of this project are: 1) development of
environmental control systems that will reduce field exposure of chickens to the Marek’s disease
virus and result in reduced incidence of Marek’s disease, and 2) development of a comparative
genomics program that will lead to the identification of predictors of virulence shifts. Initially,
objective one will be approached by developing and testing high voltage electrostatic space
charge systems (ESCS) for use in chick rearing areas and poultry houses to reduce feather dander
containing the Mareks’ disease virus. ESCS systems designed at SEPRL has been shown to
reduce dust in hatching cabinets and animal rooms. Feather dander is a major source of dust
particles. Marek’s disease is transmitted because the virus is shed in high quantities of feather
dander. Impact of ESCS on reducing environmental load of Marek’s disease virus and
transmission of Marek’s disease virus will be determined. A genomics approach will be used to
identify viral genes responsible for shifts in virulence of field MDV which will assist in vaccine
development.
OVERALL PROJECT ACCOMPLISHMENTS:
None. New project initiated in late 2003.
IMPACT:
None. New project
TECHNOLOGY TRANSFER:
None.
PUBLICATIONS:
None.
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Animal and Natural Resources Institute (ANRI)
Beltsville, MD

ANIMAL AND NATURAL RESOURCES INSTITUTE (ANRI)
Sexton, Thomas J
Director
(301) 504-8431
10300 BALTIMORE BLVD. .
BLDG. 200, RM. 217, BARC-EAST
Beltsville MD 20705
Animal Parasitic Diseases Laboratory (APDL)
Mark Jenkins, Research Leader
(301) 504-8054
10300 BALTIMORE BLVD.
BLDG. 1040, RM. 103
Beltsville MD 20705

Bovine Functional Genomics Laboratory (BFGL)
Louis C.Gasbarre, Research Leader
(301) 504-8509
10300 BALTIMORE BLVD.
BLDG. 200, RM. 8, BARC-EAST
Beltsville MD 20705
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PROJECTS
Animal Parasitic Diseases Laboratory (APDL)
• Genomic, Proteomic and Immunological Approaches to Control Avian Coccidian Parasites
• Strategies to Control Swine Parasites Affecting Food Safety
• Biosystematics and Biodiversity of Pathogens and Parasites
• Biology and Epidemiology of Neospora Caninum and Related Protozoa
Bovine Functional Genomics Laboratory (BFGL)
• Improving Milk Quality by Reducing Mastitis in Dairy Cattle
• Immunological and Genetic Basis of Resistance to Parasites of Cattle
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Animal Parasitic Diseases Laboratory (APDL)
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Genomic, Proteomic and Immunological Approaches to Control Avian
Coccidian Parasites
1265-31320-070-00D
Lillehoj, H., Fetterer, R., Allen, P., Miska, K., Jenkins, M.
Animal and Natural Resources Institute, Animal Parasitic Diseases
Laboratory
Lillehoj, H., Phone: (301) 504-6170, Fax: (301) 504-5306,
hlilleho@anri.barc.usda.gov

PROJECT OBJECTIVES:
Coccidiosis is a ubiquitous intestinal protozoan infection of poultry which seriously impairs the
growth and feed utilization of infected animals. In poultry, coccidiosis has been particularly
problematic where annual losses of over $600 million per year have been sustained by the U.S.
poultry industry alone. Each of the more than 30 billion chickens raised annually worldwide is
at risk for coccidiosis. Coccidiosis in chickens is caused by at least seven distinct species of
obligate intracellular parasites of the genus Eimeria. The pathology of coccidiosis is caused by
the rapid replication of the parasite during asexual reproduction in the cells of the gut, resulting
in diarrhea, weight loss, and anorexia. Several notable problems currently exist for effective
control of coccidiosis: 1) Disease resistant strains have been emerging very rapidly worldwide.
Therefore the effectiveness of existing pharmaceutical therapeutics have been decreasing steadily
over the last decade. This problem is compounded by our lack of understanding of the
mechanism(s) that confer(s) drug resistance and how the drug resistant strains are propagated. 2)
Knowledge of the nature of protective immunity elicited by natural infection is limited.
Vaccination against Eimeria induces species-specific immunity, and is the basis for increased
utilization of live oocyst vaccines in broiler production. However, strains of some species (a
particular problem with E. maxima) are poorly cross-protective, reducing the effectiveness of
live vaccines. 3) The limited number of existing recombinant vaccines do not offer crossprotection against all seven species of Eimeria that infect chickens. 4) Additionally, there is
worldwide consumer as well as governmental effort to reduce the use of feed additive
pharmaceuticals for animals destined for human consumption, further driving the need for more
efficacious vaccines. Our long-term goal is to develop new cost-effective strategies that will
control coccidiosis for the poultry producer. To accomplish this, we are conducting research
through a multidisciplinary approach using immunology, biochemistry, cellular and molecular
biology and functional genomics and proteomics to 1) identify host genes and traits which confer
protective immunity against all Eimeria species and use this information to develop markerassisted selection strategy for commercial broiler industry, 2) determine the immunological
pathways that provide innate and acquired host resistance, and understand the early physiological
host responses associated with the immune response and pathology, 3) develop new vaccine
strategies for induction of protective mucosal immunity, 4) identify parasite genes and gene
products that are related to growth and development and that may play roles in pathology and
drug resistance. These genes may prove to be targets for new vaccines and chemotherapy. 5)
understand the physiology of parasite development through studies of Eimeria parasites in cell
culture, 6) modulate infections through use of non-pharmaceutical feed additives, and 7)
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understand the genetic mechanisms which may drive antigenic diversity in the parasites.
Successful completion of these studies will enhance our understanding of Eimeria biology and
genetics, the development of host immunity to parasite invasion, innate disease resistance to
coccidiosis, and will assist in the development of practical, multifaceted, effective control
strategies against Eimeria sp.
OVERALL PROJECT ACCOMPLISHMENTS:
1.
Identification of Eimeria genes and gene product which are involved in immunity and
parasite development. We have targeted new structural, stress-related, and
developmentally regulated parasite proteins associated with several Eimeria species as
potential protective antigens, produced recombinant parasite proteins that have been
tested using new methods of vaccine delivery including various viral vector systems as
well as DNA vaccines. Subtracted cDNA libraries from E. tenella oocysts were produced
and over 500 ESTs representing transcripts whose expression is differentially regulated
between sporulated and unsporulated oocysts were identified. Analysis of expression of
several of these transcripts via real-time PCR methods confirmed that these transcripts
are differentially expressed. The full-length sequences of some candidates are being
obtained, and will be tested as potential targets for vaccine development. In addition,
analysis of ESTs from E. acervulina sporozoites and merozoites has resulted in
identification of four full-length candidate transcripts that will also be tested in vaccine
development. These candidates include a serine protease inhibitor, macrophage
inhibitory factor, a member of a family of surface proteins, and peroxiredoxin. All of
these molecules may be essential to parasite function, and may serve as good vaccine
targets. Recent success in characterizing genes that are important during sporulation
enhanced our knowledge of parasite development and will facilitate the development of
new therapeutics that would inhibit the formation of the infectious oocyst therefore
preventing infection of the host. A major ooccyst protein was identified and characterized
during sporulation of E. tenella. This protein can serve as an important marker of
development in Eimeria species. Further studies to examine the changes in other oocyst
proteins that occurs during sporulation using a combination of mass finger-printing
techniques and n-terminal sequencing to identify proteins characterized on 2D gels and
the use of real-time PCR and micro-array system to examine the quantitative changes in
proteins during maturation of the oocysts will complement our ongoing efforts to develop
coccidia vaccine. Investigation of enzyme changes during sporulation of E. tenella will
also lead to the identification of key enzymes associated with sporulation and sporozoite
invasion of host cells and determine if sporozoite proteins are synthesized de novo or are
incorporated from unsporulated oocysts. In efforts to find Eimerian metabolic systems
that would be suitable targets for control programs, we identified one enzyme of the
biotin-containing acetyl coA carboxylase complex (ACC1). This complex encompasses
the initial steps in synthesis of fatty acids, requisite components of cell membranes, and
has been found to be susceptible to inhibition by acetoxyphenoxypropionate (“fop”) type
herbicides in both Plasmodium sp and Toxoplasma sp. These herbicides inhibit growth of
these parasites in vitro. ACC1 activity is present in apicoplast organelles in these two
parasites. However, Eimeria growth and reproduction was not inhibited by two “fop”
herbicides when fed to coccidia-infected chickens. We have found that the presence of
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apicoplast organelles in Eimeria is questionable, and that although a genetic sequence
similar to the acetyl coA carboxylase of Toxolasma is present in the E. tenella genetic
data base (Sanger, UK), there does not seem to be a leader sequence that would target it
to an apicoplast. The complex may be in the cytoplasm, or confined to Golgi vesicles.
The presence of the ACC1 complex transcripts is being confirmed by sequencing of RTPCR products amplified from cDNA of E. tenella sporulated oocysts, and probes are
being developed to facilitate its localization histologically. These findings reveal an
exciting, fundamental metabolic difference between Eimeria sp and other apicomplexa
that may be exploitable for new control strategies. Proteins in developmental stages of
Eimeria species have been characterized. An important antigen of unknown function
previously reported in E. acervulina was identified to act as an actin binding protein,
profilin. This was the first report of profilin from apicomplexa. The structure of this
protein was deduced from the E. tenella genomic data base. The protein is conserved in
all species of Eimeria studied and is unique to the Apicomplexans. Profilin transcripts
and the subsequent protein are expressed at all stages tested
2.

Provided new information on coccidia proteins, recombinant vectors, and mucosal
delivery methods that will facilitate the development of novel vaccine strategies for avian
coccidiosis for the poultry industry. Vaccine trials using Eimeria immunogenic
recombinant vaccines have clearly demonstrated that subunit, recombinant, and DNA
vaccines can elicit protective immunity. Identification of new structural and metabolic
Eimeria proteins, other stress-related and developmentally regulated Eimeria proteins and
development of various novel vaccination strategies using attenuated, recombinant viral
vectors, recombinant antibody or various delivery methods such as gene gun, in ovo
injector have demonstrated the feasibility of eliciting protective intestinal immune
responses. A systematic proteomic approach was implemented to determine the protein
compliment of developmental stages of Eimeria and determine the interaction of these
proteins with the host immune system. Pure, live oocysts strains have been characterized
for drug sensitivity and cross protection potential. Immuno-stimulatory complexes
(ISCOMS) have been investiaged as antigen delivery systems in vaccination protocols for
avian coccidiosis. Saponins from plants native to Kazakstan were evaluated for low
toxicity and ability to form ISCOMs. The best saponins were used to prepare ISCOMs
containing crude coccidia antigens. Immunization with these ISCOMS significantly
stimulated cellular and humoral immunity in mice and provided significant protection to
re-infection in immunized chicken. Recombinant Eimeria antigens are being expressed
and will be incorporated into ISCOMS for further vaccination trials. To address problems
in cross protection studies, or in trials comparing efficacies of various anticoccidial
treatments, we have developed a protective index that takes into consideration both gross
aspects (weight gain and lesion score) and metabolic indicators (plasma carotenoids and
NO2-+NO3-) of pathology during coccidia infections. Recent cross protection studies
with several E. maxima strains indicate that parasite fecundity is a major factor in
eliciting protective immunity. Thus, genes that regulate the reproductive capacity of
Eimeria sp. will be important targets for control of avian coccidia infections. Further
studies on the role of chicken cytokines as adjuvant in DNA vaccine will enhance our
understanding of how the chicken cytokine modulate local immunity to parasites. The
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results of our studies clearly document the role of various immunomodulators such as
chicken cytokines, saponins as adjuvants that should provide additional impetus for
further investigation of their biological activities at the molecular and immunological
levels. These results provide important background information from which novel
vaccine technology can be developed for coccidiosis control.
3.

Developed a large scale screening system for testing drug and vaccine sensitivities of
field isolates of Eimeria and host immune responses to vaccination. A new method to
conduct a large scale evaluation of current anti-coccidial vaccines and drugs, and to
assess the protective host immune response to vaccination has been developed and is
being evaluated as way to create efficient management of avian coccidiosis. As evidence
of the importance of this work, several CRADAs have been initiated with poultry and
pharmaceutical companies to evaluate drug sensitivity of field strains of avian coccidia.
Furthermore, the lack of appropriate immunological reagents to study the poultry immune
responses is a major limiting factor for the progress of poultry disease research. Industry
support was obtained to test field strains of Eimeria for sensitivity to common anticoccidial drugs or live oocysts vaccines from US poultry producers. To continue the
investigation on the role of cytokine as genetic adjuvant, a National Research Initiative
grant was awarded to characterize and clone major chicken lymphokines (IFN-γ, IL-15,
IL-2, IL-16 and IL-17) that are associated with protective host immune responses to
coccidiosis to develop enzyme-linked immunosorbent assays (ELISA) to evaluate the
host immune response to vaccination on a large scale.

4.

Identified DNA and physiological markers that are associated with pathology and
immune protection in commercial meat-type chickens. . Genetic mapping using
commercial chicken strains has found quality trait loci (QTL) markers on chicken
chromosome 1 associated for resistance to coccidia, weight gain, and oocyst production.
The locus identified as "LEI0101" decreased parasite production 3000 times in broiler
chicken families. This was the first description of an association of chicken genetics with
coccidiosis resistance and this finding will be used by the poultry industry for marker
assisted selection (MAS) of breeding stocks. This research provides the groundwork to
develop novel strategies of improving the genetic capacity of chickens for enhanced
resistance to coccidiosis and was the basis for a new NRI Grant to develop a practical
marker-assisted selection strategy for avian coccidiosis in commercial broilers. New
knowledge concerning the genetics and physiology controlling the interaction of the host
and parasite are required to develop markers that can be used to optimize new treatment
strategies for avian coccidiosis. Hormonal changes associated with appetite suppression
and reduced feed intake have been identified, linking for the first time early host
pathology to neuroendocrine changes. Additionally 3-methylhistidine has been found to
be a metabolic marker associated with muscle protein breakdown and with reduced feed
intake. infections. Availability Genetic mapping (definition of DNA markers) for
resistance to coccidiosis was initiated through the Award of a Fund for Rural America
(FRA) and extended through a National Research Initiative grant which has also allowed
the construction of the cDNA library. The first normalized chicken intestinal cDNA
library containing >38,000 gene sequences has been developed. Availability of chicken
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intestinal genome database will facilitate the identification of the nature of host genes
controlling nutrition, immunity, physiology, growth and disease resistance which are
important in the studies on the mechanisms of growth and development. Development of
functional genomics technology led to the development of a Trust agreement entitled
"Application of Functional Genomics to Develop Novel Control Strategies Against
Poultry Diseases". Chicken intestinal cDNA microarray will lead to identification of host
genes which control innate and acquired immune responses to coccidiosis and facilitate
the development of novel immunological control strategies for coccidiosis. Cooperative
work with Growth Biology Cooperative work with Growth Biology Lab showed a high
coincidence of acute reduced feed intake and acute increase in the appetite suppressing
hormone ghrelin at 4 days post infection with the duodenal parasite, E. acervulina. These
changes were also coincidental with significant reduction in plasma levels of leptin, IGF1 and T3, and a significant increase in pancreatic glucagon. These hormonal changes
were followed by significant weight gain reduction. Weight gain and feed conversion are
the most economically important production parameters to poultry producers. These
studies are the first to show a significant impact of coccidia infections of the chick small
intestine on the host neuroendocrine system leading to multiple hormonal changes, and to
reveal the direct relationship they likely have with feed intake weight gain reduction and
muscle protein accretion. Because these hormonal effects occur before gross pathology is
evident, a shift in research emphasis to early host-parasite interactions may uncover the
primary biochemical and immunological host responses. This, in turn, may aid in
defining the important genes associated with resistance and susceptibility to coccidiosis.
We have found that this weight gain decrease is associated with muscle protein breakdown as assessed by increased levels of plasma 3-methylhistidine. The ratio of
reduced/oxidized glutathione decreases significantly in blood, intestinal mucosa and liver
at 6 days post infection during primary infections with both E. acervulina and E. tenella.
Reduction in the red/ox ratio is an indicator of oxidative stress, and is reported to play an
important signaling role in the development of cellular immunity.
5.

Developed molecular diagnostic method to identify Eimeria field strains and investigate
underlying molecular mechanisms of antigenic diversity of field Eimeria species. In order
to implement precision agriculture techniques in determining species of coccidia in the
field, polymerase chain reaction (PCR)-based techniques have been developed and used
to detect the seven recognized species of Eimeria. This method proved to be useful for
the industry as well as customers since it provides a fast and accurate detection of
coccidian parasites. This technique conserves time and well as resources since
determination of species composition by microscopic examination takes no less than 3
weeks. Microscopic examination is also fraught with error given the similar morphology
of these species. The PCR method is based on specific amplification of single Eimeria
species. The test, which can be completed in a single day, utilizes 7 different pairs of
oligonucleotide primers that are directed to species-specific regions of ribosomal DNA.
The validity of this technique was confirmed by the testing of several litter samples from
nearby farms. Additionally, elucidation of underlying molecular mechanisms responsible
for generation of genetic diversity of Eimeria species is important and aid in development
of recombinant vaccines. Among the 3 major species of poultry coccidia, E. tenella, E.
207

acervulina, and E. maxima, E. maxima is believed to be more antigenically diverse than
the other two species, and immunization of chickens with one strain of E. maxima does
not always protect against infections with other strains of the same species. This is
important for producers of live Eimeria oocyst vaccines which face the prospect that one
strain of E. maxima may not be sufficient for protecting chickens against coccidiosis. We
have observed that while the genetic diversity of ribosomal DNA in E. tenella and E.
acervulina is fairly small, E. maxima displays significantly greater amounts of sequence
diversity. The data collected so far suggests that the genetic organization of ribosomal
DNA in E. maxima may be substantially different than in the other two species. It is
likely that in the genome of E. maxima multiple ribosomal DNA loci exist on different
chromosomes, while in E. tenella and E. acervulina the more conventional organization
of the ribosomal DNAs is seen, with all ribosomal DNA being contained in a single
closely linked locus. This data provides the first genetic evidence that E. maxima may be
fundamentally different from other Eimeria species so far studied, and may lead to the
understanding of the mechanisms behind the antigenic diversity present in this species.
6.

Immunoenhancement of intestinal innate immunity using dietary supplementation,
probiotics, CpG oligodinucleotides, cytokines and recombinant antibodies. Due to
increasing concerns over the use of drugs in poultry production, alternative methods need
to be developed. Our studies have demonstrated that cytokines, probiotics, CpG
oligodinucleotides (ODN), vitamins and recombinant antibodies can enhance intestinal
immunity against coccidiosis. For example, IFN-γ is an important cytokine that activates
macrophages and is produced by activated lymphocytes in the intestine following
coccidiosis. Role of IFN-γ production during coccidiosis has been well studied using a
quantitative RT-PCR and recently using gene expression profiling. In E. tenella-infected
chickens, IFN-γ transcripts were detected in the spleens, cecal tonsils, and IEL following
the primary and the secondary infections with E. tenella. Multiple intramuscular
injections of chIFN-γ on one day prior to, and two and four days after infection with E.
acervulina, conferred significant protection as measured by body weight loss and oocyst
shedding in white leghorn chickens. The treatment of chicken cells with the recombinant
chIFN-γ inhibited the intracellular development of E. tenella without affecting the
sporozoite invasion of host cells. Another cytokine, interleukin-2 (IL-2) plays an
important role in the function of the immune system and is a potent growth factor for a
variety of cell types including T-cell differentiation, B-cell development and NK cell
activation. Co-injection of the IL-2 gene with the 3-1E coccidia gene enhanced the host
response to the recombinant vaccination. Recently we have assessed the effects of
directly injecting genes encoding the chicken cytokines IL-1β, IL-2, IL-8, IL-15, IFN-α,
IFN-γ, TGF-β4, or lymphotactin on chickens vaccinated with the DNA vaccine.
Lymphotactin gene, when given simultaneously with the pcDNA3-1E vaccine,
significantly protected chickens against body weight loss induced by E. acervulina
infection. Parasite replication was also significantly reduced in chickens immunized with
the pcDNA3-1E vaccine and co-injected with IL-8, lymphotactin, IFN-γ, IL-15, TGF-β4,
or IL-1β gene as compared to chickens given the pcDNA3-1E vaccine alone. These
results provide the first direct evidence that chicken cytokines exert a protective effect
against Eimeria and provide a rational basis for the use of this cytokine as a vaccine
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adjuvant against coccidiosis. The effects of dietary supplements such as vitamin A and
probiotics have been studied in coccidiosis. Overall, dietary vitamin A levels can affect
gut immunity in broiler chickens and its deficiency can cause immunosuppression at
those sites resulting in increased susceptibility to coccidiosis. Probiotic supplementation
of the intestinal microflora has been shown to enhance gut defensive mechanisms in
poultry. We have demonstrated that a Lactobacillus-based probiotic stimulated the local
immune system of broiler chickens and improved resistance to coccidia. Flow cytometric
analysis of duodenum IEL showed that chickens fed the probiotic-supplemented diet had
a significant increase in IEL T lymphocyte subpopulations and indicated that the
probiotic enhanced local immune defenses in the intestinal tract of broiler chickens
resulting in better resistance to E. acervulina. A greater understanding of the mechanisms
of enhancement of intestinal immunity using various dietary supplements would improve
the effectiveness of using these feed additives for disease control. Short
oligodeoxynucleotides (ODN) containing unmethylated CpG motifs have been shown to
be effective immunoprotective agents in mammalian models, by inducing both innate and
adaptive immune responses. We have recently identified CpG sequences that activate
chicken innate immunity and enhance protective immune response against Salmonella
and coccidia. In multiple trials, CpG ODN provided great potential as vaccine adjuvants
in chickens and enhanced disease resistance against E. acervulina infection. On the other
hand, we found that feed supplementation with high levels of fat-soluble vitamin E (DLalpha-tocopheryl acetate), a natural antioxidant, does not reduce pathology of mild or
severe E. maxima infections in chickens. Plasma levels of Vitamin E declined by 60 to
70% during the acute phase of infection in a manner correlated with decreases in plasma
carotenoids regardless of the level fed. It is postulated that ameliorative effects of
vitamin E are not observed during E. maxima infections because the vitamin is prevented
from access to infected tissues because of malabsorption and/or oxidation. Producers are
thus cautioned against wasteful use of alpha-tocopheryl acetate as a dietary supplement to
control avian coccidiosis. A number of plant products have immunostimulatory
properties, and may be useful as feed additives to control coccidiosis. Echinacea
purpurea can enhance immunity to challenge infection when fed to chicks immunized
with suboptimal doses of live oocysts. Beta glucans from yeast and hops are currently
being tested as immunostimulatory feed additives in various challenge protocols.
IMPACT:
1.
The Poultry and Animal Health Industries have shown great interest in our vaccine
research. A patent on recombinant coccidial vaccines (U.S. Patent 5,122,471) was
licensed to Nippon Zeon, Inc. CRADAs (two) were established with Nippon Zeon to
develop and field test a fowlpox virus vector system for coccidia vaccine
(Jenkins/Lillehoj). Recombinant chicken antibody technology was the basis for the U.S.
patent 6,451,984 and this technology was transferred to IDEXX Laboratories through a
CRADA to develop novel control strategies against other economically important poultry
pathogens. A CRADA with Intervet was established to produce and characterize new
vaccine strains of Eimeria for incorporation into live vaccines (Allen) that are finding
increased industrial acceptance.
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2.

3.

4.

Vital information on the drug and vaccine sensitivity trials were effectively
communicated to the poultry producers and alerted them of emerging drug resistance.
The information allows poultry producers to select the most efficacious drugs or vaccines
to combat avian coccidiosis. CRADAs have been initiated with Townsends, Inc.,
Solutions Biosciences, Inc., and Schering-Plough to test the sensitivity of Eimeria strains
isolated from broiler houses in various regions of the U.S. A highly specific and
sensitive molecular technique based on PCR amplification of DNA coding for ribosomal
RNA has been developed to rapidly determine the species composition of Eimeria
oocysts in a broiler operation. In addition, the cooperative work with the commercial
poultry operations provided new, often more virulent isolates of avian Eimeria, such that
basic research is examining strains which are present in the field. These programs have
led to the development of a novel and practical concept for enhancing poultry immunity
using lymphokines. These reagents against chicken lymphokines have led to patent filing
(Serial Number 09/534,002) and this technology led to the development of a CRADA
with Novus International, Inc. to evaluate the efficacy of field trial data of a new coccidia
vaccine delivery technology (Lillehoj) and a Trust agreement with Maine Biological
Laboratories, Inc. to apply cytokines for enhanced immunity in poultry. In summary,
these studies have set the stage for the future development of novel control strategies for
poultry diseases.
The work on the chicken genome has provided the first description of an association of
chicken genes with coccidiosis resistance. The chicken cDNA database will facilitate the
identification of the nature of host genes controlling immunity, growth and disease
resistance. These new bodies of information can be used by the poultry industry for
marker-assisted selection of resistant breeding stocks without the need to conduct large
numbers of experimental infections. The findings of an early impact of coccidia infection
on the chick neuroendocrine system and muscle metabolism provide new foci for
functional genetic selection of resistance and susceptibility coccidiosis disease resistance
and development of new metabolic markers to assess the impact of coccidiosis on the
important production parameters of growth and feed conversion.
Our research findings concerning novel vaccine strategies and the assessment of vaccine
efficacy have been used by many poultry industry in developing new commercial
coccidia vaccines. Through CRADA and Trust agreements, many technologies have
been transferred to poultry industry worldwide.

TECHNOLOGY TRANSFER:
1. A contract with Intervet Inc. was established to isolate and prepare two E. maxima strains, and
a strain of E. acervulina and E. tennella for use in live vaccines. Eimeria acervulina and E.
tenella strains have been prepared and submitted. Eimeria maxima strains are currently
undergoing purification and testing, including cross protection and drug sensitivity assessments.
2. Over 500 E. tenella cDNAs associated with oocyst development and >10,000 EST isolated
from chicken cDNA library have been deposited onto public gene databanks. Deposited 14,374
chicken cDNA isolated from chicken intestine into NCBI Genbank (GenBank accession
number:CD726833-CD740810 and CF074760-CF075157).
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3. Developed PCR based methods to identify Eimeria species from field samples as part of a
CRADA to develop control strategies against avian coccidiosis.
4. Developed MOU on "Application of Intelliject System to enhance poultry immunity" with
AviTech Inc., Hebron, MD. And transferred technology on in ovo vaccination.
5. Contract with Phytosynthese Inc. was developed to test natural product preparations which are
derived from a French company for anti-coccidial effectiveness.
6. Genes identified through screening of cDNA libraries which are important for parasite
functions will be tested for potential vaccine activity.
7. A detailed knowledge of the genetic diversity within and between Eimeria species will be
transferred to the poultry industry and will enable the implementation of precision agriculture
technologies to apply treatments or combinations of treatments optimally suited to control the
parasite variants in a particular locale.
8. The results of the identification of host genes which control coccidiosis and the development
of DNA marker based strategy for coccidiosis resistance will be transferred to the poultry
industry community.
9. New technologies enabling analysis and comparisons of multiple Eimeria species through
genetic sequencing and analysis of gene products will allow the identification of DNA and or
protein components that may be useful in the development of a multi-species subunit vaccine.
10. Vaccine technology, vaccine delivery strategies, and immunological technologies will be
transferred to poultry vaccine companies for commercial applications. Poultry producers will be
able to utilize commercially produced vaccines for the control of Eimeria in their flocks.
Monoclonal antibodies, recombinant chicken cytokines, immunoassays for poultry health
assessment and genetically engineered chicken antibodies will have immediate application to
poultry studies by scientists in academia, industry and federal and state agencies.
11. Developed a highly reliable protocol for testing the drug sensitivity of field isolates of
Eimeria obtained from commercial broiler houses. Developed a rigorous statistical evaluation
method that provides information on the efficacy of specific anti-coccidial drugs against isolated
field strains of Eimeria. This protocol was used to initiate two CRADAs with poultry
(Townsends Inc) and pharmaceutical companies (Solutions Biosciences, Inc. and ScheringPlough).
Patents:
1.
Kim J. K., Han, J. Y., Song, K. D., and Lillehoj, H.S. 2002. Recombinant ScFv
antibodies specific to Eimeria spp. responsible for coccidiosis. Patent Korean (File no.
2001-52934) and Japan (File no. 2001-266333).
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2.

Lillehoj, H. S. and Nichols, M. 2002. Chicken monoclonal antibodies specific for
coccidial antigens involved in invasion of host lymphocytes. US Patent 6,451,984

3.

Allen, P. 2001. Applied a patent for the use of ground preparations of Echinacea purpurea
feed additives to stimulate immunity elicited by live vaccination. Docket number
0217.01, Serial number 9/931,033
Date filed: 8/17/2001
Recordation date:
10/25/2001.

4.

Lillehoj, H. 2000. Monoclonal antibodies detecting chicken IFN-gamma and
development of in vitro assay. Serial Number 09/534,002, Document Number 0165.99.
Patent filed 3/24/00.

5.

Yasuda, et al., 2000. Novel DNA encoding Eimeria glyceroaldehyde-3-phosphate
dehydrogenase and uses thereof. Filed by Nippon Zeon Inc.

6.

Lillehoj, H.S., Dalloul, R. Nichols, M., and Chung, K. S., “Immunopotentiating effect of
Formitella fraxinea mushroom lectin on poultry immunity to coccidiosis. Docket No.
0161.03.

7.

Heckert, R. A., Xie, H. and Lillehoj, H. S., “ Immunomodulation of poultry by
oligonucleotides”. Filed by the Office of Technology Commercialization, University of
Maryland. November, 2003.

Cooperative Research and Development Agreements (CRADA)
58-1265-9-058 (Trust Fund Agreement with Roche Vitamins)
Effect of dietary vitamin E supplementation on chickens infected with Eimeria maxima.
Investigator, P.C. Allen
Funding: $23,000
Start: 09/01/1999
Termination: 08/31/2001
58-1265-2-F091 (Trust Fund Agreement with Phytosynthese Inc.)
Anticoccidial Effects of Plant-Derived Products
Investigator: P.C. Allen
Funding: $6,000
Start: 02/28/ 2002
Termination: 02/28/2003
1265-31320-070-13T (Trust Fund Agreement with Intervet)
Production of vaccine strains suitable for incorporation in a live vaccine for avian coccidiosis.
Investigator: P.C. Allen
Funding: $59,000
Start1: 01/01/2001
Termination: 01/01/2004
333-1265-140 (ISTC Project with Former Soviet Union Countries)
ISCOM delivery of recombinant coccidia (Eimeria) antigens.
Investigator: R. Fetterer
Funding: $ 40,000
Start: 01/01/01
Termination: 01/01/04
*Renewed Start: 09/01/2003 to 09/30/2006 with new funding $ 40,000.
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1265-32000-061-15T (CRADA with Nippon Zeon, Japan)
Development of a coccidiosis vaccine in recombinant fowlpox virus and HVT
Investigator: Mark C. Jenkins
Funding: $ 100,000
Start: 04/01/1999
Termination: 03/31/2003
58-1265-2056 (Trust Fund Cooperative Agreement with Townsends, Inc)
Testing of drug and vaccine sensitivity of Eimeria field isolates
Investigator: Mark C. Jenkins
Funding: $ 15,000
Start: 08/31/2002
Termination: 09/01/2007
58-1265-2019 (Trust Fund Cooperative Agreement with Solutions Biosciences, Inc.)
Testing of drug and vaccine sensitivity of Eimeria field isolates
Investigator: Mark C. Jenkins
Funding: $ 25,000
Start: 04/15/2002
Termination: 04/14/2006
1265-32000-050-08T (Trust Agreement with IDEXX Corp.)
Development of chicken hybridomas and other immunological reagents for chickens
Investigator: Hyun Lillehoj
Funding: $ 50,000
Start: 01/01/1997
Termination: 09/01/2002
1265-32000-050-10T (CRADA with Nippon Zeon Corp.)
Development of fowlpox virus vector system for coccidia and cytokine gene delivery to enhance
poultry immunity
Investigator: Hyun Lillehoj
Funding: $ 422, 600
Start: 03/01/2001
Termination: 12/06/2002
1265-20-00-11237 (Trust Agreement with Novus International Inc.)
Development of immunological reagents for the avian system
Investigator: Hyun Lillehoj
Funding: $ 12,000
Start: 02/01/1997
Termination: 01/01/2000
1265-32000-050-12T (CRADA with Novus International Inc.)
Development of mucosal immunization strategy against coccidiosis
Investigator: Hyun Lillehoj
Funding: $ 150,367
Start: 07/01/1998
Termination: 06/01/2000
1265-32000-050-14T 15R (CSREES National Research Initiative Grant)
Interferon-gamma-mediated immune enhancement in avian coccidiosis
Investigator: Hyun Lillehoj
Funding: $ 96,000
Start: 09/01/1998
Termination: 08/31/2003
1265-32000-050-13T (Trust Agreement with Maine Biological Laboratory)
Application of cytokines and immunological reagents for enhanced immunity in chickens
Investigator: Hyun Lillehoj
Funding: $ 50,000
Start: 02/01/1998
Termination: 01/31/2003
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1265-31320-070-01R (Fund for Rural America Grant)
DNA marker technology in commercial broiler selection programs
Investigator: Hyun Lillehoj
Funding: $ 320,000
Start: 02/01/1998
Termination: 02/01/2001
1265-32000-050-23R (Reimbursable Agreement with University of Maryland)
Development of in vitro cytokine assays for studying mucosal immunity in chickens
Investigator: Hyun Lillehoj
Funding: $ 148,589
Start: 09/01/2000
Termination: 08/31/2005
1265-31320-014-04T (Trust Agreement with Ghen Immunology Institute)
Development of novel immunological control strategy using hyperimmune egg antibodies to
prevent against coccidiosis
Investigator: Hyun Lillehoj
Funding: $ 20,000
Start: 03/01/2001
Termination: 02/28/2006
1265-31320-014-03T (Trust Agreement with Avicore Biotechnology Institute)
Application of functional genomics to develop novel control strategies against poultry diseases
Investigator: Hyun Lillehoj
Funding: $ 240,000
Start: 04/01/2001
Termination: 03/30/2006
1265-31320-070-15R (CSREES National Research Initiative Grant)
Mapping quantitative trait associated with disease resistance in commercial broiler chickens
Investigator: Hyun Lillehoj
Funding: $ 200,000
Start: 01/01/2003
Termination: 12/30/2005
1265-31320-070- (CRADA Agreement with Zeon Corp.)
DNA vaccination strategy through embryonic vaccination
Investigator: Hyun Lillehoj
Funding: $ 20,000
Start: 04/01/2003
Termination: 03/30/2008
1265-31320-070-T (Trust Agreement with Novus International Inc.)
Assessment of coccidia immune response using interferon-gamma assay
Investigator: Hyun Lillehoj
Funding: $ 10,000
Start: 04/01/2002
Termination: 03/30/2007
Agreement No. 58-1265-4-F060 (Cooperative Research Project Between ARS and Rural
Development Administration, South Korea)
Study on the mechanisms of immunomodulatory phytochemicals from fruits and vegetables in
Republic of Korea.
Investigator: Hyun Lillehoj
Funding: $ 72,000
Start: May, 1, 2004
Termination: April 30, 2007.
193-1265-154 (CRADA with Intervet Inc.) Production of vaccine strains suitable for
incorporation in a live vaccine for avian coccidiosis.
Investigator : Patricia C. Allen; funding $59,000. Start 2/1/2002,; terminate 9/1/2005.
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Other external agreement:
A material transfer agreement was established with Transfer Point, a manufacturer of yeast beta
glucans to test effectiveness of the product as an anticoccidial feed additive.
A cooperative project with Gregory Siragusa, USDA, Russel Research Center, Athens GA, is
under way to test anticoccidial activity of soluble beta glucans from hops.
A cooperative research project was undertaken with Bill Chobotar, Andrews University, to
ultrastructurally locate the acetyl coA carboxylase complex in Eimeria sp.
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PROJECT OBJECTIVES:
Swine have two prominent foodborne parasitic disease agents: the muscle worm, Trichinella
spiralis, and the tissue protozoan parasite, Toxoplasma gondii. Infective eggs from the large
roundworm, Ascaris suum, represent an emerging disease where agricultural use of pig manure
contaminated with parasite eggs may increase human infection. Outbreaks of human disease
from swine products negatively reflect on pork as a safe source of nutritious edible tissue and
lowers export potential. Molecular tests to evaluate parasite infections in meat products need to
be improved so that they are very sensitive and accurately reflect the true source of the infection.
Proper maintenance of herd health precludes infection but requires a large capital investment and
breaches in procedure can readily result in new infections. No drugs are available to adequately
cure tissue parasites, and the cost of development of new drugs by the pharmaceutical industry is
prohibitive and unpredictable. Further, secondary bacteria disease is associated with worm
infection in livestock and bacteria like Campylobacter is a major cause of diarrhea in humans. A
long-term preventative control strategy is to vaccinate against swine parasites. Cooperative
efforts between university, industry and government laboratories is directed at molecular
regulators of immunity, receptor biology, innate protective mechanisms, and antibody responses
targeted at the intestinal immune system of pigs. The basic nature of this work will also provide
information for the immunological control of microbial and viral infection in swine.
Consumers are now requesting safer food products, thus encouraging producers to raise animals
without antibiotics. Thus, producers have had to reshape the methods that they employ for
raising disease-free pigs. This will require advanced knowledge of neonatal swine immunity and
molecular tests for activators of the swine immune system such as recombinant cytokines
[interleukin-12 (IL-12) and IL-18]. Description of effects of these cytokines and of synthetic
oligonucleotides (CpG) on swine immunity, and their use to enhance neonatal swine immunity
and to stimulate appropriate protective mechanisms against food borne pathogens, will have
commercial value. Vaccines incorporating these activators would complement existing control
procedures and provide the benefits of long-term protection, cost efficiency and reduced drug
residues in the food chain. Studies of toxoplasmosis have shown that strong protective immunity
can be induced in pigs by irradiated oocysts and attenuated strains, but that immunity is not
complete and may result in low-level infection. Novel cytokine-based procedures that activate
porcine immunity by increasing interferon-gamma (IFN-gamma) levels have the potential to
enhance resistance to toxoplasmosis. The underdeveloped intestinal immune system of weaned225

pigs provides a model to test other prospective immune enhancing agents on development of
resistance to infection in neonatal pigs.
Swine disease control is most important during the first month of a pig's life due to the immature
immune system development in the newborn pig. Moreover there is rapid exposure of the
newborn to infectious agents when it moves from the birthing (farrowing) unit into nursery
facilities that house litters from numerous sows. We have asked whether administration of
exogenous immune proteins, termed cytokines, enhances neonatal immunity and disease
responses, and determines whether this will help protect young pigs from infections and stressinduced immune deficiencies. Our studies are aimed at determining the role of cytokines in the
development of the neonatal immune system of swine. Descriptions of the mucosal immune
system and the immunobiology of gastrointestinal parasite responses in neonatal and growing
pigs will provide useful and largely unique information that will be available to scientists in
other federal, academic and industry (producers, vaccine and pharmaceutical companies)
laboratories.
Traditional genetic approaches have been very effectively used by the swine industry to enhance
feed efficiency, pig meat production and reproductive traits. Recently, molecular methods have
provided new genomic markers to actively select for specific traits such as the ESR gene for
improved piglet number per litter. For pig health, inheritance of specific alleles within the swine
leukocyte antigen (SLA) complex genes have been known to positively influence disease and
vaccine responses. Broader pig health studies to determine whether defined immune markers
could be correlated with specific resistance to disease are only now being approached. Results
from these studies should provide producers with pigs that would require fewer antibiotic
treatments and better disease resistance.
In the last year the disease target of this CRIS have been expanded to include Porcine
Reproductive and Respiratory Syndrome (PRRS) and other respiratory diseases of swine.
According to the National Pork Board (NPB), PRRS costs U.S. pork producers at least $600
million annually, and thus is the most economically significant disease facing the US industry
today. PRRS affected 21.4% of all breeding herd operations and, importantly, 58.3% of
operations with >500 sows (NAHMS 2000). From 16.6-50.7% of all grow/finish operations
reported having PRRS within the previous 6 months. Losses are due not only to reduced
reproduction capacity in gilts or sows, but to other aspects of production, poor growth and
increased respiratory problems. Modified live virus vaccines are available for PRRS but protect
only against homologous viral challenges. Because PRRSV is an RNA virus its genome changes
and heterologous strains quickly arise. Thus new immune approaches are needed for prevention
of PRRS using new biotherapeutics, improved vaccines and better adjuvants.
OVERALL PROJECT ACCOMPLISHMENTS:
Determination of the risk of foodborne transmission of Toxoplasma gondii in meat products
requires a thorough epidemiological survey to allay consumer fears. Such a survey is underway
involving a large statistical sampling of market beef, pork and chicken from numerous cities in
the United States. Monitoring the levels of the parasite in actual market samples will involve
several approaches, including bioassays, serum and tissue juice antibody assays and a molecular
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assay developed with the support of National Pork Board funds. Samples are now being tested
for T. gondii and the results for each test compared. These results will assure consumers of an
accurate risk of exposure to toxoplasmosis through the commercial meat supply.
The immune system is complex and requires new tools to track the cells that respond to
infectious organisms. Members of this laboratory participated in a major international workshop
to determine the reactivity of ~200 monoclonal antibodies (mAb) against swine immune cells.
The mAb were exchanged, tested for specific reactivity and the results statistically analyzed so
that clusters of differentiation (CD) numbers could be assigned. The results are now
internationally accepted as the standard CD designation for pig immune cells, enabling scientists
worldwide to exchange data and determine which cells are essential in preventing infections or in
stimulating protective vaccine responses. In 2003-2005 a screen of 386 anti-human CD mAb
have been tested for cross-reactivity on swine cells as part of the Human Leukocyte
Differentiation Antigens (HLDA8) workshop Animal Homologues Section. This will further
increase availability of crucial anti-CD mAb for immune research in pigs.
Molecular markers of distinct Trichinella genotypes/species have been identified and developed
into a sensitive diagnostic test. This test will reduce the risk of undetected freeze resistant
Trichinella strains that could undermine the frozen meat technology that is the major commercial
and consumer-based control strategy for the inactivation of Trichinella in edible tissue. In
addition, the epidemiology of the remaining 9 other detectable genotypes can be monitored to
prevent their emergence in the U.S.
Studies of toxoplasmosis have shown that strong protective immunity can be induced in pigs by
irradiated oocysts and attenuated strains, but that immunity is not complete and may result in low
level infection. Novel cytokine-based procedures that activate porcine immunity by increasing
IFN-gamma levels have the potential to enhance resistance to toxoplasmosis. Details on the
under developed nature of the intestinal immune system of weaned-pigs provides a model to test
other prospective immune enhancing agents on development of resistance to infection in
neonatal pigs.
Swine disease control is most important during the first month of a pig's life due to an immature
immune system. ARS scientists have established methods to show how the respiratory and
intestinal immune systems develop in the neonatal piglet and have shown that the immune
system is under-developed in the intestine and, thus, less able to respond effectively against
gastrointestinal infections. Future research should determine whether treatment of these young
piglets with immune cytokine proteins will stimulate maturation of their immune system and
thus enable them to be more resistant to infectious diseases as they move into the nursery, thus
preventing piglet losses and saving producers' drug and veterinary costs.
ARS scientists at Beltsville, MD, with PIC/Sygen collaborators, have phenotyped hundreds of
young piglets from PIC stock for early indicators of immune functions. This project was
established to aid producers looking for alternatives to using antibiotics for early weaned pigs
and researched methods to identify pigs which are genetically more disease resistant. The
statistical analyses have indicated that some immune correlates of healthier and more productive
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pigs do exist; further studies will determine whether healthier pigs can be identified using
simpler genetic markers. With such markers, pigs which are more disease resistant could be
made available so that consumers would be provided with healthier pork products that contained
less drug residues.
New approaches are being explored to determine whether pigs that are genetically resistant to
disease can be identified as an alternate to using antibiotics to treat early weaned pigs. ARS
scientists at Beltsville, MD, in collaboration with PIC/Sygen have evaluated piglets' blood cell
markers associated with immune function and showed that there were significant increases in
specific T cell subsets during the first few weeks of a piglet's life. These results may help explain
why neonates are more susceptible to disease and may also indicate how producers can plan
management changes to avoid immune and disease stressors. Additionally this data indicated that
there were piglets which were genetically more resilient, based on their growth characteristics
and increased numbers of specific immune subsets at 7 weeks of age. Thus, genetic tests could
be developed to identify breeders with this trait.
Pigs are exposed to infectious agents when they are moved to new facilities and mix with pigs
from other areas. The use of antibiotics to control infection is limited and alternate therapeutic
approaches are desperately needed. In collaboration with the Biotechnology Research and
Development Corporation (BRDC) and their collaborating pharmaceutical and breeding
company partners, ARS scientists cloned and purified a new pig therapeutic, recombinant
porcine cytokine interleukin-12 (rPoIL-12). However, rPoIL-12 has limited activity in swine
because of low IL-12 receptor expression [unlike other animal species] and therefore, may not,
on its own, provide adequate stimulation of the pig immune system. This is essential information
for pharmaceutical and vaccine companies as they search for effective immune stimulants for
swine.
Modified live virus (MLV) vaccines are only partially effective in preventing new PRRSV
infections. With BRDC funding ARS scientists and Univ. Illinois researchers performed detailed
examination of immune gene expression following MLV vaccination and demonstrated that
some innate immune responses were not stimulated by PRRS MLV. To improve these responses,
they then tested innate adjuvants (interferon-alpha, IFNA, and interferon inducer poly(inosinic
acid)-poly(cytidylic acid) [poly(IC)]) as adjuvants for MLV resulting in improved interferongamma production but limited increases in protection against PRRS. Thus, these new adjuvants
will be helpful, but not sufficient, in improving PRRSV vaccines.
IMPACT:
A comprehensive panel of "designer" immune reagents has been developed to assess swine
immune responses, for use in analyses of disease and vaccine studies and neonatal pig
development. These include sensitive gene expression tests for >300 swine immune genes, mAb
markers for swine cell subsets and immune cytokines, and biotherapeutics. Products from this
CRIS's research will enhance an expanding base of scientific knowledge on mucosal and
neonatal immunology of swine, techniques and reagents for veterinary application, practical
outcomes for control of zoonotic pathogens and characterization of products with commercial
applications.
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Studies comparing pig immune gene expression to Toxoplasma gondii and Ascaris suum
infections have shown that clearly distinct T helper I (Th1) and Th2 responses can be induced.
Based on these gene expression studies swine researchers worldwide will be able to assess
protective immunity to different infectious organisms and vaccinations. These gene expression
assays will help determine whether novel cytokine-based procedures that activate porcine
immunity have the potential to enhance resistance to specific infectious agents or development of
resistance to infection in neonatal pigs.
This CRIS has developed new animal models to assess the impact of mixed infections on disease
responses and on pig health. Testing responses to secondary bacteria disease in association with
worm infection in livestock have indicated that the Th1/Th2 balance can be altered in local
mucosal tissues. This has led to cooperative studies with human clinicians for inflammatory
bowel syndrome and Crohn’s disease.
This project has tested biotherapeutic alternatives to using antibiotics for early weaned pigs and
researched methods to identify pigs which are genetically more disease resistant. The
biotherapeutic porcine IL-12 protein was proven not to be effective. The adjuvants, IFNA and
poly(IC) were partially effective as booster of anti-PRRS vaccine immunity. Studies proved that
the respiratory and intestinal immune systems develop in the neonatal piglet is under-developed
and, thus, less able to respond effectively against respiratory and gastrointestinal infections.
Some immune correlates of healthier and more productive pigs do exist; studies are underway to
determine whether healthier pigs can be identified using simpler genetic markers. With such
adjuvants and markers, pigs which are healthier could be made available so that consumers
would be provided with safer pork products that contained less drug residues.
Novel molecular parasite detection and diagnostic tests have been produced for swine parasites.
Molecular markers of distinct Trichinella genotypes/species have been identified and developed
into a sensitive diagnostic test that can be used for epidemiologic studies of the detectable
Trichinella genotypes to prevent their emergence in the U.S. A real-time, PCR-based, sensitive
diagnostic test to identify and quantitate Toxoplasma gondii DNA in tissues and other biological
samples, including meat products, has been developed and a patent application.
TECHNOLOGY TRANSFER:
The results of these studies have been presented to a number of local groups at field days and
presentations through the ARS National Visitor's Center and to scientific groups including the
American Association of Veterinary Parasitologists, the World Association for the Advancement
of Veterinary Parasitology, the Conference of Research Workers in Animal Disease, national and
international animal genome meetings, and national and international immunology meetings.
Scientists involved in this CRIS serve on the National Pork Board Toxoplasmosis Advisory
group and assist in review of the Board's programs and grant submissions.
ARS scientists are also involved in multistate projects, NC-1004 (serving in 2004 as NC-1004
Chair) and NRSP8 for animal genome studies, and NC-229 for PRRS research. Most recently
this has been evidenced by successful participation in the multistate USDA CSREES Animal and
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Plant Biosecurity grant #2003-05164: “Integrated Control and Elimination of Porcine
Reproductive and Respiratory Syndrome Virus (PRRSV) in the U.S.”
Reagents generated to study immune responses in swine have been made available to the
research community worldwide. This has included molecular probes and real-time PCR primers
and probes for swine cytokines and immune markers that have been shared internationally.
Numerous monoclonal antibodies (mAb) reactive with swine immune cell subsets (CD antigens)
and cytokines are now available through commercial sources. The results of international CD
workshops are now internationally accepted, enabling scientists worldwide to exchange data and
determine which cells are essential in preventing infections or in stimulating protective vaccine
responses. Now, in 2003-2005, the workshop involves testing for cross-reactivity on swine cells
as part of the Human Leukocyte Differentiation Antigens (HLDA8) workshop Animal
Homologues Section. This will further increase availability of crucial anti-CD mAb for immune
research in pigs.
The cloning and expression of a functional interleukin-12 (IL-12) cytokine was conducted under
a BRDC funded grant. Sponsors from the BRDC legally reviewed the patent potential of porcine
IL-12. No patent application was submitted. Availability of the cloned, expressed IL-12, is
decided by BRDC.
Patents:
The patent application for the real-time, PCR-based, diagnostic test to identify Toxoplasma DNA
in tissues and other biological samples, including meat products, was submitted to the US patent
office. Further tests to determine usefulness on commercial pork products are underway through
support of a new National Pork Board grant under the new CRIS project. Transfer of this
technology to scientists at the Centers for Disease Control and other institutions has been
ongoing .
PUBLICATIONS (Listed by CRIS objectives):
Objective #1: Develop reagents and assays to enable definition of cytokine-regulated
immune mechanisms that protect pigs.
Dawson HD, Royaee AR, Nishi S, Kuhar D, Schnitzlein WM, Zuckermann F, Urban JF, Lunney
JK. 2004. Identification of Key Immune Mediators Regulating T helper 1 Responses in Swine.
Vet. Immunol. Immunopathol. In Press.
Royaee AR, Zuckermann F, Husmann R, Calzada-Nova G, Schnitzlein WM, Lunney JK. 2004.
Cytokine response of porcine lymphoid cells in response to host vaccination with PRRS virus.
Vet. Immunol. Immunopathol. In Press.
Zarlenga DS, Dawson H, Kringel H, Solano-Aguilar G, Urban JF Jr. 2004. Molecular Cloning of
the Swine IL-4 receptor α and IL-13 receptor α1-chains: effects of experimental Toxoplasma
gondii, Ascaris suum and Trichuris suis infections on tissue mRNA levels. Vet. Immunol.
Immunopathol. In press.
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Dawson HD, Beshah E, Nishi S, Solano-Aguilar G, Morimoto M, Zhao A, Madden KB,
Ledbetter TK, Dubey JP, Shea-Donohue T, Lunney JK, Urban, JF Jr. 2004. Localized multi-gene
expression patterns support an evolving Th1/Th2-like paradigm in response to infections with
Toxoplasma gondii and Ascaris suum in pigs. Infection and Immunity. In Revision.
Martens GW, Lunney JK, Baker JE, Smith DM. 2003. Rapid Assignment of Swine Leukocyte
Antigen (SLA) Haplotypes in Pedigreed Herds using a Polymerase Chain Reaction Based Assay.
2003. Immunogenetics. 55: 395-401.
Lunney JK, Fossum C, Alm GV, Steinbach F, Wattrang E. 2002. Veterinary immunology:
opportunities and challenges. Trends in Immunology. 23: 4-6.
Solano-Aguilar G, Zarlenga D, Beshah E, Gasbarre L, Junker D, Cochran M, Dawson H, Urban
J, Lunney J. 2002. Limited effect of Recombinant porcine Interleukin 12 on porcine lymphocytes
due to a low level of IL-12 Beta 2 receptor. Vet. Immunol. Immunopathology. 89: 133-148.
Thacker E, Summerfield A, McCullough K, Ezquerra A, Dominguez J, Alonso F, Lunney J,
Sinkora J, Haverson K. 2001. Summary of workshop findings for porcine myelomonocytic
markers. Vet. Immunol. Immunopathology. 80:, 93-109.
Davis WC, Haverson K, Saalmüller A, Yang H, Lunney JK, Hamilton MJ, Pescovitz MD. 2001.
Analysis of monoclonal antibodies reacting with molecules expressed on T cells. Vet. Immunol.
Immunopathology. 80: 53-62.
Haverson K, Saalmüller A, Alvarez B, Alonso F, Bailey M, Bianchi ATJ, Boersma WJA, Chen
Z, Davis WC, Dominguez J, Engelhardt H, Ezquerra A, Grosmaire LS, Hamilton MJ,
Hollemweguer E, Huang C, Khanna KV, Kuebart G, Lackovic G, Ledbetter JA, Lee R, Llanes
D, Lunney JK, McCullough KC, Molitor T, Nielsen J, Niewold TA, Pescovitz MD, Perez de la
Lastra J, Rehakova Z, Salmon H, Schnitzlein WM, Seebach J, Simon A, Sinkora J, Sinkora M,
Stocks CR, Summerfield A, Sver L, Thacker E, Valpotic I, Yang H, Zuckermann FA, Zwart R.
2001. Overview of the Third International Workshop on Swine Leukocyte Differentiation
Antigens. Vet. Immunol. Immunopathol. 80: 5-23.
Johnson P, Keen NT, Lunney JK, Sadowsky MJ. 2001. Conference Editorial: Agricultural
Microbes Genome 2. Comparative and Functional Genomics. v. 2. p. 10-13.
Objective #2: Determine if parasite-induced polarization of swine immunity effects pig
health and susceptibility to zoonotic agents.
(Pig)
Kringel H, Dubey JP, Beshah E, Hecker R, Urban JF Jr. 2004. Effect of CpG
oligodeoxynucleotide (ODN)-induced immune activation on porcine immunity to infection with
Toxoplasma gondii. Vet. Parasitol. (in press).
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Mansfield LS, Gauthier DT, Abner SR, Jones KM, Wilder SR Urban JF Jr. 2003. Enhancement
of disease and pathology by synergy of Trichuris suis and Campylobacter jejuni in the colon of
immunologically naive swine. Am J Trop Med Hyg. 68:70-80.
Abner SR, Hill DE, Turner JR, Black ED, Bartlett P, Urban JF Jr, Mansfield LS. 2002. Response
of intestinal epithelial cells to Trichuris suis excretory-secretory products and the influence on
Campylobacter jejuni invasion under in vitro conditions. J. Parasitol. 88: 738-745.
Solano-Aguilar GI, Beshah E, Vengroski K, Zarlenga D, Jauregui L, Cosio M, Douglass LW,
Dubey JP, Lunney, JK. 2001. Cytokine and lymphocyte profile in miniature swine after oral
infection with Toxoplasma gondii oocysts. Intnl J Parasitology. 31: 187-195.
Solano-Aguilar GI, Beshah E, Vengroski K, Zarlenga D, Jauregui L, Cosio M, Douglass LW,
Dubey JP, Lunney JK. 2001. Cytokine and lymphocyte profile after oral infection with
Toxoplasma gondii oocysts. Scandinavian J. Immunology. 54: 93.
(Mouse)
Ekkens M, Liu Z, Liu Q, Whitmire J, Xiao S, Foster A, Pesce J, VanNoy J, Sharpe A, Urban JF
Jr., Gause WC. 2003. The role of OX40L interactions in the development of the Th2 response to
the gastrointestinal nematode parasite Heligmosomoides polygyrus. J. Immunol 170:384-93.
Zhao A, McDermott J, Urban JF, Gause W, Madden KB, Au Yeung K, Morris SB, Finkelman
FD, Shea-Donohue T. 2003. Dependence of IL-4, IL-13 or Nematode-Induced Alterations in
Murine Small Intestinal Smooth Muscle Contractility on Stat6 and Enteric Nerves. J Immunol
171:948-954.
Strait RT, Morris SC, Smiley K, Urban JF Jr.,, Finkelman RD. 2003. IL-4 exacerbates
anaphylaxis. J. Immunology. 170: 3835-3842.
Gause WC, Urban JF Jr., Stadecker MJ. 2003. The immune response to parasitic helminths:
insights from murine models. Trends in Immunology. 24: 269-277.
Schopf LR, Hoffmann KF, Cheever AW, Urban JF Jr., Wynn TA. 2002. IL-10 is critical for
resistance and survival during gastrointestinal helminth infection. J. Immunol. 168: 2383-2392.
Ekkens M, Liu Z, Liu Q, Foster A, Whitmire J, Pesce J, Urban JF Jr, Gause WC. 2002. Memory
Th2 effector cells can develop in the absence of B7-1/B7-2, CD28 interactions, and effector Th
cells after priming with an intestinal nematode parasite. J. Immunol. 168: 6344- 6351.
Madden KB, Whitman L, Sullivan C, Gause WC, Donaldson DD, Urban JF Jr., Katona IM,
Finkelman FD, Shea-Donohue T. 2002. Role of Stat6 and mast cells in IL-4 and IL-13-induced
alterations in murine intestinal epithelial cell function. J. Immunol. 169: 4417-4422.
Liu Z, Liu, Q., Pesce, J, Whitmire J, Ekkens M, Foster, A, VanNoy, J, Sharpe A, Urban JF Jr,
Gause WC. 2002. Nippostrongylus brasiliensis can induce B7-independent Ag-specific
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development of IL-4-producing T cells from naïve CD4 T cells in vivo. J. Immunol. 169: 69596968, 2002.
Finkelman FD, Urban JF Jr.. 2001. The other side of the coin: The protective role of the type 2
(Th2) cytokines. J. Allergy and Clinical Immunology. v.107. p.772-780.
Shea-Donohue T, Sullivan C, Finkelman FD, Madden KB, Morris SC, Goldhill J, PiñeiroCarrero V, Urban JF Jr. 2001. The Role of Interleukin-4 in Heligmosomoides polygyrus induced
alterations in murine intestinal epithelial cell function. J. Immunol. 167: 2234-2239.
Urban JF Jr., Noben-Trauth N, Schopf L, Madden K, Finkelman FD. 2001. Cutting edge: IL-4
receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal
nematode parasites. J. Immunol. 167: 6078-6081.
(Human)
Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF Jr, Weinstock JV. 2003. Exposure to
Schistosome Eggs Protects Mice from TNBS-induced Colitis. Am J Physiol Gastrointest Liver
Physiol. 284: G385-91.
Summers RW, Elliott DE, Qadir K, Urban JF Jr., Thompson R, Weinstock JV. 2003. Trichuris
suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am.
J. Gastroenterol. 98: 2034-2041.
Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R. 2002: The
possible link between de-worming and the emergence of immunological disease. J Lab Clin
Med. 139: 334-38.
Objective #3: Assess development of mucosal immune responses in pigs and the effect on
neonatal pig health and transmission of foodborne pathogens using state-of-the-art
immunological methods and cDNA microarray technology.
Zarlenga DS, La Rosa G, Pozio E, Rosenthal B. 2004. Identification and classification within the
genus, Trichinella, with special emphasis on non-encapsulated species. Vet. Parasitol. (In press).
Morimoto M, Morimoto M, Whitmire J, Xiao S, Star RA, Urban JF Jr., Gause WC. 2004.
Peripheral CD4 T cells rapidly accumulate at the host: parasite interface during an inflammatory
Th2 memory response. J. Immunol. 172(4):2424-30.
Bannerman D, Paape MJ, Lunney JK. 2004. Immunity: Innate. In Encyclopedia of Animal
Science; Pond WG, Bell AW Eds.; Marcel Dekker, Inc., New York. In Press.
Lunney JK, Paape MJ, Bannerman D. 2004.Immunity: Acquired. In Encyclopedia of Animal
Science; Pond WG, Bell AW Eds.; Marcel Dekker, Inc., New York. In Press.
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Gerrits RJ, Lunney JK, Johnson LA, Pursel VG, Rohrer GA, Dobrinsky JR. 2004. A vision for
artificial insemination and genomics to improve the global swine population. Theriogenology. In
Press.
La Rosa G, Marucci G, Zarlenga DS, Casulli A, Zarnke RL, Pozio E. 2003. A study of the ITS-2
locus in laboratory and natural isolates of Trichinella nativa and Trichinella T6 suggests an
incipient genetic divergence between the two genotypes. Int. J. Parasitol. 33; 209-216.
Morimoto M, Zarlenga DS, Beard H, Alkharouf N, Matthews BF, Urban JF Jr. 2003. Ascaris
suum: cDNA microarray analysis of 4th stage larvae (L4) during self-cure from the intestine.
Exp. Parasitol. 104: 113-121.
Lunney, J.K. 2003. In Search of Disease-Resistant Pigs. National Hog Farmer, Apr 15, 2003,
pp.30-34.
Lunney JK 2003. Are there immune gene alleles that determine whether a pig will be healthy?
Genetics of Pig Health Symposium, M Boggess, Ed.; National Pork Board Press, DesMoines,
IA. p.63-72.
Solano-Aguilar GI, Galina L, Douglass LW, Lunney JK. 2002. Developmental immunity in
neonatal pigs monitored by the function of peripheral blood mononuclear cells. Proc. 17th Cong.
Intnl. Pig Vet. Soc., Iowa. Vol. 1, p.259.
Dawson H, Nishi S, Beshah E, Solano-Aguilar G, Zarlenga D, Urban JF, Lunney JK. 2002.
Functional genomic assessment of porcine disease resistance: real time assays of porcine
immune gene expression. Proceedings 7th World Congress on Genetics Applied to Livestock
Production. #13-41.
Pozio E, Zarlenga DS. La Rosa G. 2002. The detection of encapsulated and non-encapsulated
species of Trichinella suggests the existence of two evolute lines in the genus. Parasite 8; 27-29.
Zarlenga DS, Boyd P, Lichtenfels JR, Hill D, Gamble HR. 2002. Identification and
characterization of a cDNA sequence encoding a glutamic acid-rich protein specifically
transcribed in Trichinella spiralis newborn larvae and recognized by infected swine serum. Int. J.
Parasitol. 32; 1361-1370.
Solano-Aguilar GI, Vengroski K, Beshah E, Douglass LW, Lunney JK. 2001. Characterization
of lymphocyte subsets from mucosal tissues in neonatal swine. Dev. Comp. Immunol. 25: 245263.
Jauregui LH, Higgins J, Zarlenga D, Dubey JP, Lunney JK. 2001. Development of a Real-Time
PCR Assay for Detection of Toxoplasma gondii in Pig and Mouse Tissues. J. Clin. Microbiol.
39: 2065-2071.
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Zarlenga DS, La Rosa G. 2001. Traditional and Molecular methods for parasite differentiation
within the genus Trichinella. Vet. Parasitol. 93; 279-292.
La Rosa G, Marucci G, Zarlenga DS, Pozio E. 2001. Trichinella pseudospiralis populations from
the Palearctic region and their relationship with populations of Nearctic and Australian regions.
Int. J. Parasitol. 31; 297-305.
Zarlenga DS, Higgins JA. 2001. PCR as a diagnostic and quantitative technique in veterinary
parasitology. Vet. Parasitol. 101; 215-230.
Zarlenga DS, Chute MB, Martin A, Kapel CMO. 2001. A single multiplex PCR for
differentiating all species of Trichinella with special application to the newly described T.
papuae. Parasite 8; 24-26.
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Animal Parasitic Diseases Laboratory (APDL)

Project Title:
CRIS Number:
Scientists:
Location:

Contact:

Biosystematics and Biodiversity of Pathogens and Parasites
1265-32000-068-00D
Hoberg, E.P., Lichtenfels, J.R.
Animal and Natural Resources Institute
Animal Parasitic Diseases Laboratory
United States National Parasite Collection
Hoberg, E.P. Phone: (301) 504-8588, Fax: (301) 504-8979,
ehoberg@anri.barc.usda.gov

PROJECT OBJECTIVES:
Helminth parasites are economically significant pathogens in ruminants, other food animals and
equines, contributing to over $2 billion in losses annually in the United States. Efforts to
understand epidemiology, distribution and disease and the most efficacious basis for control have
often been hampered by difficulties in identification of pathogens and parasites. A paucity of
knowledge about the species and populations involved and often limited information on
geographic and host-distribution hinders our ability to predict the outcome of host-parasite
interactions. Long-term challenges are evident that require resolution even as we develop more
refined morphological and molecular capabilities for parasite identification. Identity and
phylogenetic relationship are baseline information for defining host and geographic distribution
and patterns of parasite diversity. Recognition of cryptic, emergent, exotic and invasive
pathogens, determination of the importance of reservoir hosts such as wildlife, and elucidation of
the influence of interfaces between agricultural and wild ecosystems on the structure of helminth
faunas follow from biodiversity research. Additionally, among ruminants, the mosaic nature of
the helminth fauna, particularly hidden species diversity, impacts our abilities to recognize
emerging pathogens and invasive species or those increasingly influenced by anthropogenic and
climatological global change. Consequently, continued strategic biodiversity survey and
inventory in conjunction with phylogenetic systematic studies of parasitic groups are necessary
to provide for accurate identification, diagnostics and definition of the parasitic fauna. Ecological
perturbation linked to global change and its influence on the distribution of pathogens and
emergence of disease can only be understood with a context provided by systematics. These
issues form the framework of the current program for a series of integrated studies in systematics
and parasite biodiversity among the crown clades of the strongylate nematodes primarily in
ruminants and equines. Concurrently we will expand, and curate the specimens-collections of the
US National Parasite Collection (USNPC). An infrastructure for Biodiversity Bioinformatics will
link interactive information systems and diagnostic identification keys, with phylogenetic and
epidemiological information for dissemination on the internet. We also provide a resource for
reference specimens and information to support parasitology and animal health nationwide and
globally.
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OVERALL PROJECT ACCOMPLISHMENTS:
(1) Phylogenetic Studies Indicate That The Occurrence of Taenia Tapeworms in humans predates the development of agriculture, animal husbandry and the domestication of cattle or swine.
Taeniid tapeworms in African carnivores twice independently colonized hominids and the genus
Homo, prior to the origin of modern humans coincidental with dietary and behavioral shifts from
herbivory to scavenging and carnivory. Parasitological data provide a unique means of
elucidating historical ecology, foraging behavior, and food habits of hominids during their
evolution.
(2) Comprehensive Taxonomic and Systematic Studies of Haemonchinae- revealed 2 new species
in Haemonchus and a new species of Ashworthius. The phylogeny for Haemonchus is the
foundation for a comprehensive reference system for diagnostic criteria and development of
interactive identification keys; historically, coevolutionary and biogeographic analyses
demonstrate the pervasive role of host translocation, and parasite introduction/ emergence in the
global distributions of H. contortus, H. placei and H. similis the dominant pathogenic species in
domestic stock.
(3.) Phylogeny for Nematodirinae Nematodes- Nematodirinae are trichostrongyloid nematodes
that globally include serious pathogens of ruminants, particularly caprines; completed the first
phylogenetic analyses to reveal relationships among the 5 genera of nematodirines, and resolved
historical biogeographic and host associations in the diversification of this parasite group.
(4.) Mosaic Structure for Nematode Faunas in Ruminants from North America- Phylogenetic and
historical studies of the trichostrongyloids including Ostertagiinae, Nematodirinae, and
Haemonchinae indicate dual origins for major components of the Nearctic fauna. The Arcticboreal fauna and specifically the nematodrines, and many ostertagiines are endemic to North
America, whereas the Haemonchines and Cooperiines have a history of introduction following
Euopean contact in the 1500’s. Empirical and theoretical studies designed to examine the role of
dispersal and translocation on faunal structure indicate a complex history.
(5.) Development and Application of Epizootiological Probes- Protostrongylid muscleworms in
the genus Parelaphostrongylus are emergent parasites among wild ruminant hosts in the
continental United States. As requested by APHIS, and in collaboration with the College of
Veterinary Medicine, Oregon State University, and the Western College of Veterinary Medicine,
University of Saskatchewan, scientists of the US National Parasite Collection used comparative
morphology, and multi-locus sequencing to identify larval parasites in feces of infected hosts and
determine the geographic and host range for P. odocoilei. These studies indicated that a single
species, P. odocoilei has a geographic distribution extending from California to south-central
Alaska and the Mackenzie Mountains of the Northwest Territories and occurs in both Caprine
and Cervid hosts; the parasite was identified for the first time in Oregon.
(6.) Resources for Biodiversity Bioinformatics- represents an effective and synergistic
foundation to develop, utilize and present diverse knowledge about the distribution, host
associations, and history for parasites represented by specimens-based collections such as the US
National Parasite Collection. The Curator of the US National Parasite Collection in collaboration
with colleagues at the Southwestern Museum of Vertebrate Biology, University of New Mexico,
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the Western College of Veterinary Medicine, University of Saskatchewan, Department of
Ecology and Evolutionary Biology, Cornell University, and the Vantaa Forest Research Centre,
Rovaniemi, Finland developed protocols for comparative biodiversity studies focusing on
parasite-host assemblages in high latitude ecosystems of the Holarctic. Studies serve as models
for expansion of specimens-based collections as information systems integrating strategic field
collections and databasing for development of comparative baselines for biodiversity in a
contemporary and historical context.
(7.) Molecular Diagnostics for Equine Strongyles-in collaboration with scientists in Scotland,
Australia, and Ukraine, methods for improved diagnostics, based on morphology and DNA
probes, were developed for nematode pathogens in horses.
(8.) Diagnostic Keys for Definitive Identification of Equine Strongyles- in collaboration with V.
Kharchenko of the Ukraine Academy of Science, and with support of a research grant from the
CRDF (Civilian Research and Development Foundation), comparative morphological keys were
prepared based on redescriptions of the 70 species of equine strongyles. Included were complete
line figures and photomicrographs depiciting all significant diagnostic characters for
identification. This work will remain the benchmark for all diagnostic work on the small
strongyles, and is the foundation for any development of molecular-based probes for
identification.
IMPACT:
(1.) The typical parasite fauna in humans is far older than previously considered and indicates a
very prolonged association between humans and their characteristic food-borne pathogens. These
insights provided a new focus in comparative epidemiological studies of T. saginata, T. asiatica
and T. solium in humans and food animals for veterinarians and parasitolotigists in North
America and globally.
(2.) Improved knowledge of the species composition of this economically important genus
provides information critical to understanding patterns of host association and geographic
distribution and contributes to the development of methods and agents for controlling these
nematodes. This is the foundation for a synoptic on-line and interactive key for identification.
(3.) Information from these studies contributes to species-level analyses of Nematodirus and
Nematodirella, including species known as serious pathogens in domestic sheep and cattle, and
to improved diagnostics for these Holarctic nematodes. These studies are baselines in developing
predictive hypotheses about the response of nematodes to changing climate and ecological
perturbation. Essential and base-line information is disseminated to extension services, state
departments of agriculture ands wildlife, and to the veterinary community.
(4.) Disparate origins and adaptations to climate reveal different capacities and responses are
expected across the spectrum of nematode pathogens in ruminants within the context of global
climate change. Expansion and population increases for temperate faunas including the highly
pathogenic haemonchines is predicted. These insights are critical to any strategic planning
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process for prediction of impacts linked to global climate change and the responses of complex
host-parasite systems.
(5.) The investigation was the first to demonstrate the utility of “epizootiological probes” to
elucidate the geographic and host associations for a pathogenic parasite; a baseline is provided to
begin to understand the potential for emergence of such elaphostrongyline nematodes as a
consequence of global change and the potential for host switching to domestic stock. These
methods have broad applicability in both veterinary medicine and conservation biology,
particularly where hosts cannot be collected for complete necropsy.
(6.) Specimens collections become portals for access to critical information linking interactive
keys, phylogenetic, biological and epidemiological data through species homepages for helminth
parasites in Holarctic mammals, including those that circulate among domestic and wild
ruminants. Essentially for the veterinary and wildlife conservation communities this will
represent “one-stop shopping” for access to definitive information to identify parasites,
understand their host associations and geographic rtanges, and to predict the outcomes of
interactions among wild and domestic hosts at the interface of natural and managed ecosystems.
(7.) Improved diagnostics provides essential working tools for the identification of species
responsible for an emerging disease (larval cyathostomiasis), the development and testing of new
antiparasitic compounds required by widespread nematode resistance to current drugs, and the
testing of biological agents needed to control the more than 50 species of nematode pathogens in
horses. The control of nematodes will greatly improve the health, well being and productivity of
horses worldwide used for farming, recreation and in many countries for food.
(8.) Keys will be made available on line for access on the web. Such access will broadly
disseminate the results of this research to the veterinary and equine communities and serve to
standardize the basis for identifications of these pathogens.
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TECHNOLOGY TRANSFER NP 103 (FY 2000-2004):
(1.) US National Parasite Collection- database, informatics & specimens resources.
Internet website at: www.lpsi.barc.usda.gov/bnpcu. Serves as a primary resource for national and
global parasitology. The USNPC is the largest specimens-based collection in the world. It serves
a global constituency providing critical resources for systematics research, identification and
diagnostics. It is a foundation for a network that provides proactive and predictive data for
exotic, invasive and emergent pathogens and parasites.
BNPCU scientists provided a National Reference Collection of specimens of parasites in
animals, through development of the US National Parasite Collection, and an associated database
of specimen records to researchers worldwide via the Internet and the loan of specimens.
Impact: Parasitologists in ARS, and others working in veterinary, medical, or wildlife
parasitology, have access to the necessary specimens and database to conduct studies in
identification, classification and distribution that impact all efforts to control parasites of
agricultural or medical importance. The unique specimens, collected over a period of 150 years,
provide a storehouse of genetic information that serves as a primary resource for biodiversity
research. Outcome: The efficiency and prospects for success of all research worldwide on
parasites of animals are enhanced. The identification and control of parasites that contaminate
fish, shellfish, or red meat and/or increase the cost of its production is more accurate and
efficient, resulting in food that is safer and less expensive. Prospects are enhanced for
preventing the importation of exotic parasites that threaten American agriculture.
(2.) NSF Grant- Beringian Coevolution Project. (BS&I 0196095). 1999-2003. $240,000.
(3.) CRDF Grant, Cooperative Grants Program- Biological and Biomedical Engineering.
Comparative morphology, phylogenetic analyses and classification of Strongyloid Nematode
Parasites of Equidae. December 2001-2003. $80,000. (USNPC with Ukraine Academy of
Sciences).
(4.) ARS-former Soviet Union Scientific Cooperation Program- Collaborative Grant. Population
ecology, and systematics of the Family Protostrongylidae. February 2002-2005. (USNPC and
Uzbekistan Academy of Sciences).
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PUBLICATIONS- according to category in NP 103 (FY 2000-2004):
Diagnostics (including systematics, phylogeny, coevolution; empirical & theoretical studies;
resources for systematics research; biodiversity)
BrooksDR, Dowling APG, van Veller MGP, Hoberg EP. Ending a decade of deception: A
valiant failure, a not so valiant failure and a success story. Cladistics. 2004; 20: 32-46.
Brooks DR, Hoberg EP. Triage for the biosphere: The need and rationale for taxonomic
inventories and phylogenetic studies of parasites. Comparative Parasitology. 2000; 67: 1-25.
(order of authorship is arbitrary)
Brooks DR, Hoberg EP. Parasite systematics in the 21st Century: Opportunities and obstacles.
Trends in Parasitology. 2001; 17: 273-275.
Dowling APG, van Veller MGP, Hoberg EP, Brooks, DR. A priori and a posteriori methods in
comparative evolutionary studies of host-parasite associations. Cladistics. 2003; 19: 240-253.
Hoberg EP. Foundations for an integrative parasitology: collections archives and biodiversity
informatics. Comparative Parasitology. 2002. v.69. p.124-131.
Hoberg EP. Colonization and diversification: Historical and coevolutionary trajectories among
cestodes, pinnipeds and cetaceans. Proceedings International Congress of Parasitology X.
Monduzzi Editore, Bologna. 2002. p. 65-69.
Hoberg EP. Coevolution in marine systems. In Marine Parasites, K. Rohde (ed.). CSIRO,
Sydney, Australia. In Press.
Hoberg EP. Marine birds and their helminth parasites. In Marine Parasites, K. Rohde (ed.).
CSIRO, Sydney, Australia. In Press.
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Laboratory, Bldg. 1001, BARC-East, Beltsville, MD 20705
Dubey, J., Phone: 301-504-8128, Fax: 301-504-6273

Contact:

PROJECT OBJECTIVES:
Neosporosis, caused by Neospora caninum, is a major cause of abortion in cattle, and it also
causes paralysis in other animals. It is distributed worldwide. Sarcocystis neurona is the most
important cause of neurologic illness in horses in the United States. The objective of research
conducted on these parasites include preventing transmission of Neospora to dairy and beef
cattle, and preventing transmission of S. neurona from opossums to horses. For each parasite,
understanding their biology and epidemiology will lead to improved control.
A conservative estimate for losses associated with Neospora-induced abortion in dairy cattle in
California alone is approximately 35 million dollars annually, not accounting for the cost of
culling the cows, re-breeding the cows, and loss of milk production. Sarcocystis neurona is the
most important cause of neurologic disease in horses. It causes over 100 million dollars in annual
losses to the equine industry. Basic information is needed on the biology and epidemiology of
these parasites so that control programs based on management or vaccine strategies may be
designed. This project is related to Animal Health NP 103, Component 2-Pathogen Detection
and Diagnostics, Component 4-Animal Immunology, Component 5-Mechanisms of Disease,
Component 7-Epidemiology of Disease, and Component 8-Strategies to Control Infectious and
Non-infectious Disease. Neospora and Sarcocystis neurona are newly recognized and emerging
pathogens. This research supports national program priorities for parasites including improved
pathogen detection, monitoring and surveillance of disease, mechanisms of disease and disease
prevention and control.
OVERALL PROJECT ACCOMPLISHMENTS:
Neospora caninum, a major cause of abortion in cattle, was identified and named. Epidemiology
of N. caninum in dogs and bovines was investigated. Molecular methods have been developed to
differentiate N. caninum oocysts from oocysts of other coccidian parasites that utilize dogs as the
definitive host. This will allow for specific detection of dogs infected with N. caninum and will
advance the elucidation of the life cycle of the parasite within the dog definitive host. Molecular
studies have been conducted to identify strain differences between tissue cysts and tachyzoites of
N. caninum isolated from different geographic regions. These studies will determine if
immunization protocols and detection assays developed from one geographic isolate will be
useful for isolates from other regions. Neospora caninum infection was found in dogs even in
remote areas of the world such as the Amazon, Brazil. Studies have been conducted to determine
the life cycle and identify stages of the parasite in naturally congenitally infected puppies.
Neospora caninum was isolated for the first time from an aborted bovine fetus in Portugal and
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neosporosis was documented as the most important cause of bovine abortion in Portugal. The
pathogenesis of N. caninum infection and abortion is largely unknown. Initial studies were
conducted in pregnant cows inoculated with N. caninum at 110 day of gestation. Studies have
demonstrated placental invasion of the parasite in infected, pregnant cows. The placental
invasion by the parasite and down regulation of cytokines appears to be an important pathogenic
mechanism.
Diagnostic tests and animal models were developed to screen drugs and vaccines. A reproducible
model of congenital neosporosis was developed in mice such that female mice infected with the
parasite during gestation produce offspring that are infected with N. caninum. This mouse model
reproduces one major clinical feature of neosporosis in cattle and now provides a means of
testing vaccines against the parasite that may be used to prevent the disease in cattle. Another
important accomplishment was the complete protection against neosporosis afforded by
immunization of mice with N. caninum tachyzoite antigen. Complete protection was obtained
against congenital transfer of Neospora caninum in mice by immunization with plasmid DNA
coding for a tachyzoite dense granule protein. This result points to studies that may be conducted
in cattle and possibly reveal individual antigens that may elicit a protective response. Significant
protection was elicited against N. caninum-induced abortion in sheep by immunization of ewes
with native N. caninum tachyzoite antigen emulsified in a proprietary adjuvant.
Sarcocystis neurona, the cause of neurologic diseases in horses and other animals and fatal
encephalomyelitis in horses was named, cultured, diagnostic tests were developed, and its source
of infection (the opossum) was identified. The complete life cycle of S. neurona was documented
in a natural intermediate host, the raccoon. Fatal neurologic S. neurona infection was
documented in a cat following a routine surgical operation to remove claws suggesting that stress
can reactivate this disease. The equine model of S. neurona infection in horses was refined which
results in production of clinical sarcocystosis in the horse. The development of this model will
allow studies to determine the biology and progression of infection leading to disease in the
horse. As few as 100 sporocysts caused clinical sarcocystosis in horses. Methods to kill S.
neurona sporocysts in the environment were studied and moist heat at 60oC killed sporocysts.
Besnoitiosis is a disease related to sarcocystosis. It causes morbidity and mortality in livestock.
A new species of Besnoitia oryctofelisi was discovered and its life cycle completed in the
laboratory. The ultrastructure of Besnoitia stages was studied to aid diagnosis.
IMPACT:
TECHNOLOGY TRANSFER:
The results of these studies have been presented to a number of local, national, and international
scientific and industry groups including the American Association of Veterinary Parasitologists,
the World Association of Veterinary Parasitologists, ARPAS, and other groups.
Reagents and information supplied to drug companies formed the basis for development and
successful marketing of diagnostic kits and vaccines for neosporosis (for example, Iddex ELISA
kit for Neospora).
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46th Annual Meeting. Boston, MA, 2001. Abstract No. 32.
Rosenthal, B.M. and Dubey, J.P. Genetic diversity of Sarcocystis species that employ opossums
as their definitive host. American Society of Parasitologists 76th Annual Meeting. Albuquerque,
NM, 2001. Abstract No. 116.
Dubey, J.P. A review of Neospora caninum in cattle. Proc. III Congresso Ibérico de Reproduçno
Animal July 5th-8th. Fundaçno Cupertino Miranda-Porto, 2001. Abstract No. 25.
Souza, S.L.P., Guimarnes JR, J.S., Dubey, J.P., Gennari, S.M. PrevalLncia de anticorpos antiNeospora canium em cnes de propriedades produtoras de leite b da regino norte do estado do
paraná. Jornal Brasileiro de Patologia, 37, 2001. Abstract No. 98.
Rosypal, A.C., Lindsay, D.S., Duncan Jr, R.B., Ahmed, S.A., Zajac, AM., Dubey, J.P. Role of
nitric oxide in resistance to sporocyst induced Sarcocystis neurona infections in mice. 53rd
Annual Meeting of the Animal Disease Research Workers in Southern States, Gainesville, FL,
2001. Abstract No. 26.
Dubey, J.P. A review of neosporosis in cattle. The 10th International Congress of Parasitology,
Vancouver, Canada, 2002. Abstract No. PL1-04.
Jenkins, M.C., O’Handley, R., O’Brian, C., Dubey, J.P. Cloning of a Neospora caninium apical
complex antigen that may differentiate point source from reactivated bovine neosporosis. The
10th International Congress of Parasitology, Vancouver, Canada, 2002. Abstract No. PA-121
Almeria, S., De Marez, T., Dawson, H., Araujo R., Padilla, T., Dubey, J.P., Gasbarre, L.C.
Immune responses in dam and fetus after experimental infection of pregnant cows with
Neospora caninum. The 10th International Congress of Parasitology, Vancouver, Canada, 2002.
Abstract No. S14-3-B.
Sofaly, C.D., Reed, S.M., Gordon, J.C., Dubey, J.P., Saville, W.J.A. Effects of Sarcocystis
neurona sporocyst inoculation dose on the induction of equine protozoal myeloencephalitis
(EPM). Proceedings of the American Association of Veterinary Parasitologists 47th Annual
Meeting, Nashville, TN, 2002. Abstract No. 21.
Yai, L.E.O., Joppert, A.M., CaZón Franco, W.A., Souza L.P., Dubey, J.P., Gennari, S.M.
OcorLncia de anticorpos anti-Neospora caninum em gambás (Didephis ssp.) do município de
Sno Paulo, Brasil. 12th Congresso Brasileiro de Parasitologia Veterinária, Rio de Janeiro, Brazil,
2002. Poster No. P-066.
De Souza, S.L.P., Rossi, F.W., Dos Santos, L.C., Yai, L.E.O., CaZón Franco, W.A., Dubey, J.P.,
Gennari, S.M. OcorLncia de anticorpos anti-Neospora caninum em Cervídeos (Mazama
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govasoubira) do Brasil.12th Congresso Brasileiro de Parasitologia Veterinária, Rio de Janeiro,
Brazil, 2002. Poster No. P-133.
Da Silva Guimarnes JR, J., Souza, S.L.P., Bergamaschi, D.P., Dubey, J.P., Jenkins, M.C.,
Gennari, S.M. Neospora caninum em bovinos de exploraçno leiteira tipo B no norte do paraná,
Brasil: Comparaçno entre trLs mLtodos diagnósticos.Brasil.12th Congresso Brasileiro de
Parasitologia Veterinária, Rio de Janeiro, Brazil, 2002. Poster No. P-134.
Da Silva Guimarnes JR, J., Souza, S.L.P., Bergamaschi, D.P., Dubey, J.P., Gennari, S.M.
Neospora caninum em bovinos de exploraçno leiteira tipo B no norte do paraná, Brasil: Estudo
da prevalLncia e de fatores de risco. 12th Congresso Brasileiro de Parasitologia Veterinária, Rio
de Janeiro, Brazil, 2002. Poster No. P-135.
CaZón Franco, W.A., Silva, J.C.R., Pinter, A., Labruna, M.B., Camargo, L.M.A. de Camargo,
E.P., Bergamaschi, D.P., Dubey, J.P., Gennari, S.M. Validade do teste de aglutinaçno direta
(NAT/MAT) no dignóstico de anticorpos anti-Neospora caninum e Toxoplasma gondii em Cnes.
12th Congresso Brasileiro de Parasitologia Veterinária, Rio de Janeiro, Brazil, 2002. Poster No.
P-147.
CaZón Franco, W.A., Silva, J.C.R., Pinter, A., Souza, S.L.P., Labruna, M.B., Camargo, L.M.A.,
Camargo, E.P., Bergamaschi, D.P., Dubey, J.P., Gennari, S.M. PrevalLncia de anticorpos antiNeospora caninum em cnes da área urbana do município de Monte Negro, Rondônia, Brasil.
12th Congresso Brasileiro de Parasitologia Veterinária, Rio de Janeiro, Brazil, 2002. Poster No.
P-149.
Sreekumar, C., Hill, D.E., Fournet, V.M., Rosenthal, B.M., Lindsay, D.S., Dubey, J.P. Detection
of Hammondia heydorni-like organisms and their differentiation from Neospora caninum using
RAPD-PCR. 19th International Conference of the World Association for the Advancement of
Veterinary Parasitology, “Old Dreams –New Visions: Veterinary Parasitology in the 21st
Century” New Orleans 2003 Poster No. P-183
Lindsay, David S. and Dubey, J.P. Sarcocystit neurona (Protozoa: Apicomplexa): Description
of sporocysts, excystation and early I vitro development. American Association of Veterinary
Parasitologists 48th Annual Meeting Denver, Colorado 2003 Poster No. P-33
D.C., Dubey, J.P., Mansfield, L.S. Daily pyrantel tartrate does not prevent Sarcocystis neurona
infection in horses. American Association of Veterinary Parasitologists 48th Annual Meeting
Denver, Colorado 2003 Poster No. P-34
Dubey, J.P. Life cycle and transmission of a new species of Bessnoitia from domestic rabbits.
American Association of Veterinary Parasitologists 48th Annual Meeting Denver, Colorado
2003 Poster No P-43
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Almeria, S., Dawson, H., Dubey, J.P., Gasbarre, L. Cytokine gene expression at the maternofetal interface in pregnant cows infected with Neospora caninum. American Association of
Veterinary Parasitologists 48th Annual Meeting Denver, Colorado 2003 Poster No. P. 51
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Improving Milk Quality by Reducing Mastitis in Dairy Cattle
1265-32000-065-00D
Paape, M., Bannerman, D.
Animal and Natural Resources Institute, Bovine FunctionaL Genomics
Laboratory
Paape, M., Phone: (301) 504-8302, Fax: (301) 504-9498,
mpaape@anri.barc.usda.gov

PROJECT OBJECTIVES:
Economic loss to the dairy industry due to mastitis can be reduced by enhancing the cow's
natural defenses to bacterial infection of the mammary gland. Thus, means of improving the
cow's natural defenses are urgently needed to minimize the use of antibiotics in preventing
mammary gland infections. Widespread use of antibiotics has resulted in the development of
resistant strains of bacteria which has necessitated periodic development of new more potent
antibiotics. This poses the awesome possibility that the time is rapidly approaching when strains
of bacteria will be produced that are resistant to any and all antibiotics. The use of antibiotics
also poses the ever present problem of antibiotic contamination of the milk supply.
The bacteria causing the greatest loss to the dairy industry are Staphylococcus aureus and Gramnegative species. Staphylococcus aureus and gram-negative bacteria are ubiquitous in the
environment and result in 85% of all cases of mastitis. More importantly once inside the gland
S. aureus adhere to and penetrate tissues lining the gland to form abscesses that are impervious to
antibiotics and host defense mechanisms. This results in chronic cases of mastitis that
necessitate culling of valuable milking stock.
Infections by Gram-negative bacteria are especially debilitating if contracted soon after calving,
usually resulting in death of the cow. Death is due to the failure of the udder to control the
inflammation caused by endotoxin produced by the rapidly multiplying coliform organisms in
the milk. It is estimated that 300,000 dairy cows either die or are culled from the herd because of
acute coliform mastitis.
Current investigations are focused on determining the nature of S. aureus and Gram-negative
bacteria virulence factors and means of shoring up the animal's defenses to combat them.
Virulence factors under investigation are: 1) means of entrance of the bacteria into the gland, 2)
mechanism(s) of avoiding host cellular and humoral defenses and 3) mechanism(s) of adherence
and penetration into the tissue. Means of shoring up the animal's defenses to combat bacterial
infection and neutralization of bacterial toxins under current investigation include: 1) strain
variation in the various virulence factors, 2) strain distribution in the national herd, 3)
incorporation of the predominant virulence factors in a vaccine(s), 4) methods of delivery of the
vaccine(s), 5) immunomodulators to enhance the immune defenses, 6) nutritional factors
effecting immune function and 7) cloning of genes responsible for neutralization of endotoxin.
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OVERALL PROJECT ACCOMPLISHMENTS:
Staphylococcus aureus vaccines currently available are of limited effectiveness because they
include only 40% of the serotypes identified in the national dairy herd. A trivalent S. aureus
vaccine, that covers 100% of the serotypes in the national dairy herd, was used to immunize first
calf heifers to prevent S. aureus mastitis and was used in conjunction with antibiotics to treat
chronic S. aureus mastitis infections. The vaccine was 100% effective in protecting heifers from
S. aureus infections and 70% effective in curing chronic infections, thus, preventing at the very
beginning of the cow's productive life. This vaccine could significantly decrease dairyman's
losses due to mastitis; to that end it is being tested in commercial herds in Michigan, Maryland
and North Carolina to cure existing chronic S. aureus infections.
IMPACT:
TECHNOLOGY TRANSFER:
A phenolic teat dip was developed and shown to be effective in preventing new intramammary
infections. This teat dip will be made available to dairymen. We have shown that treatment of
beef cows at weaning by intramammary infusion of antibiotics will reduce incidence of mastitis
and improve calf weaning weights. Adoption of this technology will increase beef cattlemen's
profits.
Patents:
A patent, No. 0108.01, "Use of recombinant bovine CD14 in the treatment and prevention of
coliform mastitis in dairy cows" was prepared and submitted to the Patent Office through the
USDA Office of Technology Transfer.
PUBLICATIONS:
Lee, J.-W., Paape, M.J., Elsasser, T.H., Zhao, X. Elevated milk soluble CD14 in bovine
mammary glands challenged with Escherichia coli Lipopolysaccharide, Journal of Dairy
Science. 2003. v. 86. p.2382-2389.
Lee, J.-W., Paape, M.J., Zhao, X. Recombinent bovine soluble CD14 reduces severity of
experimental Escherichia coli mastitis in mice. Veterinary Research. 2003. v. 34, p. 306-316.
Lee, J.-W., Paape, M.J., Elsasser, T.H., Zhao, X. Recombinant soluble CD14 reduces severity of
mammary intection by Escherichia coli. Infection and Immunity. 2003. v. 71. p. 4034-4039
Bannerman, D.D., Goldblum, S.E. Mechanisms of bacterial lipopolysaccharide-induced
endothelial apoptosis. American Journal of Physiology. 2003. v. 284. p.L899-L914.
Li, X., Tupper, J.C., Bannerman, D.D., Win, R.K., Rhodes, C.J., Harlan, J.M. Phosphoinositide 3
kinase mediates toll-like receptor 4-induced activation of NF-OB in endothelial cells. Infection
and Immunity. 2003. v. 71, p. 4414-4420.
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Erwert, R.D., Eiting, K.T, Tupper, J.C., Winn, R.K., Harlan, J.M., Bannerman,D.D. Shiga toxin
induces decreased expression of the anti-apoptotic protein Mc1-1 concomitant with the onset of
endothelial apoptosis. Microbial Pathogenesis. 2003. v. 35. p. 87-93.
Diez-Fraile, A., Meyer, E.,Paape, M.J., Burvenich, C. Analysis of selective mobilization of Lselectin and Mac-1 reservoirs in bovine neutrophils and eosinophils. Veterinary Research. 2003,
v. 34. p. 57-70
Van Oostveldt, K., Paape, M.J., Dosogne, H., Burvenich, C. Effect of apoptosis on phagocytosis,
respiratory burst and CD18 adhesion receptor expression of bovine neutrophils. Domestic
Animal Endocrinology. 2003. v. 22. p. 37-50.
Lee, J.-W., Paape, M.J., Zhao, X. Soluble CD14 prevents intramammary infection by
Escherichia coli. FASEB Journal. 2003. v. 17. p. A670.
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Immunological and Genetic Basis of Resistance to Parasites of Cattle
1265-32000-072-00D
Gasbarre, L., Zarlenga, D.
Animal and Natural Resources Institute,Bovine Functional Genomics
Laboratory
Gasbarre, L., Phone: (301) 504-8509, Fax: (301) 504-8414,
lgasbarr@anri.barc.usda.gov

PROJECT OBJECTIVES:
Gastrointestinal (GI) nematode infections cause major losses to the American cattle industry due
to decreased productivity of infected animals. Current control procedures are based on the
repeated administration of anthelmintic drugs to a large proportion of the cattle herd. Attempts
to control parasites by pasture management are either ineffective, or are economically unfeasible.
The alternative to these measures is to use the host immune system to control the intensity of
parasite infection. Until recently there was little evidence that the bovine immune system was
capable of limiting the magnitude of infection by GI nematodes. Studies in our laboratory have
demonstrated that for most of the nematode species, even a short period of exposure is very
effective in inducing the bovine immune system to reduce the number of parasites that become
established in the host. The major exception to this is Ostertagia ostertagi, but even with this
species, the immune system effectively reduces parasite transmission by reducing egg output by
the female worms. These studies indicate that it is feasible to control nematode infections by
using the host immune system. Before this method of control can be implemented a number of
basic questions must be answered. At the present time nothing is known concerning the exact
mechanism that results in resistance to infection. Similarly, there is a lack of information
concerning the ability of Ostertagia to evade an immune response that appears to function very
effectively against the other nematode species. Recently we have proven that host genetics play
an important role in determining if individual cattle become immune or not, but as of this date
little information concerning the genes involved is available. Finally, there is a complete lack of
information available concerning the practical use of immunity-based systems in a modern
production system. Information in these four areas is necessary for the integration of
immunologically based control programs into a profitable and sustainable livestock management
system.
Neosporosis is a parasitic disease primarily of dairy cattle that is caused by the protozoan
parasite Neospora caninum. Although the parasite was first described as causing hind-limb
paralysis in dogs, it is now recognized as a major cause of reproductive failure in cattle
worldwide. This research program has the goal of understanding the immunological response to
N. caninum so that ways of preventing neosporosis in cattle using vaccines or passive
immunotherapy may be developed.
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OVERALL PROJECTS ACCOMPLISHMENTS:
This project began in November of 2001, as such this is the second year of the project.
Reference to the time line of the project indicates that : 1. QTL for parasite resistance have been
identified, 2. the microarrays have been at least partially developed ( i.e. more than 400 genes)
and are being used to define resistant and susceptible cattle, and 3. cDNA libraries from
Ostertagia have been prepared and are being screen for activity on the host immune system.
IMPACT:
TECHNOLOGY TRANSFER:
Presented talks to the Ambassador and Secretary of Agriculture of, Brazil on the identification of
genes affecting disease resistance in cattle. Presented talk to selected international Veterinary
students from the Cornell University Leadership program on modern concepts of parasite
control.
Developed instructional aids for parasite control for beginning dairy and beef grazers .The PCR
based diagnostic test continues to be used to assess parasite infection in local herds and validate
the purity of local laboratory strains of parasites. Scientists from Montana have contacted us to
evaluate the types of parasite infections present on local farms using this test.
PUBLICATIONS:
Wang, Y., Zarlenga, D.S., Paape, M.J., Dahl, G.E. Recombinant bovine CD-14 sensitizes the
mammary gland to lipopolysaccharide. Journal of Veterinary Immunology and
Immunopathology. 2002. v. 86. p. 115-124.
Gasbarre, L. C., Stout, W., Soder, K. Parasites. Beginning Grazier's Notebook, 2002, pp. 32-34.
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• Genetic Predisposition of Livestock to Infection by Mucosal Pathogens
• Host Response and Antigenic Variation of Respiratory Viral Agents of Livestock
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Genetic Predisposition of Livestock to Infection by Mucosal Pathogens
5438-32000-023-00D
Heaton, M., Laegreid, W., Clawson, M.
Clay Center, NE, U.S. Meat Animal Research Center, Animal Health
Research
Heaton, M., Phone: (402) 762-4362, Fax: (402) 762-4375,
heaton@email.marc.usda.gov

PROJECT OBJECTIVES:
Infectious diseases in livestock are a significant source of economic loss and represent a potential
risk to human health. Removing animals with the highest risk of disease from the production
cycle will lead to improved herd health and food safety. The ultimate goal of livestock genomics
with regard to animal health is to read an animal's DNA sequence and estimate its risk of
acquiring or maintaining infections. Our immediate aim is to evaluate natural genetic variation
in diverse populations and identify alleles that predispose livestock to infectious diseases.
Before this can be accomplished, two key issues need to be addressed: 1) the identification of
nucleotide sequence variation in host genes that play a fundamental role in the infection process
2) the identification of gene haplotypes that are associated with susceptibility or resistance to
infectious disease. Health traits of interest include: failure of passive transfer in cattle, ovine
progressive pneumonia, prion disease in cattle sheep and deer, and bovine respiratory disease
complex. Our research is designed to address these issues in commercial populations of
livestock. As these objectives are achieved for selected candidate genes, new information and
technology will be developed that will facilitate reading an animal's DNA sequence for
estimating its risk of acquiring or maintaining infections.
OVERALL PROJECT ACCOMPLISHMENTS:
Discovery of genetic markers associated with failure of passive transfer (FPT) in new born
calves. FPT is a condition in which neonates do not acquire protective serum levels of maternal
antibodies from their mothers via colostrum. Calves with FPT are at significant risk for
morbidity and mortality from infectious disease. The neonatal receptor for the Fc portion of
immunoglobin, FcRn, is a heterodimer of MHC-1 alpha-chain homolog (encoded by the FCGRT
locus) and beta-2-microglobulin (encoded by the B2M locus). This receptor functions both in
uptake of IgG1 from the neonatal intestine as well as regulating the concentration of
immunoglobin in the colostrum. Nucleotide sequence diversity was identified in these gene loci
in U.S. beef cattle and evaluated for correlation with FPT in neonatal calves. Specific alleles of
both FCGRT and B2M genes were found to have significant correlation with low serum levels of
IgG (odds ratios of 3.8 and 10.6, respectively). One combination of alleles was found only in
calves that failed passive transfer. Moreover, the two markers together accounted for 50% of the
FPT cases in the study. Thus, these alleles represent potentially useful DNA markers for
managing genetic risk of FPT.
Identification of new prion gene variation in cattle, sheep, and deer and development of accurate
DNA tests for scrapie resistance. Prion gene (PRNP) variation has been well correlated with
susceptibility to TSEs in humans, sheep, and rodents. Similar correlations have not yet been
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reported in cattle or deer; however characterization of PRNP nucleotide diversity in those
species is incomplete. We hypothesized that there is unrecognized and important nucleotide
variation in the prion genes of cattle and deer that may influence TSE susceptibility. To test this,
the complete PRNP coding region and a portion of PRNP promoter were sequenced in diverse
groups of U.S. beef cattle, white-tailed and mule deer, and U.S. sheep. Sequence comparisons
identified a total of 54 new polymorphisms. This allowed us to design the most accurate and
efficient DNA tests for scrapie resistance in sheep.
Developed the first set of bovine single nucleotide polymorphism (SNP) markers for animal
identification, parentage, and traceback in cattle. To identify SNP markers that would be
appropriate for genetic testing in commercial populations, we designed and assembled two
panels of genomic DNA: one from 96 sires from 17 breeds that represent the breadth and
composition of cattle germ plasm used in the U.S. beef industry, and another from a panel of 192
purebred American Angus from seven herds in four Midwestern states. These two panels were
used to identify and test SNP markers for determining the genetic identity and kinship of an
animal. We identified a select set of 32 highly informative SNP markers distributed among 18
autosomes and both sex chromosomes. These DNA markers were used in confirming the
country of origin for the Holstein cow in Washington State that tested positive for BSE on
December 23, 2003. There are now more than 45 SNPs in this collection.
Development of essential tools and information for large-scale automated SNP discovery and
genotyping in beef cattle. Dissection of complex traits in cattle from commercial populations
will require the ability to genotype large numbers of animals and an abundant supply of validated
DNA markers specific for candidate genes. SNP markers are a potential resource for analyzing
complex traits because of their high frequency, low mutation rates, and amenability to automated
analysis. We reported more than 45 SNPs markers and 40 haplotype structures in 9 bovine
cytokine genes. Moreover, matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) was demonstrated as a leading technology for livestock SNP
genotyping.
Expression, genetic mapping, and haplotyping of bovine genes induced by Escherichia coli
O157H7. A potential method for reducing the impact of infectious disease in livestock is to
increase the host genetic resistance to infection. The first line of defense against enteric
infections are the epithelial mucosa and the immune mechanisms activated by contact with
bacterial envelopes. This contact initiates responses leading to local inflamation and the eventual
clearance of infection. We identified and mapped two bovine genes that were differentially
expressed in bovine epithelial cells during an inflammatory response to E. coli O157H7. These
genes, interleukin (IL) 8 and epithelial cell inflammatory protein (ECIP)-1, were both members
of the C-X-C chemokine family, a group of proteins that play a pivotal role in mobilizing
inflammatory cells in response to infectious challenges. The ECIP1 gene had not previously
been identified in any species and is thought to represent a novel chemokine induced by E. coli
O157:H7. In subsequent research, we defined the IL8 haplotype structure in U.S. beef cattle and
estimated the ancestral allele.
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IMPACT:
An important application of disease research and DNA marker technology is the identification of
individuals with the highest risk for infectious disease and traceback of diseased animals. Our
research has provided more than 300 single nucleotide polymorphisms (SNP) markers and assays
to distinguish between nucleotide sequence variants of candidate genes in popular breeds of U.S.
cattle, sheep, and deer. These DNA markers have been placed in the public domain and
transferred to more than 40 companies and institutions in more than 19 countries. The markers
have facilitated the identification of genotype/phenotype associations and ultimately allowed
prediction of an individual’s genetic predisposition for infection from its DNA sequence. All of
these markers are available for use without restriction.
During the Washington State BSE, a collection of these DNA markers were used to confirm the
Canadian origin of the BSE index case. This DNA testing result coincided with the recovery of
live cattle markets. During the market drop, losses due to BSE was estimated at $10 M per day.
FPT is a serious problem in beef and dairy cattle and has both environmental and genetic
influences. The two publications resulting from this research represent the first use of SNP
markers and genetic epidemiology in cattle health traits and provide a road map for future
execution of related studies.
TECHNOLOGY TRANSFER:
Bovine SNP markers and assay designs for determining identity and parentage have been
transferred to several commercial entities for general use in the cattle industry. This has been
accomplished through peer-reviewed scientific publications, deposition of information in
GenBank at NCBI, a Specific Cooperative Agreement (SCA), and a Cooperative Research and
Development Agreement (CRADA). At least two privately held companies have already placed
their version of these cattle DNA tests in the hands of their customers. At least one large
commercial ranch in Texas has already made use of these tests for animal ID and parentage. At
least four European and Asian countries have requested the publically available SNP markers
and assay design.
SNP markers and assay design for prions genes in U.S. sheep, cattle, and deer have also been
transferred to several commercial genotyping companies and diagnostic labs for general use. Our
sheep prion genoytping assays are being used commercially in the national scrapie eradication
program. The cattle and deer information will likely be used in the epidemiology of bovine
spongiform encephalopathy (BSE) and chronic wasting disease (CWD), respectively.
PUBLICATIONS:
Clawson, M. L., M. P. Heaton, C. G. Chitko-McKown, J. M. Fox, T. P. L. Smith, W. M.
Snelling, J. W. Keele, and W. W. Laegreid. 2004. Male-specific SRY and ZFY haplotypes in
U.S. beef cattle. Animal Genetics 35:246-249.
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Clawson, M. L., M. P. Heaton, C. G. Chitko-McKown, J. M. Fox, T. P. L. Smith, W. M.
Snelling, J. W. Keele, and W. W. Laegreid. 2004. Beta-2-microglobulin haplotypes in U.S. beef
cattle and association with failure of passive transfer in newborn calves. Mamm. Genome.
15:227-236.
Heaton MP, Leymaster KA, Freking BA, Hawk DA, Smith TPL, Keele JW, Snelling WM, Fox
JM, Chitko-McKown CG, Laegreid WW. 2003. Prion gene sequence variation within diverse
groups of U.S. sheep, beef cattle, and deer. Mamm. Genome 14:765-777.
Laegreid WW, Heaton MP, Keen JE, Grosse WM, Chitko-McKown CG, Smith TPL, Keele JW,
Bennett GL, Besser TE. 2002. Association of bovine neonatal Fc receptor alpha-chain gene
(FCGRT) haplotypes with serum IgG concentration in newborn calves. Mamm. Genome 13:1-7.
M. P. Heaton, G. P. Harhay, G. L. Bennett, R. T. Stone, W. M Grosse, E. Casas, J. W. Keele, T.
P.L. Smith, C. G. Chitko-McKown, W. W. Laegreid. 2002. Selection and use of SNP markers
for identification and paternity analysis in U.S. beef cattle. Mamm. Genome 13:272-281.
Page, B. T., E. Casas, M. P. Heaton, N. G. Cullen, D. L. Hyndman, C. A. Morris, A. M.
Crawford, T. L. Wheeler, M. Koohmaraie, J. W. Keele, and T. P. L. Smith. 2002. Evaluation of
single-necleotide polymorphisms in CAPN1 for association with meat tenderness in cattle. J.
Anim. Sci. 80:3077-3085.
Heaton, M.P., C.G. McKown, W.M. Grosse, J.E. Keen, and W.W. Laegreid. 2001. Interleukin-8
haplotype structure from nucleotide sequence variation in commercial populations of US cattle.
Mamm. Genome. 12:219-225.
Smith, T.P.L., W.M. Grosse, B.A. Freking, A.J. Roberts, R.T. Stone, E. Casas, J.E. Wray, J.
White, J. Cho, S.C. Fahrenkrug, G.A. Bennett, M. P. Heaton, W.W. Laegreid, G.A. Rohrer, C.G.
Chitko-McKown, G. Pertea, I. Holt, S. Karamycheva, F. Liang, J. Quackenbush, J.W. Keele.
2001. Sequence evaluation of four pooled-tissue normalized bovine cDNA libraries and
construction of a gene index for cattle. Genome Res. 11:626-630.
Heaton, M.P., W.M. Grosse, S.M. Kappes, J.W. Keele, C.G. Chitko-McKown, L.V. Cundiff, A.
Braun, D.P. Little and W.W. Laegreid. 2001. Estimation of DNA sequence diversity in bovine
cytokine genes. Mamm. Genome. 12:32-37.
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Fox, J., Heaton, M., Vacant
Clay Center, NE, U.S. Meat Animal Research Center, Animal Health
Research
Fox, J., Phone: (402) 762-4392, Fax: (402) 762-4375,
fox@email.marc.usda.gov

PROJECT OBJECTIVES:
Respiratory viral infections caused by arteriviruses and paramyxoviruses result in significant
economic losses in the livestock industry worldwide. For example, Porcine Reproductive and
Respiratory Syndrome Virus (PRRSV) infections within the U.S. account for up to 15-20% of
the economic losses yearly in the swine industry. Such economic losses from respiratory viral
infections result from direct mortality, reduced production efficiency, and treatment/prevention
costs to combat infection. In addition, many of the respiratory bacterial infections present in
livestock result from impairment of pulmonary defense mechanisms by respiratory viral
infections. Bacterial pneumonias can result in severe losses in production, be costly to treat, and,
in some cases, persist for long periods of time. Reducing the incidence of respiratory viral
infections will not only improve production efficiency normally lost to the viral diseases, but will
also significantly reduce the incidence of bacterial pneumonia and losses that result from these
infections. There is limited information known about the host cell response to infection by these
viral agents. Examining this response is necessary to gain a better understanding of the dynamics
of the virus-to-cell interactions. The development of better vaccines will be dependent upon a
more comprehensive understanding of the virus-to-host interactions and how they effect disease
expression.
OVERALL PROJECT ACCOMPLISHMENTS:
The development of the MARC-145 cells line is perhaps the single largest accomplishment of
this project. This cell line is currently utilized world-wide for the in vitro propagation of
PRRSV. In addition, significant progress has been made on analysis of PRRSV in populations
of swine. Recombinant antigens have been developed and immunity to individual PRRSV
proteins evaluated in sera from naturally infected swine from around the country. Furthermore,
these antigens have been used to investigate the differences in immune responses over time in
swine persistently infected with PRRSV. In combination with sequence analysis of a number of
PRRSV isolates, this work will result in an understanding of the host-virus interaction in the
field. Preliminary data from these studies has indicated which viral genes are responsible for
induction of a protective immune response to PRRSV and the relevant genes cloned into vectors
for use as vaccine candidates. In addition, we have demonstrated that antibody alone is
sufficient to protect against PRRSv infection in the pregnant sow model. Using molecular
genomic approaches we have examined the host cell response to infection. Over 100 genes have
been identified whose mRNA abundance is altered as a result of PRRSV infection. Interestingly,
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as important as those responsive genes identified, are a number of genes that are not responsive
to PRRSV infection but would be expected to respond. Within these genes are those belonging
to the Type I interferon response to infection. We have shown that PRRSV specifically
interferes with the Type I interferon response resulting in little to no change in Type I interferon
levels produced by infected cells. This may have broad implications on the delayed immune
response to PRRSV infection. Further understanding and characterization of this phenomenon
may lead to the design of vaccine delivery systems that will better trigger the innate immune
response.
IMPACT:
TECHNOLOGY TRANSFER:
PRRSV sequence data has been submitted to GenBank for public access. Cultures of MARC-145
cells were distributed to several investigators.
PUBLICATIONS:
Allende R., Laegreid W.W., Kutish G.F., Galeota J.A., Wills R.W., Osorio F.A. (2000) Porcine
reproductive and respiratory syndrome virus: description of persistence in individual pigs upon
experimental infection. J Virol 74: 10834-7.
Allende R., Kutish G.F., Laegreid W.W., Lu Z., Lewis T.L., Rock D.L., Friesen J., Galeota J.A.,
Doster A.R., Osorio FA. (2000) Mutations in the genome of porcine reproductive and respiratory
syndrome virus responsible for the attenuation phenotype. Arch Virol 145: 1149-61.
Osorio F.A., Galeota J.A., Nelson E., Brodersen B., Doster A., Wills R., Zuckermann F.,
Laegreid W.W. (2002) Passive transfer of virus-specific antibodies confers protection against
reproductive failure induced by a virulent strain of porcine reproductive and respiratory
syndrome virus and establishes sterilizing immunity. Virology 302: 9-20.
Miller, L. C., Laegreid, W. W., Bono, J. L., Chitko-McKown, C. G., and Fox, J. M. (2004)
Interferon Type I response in porcine reproductive and respiratory syndrome virus-infected
MARC-145 cells. Arch Virol (in press).
Miller, L. C. and Fox, J. M. (2004) Apoptosis and porcine reproductive and respiratory syndrome
virus. Vet. Immunol. and Immunopath. (in press).
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Vector Competence and Protection of U.S. Livestock and
Wildlife from Arthropod-Borne Diseases
5410-32000-010-00D
Schmidtmann, E., Drolet, B., Mecham, J., Wilson, W., Letchworth III, G.,
Mayer, R.
Laramie, WY, Arthropod-Borne Animal Diseases Research
Schmidtmann, E., Phone: (307) 766-3630, Fax: (307) 766-3500,
eschm@uwyo.edu

PROJECT OBJECTIVES:
Project 5410-3200-010-00D.
Certain blood-feeding insects efficiently transmit several indigenous and exotic disease-causing
viruses that adversely affect the economy of the U.S. livestock industry. The emergence of West
Nile virus (WNV) in the U.S. clearly demonstrates that exotic insect-transmitted pathogens can
be imported and become established. The intentional or un-intentional importation of mosquitotransmitted Rift Valley Fever Virus would cause far more catastrophic human and animal loses
than did WNV. Therefore, the overall goal of this project is to develop knowledge and tools to
protect US livestock from current and potential insect-transmitted pathogens.
Bluetongue, epizootic hemorrhagic disease, vesicular stomatitis, and West Nile viruses account
for acute and chronic production-related losses among U.S. livestock. Of greater economic
concern in the global economy of the 21st Century, these insect-transmitted diseases trigger nontariff trade barrier restrictions that limit export sales of U.S. livestock and their germplasm. The
key role that insects play as vectors of viral pathogens is a product of: 1) insect blood-feeding on
host animals as the primary mode of arbovirus transmission in nature; 2) insects as a source of
virus amplification and maintenance; and 3) the seasonal incidence and geographical distribution
of risk for host exposure.
Research conducted under this CRIS project will benefit U.S. agriculture by providing a better
understanding of: 1) the molecular mechanisms that regulate the competence of insects that
transmit pathogenic viruses, and 2) the environmental factors that determine vector population
distribution and abundance. This research opportunity is optimised by the availability of recent
molecular and computer-aided data processing and methods that provide insights and capabilities
that were previously unavailable. Information developed through this research will benefit U.S.
livestock commodities by strengthening the rural economy, providing a continued supply of
inexpensive, wholesome food products for the American consumer, as well as promoting the
profitability and international competitiveness of livestock products. Proposed research will
support the development of novel strategies for controlling the vector, or its vector competence,
as well as provide a basis for scientifically-based domestic and international trade regulations
that protect U.S. livestock from the continuous threat of indigenous, exotic, and emerging insectborne diseases.
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OVERALL PROJECT ACCOMPLISHMENTS:
On the basis of ABADRL field and laboratory research, the biting midge, Culicoides sonorensis,
has been implicated as the primary, proven vector of bluetongue viruses in the U. S.
Evidence developed by the ABADRL also established that the northeast U.S. is bluetongue-free
because it is outside the range of C. sonorensis. The population genetics of the C. variipennis
complex in North America was investigated, and resulted in a taxonomic revision (i.e. current
subspecies were elevated to three species). It was demonstrated that levels and types of
dissolved salts in larval habitats differ among aquatic habitats occupied by the three species of
the complex. This finding opens the way for large-scale mapping and prediction of C. sonorensis
using computer-based GIS methods. The demonstration of bluetongue-free regions of the U.S.
has resulted in a relaxation of export regulations, thus improving the competitiveness of U.S.
livestock and livestock germplasm in world markets. Research that utilizes the genetic markers
and cloned genes produced by the ABADRL will increase our understanding at the molecular
level of the vector competence of C. sonorensis for bluetongue and epizootic hemorrhagic
disease viruses. Reducing the impact of existing arthropod-borne pathogens and protecting U.S.
animal agriculture from new and emerging animal pathogens is dependent on this research.
Recent ABADRL research identified a non-hematophagous insect (grasshopper) as a potential
source of infection and maintenance reservoir of vesicular stomatitis virus. This study
demonstrated that VSV replicates in grasshoppers and can spread between grasshoppers and
cattle, which may lead to better understanding the epidemiology of sporadic outbreaks of VSV
among western livestock. Analysis of the distribution of the sand fly, Lutzomyia apache, in the
mid-Rio Grande River Valley, New Mexico, using geographic information system methods
indicates a potential role for this sand fly in the epidemiology of VS viruses in the southwestern
U.S.
IMPACT:
ABADRL research has established the northeast US as a bluetongue-free region, resulting in a
relaxation of export regulations, thus improving the competitiveness of U.S. livestock and
livestock germplasm in world markets.
The ABADRL has established an Insect Vector Genomics program that has increased
understanding of the genetic components that affect the ability of insects to be disease vectors
(vector capacity) and will help predict the risk of pathogen transmission.
ABADRL’s investigations of the role of the potential of VSV transmission by several insect
species have suggested new paradigms for the epidemiology of VSV.
TECHNOLOGY TRANSFER:
Technology transfer may be expected of the VSV-specific IHC assay in the future. If a VSV
outbreak occurs, the clinical similarity between VSV and foot and mouth disease will require
rapid virus specific assays that can differentiate the two viruses. In some cases, the incriminating
positive cell culture results will have already been fixed and stained, destroying the live sample.
The IHC assay can confirm CPE as VSV-specific after live samples have been destroyed, and
therefore will be a valuable tool. The assay is ready for use in VSV-infected cell cultures. The
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use of synthetic pyrethroid insecticides as repellents for application to livestock has been
transferred via verbal and written communication to horse owners, veterinarians and
entomologists concerned about protecting animals from West Nile virus. Control methods for
larval stages of C. sonorensis have been transferred to white-tailed deer farmers who have used
the recommendations to prevent annual deer die-offs from biting midge-transmitted viruses. The
results of the multi-state Bluetongue Surveillance Pilot study have been reported to participating
producers and veterinary associations; this information will be useful in the formulation of
regulations concerning export of U.S. cattle to bluetongue-free countries. Information concerning
the presence and seasonal abundance of Culex tarsalis, the primary vector of West Nile virus in
the western U.S., has been transferred to state and county level personnel concerned with public
health and mosquito control, as well as coal bed methane gas developers whose well drilling
activities produce impoundments that support mosquito larval development.
Cooperative Research Projects have been initiated with the Department of Molecular Biology,
University of Wyoming; and the Department of Microbiology, Immunology and Pathology,
Colorado State University.
ABSTRACTS:
Nunamaker, R.A., Lockwood, J.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson,
W.C., White, D.M. and Letchworth. G.J. Are grasshoppers a source for vesicular stomatitis virus?
The ESA Annual Meeting: An Entomological Odyssey of ESA San Diego, CA December, 2001.
Lockwood, J.A., Nunamaker, R.A., Stith, C. E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson,
W.C., White, D.M. and Letchworth. G.J. Grasshoppers as vectors and reservoirs of vesicular
stomatitis. The ESA Annual Meeting: An Entomological Odyssey of ESA, November, 2002.
Campbell, C.L., McNulty, M.J., Letchworth, G.J. and Wilson, W.C. Molecular Investigations of
virus/vector interactions. OIE Symposium on Bluetongue Virus. Taormina, Italy, 2003. Abs. #B37,
pg 77. October, 2004
Letchworth, G.J., Nunamaker, R.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson,
W.C. and White, D.M. Grasshoppers as vectors and reservoirs of vesicular stomatitis. Poster. Rocky
Mountain Virology Club Meeting, Pingree Park, CO, September, 2003.
Campbell, C.L., VanDyke, K.A., Mummey, D.L., McNulty, M.J., Letchworth, G.J. and Wilson,
W.C. Functional genomics of vector competence in the arbovirus vector, Culicoides. Keystone
Symposium, “Genetic Manipulations of Insects”, February, 2004, Taos, NM.
Campbell, C.L., Vandyke, K.A., Letchworth, G.J., Drolet, B.S. and Wilson, W.C. Culicoides gene
discovery project reveals putative pharmacological factors in midge saliva. Entomological Society of
America annual meeting, Salt Lake City, UT, November, 2004.
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PUBLICATIONS:
Campbell, C.L. and Wilson, W.C. 2002. Differentially expressed midgut transcripts in
Culicoides sonorensis (Diptera: Ceratopogonidae) following Orbivirus (Reoviridae) oral feeding.
Insect Mol. Biol. 11:595-604.
O'Toole, D., Perez de Leon, A.A., Hearne, C., McHolland, L., Yun, L. Tabachnick. W.J. 2003.
Papular dermatitis induced in guinea pigs by the biting midge Culicoides sonorensis (Diptera:
Ceratopogonidae). J.Vet. Diagn. Invest. 15:67-71.
Drolet, B.S., Campbell, C.L. and Mecham, J.O. 2003. Protect yourself and your sample: Processing
arbovirus infected biting midges for viral detection assays and differential expression studies. In, J.
Richmond (ed.), Anthology of Biosafety: Arthropod-Borne Diseases, Chapter 5, pp. 53-62.
Nunamaker, R.A., Lockwood, J.A., Stith, C.E., Campbell, C.L., Schell, S.P., Drolet, B.S., Wilson,
W.C., White, D.M. and Letchworth, G.J. 2003. Grasshoppers can serve as reservoirs and vectors of
vesicular stomatitis virus. J. Med. Ent. 40:957-963.
Campbell, C.L., Mummey, D.L., Schmidtmann, E.T. and Wilson. W.C. 2004. Cultureindependent analysis of midgut microbiota in the arbovirus vector Culicoides sonorensis
(Diptera: Ceratopogonidae). J. Med. Ent. 41:340-348.
Naugle, D.E., Walker, B.L., Aldridge, C.L., Cornish, T.E., Moynahan, B.J., Holloran, M.J.,
Brown, K., Johnson, G.D., Schmidtmann, E.T., Mayer, R.T., Kato, C.Y., Matchett, R.R.,
Christiansen, T.J., Cook, W.E., Creekmore, T., Boyce, M.S., Falise, R.D. and Rinkes. T.E.
2004. West Nile virus: Pending crisis for greater sage grouse. Ecol. Letters 7: 704-713.
Campbell, C.L., McNulty, M. J., Letchworth, G. J. and Wilson, W.C. 2004. Molecular
investigations of virus/vector interactions. IV International Conference on Bluetongue.
Taormina, Italy, (In Press).
Dargatz, D. Akin, G., Green, M., Herrero, M., Holland, S., Kane, A., Knowles, K., McElwain,
T., Moser, K., Ostlund, E., Parker, M., Schmidtmann, E., Seitzinger, A. Schuler, L., Stevens, G.,
Tesar, L., White, L., Williams, L., Wineland, N., and Walton, T.E. 2004. Bluetongue
surveillance methods in the United States. IV International Conference on Bluetongue,
Taormina, Italy, (in press).
Herrero, M.V., Yarnell, W. K. and Schmidtmann, E. T. 2004. Landscape associations of the
sand fly, Lutzomyia apache (Dipetera: Psychodidae) in the southwestern United States: a
Geographic Information System analysis. J. Vect. Ecol. (in press).
Mullens, B.A., Gerry, A.C., Lysyk, T.J. and Schmidtmann, E.T. 2004. Environmental effects on
vector competence and virogenesis of bluetongue virus in Culicoides: interpreting laboratory
data in a field context. IV International Conference on Bluetongue, Taormina, Italy, (in press).
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Molecular Biology and Pathogenesis of Arboviruses
5410-32000-011-00D
Mecham, J., Drolet, B., Wilson, W. Letchworth III, G., Schmidtmann, E.,
Mayer, R.
Laramie, WY, Arthropod-Borne Animal Diseases Research
Mecham, J., Phone: (307) 766-3620, Fax: (307) 766-3500,
jmecham@uwyo.edu

PROJECT OBJECTIVES:
Project 5410-32000-011-00D.
Arthropod-borne viruses (arboviruses) are important pathogens of livestock and have a
significant impact on the U.S. livestock industry. These viruses have a complex life cycle and
infect both vertebrate and invertebrate hosts. The proposed research will delineate viral and host
characteristics important in the infection cycle, epidemiology, and pathogenesis of these viruses.
This information will provide the basis for the development of more effective diagnostics and
novel control strategies. The Arthropod-Borne Animal Diseases Research Laboratory is
developing the tools necessary to diagnose, control and asses risk of insect-transmitted pathogens
of current concern to US livestock industry; however, the technology developed could be rapidly
adapted to respond to emerging disease concerns.
Specifically, the differences in replication of BTV and EHDV in vertebrate and invertebrate
hosts are not well understood. Research to determine the mechanisms of replication of these
viruses in these different hosts may reveal weaknesses that can be used to develop unique control
strategies or improved vaccines. BTV and EHDV undergo genetic mutation and reassortment to
give rise to new viral strains. Investigating the genetic relationships and evolution of these
orbiviruses will provide more information on the epidemiology of disease and assist with
development of improved diagnostics and control strategies. Such information will aid the
development of rapid, field deployable diagnostic tests for the detection of viral antibody, viral
particles, viral antigens, and viral nucleic acids. The pathogenesis of epizootic hemorrhagic
disease virus (EHDV) infection in cattle is not well understood. Research will determine if the
difference in EHDV virulence between cattle and deer is related to endothelial cell tropism and
the effect on the fetus of EHDV infection in pregnant cattle. Effective control of infections
caused by BTV and EHDV requires sensitive and specific diagnostics. Epizootics caused by
West Nile and vesicular stomatitis viruses have resulted in significant morbidity and mortality in
the equine and bovine industries. At present there is no vaccine for VSV and only a provisionally
licensed killed vaccine for WNV. The development and evaluation of vaccines for both these
viruses is proposed. Monitoring of West Nile Virus infected mosquitoes is necessary for
effective vector control. Current WNV surveillance measures are time consuming and costly due
to manual mosquito sorting and a two-step diagnostic procedure (RNA isolation and RT-PCR).
This laboratory is developing a diagnostic procedure, based on RNA capture that will eliminate
the above steps and can be coupled with mosquito species-specific markers. The dual
determination of mosquito species and presence or absence of WNV should expedite WNV
surveillance and also serve as a model system for other arboviruses.
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OVERALL PROJECT ACCOMPLISHMENTS:
Project 5410-32000-011-00D.
ABADRL research has laid the foundation for the development of diagnostic tests and control
strategies for arboviruses. Prior research yielded information on the molecular characteristics of
BTV, EHDV, WNV and VSV and a greater understanding of the evolutionary relationships of
members of these virus groups, viral characteristics associated with virulence and pathogenesis,
replication in both invertebrate vectors and vertebrate hosts, and the immune response of the
vertebrate host following viral infection. Genetic studies produced epidemiological information
relating to the evolution and movement of the BTV and EHDV serogroups. Genetic and protein
characterization of BTV and EHDV led to the identification and characterization of the BTV
protein (VP7) that is important in infection of the Culicoides vector and the development of both
gene-based and antibody-based diagnostic procedures with increased sensitivity and specificity.
The function of different viral proteins in neutralization, virulence and pathogenesis was
investigated and described. Genes from BTV, EHDV, VSV, and WNV were cloned into
expression vectors capable of infecting various cells. Methods were developed to increase the
expression of specific viral proteins. These vectors and the expressed proteins will be used in
DNA vaccine trials, as recombinant vaccines as a source of antigen for the development of
diagnostic assays, and as tools to analyze steps in viral replication in both vertebrate and
invertebrate hosts. A number of cell lines were developed and identified for studying BTV,
EHDV and VSV replication. Culicoides sonorensis cell lines from colony and field populations
were developed and characterized. Vector cell lines are essential tools in dissection of vectorvirus interactions. Cell lines were identified that do not support productive infection of BTV,
and are being used to elucidate the steps of virus replication in vertebrate cells. Genes from an
equine isolate of WNV have been cloned and are being used as standards for the development of
diagnostic reagents and for recombinant vaccines. The ABADRL participated in a collaborative
study with Colorado State University and the Centers for Disease Control in Fort Collins that
indicated there is little risk that horses infected with West Nile virus can transmit virus back to
mosquitoes.
The role of C. sonorensis as a vector of VSV has been examined in the laboratory using
procedures, such as immunohistochemistry, which show that VSV passes through both the
midgut and salivary barriers, and thus infected insects may be competent biologic vectors. The
presence of VSV in the eggs suggests that VSV may transfer vertically from females to their
offspring. Both RT-PCR and in situ hybridization assays were used to confirm VSV replication
in the virus fed insects.
The role of Culicoides saliva in arboviral infections is not known. ABADRL scientists initiated
experiments to determine whether Culicoides saliva had an effect on the ability of VSV to
establish an infection in horse skin cells. Viral infection increased with increasing amounts of
insect saliva, potentiating the infection.
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IMPACT:
ABADRL has developed several immunological or genetic based diagnostic tests or
modifications of these assays that are used worldwide. Some of these assays are available
commercially. These test are rapid, sensitive and have been used to set the diagnostic standards
for international trade requirements.
Information produced by the ABADRL on the pathogensis of arboviral diseases has been used in
risk assessment and in international trade negotiations.
ABADRL scientists are sought nationally and internationally for scientific advice on diagnosis,
control and monitoring of emerging and indigenous insect-transmitted pathogens.
TECHNOLOGY TRANSFER (Recent):
Antibodies, PCR reagents and diagnostic protocols have been provided to researchers and
diagnosticians in the U.S. and in several foreign countries.
A competitive enzyme-linked immunosorbent assay for detection of antibody to epizootic
hemorrhagic disease virus developed at the ABADRL has been transferred to the NVSL, Ames,
IA for further testing and validation.
Culicoides sonorensis cell lines were distributed to researchers in the U.S. for isolation and
characterization of arboviruses.
Cooperative agreements were established with the Wyoming Agriculture Department, the
Wyoming Game and Fish Department, the Wyoming Public Health Department were
established, the University of Wyoming School of Pharmacy, the University of Wyoming GIS
center, and with Dow Agrosciences.
Collaborations continued or were developed with the University of Wyoming, the University of
California, Davis, and with Louisiana State University.
Reviews of research at the ABADRL and modern detection methods for bluetongue, epizootic
hemorrhagic and vesicular stomatitis disease viruses was presented to National Cattlemen,
Wyoming Stockgrowers Association/Wyoming Woolgrowers Association Wyoming Wool
Growers representatives, National Quarantine Instititute, Qindao China, and the U.S. Armed
Forces Research Institute for Infectious Diseases. Most of this technology is available to
industry partners and new methods are currently being validated.
Research information was presented at meetings of the OIE Symposium for bluetongue virus,
U.S. Animal Health Association Meeting, American Society for Virology Meeting, Keystone
symposium, Colorado State University’s Infectious Diseases Colloquium and the Rocky
Mountain Virology Club Meeting.
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Drolet, B.S. Culicoides sonorensis as a potential biological vector for vesicular stomatitis virus.
American Society for Virology. Madison, Wisconsin. July, 2001.
Mecham, J.O. and Wilson, W.C. Application of baculovirus expressed antigens in enzymelinked immunosorbent assays for detection of antibody to bluetongue and epizootic hemorrhagic
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Keystone Symposium. February, 2004.
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bluetongue virus in vectors. OIE Symposium on Bluetongue Virus. Taormina, Italy, 2003. pg
40. October, 2004.
White, D.M. and Mecham, J.O. Possibility of bluetongue virus in bovine skin. OIE Symposium
on Bluetongue Virus. Taormina, Italy, 2003. Abs. #C9, pg 96. October, 2004.
Wilson, W.C., Stallknecht, D.E. and Mecham, J.O. Field-deployable real-time PCR detection
of bluetongue and epizootic hemorrhagic disease viral RNA. OIE Symposium on Bluetongue
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Mecham, J.O., White, D.M., Drolet, B.S. and Wilson, W.C. Persistence of Bluetongue Virus in the
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Johnson, D.J., Wilson, W.C., and Paul, P.S. 2000.Validation of a reverse transcriptase multiplex
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assay for the detection of antibody to epizootic hemorrhagic disease of deer virus. J. Vet. Diagn.
Invest. 12:142-145.
Wilson, W.C., Ma, H.-C., Venter, E.H., van Djik, A.A., Seal, B.S. and Mecham, J.O. 2000.
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Assoc. (In preparation).
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Arthropod-Borne Animal Diseases Research
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Development and Validation of Rapid Field Deployable Genetic Tests for
Vesicular Stomatitis Virus
5410-32000-012-00X
Wilson, W., Mayer, R., Letchworth III, G.
Laramie, Wyoming
Arthropod-Borne Animal Diseases Research
Wilson, W., Phone: (307) 766-3622, Fax: (307) 766-3500
wcwilson@uwyo.edu

PROJECT OBJECTIVES:
The objectives of this research project are to: 1) generate basic epidemiological information
about vesicular stomatitis virus (VSV) occurrence in endemic areas in southern Mexico and
Costa Rica for development and design of field validation study; 2) perform field validation of
VSV rapid diagnostic tests in well-documented infected and non-infected cattle herds in Mexico
and Costa Rica.
The approach will include the establishment of sentinel herds in selected areas of southern
Mexico and Costa Rica with various levels of documented clinical VS activity. Basic
information about previous history of clinical disease will be collected at the beginning of the
study in order to determine the historical occurrence of VSV at each farm. Rapid diagnostic tests
developed at Plum Island Animal Disease Center (PIADC) and Arthropod-borne Animal
Diseases Research Laboratory (ABADRL) will be evaluated in laboratory. The most promising
tests will then be validated in the field. Collaborative teams will carry out rapid diagnostic tests
in the field during periods of high VSV activity previously identified by this study. Viruses from
clinical cases as well as environmental or arthropod samples will be genetically characterized at
PIADC and ABADRL.
OVERALL PROJECT ACCOMPLISHMENTS:
This project was supported by one-time funding from Homeland Security and was initiated in
2003. Clinical samples were collect from endemic area in Mexico and Central America. Over
600 of these samples were processed for VI with immuno-histochemistry verification and rapid
real-time PCR. One group of samples was missed by the real-time PCR. Sequence analysis of
the virus from these samples was used to modify the real-time PCR. The final validation has
been delayed due to facilities failures at the ABADRL.
IMPACT:
The potential for introduction or emergence of indigenous insect transmitted diseases
necessitates rapid and accurate methods to detect and measure the severity of infection by
arborviruses. The ABADRL with Plum Island Animal Disease Center collaborators have
developed a rapid real-time nucleic acid amplification assay (RT-PCR) VSV. Laboratory
diagnostic validation of the VSV test was favourable and will differentiate VSV infection from
Foot and Mouth Disease Virus, however, field validation resulted is some false negative results.
The test has been modified based on these samples and the new test is currently being evaluated
and was utilized to investigate the outbreak of VSV in Texas, New Mexico and Colorado the
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summer of 2004.. This test will enhance certification of animals and germplasm for international
trade and the ability to monitor the extent of a disease outbreak. This technology could rapidly
be developed in case of an outbreak of an emerging arboviral pathogen, an intentional or unintentional introduction or random evolutionary change in an indigenous virus.
TECHNOLOGY TRANSFER:
Provided training on real-time PCR for detection of vesicular stomatitis virus
to Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica and Laboratorio
de Diagnóstico de Enfermedades Vesiculares, Panama City, Panama, May 2004.
PUBLICATIONS:
Rodriguez, L.L., Pauszek, S.J., Smoliga G. and Wilson, W.C. 2004. Phylogeny-Based
Multiplex Real-Time RT-PCR for Rapid Detection of Vesicular Stomatitis Viruses NJ and IN-1
from Diverse Geographical Regions. Proc. U.S. Anim. Health Assoc. (In preparation).
Letchworth, G.J., Jiménez, C., Herrero, M., Cornish, T.E., Wilson, W.C., Smoliga, G. S.,
Pauszek, J., Dornak, C., George, M., Rodriguez, L.L. 2004. Validation of a Real-Time RT-PCR
for Vesicular Stomatitis Virus. Proc. U.S. Anim. Health Assoc. (In preparation).
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Poisonous Plant Research
Logan, UT

Lynn James, Research Leader
USDA, ARS, NPA, POISONOUS PLANT RESEARCH LAB
1150 EAST 1400 NORTH
Logan UT 84341
(435) 752-2941
Poisonous Plant Research, Logan, UT
• Investigation of Lupine-Induced Crooked Calf Disease in the Northwest
• Poisoning of Livestock by Various Larkspur Species(Delphinium)
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Poisonous Plant Research Projects, Logan, UT
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Investigation of Lupine-Induced Crooked Calf Disease in the Northwest
5428-32000-011-01S
James, L., Pfister, J., Ralphs, M., Panter, K.
Logan, Utah
Poisonous Plant Research
James, L., Phone: (435) 752-2941, Fax: (435) 753-5681
lfjpprl@cc.usu.edu

PROJECT OBJECTIVES:
Lupines continue to cause significant losses to the livestock industry in the western U.S. from
induced 'crooked calf syndrome'. In the spring of 2003, large losses were reported in California,
Oregon, Idaho, Western Canada and Washington State. We have done extensive research over
the last 3 years in the Scabland region of eastern Washington where lupines are widespread and
cause large losses every year to cattle producers. The teratogenic lupine identified was L.
leucophyllus which contains relatively large concentrations of the teratogenic alkaloid anagyrine.
Lupine-induced 'crooked calf disease' is responsible for significant losses to cattle producers in
the western U.S. every year. In the last five years increasing incidences of the disease have been
reported. In 1997, a massive loss occurred in the scablands of Washington State. Three studies
have been initiated to answer significant questions. (1) what factors contribute to the increased
consumption of lupine plants resulting in large losses; (2) what animal factors contribute to the
increased incidence of 'crooked calf disease'; (3) which range areas are high risk for large losses.
A combination of cows native to the Scabland region and naive cows have been used in the
grazing studies.
OVERALL PROJECT ACCOMPLISHMENTS:
Lactating cows were fed Lupinus leucophyllus at Washington State University. Extraction and
analytical protocols were developed in our laboratory for analysis of lupine alkaloids in milk.
Significant levels of teratogenic alkaloids were detected in the blood and milk of cows fed L.
leucophyllus and absorption and elimination profiles were determined in blood and milk.
Analyses were completed from grazing trials in Washington State with fat and thin cows. There
was a significant correlation between body condition and when cattle started to graze lupines and
how long they grazed lupine plants. Eventually all animals ate substantial quantities of lupine,
but thin animals ate more lupine at times, thus we believe the risk of intoxication is particularly
high for thin cows compared to cattle with higher body condition scores. Data analyses were
completed and published from an earlier cooperative research project with the University of
Idaho at the Dubois Sheep Experiment Station that demonstrated that thin sheep more rapidly
absorbed toxic alkaloids than did fat sheep, and conversely thin sheep showed slower elimination
of alkaloids compared to fat animals. This strongly suggests that toxicokinetics of the teratogenic
alkaloids may be significantly altered based on animal body condition.
In grazing seasons 2001-2003 cows started eating lupine around the first of July after annual
cheatgrass had matured and dried out, and other forbs were grazed out or matured (Lupine
consumption ranged from 17 to 25% of diets). This period of consumption overlaped the critical
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period of gestation (40-70 day of pregnancy) if the traditional breeding season begins May 1.
Cattle should be removed from lupine areas during this period.
IMPACT:
TECHNOLOGY TRANSFER:
Information about alkaloid content, susceptible stages of gestation and relative risk of grazing in
specific pastures has been transferred to extension agents and ranchers through meetings, phone
conversations and written recommendations. Many management options are currently available
based on available knowledge about which alkaloids in the plant are a threat, susceptible stages
of gestation, effective herbicides and management techniques to reduce losses.
Management to reduce livestock losses from poisonous plants. Influence of drought on losses to
toxic plants. Presented at the Arizona Strip Workshop, March 26, 2003, Kanab Utah, and March
27, 2003, St. George, Utah. Sponsored by Arizona and Utah Extension Services. The information
presented at these workshop is available to ranchers and is being implemented in many grazing
programs.
List your most important publications in the popular press and presentations to organizations and
articles written about your work. (NOTE: This does not replace your peer-reviewed publications
listed in Question 9).
by Michael Ralphs, Kip Panter, Jim Pfister, Clive Gay and Ernie Motteram. 2003. Cattle
Consumption of lupine in the scablands of Eastern Washington, Presented at Society for Range
Management annual meeting, Feb 2, Casper WY.
Panter, K.E. 2003. Presented seminar on toxic and teratogenic plants at 'Plant Interactions and
the Effect of Global Warming on Alpine Biodiversity' workshop in Kazbegi, Republic of
Georgia, June 30-July 6.
Pfister, J.A. 2003. Presented two workshops at the Arizona Strip, March 26, 2003, Kanab Utah,
and March 27, St. George, Utah. Sponsored by Arizona and Utah Extension Services.
PUBLICATIONS:
Panter, K.E., James, L.F., Wang, S., Gardner, D.R., Waffield, W., Molyneux, R.J., Stegelmeier,
B.L. and Bunch, T.D. 2003. Use of Bovine Embryos Produced by In Vitro Fertilization
Techniques to Screen Poisonous Plant Toxins for Cytotoxicity, In: T. Acamovic, C.S. Stewart
and T.W. Pennycott, eds. CABI Publishing, Oxon, UT.
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Poisonous Plant Research, Logan, UT
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Poisoning of Livestock by Various Larkspur Species(Delphinium)
5428-32630-009-00D
James, L., Lee, S., Gardner, D., Pfister, J.,ralphs, M., Stegelmeier, B.
Panter, K., Vacant
Logan, UT, Poisonous Plant Research
James, L, Phone: (435) 752-2941, Fax: (435) 753-5681,
lfjpprl@cc.usu.edu

PROJECT OBJECTIVES:
Larkspur (Delphinium spp.) poisoning causes serious economic loss to livestock producers
grazing cattle on many western ranges. The objectives of the multidisciplinary research are: (1)
isolate and identify individual alkaloids from Delphinium species; test these alkaloids for
toxicity; confirm structure activity relationships for new alkaloids; (2) develop analytical and
diagnostic methods for larkspur alkaloids, including development of immunogenic alkaloid
protein conjugates and antibody based detection methods and potential vaccine development; (3)
investigate mechanisms of intoxication, including toxin metabolism and clearance, and
treatment of intoxicated animals; and (4) determine plant, animal, or environmental factors
influencing larkspur consumption and continue development of management strategies to reduce
losses for all classes of larkspur.
OVERALL PROJECT ACCOMPLISHMENTS:
Developed the Fourier transform infrared spectroscopic method of analysis of toxic and total
alkaloid levels in tall larkspur, thus allowing for rapid analysis of thousands of samples.
Elucidated the comparative toxicity of 24 alkaloids from larkspurs and structure activity
relationships. Understanding toxicity has important implications for developing rational
treatments to reduce losses.
Developed grazing strategies to reduce losses to tall larkspurs. Continued implementation of
early- and late-season grazing strategies has resulted in reduced cattle losses for ranchers grazing
on tall larkspur-infested pastures.
Determined that cattle eat tall larkspur in a cyclic "toxification-detoxification" pattern after
ingesting a daily threshold of 14-18 mg toxic alkaloid/kg b.w. This research helps to understand
patterns of consumption and how much larkspur is necessary to poison cattle.
Determined that when cattle eat larkspur, adverse postingestive consequences regulate
consumption, not plant flavor (i.e., taste and smell). Increases in the toxic alkaloid concentration
deter consumption by sheep, but have little impact on short-term consumption by cattle. This
research provides fundamental information about when and why cattle eat larkspurs.
Determined that mineral supplementation does not affect the amount of larkspur consumed by
grazing cattle, indicating that producers can save money by providing mineral supplements as
necessary for nutritional needs, rather than using minerals to alter larkspur consumption.
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Developed aversive conditioning as a potentially viable tool for ranchers. This practice could
potentially greatly reduce the risk of cattle losses for those livestock producers that implement
aversive conditioning.
Developed herbicidal control recommendations for tall larkspurs. Ranchers with dense
populations of larkspur can greatly reduce losses and enhance economic returns through the use
of herbicides.
Verified that sheep grazing before cattle can reduce larkspur availability and acceptability to
cattle grazing afterward.
Collaborative work with Colorado State University investigated the mechanism of action of
MLA, nudicauline, 12-deacetylnudicauline, barbanine, and deltaline. It was determined that the
alkaloids block nicotinic acetylcholine (nAch) receptors postsynaptically. The potency of
deltaline is much lower, indicating that deltaline does not bind as tightly as do the other alkaloids
at nAch receptors.
IMPACT:
TECHNOLOGY TRANSFER:
Toxic larkspur alkaloid analyses done on a number of plant samples for ranchers and extension
personnel. This is a useful tool for ranchers to help determine if they can begin grazing with low
risk, or continue to graze, a particular pasture or allotment.
The management concepts referred to as "primary toxic window" and "early season grazing"
have been developed and transmitted to numerous ranchers and USFS personnel. These
concepts are based on plant chemistry and cattle diet selection patterns, and are being used to
reduce losses on summer-grazed Forest Service allotments where tall larkspur is problematic.
PUBLICATIONS:
Gardner, D.R., Ralphs, M.H., Turner, D., Welsh, S. Taxonomic Implications of Diterpene
Alkaloids in Three Toxic Tall Larkspur Species (Delphinium SPP.). Biochemical Systematics
and Ecology. 2002.
Li, X., Gardner, D.R., Ralphs, M.H., Wang, R. Development of STS and CAPS Markers for
Identification Three Tall
Larkspurs (Delphinium SPP.). Genome. 2002.
Pfister, J.A., Ralphs, M.H. Gardner, D.R., Stegelmeier, B.L., Manners, G.D., Panter, K.E. and
Lee, S.T. 2002. Management of three toxic Delphinium species based on alkaloid
concentrations. Biochemical Systematics Ecology 30:129-138
Panter, K.E., Manners, G.D., James, L.F., Gardner, D.R., Ralphs, M.H., Pfister, J.A.,
Stegelmeier, B.L., Lee, S.T. Larkspur Poisoning: Toxicology and Alkaloid Structure Activity
Relationships. Biochemical Systematics and Ecology. 2002.
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Panter, K.E., James, L.F., Gardner, D.R., Ralphs, M.H., Pfister, J.A., Stegelmeier, B.L., Lee, S.T.
Reproductive Losses to Poisonous Plants: Influence of Management Strategies. Journal of Range
Management. 2002.
Pfister, J.A., Gardner, D.R., Stegelmeier, B.L., Knight, A.P., Waggoner, Jr., J.W. and Hall, J.O.
2002. Plains larkspur (Delphinium geyerii) grazing by cattle in Wyoming. Journal of Range
Management 55:350-359.
Li, X., Ralphs, M.H., Gardner, D.R., Wang, R.R.-C. 2002. Genetic variation within and among
22 accessions of three tall larkspur species (Delphinium spp.) based RAPD markers.
Biochemical Systematics Ecology, 30:91-102.
Welch, S.L. and M.H. Ralphs. 2002. Some tall larkspurs (Delphinium-Ranunculaceae), a
taxonomic review. Biochemical Systematics Ecology 30:103-112.
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Poultry Research
Mississippi State, MS

Scott Branton, Research Leader
(662) 320-7478
POULTRY RESEARCH UNIT
P. O. BOX 5367
Mississippi State MS 39762
PROJECTS
Poultry Research
• Diagnosis and Control of Mycoplasmosis in Poultry
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Poultry Research Projects
Project Title:
CRIS Number:
Scientists:
Location:
Contact:

Diagnosis and Control of Mycoplasmosis in Poultry
6406-32000-006-00D
Branton, S., Vacant, Vacant, Vacant
Mississippi State, MS, Poultry Research
Branton, S., Phone: (662) 320-7608, x. 7608, Fax: (662) 320-7589
slbranton@ars.usda.gov

PROJECT OBJECTIVES:
Mycoplasmas negatively impact both interstate movement and international export of poultry
and are a major factor in limiting production in both meat-type and layer-type chickens. This
research seeks to define the impact of the various poultry mycoplasmas, to develop test
procedures to identify infected flocks, and to develop new vaccines against the organism.
OVERALL PROJECT ACCOMPLISHMENTS:
Major accomplishments over the life of the project include: 1) the finding that Mycoplasma
gallisepticum isolation occurs more frequently (300% increase) and with greater ease from the
palatine fissure in the roof of the chicken¿s mouth as compared to traditional tracheal isolation,
impact - fewer swabs are required to isolate the organism and swabs are easier to obtain with less
stress to the chicken, 2) the finding that the chicken remains infected over its life and that neither
isolation nor disinfection of its environment will rid the chicken of the organism, impact - unless
you can depopulate an infected farm, you cannot get rid of the organism from the flock, 3) that
the cellular profile of the chicken's blood reflects an acute infection with mycoplasma; however,
the cellular blood profile of the chronically infected chicken is similar to control hens, despite the
fact that the organism can still be isolated from the chronically infected hen, impact - the
chicken's immune system is apparently "tricked" by the organism into believing there is no need
to continue mounting an immune response, 4) that the addition of the commonly used therapeutic
agent ammonium chloride in layer chickens hinders the bacteriological recovery of Mycoplasma
gallisepticum from chickens, impact - a diagnostician needs to know that a flock is being treated
with ammonium chloride when he is attempting to isolate the organism and therefore take a
greater number of swabs in order to assure the organism's isolation when the flock is actually
infected, and 5) that vaccination of chickens at 10 weeks of age with the F strain of Mycoplasma
gallisepticum does not reduce egg production over a 44-week laying cycle, impact - since 1979,
flock managers have used the F strain of Mycoplasma gallisepticum with the understanding that
the vaccine reduces egg production by approximately 7 eggs/hen over a 45-week laying cycle.
IMPACT:
The work addresses these objectives under our OSQR Project Plan: optimization of current MG
vaccination protocols for layer hens; the design and production of an efficacious recombinant
MG vaccine by molecular technologies for use in egg-type (layer hen) and potentially meat-type
(broiler and turkey) production systems; and to determine the mechanisms by which MG
vaccinations induce immunological change. New and improved regimens for use with currently
available vaccines will be the initial products of this research. Concurrently, a recombinant
vaccine(s) effective against MG will be developed. The molecular technologies used to develop
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the recombinant vaccine are also anticipated to provide information regarding the pathogenicity
of MG.
TECHNOLOGY TRANSFER:
A self-propelled poultry vaccinating machine was developed which delivers Mycoplasma
gallisepticum vaccines uniformly and consistently and was transferred to commercial table-egg
producers. The technology is undergoing field trials which should end in August 2003, at which
time, the technology will be delivered to the poultry industry in both refereed journal and popular
press article. There are no constraints to the adoption durability of this technology.
PUBLICATIONS:
Peebles, E.D., Parker, T.A., Branton, S.L., Willeford, K.O., Jones, M.S., Gerard, P.D., Pharr,
G.T., Maslin, W.R. Effects of an S6 Strain of Mycoplasma gallisepticum inoculation before
beginning of lay on the Leukocytic characteristics of commercial layers. Avian Diseases. 2004.
v. 48. p. 196-201.
Wan, X., Branton, S.L., Hanson, L.A., Pharr, G.T. Identification and initial characterization of a
putative Mycoplasma gallinarum leucine aminopeptidase gene. Current Microbiology. 2004. v.
48. p. 32-38.
Wan, X., Branton, S.L., Hughlett, M.B., Hanson, L.A., Pharr, G.T. Expression and subcellular
location of a leucine aminopeptidase of Mycoplasma gallinarum. International Journal of
Poultry Science. 2004. v. 3(1). p. 70-74.
Burnham, M.R., Peebles, E.D., Branton, S.L., Jones, M.S., Gerard, P.D. Effects of F-Strain
Mycoplasma gallisepticum inoculation at twelve weeks of age on the blood characteristics of
commercial egg laying hens. Poultry Science. 2003. v. 82. p. 1397-1402.
Burnham, M.R., Peebles, E.D., Branton, S.L., Walzem, R.L., Gerhard, P.D. Effects of F-Strain
Mycoplasma gallisepticum inoculation on serum very low density lipoprotein diameter and
fractionation of cholesterol among lipoproteins in commercial egg-laying hens. Poultry Science.
2003. v. 82. p. 1630-1636.
Branton, S.L., Bearson, S.M.D., Bearson, B.L., Maslin, W.R., Collier, S.D., Evans, J.D., Miles,
D.M., Pharr, G.T. Mycoplasma gallinarum infection in commercial layers and onset of fatty liver
hemorrhagic syndrome. Avian Diseases. 2003. v. 47. p. 458-462.
Burnham, M.R., Peebles, E.D., Branton, S.L., Maurice, D.V., Gerard, P.D. Effects of F-strain
Mycoplasma gallisepticum inoculation at twelve weeks of age on egg yolk composition in
commercial egg laying hens. Poultry Science. 2003. v. 82. p. 577-584.
Parker, T.A., Branton, S.L., Jones, M.S., Peebles, E.D., Gerard, P.D., Willeford, K.O., Burnham,
M.R., Maslin, W.R. Effects of an S6 strain of Mycoplasma gallisepticum challenge before
beginning of lay on various egg characteristics in commercial layers. Avian Diseases. 2002. v.
46. p. 593-597.
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Pharr, G.T., Branton, S.L., Hanson, L.A., Minion, F.C., Hughlett, M.B., Wan, X.
Characterization of the pMGA genes from the F-Strain (vaccine strain) of Mycoplasma
gallisepticum. International Journal of Poultry Science. 2002. v. 1(4). p. 63-73.
Peebles, E.D., Branton, S.L., Burnham, M.R., Gerard, P.D. 2003. Influences of supplemental
dietary poultry fat and F-Strain Mycoplasma gallisepticum infection on the early performance of
commercial egg laying hens. Poultry Science. 2003. v. 82. p. 596-602.
Branton, S.L., Bearson, S.M.D., Bearson, B., Lott, B.D., Maslin, W.R., Pharr, G.T., Collier,
S.D., Boykin, D.L. The effects of 6/85 live Mycoplasma gallisepticum vaccine 6/85 in
commercial layer hens over a 13-week laying cycle on egg production and selected egg quality
parameters and egg size distribution when challenged before beginning of lay. Avian Diseases.
2002. v. 6. p. 423-428.
Burnham, M.R., Branton, S.L., Peebles, E.D., Jones, M.S., Lott, B.D., Yeatman, J.B.,
Whitmarsh, S.K., Gerard, P.D. Digestive and reproductive organ characteristics in commercial
laying hens as affected by F-strain Mycoplasma gallisepticum. Poultry Science. 2001. v. 80.
(Suppl. 1) p. 136.
Burnham, M.R., Branton, S.L., Peebles, E.D., Walzem, R.C., Whitmarch, S.K., Gerard, P.D.
Effects of F-strain Mycoplasma gallisepticum on serum lipids and lipoprotein profiles in
commercial laying hens. Poultry Science. 2001. v. 80. (Suppl. 1) p. 15.
Burnham, M.R., Walzem, R.L., Peebles, E.D., Branton, S.L., Whitmarsh, S.K., Gerard, P.D.
Effects of fasting on serum lipids and lipoprotein profiles in commercial laying hens. Poultry
Science. 2001. v. 80. (Suppl. 1) p. 19.
Jones, M.S., Peebles, E.D., Branton, S.L., Willeford, K.O., Pharr, G.T., Montgomery, R.D.,
Parker, T.A., Whitmarsh, S.K., Maslin, W.R. Effects of an immunodulator and phasic challenges
of S6 strain Mycoplasma gallisepticum and escherichia coli on egg production and egg
characteristics of commercial laying hens during peak and post-peak lay. Poultry Science. 2001.
v. 80. (Suppl. 1) p. 16.
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Poultry Production and Products Safety
Research
Fayetteville, AR

Poultry Production and Products Safety Research, Fayetteville, AR
Ann M. Donoghue, Research Leader
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Evaluation of Ascites in Poultry
6226-32000-004-00D
Balog, J., Donoghue, A.
Fayetteville, AR, Poultry Production and Products Safety Research
Balog, J., Phone: (479) 575-6299, Fax: (479) 575-4202, jbalog@uark.edu

PROJECT OBJECTIVES:
Ascites is an often fatal metabolic disease thought to be caused by the birds' heart and lungs not
being able to support the rapid growth of modern commercial broilers. The disease is
characterized as congestive heart failure, with a build up of fluid in the abdominal cavity of the
bird. Ascites can be experimentally induced by rearing poultry in hypobaric (low pressure)
chambers that simulate high altitude by reducing available oxygen. ARS has the only large-scale
hypobaric chamber (holds up to 480 birds) in the world to study ascites. This model is being
used to evaluate the etiology of ascites and methods to reduce the natural occurrence of ascites in
the poultry industry. Our research has demonstrated a genetic basis for ascites. Our current
research effort is to identify the gene or gene products associated with the syndrome.
OVERALL PROJECT ACCOMPLISHMENTS:
Our past work on ascites syndrome in broilers is directly related to Animal Health National
Program, NP 103 by virtue of the disease aspect, and since it is generally accepted that ascites
syndrome has a large genetic component our work is also related to the Genetic Improvement
component of Food Animal Production National Program, NP 101. While the influence of
genetics in the etiology of the disease has been recognized for years, lines of broilers that can
serve as experimental models were not available. Our most significant accomplishment over the
life of this project is that we, along with our collaborator Dr. Nicholas B. Anthony of the
University of Arkansas, have developed two lines of birds that vary in their ascites response to
high altitude (low oxygen pressure) and have collected tissue samples from both lines of birds.
Genetic selection has resulted in divergent line responses, with the ascites-resistant line
exhibiting 26% ascites mortality, while the ascites-susceptible line exhibits 98.5% ascites
mortality. These lines of birds and their tissue samples will be used to determine if genetic
markers exist that could be used to improve breeder selection for ascites resistance.
Over the past several years, we have fine-tuned the hypobaric chamber experimental model for
inducing ascites.
Previous hypobaric
chambers were only able to accommodate
15 birds at a time. Our chamber can hold
480 birds to six weeks of age, thereby
greatly increasing the sensitivity of our
experiments. Additionally, results of recent
studies show that birds need not be
maintained at high altitude for the entire 6
weeks grow-out to produce a high incidence
of ascites mortality and that bird numbers
can be maximized and equipment failure can
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be compensated for by moving birds out of the chamber. Once the experimental model was
established, we investigated several ways to reduce ascites mortality in broilers. We have found
that dietary aspirin at fairly low levels can reduce ascites. Since dietary aspirin would be an
inexpensive and relatively easy method to use in commercial poultry operations, there is great
potential to impact broiler production. We have determined that correct timing of feed
restriction can reduce ascites mortality, without sacrificing final body weight. This finding was
particularly important because feed restriction is commonly used in the poultry industry, yet
frequently the timing is incorrect, which results in birds being delayed going to market.
Our recent investigations of the molecular basis of ascites syndrome have resulted in several
major accomplishments. We were awarded a grant from the U.S. Poultry and Egg Association
(#58-6226-2-0002) for our proposal titled 'Molecular Genetics of Ascites Syndrome (Pulmonary
Hypertension Syndrome) in Broilers' to conduct research to determine if mutations in the coding
region of the bone morphogenetic protein receptor 2 (BMPR2) were linked to ascites
susceptibility in broilers. Utilizing commercial broiler crosses and the ascites-susceptible and
ascites-resistant lines, we sequenced the BMPR2 messenger RNA (mRNAs) of ascitic and nonascitic birds and then compared these sequences with the published BMPR2 gene. No mutations
were found in the mRNA that altered the BMPR-II protein, but 13 single nucleotide
polymorphisms (SNPs) were detected, and we determined that BMPR-II protein levels are
increased in ascitic birds. Although it appears that ascites is not caused by the same mutation
that causes FPPH, regulation of BMPR2 expression is different in birds that develop ascites and
we now have 13 SNPs that can be useful in gene mapping.
IMPACT:
Utilizing the world’s largest capacity hypobaric chamber for poultry, we, along with our
collaborator Dr. Nicholas B. Anthony of the University of Arkansas, have developed two lines of
birds that vary in their ascites response to high altitude (low oxygen pressure) and have collected
tissue samples from both lines of birds. Genetic selection has resulted in divergent line
responses with the ascites-resistant line exhibiting 26% ascites mortality, while the ascitessusceptible line exhibits 98.5% ascites mortality. These lines of birds and their tissue samples
are being used to evaluate the molecular etiology of ascites and to determine if genetic markers
exist that could be used to improve breeder selection for ascites resistance. Continued molecular
work into the etiology of ascites syndrome led us to report that there are significant differences in
the levels of seven electron transport proteins in ascitic birds compared with non-ascitic birds.
We also identified 14 single nucleotide polymorphisms in the coding region of chicken bone
morphogenetic protein receptor II and mapped this gene to the chicken chromosome 7. We also
determined that mutations in the chicken bone morphogenetic protein receptor II gene of the
chicken are not responsible for ascites susceptibility.
TECHNOLOGY TRANSFERS:
The molecular genetic component of ascites syndrome is of great interest to the poultry industry,
particularly the primary poultry breeding companies, because of this a Cooperative Research and
Development Agreement (CRADA) was established with Cobb-Vantress, Inc. This CRADA
'Characterization of the Genetic Basis for Ascites Syndrome' supports an in-depth investigation
of the molecular aspects of ascites susceptibility by utilizing the ascites susceptible and resistant
lines of broilers. This CRADA allows for greater interaction between ARS scientists and Cobb-
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Vantress, Inc., a primary poultry breeding company, and has potential to benefit the poultry
industry as a whole.
PUBLICATIONS:
Balog, J. M., Anthony, N. B., Cooper, M. A., Kidd, B. D., Huff, G. R., Huff, W. E. and Rath, N.
C. Ascites syndrome and related pathologies in feed restricted broilers raised in a hypobaric
chamber. Poultry Sci.79:318-323. 2000.
Balog, J.M., Huff, G. R., Rath, N. C., and Huff, W. E. Effect of dietary aspirin on ascites in
broilers raised in a hypobaric chamber. Poultry Sci. 79:1101-1105. 2000.
Balog, J.M., Anthony, N. B., Kidd, B. D., Liu, X., Cooper, M. A., Huff, G. R., Huff, W. E.,
Wideman, R. F., and Rath, N. C. Genetic selection of broiler lines that differ in their ascites
susceptibility. 2. Response of the ascites lines to cold stress and bronchus occlusion. 13th World
Poultry Science Association European Symposium on Poultry Nutrition. Blankenberge,
Belgium. pp. 329-330. 2001. (Proceedings)
Anthony, N.B., Balog, J. M., Hughes, J. D., Stamps, L., Cooper, M. A., Kidd, B. D., Liu, X.,
Huff, G. R., Huff, W. E., and Rath, N. C. Genetic selection of broiler lines that differ in their
ascites susceptibility. 1. Selection under hypobaric conditions. 13th World Poultry Science
Association European Symposium on Poultry Nutrition. Blankenberge, Belgium. pp. 327-328.
2001. (Proceedings)
Cisar, C. R., Balog, J. M., Anthony, N. B., and Donoghue, A. M. Genetic selection of broiler
lines that differ in their ascites susceptibility 3. Progress on identification of differentially
expressed genes in ascitic and non-ascitic birds. 13th World Poultry Science Association
European Symposium on Poultry Nutrition, Blankenberge, Belgium. pp. 331-332. 2001.
(Proceedings)
Balog, J. M., Kidd, B. D., Huff, W. E., Huff, G. R., Rath, N. C., and Anthony, N. B. Effect of
cold stress on broilers selected for resistance or susceptibility to ascites syndrome. Poultry Sci.
81:1383-87. 2003.
Balog, J. M. Ascites syndrome (pulmonary hypertension) in broiler chickens: Are we seeing the
light at the end of the tunnel? Avian and Poultry Biology Reviews, 14(3):99–126. 2003.
Cisar, C. R., Balog, J. M., Anthony, N. B., and Donoghue, A. M. Sequence analysis of bone
morphogenetic protein receptor type II mRNA from ascitic and non-ascitic commercial broilers.
Poultry Sci. 82:1494-99. 2003.
Cisar, C. R., Balog, J. M., and Donoghue, A. M. The chicken bone morphogenetic protein
receptor type II (BMPR2) gene maps to chromosome 7. Animal Genetics 34:475-476. 2003.
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Decreasing Production Related Bone Diseases in Poultry
6226-32000-002-00D
Rath, N., Donoghue, A.
Fayetteville, AR, Poultry Production and Products Safety Research
Rath, N., Phone: (479) 575-6189, Fax: (479) 575-4202, nrath@uark.edu

PROJECT OBJECTIVES:
Leg problems are major metabolic skeletal problems in meat-type poultry often affecting fastgrowing chickens and turkeys. Tibial dyschondroplasia (TD) is a common growth plate problem
in which the proper development cartilage is impaired, preventing bone development at the
growing end of leg bones. Consequently the growth plate and bone become fragile, prone to
deformities and infections. The etiology of TD is unknown but it is a complex disease since it
can be related to a chondrocyte development, vascularization, cartilage modeling, cell survival,
and differentiation that are regulated by a number of nutritional, physiological, and
environmental factors. We are trying to understand the cellular and biochemical basis of TD so
that it can be controlled by appropriate dietary interventions. We are developing experimental
models of TD that can be used to understand the mechanisms of the disease and screen the
dietary supplements that can prevent the problem in growing poultry.
OVERALL PROJECT ACCOMPLISHMENTS:
Over the past several years we have studied poultry leg problem and their causes particularly
relating to tibial dyschondroplasia (TD). We have also done some work on the aspects of poultry
immunity, particularly on the role of certain blood proteins called 'acute phase protein' that
modify immunity and affect disease resistance. We have demonstrated that TD is caused by an
unusual cell death in the growth plate, which affects cartilage replacement by bone in healthy
animals. In investigating the causes of poultry skeletal problems, we also described a
phenomenon of subchondral infarct in turkeys that may lead to an initial infection of bone
leading to turkey osteomyelitis. Because bacteria tend to colonize dead tissues, dead cartilage in
TD-affected bones may facilitate infection, resulting in diseases, such as osteomyelitis. Our
research also showed that a commonly used pestiicide (thiram) known to increase the incidence
of TD does so by causing chondrocyte death. To understand the physiological sequences of TD,
we have currently developed a model with which we can induce TD in susceptible birds with
only two days of feeding with thiram, which we hope will lead to a better understanding of the
mechanisms of TD and design methods for its prevention. Prevention of unusual cell death in
the growth plate which appears to be a key factor in the mechanisms TD, may lead to the
reduction of the incidence of TD in the future. We also showed that bone strength is better
related to the content of bone collagen cross-links than to bone minerals, and that younger birds
have substantially lower content of collagen cross-links. This gives us the opportunity to
improve bone strength by manipulating collagen cross-link content of bone. We also developed
a novel staining procedure for avian heterophils, which facilitates their fluorescent localization in
tissues. A bioassay of avian interleukin-6 was developed in our lab. We identified ovotransferrin
as an avian acute phase protein. We developed an ELISA for its measurements in blood and
showed its immunomodulating properties. This research provides a tool for the diagnosis of
health problems and stress in poultry. It also provides opportunity to investigate the role of
ovotransferrin as an immunomodulating agent. We identified the presence of matrix
metalloproteinase (MMP) in bile as an exocrine product and hypothesized its possible function in
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digestive physiology. Currently, we have developed a new chicken macrophage cell line that can
be used to better understand the innate immune process in poultry.
IMPACT:
Comparing age dependent changes in different bone constituents to bone strength we found that
pyridinium crosslinks of collagen are better related to bone strength raising the possibility that
improving collagen crosslinks will improve bone strength. We showed that tibial
dyschondroplasia (TD), a metabolic cartilage defect is caused by a premature cell death in the
maturing zone cartilage which is a basis of this problem. We have developed an experimental
model of TD using a pesticide thiram, which induces the disease in young chickens following a
brief exposure to this agent. This model will enable to explore the cellular and molecular
mechanisms of TD and can be used to determine if certain nutrients can protect against the
disease. Leg problems cost poultry industry an economic loss in excess of $200 million dollars
annually in USA. By understanding the mechanism and the etiology of these problems it will be
possible not only prevent economic losses but also improve production efficiency and welfare.
We developed a bioassay method for avian interleukin-6, a novel fluorescent staining method for
avian heterophils, and a new chicken macrophage cell line HTC. We identified serum
ovotransferrin as a major avian acute phase protein that has immunomodulatory effects and can
be used as a diagnostic indicator of poultry health problems. These studies provide basic tools to
understand the basis of poultry health and disease resistance that will improve health and well
being.
TECHNOLOGY TRANSFERS:
Our research is made available to the public through publications in journals, news magazines,
presentations in meetings and conferences, and personal communications with other scientists
and poultry growers. We have provided the macrophage cell line HTC to researchers in
universities and government labs. We have trained students (both graduates and undergraduates)
from the Poultry Science, Animal Science, and Food Science Departments at the University of
Arkansas. We have provided our knowledge of bone disease, the analytical methods to
academicians and representatives of poultry industries.
PUBLICATIONS:
Rath, N. C., Bayyari, G. R., Balog, J. M. Huff, W. E. Physiological studies of turkey tibial
dyschondroplasia, Poult. Sci., 1994 73: 416-424.
Rath, N. C., Bayyari, G. R., Beasley, J. N., Huff, W. E. and Balog, J. M. Age related changes in
the incidence of tibial dyschondroplasia in turkeys. Poult. Sci., 73: 1254-1259, 1994.
Rath, N. C., Huff, W. E., Bayyari, G. R. and Balog, J. M. Identification of transforming growth
factor-$ and interleukin-6 in chicken ascites fluid. Avian Dis. 39: 382-389, 1995.
Rath, N. C., Huff, W. E., Balog, J. M., Bayyari, G. R. and Reddy, P. R. Matrix
metalloproteinase activity in avian tibial dyschondroplasia. Poult. Sci. 76: 501-505, 1997.
Rath, N. C., Huff, W. E., Balog, J. M. and Bayyari, G. R. Cell death in avian tibial
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dyschondroplasia. Avian Dis. 42: 72-79, 1998.
Rath, N. C., Huff, G. R., Balog, J. M. and Huff, W. E. Fluorescein isothiocyanate staining and
characterization of avian heterophils, Vet. Immunol. Immunopathol. 64: 83-95, 1998.
Rath, N. C., Huff, G. R., W. E., Huff, and Balog, J. M., Factors regulating bone
maturity and strength in poultry. Poultry Sci. 79:1024-1032, 2000.
Xie, H., Huff, G. R., Huff, W. E, Balog, J. M., Holt, P., and Rath, N. C. Identification of
ovotransferrin as an acute phase protein in chickens. Poultry Sci. 81:112-120. 2002.
Xie H, Newberry L., Clark F.D., Huff, W. E., Huff, G. R., Balog, J. M., Rath, N. C. Changes in
serum ovotransferrin levels in chickens with experimentally induced inflammation and diseases.
Avian Dis. 46:122-131. 2002.
Xie, H., Huff, G. R., Huff, W. E., Balog, J. M., Rath, N.C. Effects of ovotransferrin on chicken
macrophages and heterophil-granulocytes. Dev. Comp. Immunol. 26:805-815. 2002.
Rath, N. C., 2003. Tibial dyschondroplasia, a poultry leg problem. Feed Info.
www.feedinfo.com/asp/scientific/science_res.asp?id_sci=2120 10/7/2003.
Rath, N.C.,Parcells, M., Xie, H. and Santin, E. Characterization of a spontaneously transformed
chicken mononuclear cell line, Vet. Immunol. Immunopathol. 96:93-104. 2003.
Rath, N.C., Huff, W. E., Balog, J. M., and Huff, G. R. Comparative efficacy of different
dithiocarbamates to induce tibial dyschondroplasia in poultry. Poultry Sci. 83: 266-274. 2004.
Rath, N. C., Huff, W. E., Huff, G. R., and Balog, J. M. Mechanisms of thiram-induced tibial
dyschondroplasia in chickens. World’s Poultry Congress, 2004.
Rath, N.C., Balog, J.M., Huff, W.E., Huff, G.R. Chondrocyte maturation in thiram-induced tibial
dyschondroplasia in poultry. Proceedings of XIII Congress of the World Veterinary and Poultry
Association. 2003. p. 114.
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Index
Anaplasmosis
Avian Influenza (AI)
Avian Leukosis Virus (ALV)
Avian Pneumovirus (APV)
Bovine Viral Diarrhea Virus (BVDV)
Brucellosis
Chronic Wasting Disease (CWD)
Classical Swine Fever Virus (CSFV)
Coccidiosis
Foot-and-Mouth Disease Virus (FMDV)
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Immunological Reagents
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Listeria monocytogenes
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Mycobacterium paratuberculosis (Johne’s Disease)
Mycoplasma gallisepticum (MG)
Malignant Catarrhal Fever (MCF)
Marek’s Disease Virus (MDV)
Newcastle Disease
Milk Fever
Neosporosis
Pine Needle Abortion
Porcine Reproductive and Respiratory Syndrome (PRRS)
Poult Enteritis Mortality Syndrome (PEMS)
Pox viruses
Scrapie
Swine Influenza Virus (SIV)
Toxoplasmosis
Trichinellosis
Tuberculosis
Vesicular Stomatitis Virus (VSV)
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